{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 547182, "items": [{"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T11:47:42Z", "timestamp": 1574509662528}, "reference-count": 47, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2013, 3, 1]], "date-time": "2013-03-01T00:00:00Z", "timestamp": 1362096000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Contraception"], "published-print": {"date-parts": [[2013, 3]]}, "DOI": "10.1016/j.contraception.2012.08.036", "type": "journal-article", "created": {"date-parts": [[2012, 10, 10]], "date-time": "2012-10-10T16:34:39Z", "timestamp": 1349886879000}, "page": "288-295", "source": "Crossref", "is-referenced-by-count": 23, "title": ["7\u03b1-Methyl-19-nortestosterone (MENTR): the Population Council's contribution to research on male contraception and treatment of hypogonadism"], "prefix": "10.1016", "volume": "87", "author": [{"given": "Eberhard", "family": "Nieschlag", "sequence": "first", "affiliation": []}, {"given": "Narender", "family": "Kumar", "sequence": "additional", "affiliation": []}, {"given": "R\u00e9gine", "family": "Sitruk-Ware", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Contraception"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0010782412008025?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0010782412008025?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 7, 4]], "date-time": "2019-07-04T15:16:28Z", "timestamp": 1562253388000}, "score": 91.31955, "issued": {"date-parts": [[2013, 3]]}, "references-count": 47, "journal-issue": {"published-print": {"date-parts": [[2013, 3]]}, "issue": "3"}, "alternative-id": ["S0010782412008025"], "URL": "http://dx.doi.org/10.1016/j.contraception.2012.08.036", "ISSN": ["0010-7824"], "issn-type": [{"value": "0010-7824", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T23:26:54Z", "timestamp": 1574119614686}, "reference-count": 0, "publisher": "Wiley", "issue": "1", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 9374, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["International Journal of Gynecology & Obstetrics"], "published-print": {"date-parts": [[1990, 1]]}, "DOI": "10.1016/0020-7292(90)90195-q", "type": "journal-article", "created": {"date-parts": [[2004, 4, 18]], "date-time": "2004-04-18T16:05:17Z", "timestamp": 1082304317000}, "page": "88-89", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Combination of 19-nortestosterone-hexyloxyphenylpropionate (Anadur) and depot-metroxyprogesterone-acetate (Clinovir) for male contraception"], "prefix": "10.1002", "volume": "31", "author": [{"given": "UA", "family": "Knuth", "sequence": "first", "affiliation": []}, {"given": "C-H", "family": "Yeung", "sequence": "additional", "affiliation": []}, {"given": "E", "family": "Nieschlag", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2004, 4, 10]]}, "container-title": ["International Journal of Gynecology & Obstetrics"], "language": "en", "link": [{"URL": "http://api.elsevier.com/content/article/PII:002072929090195Q?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://api.elsevier.com/content/article/PII:002072929090195Q?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1016%2F0020-7292%2890%2990195-Q", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1016%2F0020-7292(90)90195-Q", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1016/0020-7292(90)90195-Q", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 4]], "date-time": "2018-08-04T04:08:27Z", "timestamp": 1533355707000}, "score": 42.724155, "issued": {"date-parts": [[1990, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1990, 1]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.1016/0020-7292(90)90195-q", "archive": ["Portico"], "ISSN": ["0020-7292"], "issn-type": [{"value": "0020-7292", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T06:49:12Z", "timestamp": 1574405352371}, "publisher-location": "Berlin, Heidelberg", "reference-count": 21, "publisher": "Springer Berlin Heidelberg", "isbn-type": [{"value": "9783540783541", "type": "print"}, {"value": "9783540783558", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2010]]}, "DOI": "10.1007/978-3-540-78355-8_27", "type": "book-chapter", "created": {"date-parts": [[2010, 1, 13]], "date-time": "2010-01-13T14:20:21Z", "timestamp": 1263392421000}, "page": "557-564", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Male Contribution to Contraception"], "prefix": "10.1007", "author": [{"given": "Eberhard", "family": "Nieschlag", "sequence": "first", "affiliation": []}], "member": "297", "reference": [{"key": "27_CR1_27", "author": "All Party Parliamentary Group on Population, Development and Reproductive Health", "year": "2007", "unstructured": "All Party Parliamentary Group on Population, Development and Reproductive Health (2007) Return of the population growth factor: Its impact upon the Millennium Development Goals. House of Commons, London", "volume-title": "Return of the population growth factor: Its impact upon the Millennium Development Goals"}, {"key": "27_CR2_27", "first-page": "3", "volume": "31", "author": "RA Anderson", "year": "1997", "unstructured": "Anderson RA, Baird DT (1997) Progress towards a male pill. IPPF Med Bull 31:3\u20134", "journal-title": "IPPF Med Bull"}, {"key": "27_CR3_27", "first-page": "304", "volume": "88", "author": "K April", "year": "1993", "unstructured": "April K, K\u00f6ster R, Schreiner W (1993) Wie effektiv sch\u00fctzen Kondome vor einer HIV-\u00dcbertragung? Med Klinik 88: 304\u2013311", "journal-title": "Med Klinik"}, {"key": "27_CR4_27", "doi-asserted-by": "publisher", "first-page": "3", "DOI": "10.1080/13625180601012311", "volume": "12", "author": "G Benagiano", "year": "2007", "unstructured": "Benagiano G, Bastianello C, Farris M (2007) Contraception: A social revolution. Europ Contracept Reprod Health Care 12:3\u201312", "journal-title": "Europ Contracept Reprod Health Care"}, {"key": "27_CR5_27", "doi-asserted-by": "publisher", "first-page": "727", "DOI": "10.1353/dem.2006.0030", "volume": "43", "author": "T Bengtson", "year": "2006", "unstructured": "Bengtson T, Dribe M (2006) Deliberate control in a natural fertility population: Southern Sweden, 1766\u20131864. Demography 43:727\u2013746", "journal-title": "Demography"}, {"key": "27_CR6_27", "author": "H Birg", "year": "2001", "unstructured": "Birg H (2001) Die demographische Zeitwende. 4. Auflage, C.H. Beck, M\u00fcnchen", "volume-title": "Die demographische Zeitwende"}, {"key": "27_CR7_27", "first-page": "128", "volume": "24", "author": "J Bonnar", "year": "1999", "unstructured": "Bonnar J, Flynn A, Freundl G, Kirkman R, Royston R, Snowden R (1999) Personal hormone monitoring for contraception. Br J Fam Plann 24:128\u2013134", "journal-title": "Br J Fam Plann"}, {"key": "27_CR8_27", "author": "M Connelly", "year": "2008", "unstructured": "Connelly M (2008) Fatal misconception: The struggle to control world population. Belknap Press of Harvard University Press, Cambridge, MA", "volume-title": "Fatal misconception: The struggle to control world population"}, {"key": "27_CR9_27", "doi-asserted-by": "publisher", "first-page": "341", "DOI": "10.1056/NEJM199408113310601", "volume": "331", "author": "I Vincenzi De", "year": "1994", "unstructured": "De Vincenzi I for the European Study Group on Heterosexual Transmission of HIV (1994) A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. N Engl J Med 331:341\u2013346", "journal-title": "N Engl J Med"}, {"key": "27_CR10_27", "unstructured": "Gallo MF, Grimes DA, Lopez LM, Schulz KF (2006) Non-latex versus latex male condoms for contraception. Cochrane Database Syst Rev CD 003550"}, {"key": "27_CR11_27", "doi-asserted-by": "publisher", "first-page": "549", "DOI": "10.1093/humrep/deh574", "volume": "20", "author": "K Heinemann", "year": "2005", "unstructured": "Heinemann K, Saad F, Wiesemes M, White S, Heinemann L (2005) Attitudes toward male fertility control: Results of a multinational survey on four continents. Hum Reprod 20:549\u2013556", "journal-title": "Hum Reprod"}, {"key": "27_CR12_27", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1055/s-2007-1023815", "volume": "51", "author": "UA Knuth", "year": "1991", "unstructured": "Knuth UA, M\u00fchlenstedt D (1991) Kinderwunschdauer, kontrazeptives Verhalten und Rate vorausgegangener Infertil-it\u00e4tsbehandlung. Geburtsh Frauenheilk 51:1\u20137", "journal-title": "Geburtsh Frauenheilk"}, {"key": "27_CR13_27", "doi-asserted-by": "publisher", "first-page": "1890", "DOI": "10.1210/jc.2009-0704", "volume": "94", "author": "E Nieschlag", "year": "2009", "unstructured": "Nieschlag E (2009) Male hormonal contraception: love's labour's lost? J Clin Endocrinol Metab 94: 1890\u20131892", "journal-title": "J Clin Endocrinol Metab"}, {"key": "27_CR14_27", "doi-asserted-by": "crossref", "first-page": "554", "DOI": "10.1016/S0140-6736(05)70774-1", "volume": "365", "author": "E Nieschlag", "year": "2005", "unstructured": "Nieschlag E, Henke A (2005) Hopes for male contraception. Lancet 365:554\u2013556", "journal-title": "Lancet"}, {"key": "27_CR15_27", "doi-asserted-by": "publisher", "first-page": "17", "DOI": "10.1016/S0010-7824(97)00069-3", "volume": "56", "author": "MJ Rosenberg", "year": "1997", "unstructured": "Rosenberg MJ, Waugh MS (1997) Latex condom breakage and slippage in a controlled clinical trial. Contraception 56:17\u201321", "journal-title": "Contraception"}, {"key": "27_CR16_27", "doi-asserted-by": "publisher", "first-page": "279", "DOI": "10.1016/0010-7824(92)90008-H", "volume": "46", "author": "M Steiner", "year": "1992", "unstructured": "Steiner M, Foldesy R, Cole D, Carter E (1992) Study to determine the correlation between condom breakage in human use and laboratory test results. Contraception 46: 279\u2013288", "journal-title": "Contraception"}, {"key": "27_CR17_27", "doi-asserted-by": "crossref", "first-page": "818", "DOI": "10.1016/j.fertnstert.2006.11.003", "volume": "87", "author": "JF Strauss", "year": "2007", "unstructured": "Strauss JF, Chaudhuri G (2007) The accelerated pace of pharma abandonment of research and development in family planning and fertility: Will reproductive health technology be frozen in time? Fertil Steril 87:818\u2013718", "journal-title": "Fertil Steril"}, {"key": "27_CR18_27", "author": "J Trussell", "first-page": "779", "year": "1998", "unstructured": "Trussell J (1998) Contraceptive efficacy. In: Hatcher RA, Trussell J, Stewart F (eds) Contraceptive technology. New York Ardent Media, New York, pp. 779\u2013844", "volume-title": "Contraceptive technology"}, {"key": "27_CR19_27", "first-page": "128", "volume": "4", "author": "K Vogelsong", "year": "2008", "unstructured": "Vogelsong K, Gabelnick HL, Nieschlag E (2008) Partnerships offer promise in developing systemic methods of male fertility regulation. Global Forum Update on Research for Health 4:128\u2013130", "journal-title": "Global Forum Update on Research for Health"}, {"key": "27_CR20_27", "doi-asserted-by": "publisher", "first-page": "1635", "DOI": "10.1016/0277-9536(93)90352-5", "volume": "36", "author": "SC Weller", "year": "1993", "unstructured": "Weller SC (1993) A meta-analysis of condom effectiveness in reducing sexually transmitted HIV. Soc Sci Med 36: 1635\u20131644", "journal-title": "Soc Sci Med"}, {"key": "27_CR21_27", "unstructured": "WHO (2004) The male latex condom: Specifications and guidelines for condom procurement. Geneva"}], "container-title": ["Andrology"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-3-540-78355-8_27", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 11]], "date-time": "2019-03-11T20:05:19Z", "timestamp": 1552334719000}, "score": 42.669533, "issued": {"date-parts": [[2010]]}, "ISBN": ["9783540783541", "9783540783558"], "references-count": 21, "URL": "http://dx.doi.org/10.1007/978-3-540-78355-8_27", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T15:45:21Z", "timestamp": 1574264721039}, "reference-count": 0, "publisher": "S. Karger AG", "issue": "6", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Horm Res"], "published-print": {"date-parts": [[1978]]}, "DOI": "10.1159/000178934", "type": "journal-article", "created": {"date-parts": [[2008, 11, 29]], "date-time": "2008-11-29T14:18:13Z", "timestamp": 1227968293000}, "page": "394-403", "source": "Crossref", "is-referenced-by-count": 3, "title": ["Hormone Diagnosis in Male Hypogonadism and Infertility"], "prefix": "10.1159", "volume": "9", "author": [{"given": "E.", "family": "Nieschlag", "sequence": "first", "affiliation": []}], "member": "127", "container-title": ["Hormone Research"], "language": "en", "link": [{"URL": "http://www.karger.com/Article/Pdf/178934", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 10, 27]], "date-time": "2017-10-27T10:56:43Z", "timestamp": 1509101803000}, "score": 40.261345, "issued": {"date-parts": [[1978]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1978]]}, "issue": "6"}, "URL": "http://dx.doi.org/10.1159/000178934", "ISSN": ["1423-0046", "0301-0163"], "issn-type": [{"value": "0301-0163", "type": "print"}, {"value": "1423-0046", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T09:16:41Z", "timestamp": 1574414201974}, "publisher-location": "Berlin, Heidelberg", "reference-count": 48, "publisher": "Springer Berlin Heidelberg", "isbn-type": [{"value": "9783642682254", "type": "print"}, {"value": "9783642682230", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1982]]}, "DOI": "10.1007/978-3-642-68223-0_8", "type": "book-chapter", "created": {"date-parts": [[2011, 11, 2]], "date-time": "2011-11-02T10:22:12Z", "timestamp": 1320229332000}, "page": "103-115", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Androgen Therapy in Hypogonadism and Infertility"], "prefix": "10.1007", "author": [{"given": "E.", "family": "Nieschlag", "sequence": "first", "affiliation": []}, {"given": "C. W.", "family": "Freischem", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "8_CR1", "doi-asserted-by": "publisher", "first-page": "1989", "DOI": "10.1172/JCI103978", "volume": "38", "author": "JV Carbone", "year": "1959", "unstructured": "Carbone JV, Grodsky GM, Hjelte V (1959) Effect of hepatic dysfunction on circulating levels of sulphobromopthalein and its metabolites. J Clin Invest 38:1989\u20131996", "journal-title": "J Clin Invest"}, {"key": "8_CR2", "doi-asserted-by": "crossref", "first-page": "64", "DOI": "10.1016/S0015-0282(16)43039-6", "volume": "29", "author": "CW Charny", "year": "1978", "unstructured": "Charny CW, Gordon JA (1978) Testosterone rebound therapy: a neglected modality. Fertil Steril 29:64\u201368", "journal-title": "Fertil Steril"}, {"key": "8_CR3", "doi-asserted-by": "crossref", "first-page": "789", "DOI": "10.1530/acta.0.0790789", "volume": "79", "author": "A Coert", "year": "1975", "unstructured": "Coert A, Geelen J, de Visser J, van der Vies J (1975) The pharmacology and metabolism of testosterone undecanoate (TU), a new orally active androgen. Acta Endocrinol 79:789\u2013800", "journal-title": "Acta Endocrinol"}, {"key": "8_CR4", "doi-asserted-by": "publisher", "first-page": "121", "DOI": "10.1159/000178904", "volume": "9", "author": "PR Daggett", "year": "1978", "unstructured": "Daggett PR, Wheeler MJ, Nabarro JDN (1978) Oral testosterone: a reappraisal. Horm Res 9:121\u2013129", "journal-title": "Horm Res"}, {"key": "8_CR5", "doi-asserted-by": "publisher", "first-page": "429", "DOI": "10.1111/j.1365-2605.1980.tb00131.x", "volume": "3", "author": "CH Danner", "year": "1980", "unstructured": "Danner Ch, Frick J (1980) Androgen substitution with testosterone-containing nasal drops. Int J Androl 3:429\u2013435", "journal-title": "Int J Androl"}, {"key": "8_CR6", "doi-asserted-by": "publisher", "first-page": "955", "DOI": "10.1210/jcem-48-6-955", "volume": "48", "author": "JM Davidson", "year": "1979", "unstructured": "Davidson JM, Camargo CA, Smith ER (1979) Effects of androgens on sexual behaviour in hypogonadal men. J Clin Endocrinol Metab 48:955\u2013958", "journal-title": "J Clin Endocrinol Metab"}, {"key": "8_CR7", "doi-asserted-by": "crossref", "first-page": "177", "DOI": "10.1530/acta.0.0910177", "volume": "91", "author": "WE Lange de", "year": "1979", "unstructured": "de Lange WE, Snoep MC, Doorenbos H (1979) The effect of short-term testosterone treatment in boys with delayed puberty. Acta Endocrinol 91:177\u2013183", "journal-title": "Acta Endocrinol"}, {"key": "8_CR8", "doi-asserted-by": "crossref", "first-page": "289", "DOI": "10.1001/archinte.1965.03870020129023", "volume": "116", "author": "AA Lorimer de", "year": "1965", "unstructured": "de Lorimer AA, Gordan GS, L\u00f6we RC, Carbone JV (1965) Methyltestosterone: related steroids and liver function. Arch Intern Med 116:289\u2013294", "journal-title": "Arch Intern Med"}, {"key": "8_CR9", "doi-asserted-by": "publisher", "first-page": "430", "DOI": "10.1016/S0140-6736(75)91494-4", "volume": "1", "author": "GC Farrell", "year": "1975", "unstructured": "Farrell GC, Uren RF, Perkins KW, Joshua DE, Baird PJ, Kronenburg H (1975) Androgen- induced hepatoma. Lancet 1:430\u2013432", "journal-title": "Lancet"}, {"key": "8_CR10", "first-page": "1", "volume": "3", "author": "F Franchi", "year": "1978", "unstructured": "Franchi F, Luisi M, Kicovic PM (1978) Long-term study of oral testosterone undecanote in hypogonadal males. Int J Androl 3:1\u20139", "journal-title": "Int J Androl"}, {"key": "8_CR11", "doi-asserted-by": "publisher", "first-page": "345", "DOI": "10.1007/BF00605634", "volume": "16", "author": "H Frey", "year": "1979", "unstructured": "Frey H, Aakvaag A, Saanum D, Falch J (1979) Bioavailability of oral testosterone in males. Eur J Clin Pharmacol 16:345\u2013349", "journal-title": "Eur J Clin Pharmacol"}, {"issue": "[Suppl]", "key": "8_CR12", "first-page": "35", "volume": "24", "author": "J Frick", "year": "1976", "unstructured": "Frick J, Bartsch G, Marberger H (1976) Steroidal compounds (injectable and implants) affecting spermatogenesis in men. J Reprod Fertil [Suppl] 24:35\u201347", "journal-title": "J Reprod Fertil"}, {"key": "8_CR13", "doi-asserted-by": "crossref", "first-page": "465", "DOI": "10.1016/S0015-0282(16)32108-2", "volume": "6", "author": "PL Getzoff", "year": "1955", "unstructured": "Getzoff PL (1955) Clinical evaluation of testicular biopsy and the rebound phenomenon. Fertil Steril 6:465\u2013474", "journal-title": "Fertil Steril"}, {"key": "8_CR14", "doi-asserted-by": "publisher", "first-page": "287", "DOI": "10.1111/j.1439-0272.1975.tb00942.x", "volume": "7", "author": "RD Gordon", "year": "1975", "unstructured": "Gordon RD, Thomas MJ, Poynting JM, Stocks AE (1975) Effect of mesterolone on plasma LH, FSH and testosterone. Andrologia 7:287\u2013296", "journal-title": "Andrologia"}, {"key": "8_CR15", "doi-asserted-by": "crossref", "first-page": "529", "DOI": "10.1530/acta.0.0280529", "volume": "28", "author": "C Hamburger", "year": "1958", "unstructured": "Hamburger C (1958) Testosterone treatment and 17-ketosteroid excretion. Acta Endocrinol 28:529\u2013536", "journal-title": "Acta Endocrinol"}, {"key": "8_CR16", "doi-asserted-by": "crossref", "first-page": "4", "DOI": "10.1001/archsurg.1951.01250040007003", "volume": "53", "author": "NJ Heckel", "year": "1951", "unstructured": "Heckel NJ (1951) Spermatogenic rebound in the human following the administration of testosterone propionate. AMA Arch Surg 53:4\u20138", "journal-title": "AMA Arch Surg"}, {"key": "8_CR17", "doi-asserted-by": "crossref", "first-page": "49", "DOI": "10.1016/S0015-0282(16)30784-1", "volume": "3", "author": "NJ Heckel", "year": "1952", "unstructured": "Heckel NJ, McDonald JH (1952) The rebound phenomenon of the spermatogenic activity of the human testis following the administration of testosterone propionate. Fertil Steril 3:49\u201361", "journal-title": "Fertil Steril"}, {"key": "8_CR18", "doi-asserted-by": "publisher", "first-page": "393", "DOI": "10.1016/S0083-6729(08)60815-8", "volume": "5", "author": "CG Heller", "year": "1947", "unstructured": "Heller CG, Maddock WO (1947) The clinical uses of testosterone in the male. Vitam Horm 5:393\u2013432", "journal-title": "Vitam Horm"}, {"key": "8_CR19", "first-page": "816", "volume": "10", "author": "CG Heller", "year": "1950", "unstructured": "Heller CG, Nelson WO, Hill IC, Henderson E, Maddock O, Jungck EC (1950 a) The effect of testosterone administration upon the human testis. J Clin Endocrinol 10:816", "journal-title": "J Clin Endocrinol"}, {"key": "8_CR20", "doi-asserted-by": "crossref", "first-page": "415", "DOI": "10.1016/S0015-0282(16)30302-8", "volume": "1", "author": "CG Heller", "year": "1950", "unstructured": "Heller CG, Nelson WO, Hill IB, Henderson E, Maddock WO, Jungck EC, Paulsen CA, Mortimore GE (1950b) Improvement in spermatogenesis following depression of the human testis with testosterone. Fertil Steril 1:415\u2013422", "journal-title": "Fertil Steril"}, {"key": "8_CR21", "doi-asserted-by": "publisher", "first-page": "27", "DOI": "10.1016/0378-4274(77)90017-0", "volume": "1", "author": "R Heywood", "year": "1977", "unstructured": "Heywood R, Hunter B, Green OP, Kennedy SJ (1977a) The toxicity of methyltestosterone in the rat. Toxicol Lett 1:27\u201331", "journal-title": "Toxicol Lett"}, {"key": "8_CR22", "doi-asserted-by": "crossref", "first-page": "357", "DOI": "10.1016/0300-483X(77)90053-1", "volume": "7", "author": "R Heywood", "year": "1977", "unstructured": "Heywood R, Chesterman H, Ball SA, Wadsworth PF (1977b) Toxicity of methyltestosterone in the beagle dog. Toxicol Lett 7:357\u2013365", "journal-title": "Toxicol Lett"}, {"key": "8_CR23", "doi-asserted-by": "publisher", "first-page": "875", "DOI": "10.1007/BF01483589", "volume": "54", "author": "HJ Horst", "year": "1976", "unstructured": "Horst HJ, H\u00f6ltje WJ, Dennis M, Coert A, Geelen J, Voigt KD (1976) Lymphatic absorption and metabolism of orally administered testosterone undecanoate in man. Klin Wochenschr 54:875\u2013879", "journal-title": "Klin Wochenschr"}, {"key": "8_CR24", "author": "SG Johnsen", "first-page": "123", "year": "1978", "unstructured": "Johnsen SG (1978) Long-term androgen therapy with oral testosterone. In: Patanelli DJ (ed) Hormonal control of male fertility. DHEW publication No (NIH) 78\u20131097, Bethesda, p 123\u2013143", "volume-title": "Hormonal control of male fertility"}, {"key": "8_CR25", "doi-asserted-by": "publisher", "first-page": "1473", "DOI": "10.1016/S0140-6736(74)90216-5", "volume": "2", "author": "SG Johnsen", "year": "1974", "unstructured": "Johnsen SG, Bennet EP, Jensen VG (1974) Therapeutic effectiveness of oral testosterone. Lancet 2:1473\u20131475", "journal-title": "Lancet"}, {"key": "8_CR26", "doi-asserted-by": "crossref", "first-page": "233", "DOI": "10.1002/cpt1976202233", "volume": "20", "author": "SG Johnsen", "year": "1976", "unstructured": "Johnsen SG, Kampmann JP, Bennet EP, J\u00f6rgensen F (1976) Enzyme induction by oral testosterone. Clin Pharmacol Ther 20:233\u2013237", "journal-title": "Clin Pharmacol Ther"}, {"key": "8_CR27", "doi-asserted-by": "publisher", "first-page": "38", "DOI": "10.1016/S0022-3476(73)80007-1", "volume": "82", "author": "JG Kaplan", "year": "1973", "unstructured": "Kaplan JG, Moshant T, Bernstein R, Parks JS, Bongiovanni AM (1973) Constitutional delay of growth and development: Effects of treatment with androgens. J Pediatr 82:38\u201343", "journal-title": "J Pediatr"}, {"key": "8_CR28", "author": "J Kato", "first-page": "603", "year": "1977", "unstructured": "Kato J (1977) Steroid hormone receptors in brain, hypothalamus, and hypophysis. In: Pasqualini JR (ed) Receptors and mechanism of action of steroid hormones, vol 8. Dekker, New York Basel, pp 603\u2013672", "volume-title": "Receptors and mechanism of action of steroid hormones"}, {"key": "8_CR29", "first-page": "228", "volume": "25", "author": "N Kies", "year": "1974", "unstructured": "Kies N (1974) Die klimakterische Symptomatologie aus klinisch-psychologischer Sicht. Med Welt 25:228\u2013235", "journal-title": "Med Welt"}, {"key": "8_CR30", "doi-asserted-by": "publisher", "first-page": "121", "DOI": "10.1111/j.1365-2605.1980.tb00101.x", "volume": "3", "author": "H Kloer", "year": "1980", "unstructured": "Kloer H, Hoogen H, Nieschlag E (1980) Trial of high-dose testosterone undecanote in treatment of male infertility. Int J Androl 3:121\u2013129", "journal-title": "Int J Androl"}, {"key": "8_CR31", "doi-asserted-by": "crossref", "first-page": "73", "DOI": "10.1530/acta.0.0540073", "volume": "54", "author": "HL Kr\u00fcskemper", "year": "1967", "unstructured": "Kr\u00fcskemper HL, Noell G (1967) Steroidstruktur und Lebertoxizit\u00e4t. Acta Endocrinol 54:73\u201380", "journal-title": "Acta Endocrinol"}, {"key": "8_CR32", "doi-asserted-by": "crossref", "first-page": "469", "DOI": "10.1016/S0015-0282(16)41119-2", "volume": "26", "author": "H Lamensdorf", "year": "1975", "unstructured": "Lamensdorf H, Compere D, Begley G (1975) Testosterone rebound therapy in the treatment of male infertility. Fertil Steril 26:469\u2013472", "journal-title": "Fertil Steril"}, {"key": "8_CR33", "author": "S Liao", "first-page": "159", "year": "1976", "unstructured": "Liao S (1976) Receptors in the mechanism of action of androgens. In: Pasqualini JR (ed) Receptors and mechanism of action of steroid hormones, vol 8. Dekker, New York Basel, pp 159\u2013214", "volume-title": "Receptors and mechanism of action of steroid hormones"}, {"key": "8_CR34", "doi-asserted-by": "publisher", "first-page": "396", "DOI": "10.1210/jcem-49-3-396", "volume": "49", "author": "SP Marynick", "year": "1979", "unstructured": "Marynick SP, Loriaux DL, Sherins RJ, Pita JC, Lipsett MB (1979) Evidence that testosterone can suppress pituitary gonadotrophin secretion independently of peripheral aromatization. J Clin Endocrinol Metab 49:396\u2013398", "journal-title": "J Clin Endocrinol Metab"}, {"key": "8_CR35", "doi-asserted-by": "crossref", "first-page": "990", "DOI": "10.1016/S0022-5347(17)66913-1", "volume": "75", "author": "JH McDonald", "year": "1956", "unstructured": "McDonald JH, Heckel NJ (1956) Further observations on the rebound phenomenon in the treatment of certain types of spermatogenic dysfunction. J Urol 75:990\u2013992", "journal-title": "J Urol"}, {"key": "8_CR36", "doi-asserted-by": "publisher", "first-page": "1123", "DOI": "10.1055/s-2008-1070466", "volume": "106", "author": "E Nieschlag", "year": "1981", "unstructured": "Nieschlag E (1981) Ist die Anwendung von Methyltestosteron obsolet? Dtsch Med Wochenschr 106:1123\u20131125", "journal-title": "Dtsch Med Wochenschr"}, {"key": "8_CR37", "doi-asserted-by": "crossref", "first-page": "366", "DOI": "10.1530/acta.0.0790366", "volume": "79", "author": "E Nieschlag", "year": "1975", "unstructured": "Nieschlag E, Mauss J, Coert A, Kicovic P (1975) Plasma androgen levels in men after oral administration of testosterone or testosterone undecanoate. Acta Endocrinol 79:366\u2013374", "journal-title": "Acta Endocrinol"}, {"key": "8_CR38", "doi-asserted-by": "publisher", "first-page": "138", "DOI": "10.1159/000178721", "volume": "7", "author": "E Nieschlag", "year": "1976", "unstructured": "Nieschlag E, C\u00fcppers HJ, Wiegelmann W, Wickings EJ (1976) Bioavailability and LH-sup- pressing effect of different testosterone preparations in normal and hypogonadal men. Horm Res 7:138\u2013145", "journal-title": "Horm Res"}, {"key": "8_CR39", "doi-asserted-by": "publisher", "first-page": "145", "DOI": "10.1111/j.1365-2362.1977.tb01588.x", "volume": "7", "author": "E Nieschlag", "year": "1977", "unstructured": "Nieschlag E, C\u00fcppers HJ, Wickings EJ (1977) Influence of sex, testicular development and liver function on the bioavailability of oral testosterone. Eur J Clin Invest 7:145\u2013147", "journal-title": "Eur J Clin Invest"}, {"key": "8_CR40", "doi-asserted-by": "publisher", "first-page": "607", "DOI": "10.1016/0010-7824(78)90045-8", "volume": "18", "author": "E Nieschlag", "year": "1978", "unstructured": "Nieschlag E, Hoogen H, B\u00f6lk M, Schuster H, Wickings EJ (1978) Clinical trial with testosterone undecanoate for male fertility control. Contraception 18:607\u2013614", "journal-title": "Contraception"}, {"key": "8_CR41", "author": "E Nieschlag", "first-page": "133", "year": "1979", "unstructured": "Nieschlag E, Benkert O, Comhaire F, Doerr P, Schmidt H, Serio M (1979) The male climacteric (workshop report). In: van Keep PA, Serr DM, Greenblatt RB (eds) Female and male climacteric. MTP Press, Lancaster, pp 133\u2013139", "volume-title": "Female and male climacteric", "DOI": "10.1007/978-94-011-9720-5_12", "doi-asserted-by": "crossref"}, {"key": "8_CR42", "author": "DJ Patanelli", "first-page": "78", "year": "1978", "unstructured": "Patanelli DJ (ed) (1978) Proceedings of hormonal control of male fertility. DHEW publication No (NIH) 78\u20131097, Bethesda", "volume-title": "Proceedings of hormonal control of male fertility"}, {"key": "8_CR43", "doi-asserted-by": "crossref", "first-page": "498", "DOI": "10.1016/S0015-0282(16)39077-X", "volume": "23", "author": "MJ Rowley", "year": "1972", "unstructured": "Rowley MJ, Heller CG (1972) The testosterone rebound phenomenon in the treatment of male infertility. Fertil Steril 23:498\u2013504", "journal-title": "Fertil Steril"}, {"key": "8_CR44", "doi-asserted-by": "crossref", "first-page": "201", "DOI": "10.1016/S0015-0282(16)44543-7", "volume": "33", "author": "M Schulte-Beerb\u00fchl", "year": "1980", "unstructured": "Schulte-Beerb\u00fchl M, Nieschlag E (1980) Comparison of testosterone, DHT, LH and FSH in serum after injection of testosterone enanthate or testosterone cypionate. Fertil Steril 33:201\u2013203", "journal-title": "Fertil Steril"}, {"key": "8_CR45", "doi-asserted-by": "publisher", "first-page": "124", "DOI": "10.1016/S0140-6736(59)90005-4", "volume": "1", "author": "AW Spence", "year": "1959", "unstructured": "Spence AW, Medvei VC (1959) Testosterone in defective spermatogenesis. Lancet 1:124\u2013127", "journal-title": "Lancet"}, {"key": "8_CR46", "doi-asserted-by": "publisher", "first-page": "325", "DOI": "10.1016/0002-9343(50)90065-9", "volume": "8", "author": "FC Werner", "year": "1950", "unstructured": "Werner FC, Hamger FM, Kritzler RA (1950) Jaundice during methyltestosterone therapy. Am J Med 8:325\u2013331", "journal-title": "Am J Med"}, {"key": "8_CR47", "doi-asserted-by": "publisher", "first-page": "261", "DOI": "10.1016/S0140-6736(77)90949-7", "volume": "2", "author": "DP Westaby", "year": "1977", "unstructured": "Westaby DP, Paradinas FK, Ogle SK, Randell JB, Hurray-Lyon IM (1977) Liver damage from long-term methyltestosterone. Lancet 2:261\u2013263", "journal-title": "Lancet"}, {"key": "8_CR48", "doi-asserted-by": "publisher", "first-page": "116", "DOI": "10.1016/S0022-3476(76)80742-1", "volume": "88", "author": "MA Zachmann", "year": "1976", "unstructured": "Zachmann MA, Murset G, Gnehm HE, Prader A (1976) Testosterone treatment of excessively tall boys. J Pediatr 88:116\u2013123", "journal-title": "J Pediatr"}], "container-title": ["Treatment of Male Infertility"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-3-642-68223-0_8", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 4]], "date-time": "2019-11-04T22:32:22Z", "timestamp": 1572906742000}, "score": 38.48204, "issued": {"date-parts": [[1982]]}, "ISBN": ["9783642682254", "9783642682230"], "references-count": 48, "URL": "http://dx.doi.org/10.1007/978-3-642-68223-0_8", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T18:45:02Z", "timestamp": 1574793902072}, "reference-count": 25, "publisher": "Elsevier BV", "issue": "6", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1989, 6, 1]], "date-time": "1989-06-01T00:00:00Z", "timestamp": 612662400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Fertility and Sterility"], "published-print": {"date-parts": [[1989, 6]]}, "DOI": "10.1016/s0015-0282(16)60735-5", "type": "journal-article", "created": {"date-parts": [[2016, 5, 6]], "date-time": "2016-05-06T20:18:12Z", "timestamp": 1462565892000}, "page": "1011-1018", "source": "Crossref", "is-referenced-by-count": 42, "title": ["Combination of 19-nortestosterone-hexyloxyphenylpropionate (Anadur)* and depot-medroxyprogesterone-acetate (Clinovir)\u2020 for male contraception"], "prefix": "10.1016", "volume": "51", "author": [{"given": "Ulrich A.", "family": "Knuth", "sequence": "first", "affiliation": []}, {"given": "Ching-Hei", "family": "Yeung", "sequence": "additional", "affiliation": []}, {"given": "Eberhard", "family": "Nieschlag", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Fertility and Sterility"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0015028216607355?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0015028216607355?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 9, 12]], "date-time": "2018-09-12T09:23:09Z", "timestamp": 1536744189000}, "score": 38.095333, "issued": {"date-parts": [[1989, 6]]}, "references-count": 25, "journal-issue": {"published-print": {"date-parts": [[1989, 6]]}, "issue": "6"}, "alternative-id": ["S0015028216607355"], "URL": "http://dx.doi.org/10.1016/s0015-0282(16)60735-5", "ISSN": ["0015-0282"], "issn-type": [{"value": "0015-0282", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T20:55:42Z", "timestamp": 1575233742240}, "publisher-location": "Berlin, Heidelberg", "reference-count": 105, "publisher": "Springer Berlin Heidelberg", "isbn-type": [{"value": "9783662044933", "type": "print"}, {"value": "9783662044919", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2001]]}, "DOI": "10.1007/978-3-662-04491-9_20", "type": "book-chapter", "created": {"date-parts": [[2013, 6, 11]], "date-time": "2013-06-11T00:19:27Z", "timestamp": 1370909967000}, "page": "399-418", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Male Contribution to Contraception"], "prefix": "10.1007", "author": [{"given": "E.", "family": "Nieschlag", "sequence": "first", "affiliation": []}, {"given": "H. M.", "family": "Behre", "sequence": "additional", "affiliation": []}, {"given": "U.", "family": "Engelmann", "sequence": "additional", "affiliation": []}, {"given": "U.", "family": "Schwarzer", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "20_CR1", "doi-asserted-by": "publisher", "first-page": "534", "DOI": "10.1210/jcem-56-3-534", "volume": "56", "author": "FB Akhtar", "year": "1983", "unstructured": "Akhtar FB, Marshall GR, Wickings EJ, Nieschlag E (1983a) Reversible induction of azoospermia in rhesus monkeys by constant infusion of a GnRH agonist using osmotic minipumps. J Clin Endocrinol Metab 56:534", "journal-title": "J Clin Endocrinol Metab"}, {"key": "20_CR2", "doi-asserted-by": "publisher", "first-page": "461", "DOI": "10.1111/j.1365-2605.1983.tb00560.x", "volume": "6", "author": "FB Akhtar", "year": "1983", "unstructured": "Akhtar FB, Marshall GR, Nieschlag E (1983b) Testosterone supplementation attenuates the antifertility effects of an LHRH agonist in male monkeys. Int J Androl 6:461", "journal-title": "Int J Androl"}, {"key": "20_CR3", "author": "Alan Guttmacher Institute", "year": "1999", "unstructured": "Alan Guttmacher Institute (1999) Sharing responsibility: women, society and abortion worldwide. New York", "volume-title": "Sharing responsibility: women, society and abortion worldwide"}, {"key": "20_CR4", "first-page": "579", "volume": "33", "author": "PM Alderman", "year": "1991", "unstructured": "Alderman PM (1991) Complications in a series of 1224 vasectomies. J Fam Pract 33:579\u2013584", "journal-title": "J Fam Pract"}, {"key": "20_CR5", "first-page": "407", "volume": "20", "author": "BD Anawalt", "year": "1999", "unstructured": "Anawalt BD, Bebb RA, Bremner WJ, Matsumoto AM (1999) A lower dosage levonorgestrel and testosterone combination effectively suppresses spermatogenesis and circulating gonadotropin levels with fewer metabolic effects than higher dosage combinations. J Androl 20:407\u2013414", "journal-title": "J Androl"}, {"key": "20_CR6", "first-page": "3", "volume": "31", "author": "RA Anderson", "year": "1997", "unstructured": "Anderson RA, Baird DT (1997) Progress towards a male pill. IPPF Med Bull 31:3\u20134", "journal-title": "IPPF Med Bull"}, {"key": "20_CR7", "first-page": "304", "volume": "88", "author": "K April", "year": "1993", "unstructured": "April K, K\u00f6ster R, Schreiner W (1993) Wie effektiv sch\u00fctzen Kondome vor einer HIV-\u00dcbertragung? Med Klinik 88:304\u2013311", "journal-title": "Med Klinik"}, {"key": "20_CR8", "doi-asserted-by": "publisher", "first-page": "427", "DOI": "10.1210/jc.77.2.427", "volume": "77", "author": "CJ Bagatell", "year": "1993", "unstructured": "Bagatell CJ, Matsumoto AM, Christensen RB, Rivier JE, Bremner WJ (1993) Comparison of a gonadotropin-releasing hormone antagonist plus testosterone (T) versus T alone as a potential male contraceptive regimen. J Clin Endocrinol Metab 77:427", "journal-title": "J Clin Endocrinol Metab"}, {"key": "20_CR9", "doi-asserted-by": "publisher", "first-page": "757", "DOI": "10.1210/jc.81.2.757", "volume": "81", "author": "RA Bebb", "year": "1996", "unstructured": "Bebb RA, Anawalt BD, Christensen RB, Paulsen CA, Bremner WJ, Matsumoto AM (1996) Combined administration of levornorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach. J Clin Endocrinol Metab 81:757\u2013762", "journal-title": "J Clin Endocrinol Metab"}, {"key": "20_CR10", "doi-asserted-by": "publisher", "first-page": "84", "DOI": "10.1210/jc.74.1.84", "volume": "74", "author": "HM Behre", "year": "1992", "unstructured": "Behre HM, Nashan D, Hubert W, Nieschlag E (1992) Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception. J Clin Endocrinol Metab 74:84", "journal-title": "J Clin Endocrinol Metab"}, {"key": "20_CR11", "doi-asserted-by": "publisher", "first-page": "241", "DOI": "10.1111/j.1365-2265.1994.tb02475.x", "volume": "40", "author": "HM Behre", "year": "1994", "unstructured": "Behre HM, B\u00f6ckers A, Schlingheider A, Nieschlag E (1994) Sustained suppression of serum LH, FSH and testosterone and increase of high-density lipoprotein cholesterol by daily injections of the GnRH antagonist cetrorelix over 8 days in normal men. Clin Endocrinol 40:241", "journal-title": "Clin Endocrinol"}, {"key": "20_CR12", "doi-asserted-by": "publisher", "first-page": "2394", "DOI": "10.1210/jc.80.8.2394", "volume": "80", "author": "HM Behre", "year": "1995", "unstructured": "Behre HM, Baus S, Kliesch S, Keck C, Simoni M, Nieschlag E (1995) Potential of testosterone buciclate for male contraception: endocrine differences between responders and non-responders. J Clin Endocrinol Metab 80:2394\u20132403", "journal-title": "J Clin Endocrinol Metab"}, {"key": "20_CR13", "doi-asserted-by": "crossref", "first-page": "505", "DOI": "10.1016/S0022-5347(17)38381-7", "volume": "145", "author": "AM Belker", "year": "1991", "unstructured": "Belker AM, Thomas AJ, Fuchs EF, Konnak JW, Sharlip ID (1991) Result of 1,469 microsurgical vasectomy reversals by the vasovasostomy study group. J Urol 145:505\u2013511", "journal-title": "J Urol"}, {"key": "20_CR14", "first-page": "128", "volume": "24", "author": "J Bonnar", "year": "1999", "unstructured": "Bonnar J, Flynn A, Freundl G, Kirkman R, Royston R, Snowden R (1999) Personal hormone monitoring for contraception. Br J Fam Plann 24:128\u2013134", "journal-title": "Br J Fam Plann"}, {"key": "20_CR15", "doi-asserted-by": "publisher", "first-page": "1244", "DOI": "10.1210/jc.84.4.1244", "volume": "84", "author": "D B\u00fcchter", "year": "1999", "unstructured": "B\u00fcchter D, von Eckardstein S, von Eckardstein A, Kamischke A, Simoni M, Behre HM, Nieschlag E (1999) Clinical trial of transdermal testosterone and oral levonorgestrel for male contraception. J Clin Endocrinol Metab 84:1244\u20131249", "journal-title": "J Clin Endocrinol Metab"}, {"key": "20_CR16", "doi-asserted-by": "publisher", "first-page": "141", "DOI": "10.1093/humupd/5.2.141", "volume": "5", "author": "TG Cooper", "year": "1999", "unstructured": "Cooper TG, Yeung CH (1999) Recent biochemical approaches to post-testicular, epididymal contraception. Hum Reprod Update 5:141\u2013152", "journal-title": "Hum Reprod Update"}, {"key": "20_CR17", "doi-asserted-by": "publisher", "first-page": "567", "DOI": "10.1016/0090-4295(83)90297-2", "volume": "22", "author": "LR Cos", "year": "1983", "unstructured": "Cos LR, Valvo JR, Davis RS, Cockett ATK (1983) Vasovasostomy: current state of the art. Urology 22:567\u2013575", "journal-title": "Urology"}, {"key": "20_CR18", "author": "F Deindl", "year": "1990", "unstructured": "Deindl F (1990) Die Refertilisationssituation in der Bundesrepublik Deutschland, der Republik \u00d6sterreich und der Schweiz \u2014 eine Dreil\u00e4nderumfrage. Inaugural-Dissertation, Ruhr-Universit\u00e4t Bochum", "volume-title": "Inaugural-Dissertation, Ruhr-Universit\u00e4t Bochum"}, {"key": "20_CR19", "doi-asserted-by": "publisher", "first-page": "276", "DOI": "10.1016/S0140-6736(84)90144-2", "volume": "1", "author": "D Delanoe", "year": "1984", "unstructured": "Delanoe D, Fougeyrollas B, Meyer L, Thonneau P (1984) Androgenisation of female partners of men on medroxyprogesterone acetate/percutaneous testosterone contraception. Lancet 1:276", "journal-title": "Lancet"}, {"key": "20_CR20", "doi-asserted-by": "crossref", "first-page": "556", "DOI": "10.1016/S0022-5347(17)60279-9", "volume": "110", "author": "FC Derrick", "year": "1973", "unstructured": "Derrick FC, Yarbbrough W, Agostino JD (1973) Vasovasostomy: results of questionnaire of members of the American Urological Association. J Urol 110:556\u2013557", "journal-title": "J Urol"}, {"key": "20_CR21", "doi-asserted-by": "publisher", "first-page": "11", "DOI": "10.1038/370011a0", "volume": "370", "author": "C Djerassi", "year": "1994", "unstructured": "Djerassi C, Leibo SP (1994) A new look at male contraception. Nature 370:11\u201312", "journal-title": "Nature"}, {"key": "20_CR22", "doi-asserted-by": "publisher", "first-page": "341", "DOI": "10.1056/NEJM199408113310601", "volume": "331", "author": "De Vincenzi I for the European Study Group on Heterosexual Transmission of HIV", "year": "1994", "unstructured": "De Vincenzi I for the European Study Group on Heterosexual Transmission of HIV (1994) A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. N Engl J Med 331:341\u2013346", "journal-title": "N Engl J Med"}, {"key": "20_CR23", "doi-asserted-by": "publisher", "first-page": "475", "DOI": "10.1046/j.1464-410x.1999.00206.x", "volume": "84", "author": "MJ Drake", "year": "1999", "unstructured": "Drake MJ, Mills IW, Cranston D (1999) On the chequered history of vasectomy. Br J Urol Int 84:475\u2013481", "journal-title": "Br J Urol Int"}, {"key": "20_CR24", "doi-asserted-by": "crossref", "first-page": "64", "DOI": "10.1016/S0022-5347(17)39867-1", "volume": "143", "author": "UH Engelmann", "year": "1990", "unstructured": "Engelmann UH, Schramek P, Tomamichel G, Deindl F, Senge TH (1990) Vasectomy reversal in central Europe: results of a questionnaire of urologists in Austria, Germany and Switzerland. J Urol 143:64\u201367", "journal-title": "J Urol"}, {"key": "20_CR25", "first-page": "413", "volume": "71", "author": "TMM Farley", "year": "1993", "unstructured": "Farley TMM; Meirik O, Mehta S, Waites GMH (1993) The safety of vasectomy: recent concerns. Bull WHO 71:413\u2013419", "journal-title": "Bull WHO"}, {"key": "20_CR26", "first-page": "1", "volume": "2", "author": "NR Farnsworth", "year": "1982", "unstructured": "Farnsworth NR, Waller DP (1982) Current status of plant products reported to inhibit sperm. Res Front Fertil Regul 2:1\u201316", "journal-title": "Res Front Fertil Regul"}, {"key": "20_CR27", "first-page": "8", "volume": "5", "author": "KM Feber", "year": "1999", "unstructured": "Feber KM, Ruiz HE (1999) Vasovasostomy: macroscopic approach and retrospective review. Techniques Urol 5:8\u201311", "journal-title": "Techniques Urol"}, {"key": "20_CR28", "doi-asserted-by": "publisher", "first-page": "100", "DOI": "10.2307/2136106", "volume": "27", "author": "R Forste", "year": "1995", "unstructured": "Forste R, Tanfer K, Tedrow L (1995) Sterilization among currently married men in the United States, 1991. Fam Plann Perspect 27:100\u2013107, 122", "journal-title": "Fam Plann Perspect"}, {"key": "20_CR29", "doi-asserted-by": "publisher", "first-page": "81", "DOI": "10.2307/2991645", "volume": "31", "author": "RG Frezieres", "year": "1999", "unstructured": "Frezieres RG, Walsh TL, Nelson AL, Clark VA, Coulson AH (1999) Evaluation of the efficacy of a polyurethane condom: results from a randomized, controlled clinical trial. Fam Plann Perspect 31:81\u201387", "journal-title": "Fam Plann Perspect"}, {"key": "20_CR30", "doi-asserted-by": "publisher", "first-page": "1392", "DOI": "10.1056/NEJM199205213262104", "volume": "326", "author": "E Giovanucci", "year": "1992", "unstructured": "Giovanucci E, Tosteson TD, Speizer FE, Vessey MP, Colditz GA (1992) A long-term study of mortality in men who have undergone vasectomy. N Engl J Med 326:1392\u20131398", "journal-title": "N Engl J Med"}, {"key": "20_CR31", "doi-asserted-by": "publisher", "first-page": "873", "DOI": "10.1001/jama.1993.03500070053028", "volume": "269", "author": "E Giovanucci", "year": "1993", "unstructured": "Giovanucci E, Ascherio A, Rimm EB, Colditz GA, Stampfer MJ, Willett WC (1993) A prospective cohort study of vasectomy and prostate cancer in US men. JAMA 269:873\u2013877", "journal-title": "JAMA"}, {"key": "20_CR32", "doi-asserted-by": "publisher", "first-page": "38", "DOI": "10.1111/j.1365-2605.1986.tb00866.x", "volume": "9", "author": "A Giwercman", "year": "1986", "unstructured": "Giwercman A, Skakkebaek NE (1986) The effect of salicylazosulphapyridine (sulphasalazine) on male fertility. A review. Int J Androl 9:38", "journal-title": "Int J Androl"}, {"key": "20_CR33", "first-page": "119", "volume": "33", "author": "P Goebel", "year": "1987", "unstructured": "Goebel P, Ortmann K, Blattner TH (1987) Vasektomie und Beziehungssituation \u2014 eine empirische Untersuchung an 156 M\u00e4nnern (Paaren). Zschr Psychosom Med 33:119\u2013138", "journal-title": "Zschr Psychosom Med"}, {"key": "20_CR34", "doi-asserted-by": "publisher", "first-page": "188", "DOI": "10.1016/S0022-5347(01)64053-9", "volume": "159", "author": "M Goldstein", "year": "1998", "unstructured": "Goldstein M, Shihua PhL, Matthews GJ (1998) Microsurgical Vasovasostomy: The microdot technique of precision suture placement. J Urol 159:188\u2013190", "journal-title": "J Urol"}, {"key": "20_CR35", "doi-asserted-by": "publisher", "first-page": "1326", "DOI": "10.1210/jc.75.5.1326", "volume": "175", "author": "DJ Handelsman", "year": "1992", "unstructured": "Handelsman DJ, Conway AJ, Boylan LM (1992) Suppression of human spermatogenesis by testosterone implants. J Clin Endocrinol Metab 175:1326", "journal-title": "J Clin Endocrinol Metab"}, {"key": "20_CR36", "doi-asserted-by": "publisher", "first-page": "69", "DOI": "10.1111/j.1600-0897.1994.tb00849.x", "volume": "31", "author": "A Heidenreich", "year": "1994", "unstructured": "Heidenreich A, Bonfig R, Wilbert DM, Strohmaier WL, Engelmann UH (1994) Risk factors for antisperm antibodies in infertile men. Am J Reprod Immunol 31:69\u201376", "journal-title": "Am J Reprod Immunol"}, {"key": "20_CR37", "first-page": "452", "volume": "28", "author": "HD Hiersche", "year": "1995", "unstructured": "Hiersche HD, Hiersche F (1995) Die Sterilisation geistig Behinderter. Gyn\u00e4kologe 28:452\u2013458", "journal-title": "Gyn\u00e4kologe"}, {"key": "20_CR38", "first-page": "25", "volume": "111", "author": "L Isnardi", "year": "1896", "unstructured": "Isnardi L (1896) Die Behandlung der senilen Dysurie mit Durchschneidung und doppelseitiger Ligatur der vasa deferentia. Ther Wochenschr 111:25\u201336", "journal-title": "Ther Wochenschr"}, {"key": "20_CR39", "doi-asserted-by": "publisher", "first-page": "1757", "DOI": "10.1093/humrep/13.7.1757", "volume": "13", "author": "AM Jequier", "year": "1998", "unstructured": "Jequier AM, Pryor JP (1998) Is vasectomy of long term benefits? Hum Reprod 13:1757\u20131760", "journal-title": "Hum Reprod"}, {"key": "20_CR40", "doi-asserted-by": "publisher", "first-page": "662", "DOI": "10.1093/jnci/87.9.662", "volume": "87", "author": "EM John", "year": "1995", "unstructured": "John EM, Whittemore AS, Wu AH, Kolonel LN, Hislop TG, Howe GR, West DW, Hankin J, Dreon DM, Teh CZ (1995) Vasectomy and prostate cancer: results from a multiethnic casecontrol study. J Natl Cancer Inst 87:662\u2013669", "journal-title": "J Natl Cancer Inst"}, {"key": "20_CR41", "doi-asserted-by": "publisher", "first-page": "43", "DOI": "10.1046/j.1365-2265.2000.01024.x", "volume": "53", "author": "A Kamischke", "year": "2000", "unstructured": "Kamischke A, Nieschlag E (2000) Intramuscular testosterone undecanoate with or without oral levonorgestrel: a randomized placebo controlled clinical trial for male contraception. Clin Endocrinol 53:43\u201352", "journal-title": "Clin Endocrinol"}, {"key": "20_CR42", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1055/s-2007-1023815", "volume": "51", "author": "UA Knuth", "year": "1991", "unstructured": "Knuth UA, M\u00fchlenstedt D (1991) Kinderwunschdauer, kontrazeptives Verhalten und Rate vorausgegangener Infertilit\u00e4tsbehandlung. Geburtsh Frauenheilkd 51:1\u20137", "journal-title": "Geburtsh Frauenheilkd"}, {"key": "20_CR43", "doi-asserted-by": "crossref", "first-page": "814", "DOI": "10.1016/S0015-0282(16)49043-6", "volume": "44", "author": "UA Knuth", "year": "1985", "unstructured": "Knuth UA, Behre HM, Beikien L, Bents H, Nieschlag E (1985) Clinical trial of 19-nortestosterone-hexyloxyphenylpropionate (Anadur) for male fertility regulation. Fertil Steril 44:814", "journal-title": "Fertil Steril"}, {"key": "20_CR44", "doi-asserted-by": "crossref", "first-page": "1011", "DOI": "10.1016/S0015-0282(16)60735-5", "volume": "51", "author": "UA Knuth", "year": "1989", "unstructured": "Knuth UA, Yeung CH, Nieschlag E (1989) Combination of 19-nortestosterone-hexyloxyphenylpropionate (Anadur) and depot-medroxyprogesterone-acetate (Clinovir) for male contraception. Fertil Steril 51:1011", "journal-title": "Fertil Steril"}, {"key": "20_CR45", "doi-asserted-by": "publisher", "first-page": "169", "DOI": "10.1017/S0021932000009093", "volume": "5", "author": "KL Kohli", "year": "1973", "unstructured": "Kohli KL (1973) Motivational factors and socioeconomic characteristics of vasectomized males. J Biosoc Sci 5:169\u2013177", "journal-title": "J Biosoc Sci"}, {"key": "20_CR46", "author": "JM Leonard", "first-page": "223", "year": "1978", "unstructured": "Leonard JM, Paulsen CA (1978) Contraceptive development studies for males: oral and parenteral steroid hormone administation. In: Pantanelli DJ (ed) Hormonal control of male fertility. Department of Health, Education and Welfare. National Institutes of Health, Bethesda, pp 223", "volume-title": "Hormonal control of male fertility. Department of Health, Education and Welfare"}, {"key": "20_CR47", "doi-asserted-by": "publisher", "first-page": "1848", "DOI": "10.1016/S0022-5347(05)68824-6", "volume": "161", "author": "SM Lesko", "year": "1999", "unstructured": "Lesko SM, Louik C, Vezina R, Rosenberg L, Shapiro S (1999) Vasectomy and prostate cancer. J Urol 161:1848\u20131853", "journal-title": "J Urol"}, {"key": "20_CR48", "doi-asserted-by": "publisher", "first-page": "255", "DOI": "10.1016/0010-7824(93)90144-V", "volume": "48", "author": "X Liu", "year": "1993", "unstructured": "Liu X, Li S (1993) Vasal sterilization in China. Contraception 48:255\u2013265", "journal-title": "Contraception"}, {"key": "20_CR49", "doi-asserted-by": "publisher", "first-page": "637", "DOI": "10.1093/humrep/15.3.637", "volume": "15", "author": "CW Martin", "year": "2000", "unstructured": "Martin CW, Anderson RA, Cheng L, Ho PC, van der Spuy Z, Smith KB, Glasier AF, Everington D, Baird DT (2000) Potential impact of hormonal male contraception: cross cultural implications for development of novel preparations. Hum Reprod 15:637\u2013645", "journal-title": "Hum Reprod"}, {"key": "20_CR50", "doi-asserted-by": "publisher", "first-page": "3018", "DOI": "10.1210/jc.81.8.3018", "volume": "81", "author": "MC Meriggiola", "year": "1996", "unstructured": "Meriggiola MC, Paulsen CA, Bremner WJ, Flamigni C (1996) A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive. J Clin Endocrinol Metab 81:3018\u20133023", "journal-title": "J Clin Endocrinol Metab"}, {"key": "20_CR51", "doi-asserted-by": "publisher", "first-page": "844", "DOI": "10.1016/S0015-0282(97)00363-4", "volume": "68", "author": "MC Meriggiola", "year": "1997", "unstructured": "Meriggiola MC, Bremner WJ, Constantino A, Pavani A, Capelli M, Flamigni C (1997) An oral regimen of cyproterone acetate and testosterone undecanoate for spermatogenic suppression in men. Fertil Steril 68:844\u2013850", "journal-title": "Fertil Steril"}, {"key": "20_CR52", "doi-asserted-by": "publisher", "first-page": "186", "DOI": "10.1111/j.1365-2605.1994.tb01241.x", "volume": "17", "author": "R Mieusset", "year": "1994", "unstructured": "Mieusset R, Bujan L (1994) The potential of mild testicular heating as a safe, effective and reversible contraceptive method for men. Int J Androl 17:186\u2013191", "journal-title": "Int J Androl"}, {"key": "20_CR53", "doi-asserted-by": "publisher", "first-page": "237", "DOI": "10.1055/s-1999-13324", "volume": "30", "author": "B Miltsch", "year": "1999", "unstructured": "Miltsch B, Senn E (1999) Vasektomie: Pr\u00e4operative Bedenken und postoperative Akzeptanz. Aktuel Urol 30:237\u2013241", "journal-title": "Aktuel Urol"}, {"key": "20_CR54", "doi-asserted-by": "publisher", "first-page": "393", "DOI": "10.1016/S0010-7824(80)80017-5", "volume": "21", "author": "L Moltz", "year": "1980", "unstructured": "Moltz L, R\u00f6mmler A, Post A, Schwartz U, Hammerstein J (1980) Medium dose cyproterone acetate (CPA): effects on hormone secretion and on spermatogenesis in men. Contraception 21:393", "journal-title": "Contraception"}, {"key": "20_CR55", "doi-asserted-by": "publisher", "first-page": "2620", "DOI": "10.1001/jama.1993.03500200034015", "volume": "269", "author": "National Institutes of Health", "year": "1993", "unstructured": "National Institutes of Health (1993) Does vasectomy cause prostate cancer? JAMA 269:2620", "journal-title": "JAMA"}, {"key": "20_CR56", "author": "E Nieschlag", "first-page": "395", "year": "1986", "unstructured": "Nieschlag E (1986) Reasons for abandoning immunization against FSH as an approach to male fertility regulation. In: Zatuchni GI, Goldsmith A, Spieler JM, Sciarra JJ (eds) Male contraception: advances and future prospects. Harper and Row, Philadelphia, pp 395\u2013400", "volume-title": "Male contraception: advances and future prospects"}, {"key": "20_CR57", "doi-asserted-by": "publisher", "first-page": "1107", "DOI": "10.1055/s-2008-1068202", "volume": "112", "author": "E Nieschlag", "year": "1987", "unstructured": "Nieschlag E (1987) Vasektomie \u2014 pro und contra. Dtsch Med Wochenschr 112:1107\u20131109", "journal-title": "Dtsch Med Wochenschr"}, {"key": "20_CR58", "author": "E Nieschlag", "first-page": "477", "year": "1992", "unstructured": "Nieschlag E, Behre HM, Weinbauer GF (1992) Hormonal male contraception: A real chance? In: Nieschlag E, Habenicht UF (eds) Spermatogenesis \u2014 fertilitzation \u2014 contraception. Molecular, cellular and endocrine events in male reproduction. Springer, Berlin Heidelberg New York, pp 477\u2013501", "volume-title": "Spermatogenesis \u2014 fertilitzation \u2014 contraception. Molecular, cellular and endocrine events in male reproduction", "DOI": "10.1007/978-3-662-02815-5_20", "doi-asserted-by": "publisher"}, {"key": "20_CR59", "author": "E Nieschlag", "first-page": "243", "year": "1996", "unstructured": "Nieschlag E, Behre HM (1996) Hormonal male contraception: Suppression of spermatogenesis with GnRH antagonists and testosterone. In: Filicori M (ed) Treatment with GnRH analogs: controversies and perspectives. Parthenon, London, pp 243\u2013248", "volume-title": "Treatment with GnRH analogs: controversies and perspectives"}, {"key": "20_CR60", "doi-asserted-by": "publisher", "first-page": "607", "DOI": "10.1016/0010-7824(78)90045-8", "volume": "18", "author": "E Nieschlag", "year": "1978", "unstructured": "Nieschlag E, Hoogen H, B\u00f6lk M, Schuster H, Wickings EJ (1978) Clinical trial with testosterone undecanoate for male fertility control. Contraception 18: 607", "journal-title": "Contraception"}, {"key": "20_CR61", "doi-asserted-by": "publisher", "first-page": "894", "DOI": "10.1016/0140-6736(90)90487-P", "volume": "335", "author": "A Nirapathpongporn", "year": "1990", "unstructured": "Nirapathpongporn A, Huber DH, Krieger JN (1990) No-scalpel vasectomy at the King\u2019s birthday vasectomy festival. Lancet 335:894\u2013895", "journal-title": "Lancet"}, {"key": "20_CR62", "doi-asserted-by": "publisher", "first-page": "867", "DOI": "10.1001/jama.1899.92450430021001d", "volume": "33", "author": "AJ Ochsner", "year": "1899", "unstructured": "Ochsner AJ (1899) Surgical treatment of habitual criminals. JAMA 33:867\u2013868", "journal-title": "JAMA"}, {"key": "20_CR63", "doi-asserted-by": "crossref", "first-page": "229", "DOI": "10.1016/S0022-5347(17)69369-8", "volume": "59", "author": "VJ O\u2019Connor", "year": "1948", "unstructured": "O\u2019Connor VJ (1948) Anastomosis of the vas deferens after purposeful division for sterility. J Urol 59:229\u2013233", "journal-title": "J Urol"}, {"key": "20_CR64", "author": "SN Pavlou", "year": "1994", "unstructured": "Pavlou SN, Herodotou D, Curtain M, Minaretzis D (1994) Complete suppression of spermatogenesis by co-administration of a GnRH antagonist plus a physiologic dose of testosterone. 76th Meeting Endocrine Society, Abstract 1324", "series-title": "76th Meeting Endocrine Society", "volume-title": "Complete suppression of spermatogenesis by co-administration of a GnRH antagonist plus a physiologic dose of testosterone"}, {"key": "20_CR65", "doi-asserted-by": "publisher", "first-page": "53", "DOI": "10.1111/j.1365-2605.1982.tb00304.x", "volume": "28", "author": "MR Prasad", "year": "1982", "unstructured": "Prasad MR, Diczfalusy NE (1982) Gossypol. Int J Androl [Suppl] 28:53", "journal-title": "Int J Androl [Suppl]"}, {"key": "20_CR66", "doi-asserted-by": "publisher", "first-page": "77", "DOI": "10.1093/occmed/35.3.77", "volume": "35", "author": "PE Randall", "year": "1985", "unstructured": "Randall PE, Marcuson RW (1985) Absence from work following vasectomy. J Soc Occup Med 35:77\u201378", "journal-title": "J Soc Occup Med"}, {"key": "20_CR67", "doi-asserted-by": "crossref", "first-page": "228", "DOI": "10.1358/dof.1994.019.03.238584", "volume": "19", "author": "T Reissmann", "year": "1994", "unstructured": "Reissmann T, Engel J, Kutscher B, Bernd M, Hilgard P, Peukert M, Szelenyi I, Reichert S, Gonzales-Barcena D, Nieschlag E, Comary-Schally AM, Schally AV (1994) Cetrorelix. Drugs Future 19:228\u2013237", "journal-title": "Cetrorelix. Drugs Future"}, {"key": "20_CR68", "first-page": "577", "volume": "39", "author": "RD Reynolds", "year": "1994", "unstructured": "Reynolds RD (1994) Vas deferens occlusion during no-scalpel vasectomy. J Fam Pract 39:577\u2013582", "journal-title": "J Fam Pract"}, {"key": "20_CR69", "doi-asserted-by": "publisher", "first-page": "103", "DOI": "10.1111/j.1464-410X.1995.tb07881.x", "volume": "76", "author": "SAH Rizvi", "year": "1995", "unstructured": "Rizvi SAH, Naqvi SAA, Hussain Z (1995) Ethical issues in male sterilization in developing countries. Br J Urol 76:103\u2013105", "journal-title": "Br J Urol"}, {"key": "20_CR70", "doi-asserted-by": "publisher", "first-page": "17", "DOI": "10.1016/S0010-7824(97)00069-3", "volume": "56", "author": "MJ Rosenberg", "year": "1997", "unstructured": "Rosenberg MJ, Waugh MS (1997) Latex condom breakage and slippage in a controlled clinical trial. Contraception 56:17\u201321", "journal-title": "Contraception"}, {"key": "20_CR71", "doi-asserted-by": "publisher", "first-page": "67", "DOI": "10.2307/1966249", "volume": "14", "author": "JA Ross", "year": "1983", "unstructured": "Ross JA, Huber DH (1983) Acceptance and prevalence of vasectomy in developing countries. Stud Fam Plan 14:67\u201373", "journal-title": "Stud Fam Plan"}, {"key": "20_CR72", "first-page": "409", "volume": "91", "author": "S Roth", "year": "1994", "unstructured": "Roth S, Hertle L (1994) Verursacht die Sterilisations-Vasekto-mie ein Prostatakarzinom? Dt \u00c4rztebl 91:409\u2013410", "journal-title": "Dt \u00c4rztebl"}, {"key": "20_CR73", "doi-asserted-by": "publisher", "first-page": "1697", "DOI": "10.1016/S0022-5347(01)64837-7", "volume": "157", "author": "I Rothman", "year": "1997", "unstructured": "Rothman I, Berger RE, Cummings P, Jessen J, Muller ChH, Chapman W (1997) Randomized clinical trial of an absorbable stent for vasectomy reversal. J Urol 157:1697\u20131700", "journal-title": "J Urol"}, {"key": "20_CR74", "doi-asserted-by": "publisher", "first-page": "429", "DOI": "10.1016/0010-7824(92)90156-N", "volume": "45", "author": "P Russell-Brown", "year": "1992", "unstructured": "Russell-Brown P, Piedrahita C, Foldesy R, Steiner M, Townsend J (1992) Comparison of condom breakage during human use with performance in laboratory testing. Contraception 45:429\u2013437", "journal-title": "Contraception"}, {"key": "20_CR75", "doi-asserted-by": "publisher", "first-page": "136", "DOI": "10.1111/j.1365-2605.1979.tb00047.x", "volume": "2", "author": "FA Sanches", "year": "1979", "unstructured": "Sanches FA, Brache V, Leon P, Faundes A (1979) Inhibition of spermatogenesis with monthly injections of medroxyprogesterone acetate and low dose testosterone enanthate. Int J Androl 2:136", "journal-title": "Int J Androl"}, {"key": "20_CR76", "doi-asserted-by": "publisher", "first-page": "680", "DOI": "10.1111/j.1365-2605.1978.tb00517.x", "volume": "2", "author": "SB Schearer", "year": "1978", "unstructured": "Schearer SB (1978) The use of progestins and androgens as a male contraceptive. Int J Androl [Suppl] 2:680", "journal-title": "Int J Androl [Suppl]"}, {"key": "20_CR77", "first-page": "29", "volume": "22", "author": "C Schirren", "year": "1983", "unstructured": "Schirren C (1983) Erfahrungen mit der Vasektomie. Urologe A 22:29\u201334", "journal-title": "Urologe A"}, {"key": "20_CR78", "doi-asserted-by": "publisher", "first-page": "19", "DOI": "10.1210/jcem-59-1-19", "volume": "59", "author": "T Sch\u00fcrmeyer", "year": "1984", "unstructured": "Sch\u00fcrmeyer T, Knuth UA, Freischem CW, Sandow J, Akhtar FB, Nieschlag E (1984) Suppression of pituitary and testicular function in normal men by constant gonadotropin-releasing hormone agonist infusion. J Clin Endocrinol Metab 59:19", "journal-title": "J Clin Endocrinol Metab"}, {"key": "20_CR79", "author": "SJ Segal", "year": "1985", "unstructured": "Segal SJ (1985) Gossypol: a potential contraceptive for men. Plenum, New York", "volume-title": "Gossypol: a potential contraceptive for men"}, {"key": "20_CR80", "first-page": "411", "volume": "75", "author": "HC Sharp", "year": "1902", "unstructured": "Sharp HC (1902) The severing of the vasa deferentia and its relation to the neuropsychopathic constitution. NY Med J 75:411\u2013414", "journal-title": "NY Med J"}, {"key": "20_CR81", "doi-asserted-by": "crossref", "first-page": "72", "DOI": "10.1016/S0015-0282(16)42320-4", "volume": "28", "author": "SJ Silber", "year": "1977", "unstructured": "Silber SJ (1977) Perfect anatomical reconstruction of vas deferens with a new microscopic surgical technique. Fertil Steril 28:72\u201377", "journal-title": "Fertil Steril"}, {"key": "20_CR82", "doi-asserted-by": "publisher", "first-page": "370", "DOI": "10.2105/AJPH.75.4.370", "volume": "75", "author": "GL Smith", "year": "1985", "unstructured": "Smith GL, Taylor GP, Smith KF (1985) Comparative risks and costs of male and female sterilization. Am J Pub Health 75:370\u2013374", "journal-title": "Am J Pub Health"}, {"key": "20_CR83", "doi-asserted-by": "crossref", "first-page": "625", "DOI": "10.1530/acta.0.1020625", "volume": "102", "author": "J-C Soufir", "year": "1983", "unstructured": "Soufir J-C, Jouannet P, Marson J, Soumah A (1983) Reversible inhibition of sperm production and gonadotropin secretion in men following combined oral medroxyprogesterone acetate and percutaneous testosterone treatment. Acta Endocrinol 102:625", "journal-title": "Acta Endocrinol"}, {"key": "20_CR84", "doi-asserted-by": "publisher", "first-page": "279", "DOI": "10.1016/0010-7824(92)90008-H", "volume": "46", "author": "M Steiner", "year": "1992", "unstructured": "Steiner M, Foldesy R, Cole D, Carter E (1992) Study to determine the correlation between condom breakage in human use and laboratory test results. Contraception 46:279\u2013288", "journal-title": "Contraception"}, {"key": "20_CR85", "doi-asserted-by": "publisher", "first-page": "51", "DOI": "10.2307/1966591", "volume": "21", "author": "J Trussell", "year": "1990", "unstructured": "Trussell J, Hatcher RA, Cates W, Stewart FH, Kost K (1990) Contraceptive failure in the United States: an update. Stud Fam Plan 21:51\u201354", "journal-title": "Stud Fam Plan"}, {"key": "20_CR86", "doi-asserted-by": "publisher", "first-page": "815", "DOI": "10.1001/archpsyc.1979.01780070093011", "volume": "36", "author": "R Vaughn", "year": "1979", "unstructured": "Vaughn R (1979) Behavioral response to vasectomy. Arch Gen Psychiatry 36:815\u2013821", "journal-title": "Arch Gen Psychiatry"}, {"key": "20_CR87", "doi-asserted-by": "crossref", "first-page": "210", "DOI": "10.1093/oxfordjournals.bmb.a072599", "volume": "49", "author": "GMH Waites", "year": "1993", "unstructured": "Waites GMH (1993) Male fertility regulation: the challenges for the year 2000. Br Med Bull 49:210", "journal-title": "Br Med Bull"}, {"key": "20_CR88", "doi-asserted-by": "publisher", "first-page": "8", "DOI": "10.1046/j.1365-2605.1998.00092.x", "volume": "21", "author": "GMH Waites", "year": "1998", "unstructured": "Waites GMH, Wang C, Griffin PD (1998) Gossypol: reasons for its failure to be accepted as a safe, reversible male antifertility drug. Int J Androl 21:8\u201312", "journal-title": "Int J Androl"}, {"key": "20_CR89", "doi-asserted-by": "publisher", "first-page": "245", "DOI": "10.1016/0010-7824(80)90005-0", "volume": "21", "author": "C Wang", "year": "1980", "unstructured": "Wang C, Yeung KK (1980) Use of low-dosage oral cyproterone acetate as a male contraceptive. Contraception 21:245", "journal-title": "Contraception"}, {"key": "20_CR90", "doi-asserted-by": "publisher", "first-page": "334", "DOI": "10.1016/S0015-0282(97)81525-7", "volume": "68", "author": "C Wang", "year": "1997", "unstructured": "Wang C, McDonald V, Leung A, Superlano L, Berman N, Hull L, Swerdloff RS (1997) Effect of increased scrotal temperature on sperm production in normal men. Fertil Steril 68:334\u2013339", "journal-title": "Fertil Steril"}, {"key": "20_CR91", "doi-asserted-by": "publisher", "first-page": "328", "DOI": "10.1055/s-2008-1060464", "volume": "23", "author": "W Weidner", "year": "1992", "unstructured": "Weidner W, Wei\u00dfbach L (1992) Freiwillige Vasektomie in der Familienplanung \u2014 Gedanken zur Nutzen-Risiko-Analyse. Aktuel Urol 23:328\u2013331", "journal-title": "Aktuel Urol"}, {"key": "20_CR92", "doi-asserted-by": "publisher", "first-page": "284", "DOI": "10.1210/jcem-67-2-284", "volume": "67", "author": "GF Weinbauer", "year": "1988", "unstructured": "Weinbauer GF, G\u00f6ckeler E, Nieschlag E (1988) Testosterone prevents complete suppression of spermatogenesis in the gonadotropin-releasing hormone (GnRH) antagonist-treated nun-human primate (Macaca fascicularis). J Clin Endocrinol Metab 67:284", "journal-title": "J Clin Endocrinol Metab"}, {"key": "20_CR93", "doi-asserted-by": "publisher", "first-page": "1635", "DOI": "10.1016/0277-9536(93)90352-5", "volume": "36", "author": "SC Weller", "year": "1993", "unstructured": "Weller SC (1993) A meta-analysis of condom effectiveness in reducing sexually transmitted HIV. Soc Sci Med 36:1635\u20131644", "journal-title": "Soc Sci Med"}, {"key": "20_CR94", "author": "WHO", "year": "1998", "unstructured": "WHO (1972\u20131998) Special programme of research, development and research training in human reproduction. Annual and biannual reports. WHO, Genf", "volume-title": "Special programme of research, development and research training in human reproduction. Annual and biannual reports"}, {"key": "20_CR95", "doi-asserted-by": "publisher", "first-page": "955", "DOI": "10.1016/0140-6736(90)92416-F", "volume": "336", "author": "WHO Task Force on Methods for the Regulation of Male Fertility", "year": "1990", "unstructured": "WHO Task Force on Methods for the Regulation of Male Fertility (1990) Contraceptive efficacy of testosterone-induced azoospermia in normal men. Lancet 336:955\u2013959", "journal-title": "Lancet"}, {"key": "20_CR96", "doi-asserted-by": "crossref", "first-page": "1062", "DOI": "10.1016/S0015-0282(16)56411-5", "volume": "60", "author": "WHO Task Force on Methods for the Regulation of Male Fertility", "year": "1993", "unstructured": "WHO Task Force on Methods for the Regulation of Male Fertility (1993) Comparison of two androgens plus depot-me-droxyprogesterone acetate for suppression to azoospermia in Indonesian men. Fertil Steril 60:1062", "journal-title": "Fertil Steril"}, {"key": "20_CR97", "doi-asserted-by": "publisher", "first-page": "157", "DOI": "10.1111/j.1365-2605.1995.tb00405.x", "volume": "18", "author": "WHO Task Force on Methods for the Regulation of Male Fertility", "year": "1995", "unstructured": "WHO Task Force on Methods for the Regulation of Male Fertility (1995) Rate of testosterone-induced suppression to severe oligozoospermia or azoospermia in two multinational clinical studies. Int J Androl 18:157\u2013165", "journal-title": "Int J Androl"}, {"key": "20_CR98", "doi-asserted-by": "crossref", "first-page": "821", "DOI": "10.1016/S0015-0282(16)58221-1", "volume": "65", "author": "WHO Task Force on Methods for the Regulation of Male Fertility", "year": "1996", "unstructured": "WHO Task Force on Methods for the Regulation of Male Fertility (1996) Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men. Fertil Steril 65:821\u2013829", "journal-title": "Fertil Steril"}, {"key": "20_CR99", "author": "WHO/HRP", "year": "1997", "unstructured": "WHO/HRP (1997) Preclinical and clinical requirements for approval to market non-latex condoms. WHO, Genf", "volume-title": "Preclinical and clinical requirements for approval to market non-latex condoms"}, {"key": "20_CR100", "doi-asserted-by": "publisher", "first-page": "532", "DOI": "10.1016/0090-4295(79)90465-5", "volume": "13", "author": "R Wicklund", "year": "1979", "unstructured": "Wicklund R, Alexander NJ (1979) Vasovasostomy: evaluation of success. Urology 13:532\u2013534", "journal-title": "Urology"}, {"key": "20_CR101", "author": "D Wolfers", "year": "1974", "unstructured": "Wolfers D, Wolfers H (1974) Vasectomy and vasectomania. Mayflower Books, London", "volume-title": "Vasectomy and vasectomania"}, {"key": "20_CR102", "first-page": "41", "volume": "1", "author": "N Wright", "year": "1977", "unstructured": "Wright N, Johnson B, Wiggins P, Vessey M (1977) The use of sterilisation as a method of birth control among participants in the Oxford/Family Planning Association Contraceptive Study. Fertil Contracept 1:41\u201344", "journal-title": "Fertil Contracept"}, {"key": "20_CR103", "doi-asserted-by": "publisher", "first-page": "112", "DOI": "10.1210/jc.84.1.112", "volume": "84", "author": "FC Wu", "year": "1999", "unstructured": "Wu FC, Balasubramanian R, Mulders TM, Coelingh-Benningk HJ (1999) Oral progestogen combined with testosterone as a potential male contraceptive: additive effects between desogestrel and testosterone enanthate in suppression of spermatogenesis, pituitary-testicular axis, and lipid metabolism. J Clin Endocrinol Metab 84:112\u2013122", "journal-title": "J Clin Endocrinol Metab"}, {"key": "20_CR104", "doi-asserted-by": "publisher", "first-page": "2", "DOI": "10.1046/j.1365-2605.1998.00091.x", "volume": "21", "author": "Z-H Yu", "year": "1998", "unstructured": "Yu Z-H, Chan HC (1998) Gossypol as a male antifertility agent \u2014 why studies should have been continued. Int J Androl 21:2\u20137", "journal-title": "Int J Androl"}, {"key": "20_CR105", "doi-asserted-by": "publisher", "first-page": "3642", "DOI": "10.1210/jc.84.10.3642", "volume": "84", "author": "GY Zhang", "year": "1999", "unstructured": "Zhang GY, Gu YQ, Wang XH, Cui YG, Bremner WJ (1999) A clinical trial of injectable testosterone undecanoate as a potential male contraceptive in normal Chinese men. J Clin Endocrinol Metab 84:3642\u20133647", "journal-title": "J Clin Endocrinol Metab"}], "container-title": ["Andrology"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-662-04491-9_20", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 14]], "date-time": "2019-05-14T01:40:24Z", "timestamp": 1557798024000}, "score": 37.60511, "issued": {"date-parts": [[2001]]}, "ISBN": ["9783662044933", "9783662044919"], "references-count": 105, "URL": "http://dx.doi.org/10.1007/978-3-662-04491-9_20", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T08:37:59Z", "timestamp": 1575275879591}, "publisher-location": "Berlin, Heidelberg", "reference-count": 83, "publisher": "Springer Berlin Heidelberg", "isbn-type": [{"value": "9783662034576", "type": "print"}, {"value": "9783662034552", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1997]]}, "DOI": "10.1007/978-3-662-03455-2_20", "type": "book-chapter", "created": {"date-parts": [[2013, 9, 13]], "date-time": "2013-09-13T13:26:22Z", "timestamp": 1379078782000}, "page": "375-393", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Male Contribution to Contraception"], "prefix": "10.1007", "author": [{"given": "E.", "family": "Nieschlag", "sequence": "first", "affiliation": []}, {"given": "H. M.", "family": "Behre", "sequence": "additional", "affiliation": []}, {"given": "U.", "family": "Engelmann", "sequence": "additional", "affiliation": []}, {"given": "L.", "family": "Hertle", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "20_CR1", "doi-asserted-by": "publisher", "first-page": "534", "DOI": "10.1210/jcem-56-3-534", "volume": "56", "author": "FB Akhtar", "year": "1983", "unstructured": "Akhtar FB, Marshall GR, Wickings EJ, Nieschlag E (1983a) Reversible induction of azoospermia in rhesus monkeys by constant infusion of a GnRH agonist using osmotic mini-pumps. J Clin Endocrinol Metab 56:534\u2013540.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "20_CR2", "doi-asserted-by": "publisher", "first-page": "461", "DOI": "10.1111/j.1365-2605.1983.tb00560.x", "volume": "6", "author": "FB Akhtar", "year": "1983", "unstructured": "Akhtar FB, Marshall GR, Nieschlag E (1983b) Testosterone supplementation attenuates the antifertility effects of an LHRH agonist in male monkeys. Int J Androl 6:461\u2013468.", "journal-title": "Int J Androl"}, {"key": "20_CR3", "first-page": "579", "volume": "33", "author": "PM Alderman", "year": "1991", "unstructured": "Alderman PM (1991) Complications in a series of 1224 vasectomies. J Farn Pract 33:579\u2013584.", "journal-title": "J Farn Pract"}, {"key": "20_CR4", "first-page": "304", "volume": "88", "author": "K April", "year": "1993", "unstructured": "April K, K\u00f6ster R, Schreiner W (1993) Wie effektiv sch\u00fctzen Kondome vor einer HIV-\u00dcbertragung?. Med Klin 88:304\u2013311.", "journal-title": "Med Klin"}, {"key": "20_CR5", "doi-asserted-by": "publisher", "first-page": "427", "DOI": "10.1210/jc.77.2.427", "volume": "77", "author": "CJ Bagatell", "year": "1993", "unstructured": "Bagatell CJ, Matsumoto AM, Christensen RB, Rivier JE, Bremner WJ (1993) Comparison of a gonadotropin-releasing hormone antagonist plus testosterone (T) versus T alone as a potential male contraceptive regimen. J Clin Endocrinol Metab 77:427\u2013432.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "20_CR6", "doi-asserted-by": "publisher", "first-page": "757", "DOI": "10.1210/jc.81.2.757", "volume": "81", "author": "RA Bebb", "year": "1996", "unstructured": "Bebb RA, Anawalt BD, Christensen RB, Paulsen CA, Bremner WJ, Matsumoto AM (1996) Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach. J Clin Endocrinol Metab 81:757\u2013762.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "20_CR7", "doi-asserted-by": "publisher", "first-page": "84", "DOI": "10.1210/jc.74.1.84", "volume": "74", "author": "HM Behre", "year": "1992", "unstructured": "Behre HM, Nashan D, Hubert W, Nieschlag E (1992) Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception. J Clin Endocrinol Metab 74:84\u201390.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "20_CR8", "doi-asserted-by": "publisher", "first-page": "241", "DOI": "10.1111/j.1365-2265.1994.tb02475.x", "volume": "40", "author": "HM Behre", "year": "1994", "unstructured": "Behre HM, B\u00f6ckers A, Schlingheider A, Nieschlag E (1994) Sustained suppression of serum LH, FSH and testosterone and increase of high-density lipoprotein cholesterol by daily injections of the GnRH antagonist Cetrorelix over 8 days in normal men. Clin Endocrinol (Oxf) 40:241\u2013248.", "journal-title": "Clin Endocrinol (Oxf)"}, {"key": "20_CR9", "doi-asserted-by": "publisher", "first-page": "2394", "DOI": "10.1210/jc.80.8.2394", "volume": "80", "author": "HM Behre", "year": "1995", "unstructured": "Behre HM, Baus S, Kliesch S, Keck C, Simoni M, Nieschlag E (1995) Potential of testosterone buciclate for male contraception: endocrine differences between responders and non-responders. J Clin Endocrinol Metab 80:2394\u20132403.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "20_CR10", "doi-asserted-by": "crossref", "first-page": "505", "DOI": "10.1016/S0022-5347(17)38381-7", "volume": "145", "author": "AM Belker", "year": "1991", "unstructured": "Belker AM, Thomas AJ, Fuchs EF, Konnak JW, Sharlip ID (1991) Results of 1,469 microsurgical vasectomy reversals by the vasovasostomy study group. J Urol 145:505\u2013511.", "journal-title": "J Urol"}, {"key": "20_CR11", "doi-asserted-by": "publisher", "first-page": "567", "DOI": "10.1016/0090-4295(83)90297-2", "volume": "22", "author": "LR Cos", "year": "1983", "unstructured": "Cos LR, Valvo JR, Davis RS, Cockett ATK (1983) Vasovasostomy: current state of the art. Urology 22:567\u2013575.", "journal-title": "Urology"}, {"key": "20_CR12", "unstructured": "Declaration of the International Symposium on \u201cContraceptive Research and Development for the 2000 and beyond, Mexico City 1993\u201d (1994) In: Van Look PFA, P\u00e9rez-Pallacios G (eds) Contraceptive research and development 1984\u20131994. Oxford University Press, Delhi, pp 543\u2013546."}, {"key": "20_CR13", "unstructured": "Deindl F (1990) Die Refertilisationssituation in der Bundesrepublik Deutschland, der Republik \u00d6sterreich und der Schweiz-eine Dreil\u00e4nderumfrage. Thesis, Ruhr-Universit\u00e4t, Bochum."}, {"key": "20_CR14", "doi-asserted-by": "publisher", "first-page": "276", "DOI": "10.1016/S0140-6736(84)90144-2", "volume": "1", "author": "D Delanoe", "year": "1984", "unstructured": "Delanoe D, Fougeyrollas B, Meyer L, Thonneau P (1984) Androgenisation of female partners of men on medroxyprogesterone acetate/percutaneous testosterone contraception. Lancet 1:276.", "journal-title": "Lancet"}, {"key": "20_CR15", "doi-asserted-by": "crossref", "first-page": "556", "DOI": "10.1016/S0022-5347(17)60279-9", "volume": "110", "author": "FC Derrick", "year": "1973", "unstructured": "Derrick FC, Yarbrough W, Agostino JD (1973) Vasovasostomy: results of questionnaire of members of the American Urological Association. J Urol 110:556\u2013557.", "journal-title": "J Urol"}, {"key": "20_CR16", "doi-asserted-by": "publisher", "first-page": "11", "DOI": "10.1038/370011a0", "volume": "370", "author": "C Djerassi", "year": "1994", "unstructured": "Djerassi C, Leibo SP (1994) A new look at male contraception. Nature 370:11\u201312.", "journal-title": "Nature"}, {"key": "20_CR17", "doi-asserted-by": "crossref", "first-page": "64", "DOI": "10.1016/S0022-5347(17)39867-1", "volume": "143", "author": "UH Engelmann", "year": "1990", "unstructured": "Engelmann UH, Schramek P, Tomamichel G, Deindl F, Senge T (1990) Vasectomy reversal in central Europe: results of a questionnaire of urologists in Austria, Germany and Switzerland. J Urol 143:64\u201367.", "journal-title": "J Urol"}, {"key": "20_CR18", "first-page": "413", "volume": "71", "author": "TMM Farley", "year": "1993", "unstructured": "Farley TMM, Meirik O, Mehta S, Waites GMH (1993) The safety of vasectomy: recent concerns. Bull World Health Organ 71:413\u2013419.", "journal-title": "Bull World Health Organ"}, {"key": "20_CR19", "first-page": "1", "volume": "2", "author": "NR Farnsworth", "year": "1982", "unstructured": "Farnsworth NR, Waller DP (1982) Current status of plant products reported to inhibit sperm. Res Frontiers Fertil Regul 2:1\u201316.", "journal-title": "Res Frontiers Fertil Regul"}, {"key": "20_CR20", "doi-asserted-by": "publisher", "first-page": "100", "DOI": "10.2307/2136106", "volume": "27", "author": "R Forster", "year": "1995", "unstructured": "Forster R, Tanfer K, Tedrow L (1995) Sterilization among currently married men in the United States, 1991. Fam Plann Perspect 27:100\u2013107, 122.", "journal-title": "Fam Plann Perspect"}, {"key": "20_CR21", "doi-asserted-by": "publisher", "first-page": "1392", "DOI": "10.1056/NEJM199205213262104", "volume": "326", "author": "E Giovannucci", "year": "1992", "unstructured": "Giovannucci E, Tosteson TD, Speizer FE, Vessey MP, Colditz GA (1992) A long-term study of mortality in men who have undergone vasectomy. N Engl J Med 326:1392\u20131398.", "journal-title": "N Engl J Med"}, {"key": "20_CR22", "doi-asserted-by": "publisher", "first-page": "873", "DOI": "10.1001/jama.1993.03500070053028", "volume": "269", "author": "E Giovannucci", "year": "1993", "unstructured": "Giovannucci E, Asherio A, Rimm EB, Colditz GA, Stampfer MJ, Willett WC (1993) A prospective cohort study of vasectomy and prostate cancer in US men. JAMA 269:873\u2013877.", "journal-title": "JAMA"}, {"key": "20_CR23", "doi-asserted-by": "publisher", "first-page": "38", "DOI": "10.1111/j.1365-2605.1986.tb00866.x", "volume": "9", "author": "A Giwercman", "year": "1986", "unstructured": "Giwercman A, Skakkebaek NE (1986) The effect of salicylazo-sulphapyridine (sulphasalazine) on male fertility. A review. Int J Androl 9:38\u201352.", "journal-title": "Int J Androl"}, {"key": "20_CR24", "first-page": "119", "volume": "33", "author": "P Goebel", "year": "1987", "unstructured": "Goebel P, Ortmann K, Blattner T (1987) Vasektomie und Beziehungssituation-eine empirische Untersuchung an 156 M\u00e4nnern (Paaren). Z Psychosom Med 33:119\u2013138.", "journal-title": "Z Psychosom Med"}, {"key": "20_CR25", "doi-asserted-by": "crossref", "first-page": "699", "DOI": "10.1016/S0015-0282(16)47435-2", "volume": "40", "author": "M Goldstein", "year": "1983", "unstructured": "Goldstein M (1983) Vasectomy failure using an open-ended technique. Fertil Steril 40:699\u2013700.", "journal-title": "Fertil Steril"}, {"key": "20_CR26", "doi-asserted-by": "publisher", "first-page": "1326", "DOI": "10.1210/jc.75.5.1326", "volume": "175", "author": "DJ Handelsman", "year": "1992", "unstructured": "Handelsman DJ, Conway AJ, Boylan LM (1992) Suppression of human spermatogenesis by testosterone implants. J Clin Endocrinol Metab 175:1326\u20131332.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "20_CR27", "doi-asserted-by": "publisher", "first-page": "69", "DOI": "10.1111/j.1600-0897.1994.tb00849.x", "volume": "31", "author": "A Heidenreich", "year": "1994", "unstructured": "Heidenreich A, Bonfig R, Wilbert DM, Strohmaier WL, Engelmann UH (1994) Risk factors for antisperm antibodies in infertile men. Am J Reprod Immunol 31:69\u201376.", "journal-title": "Am J Reprod Immunol"}, {"key": "20_CR28", "first-page": "452", "volume": "28", "author": "H-D Hiersche", "year": "1995", "unstructured": "Hiersche H-D, Hiersche F (1995) Die Sterilisation geistig Behinderter. Gyn\u00e4kologe 28:452\u2013458.", "journal-title": "Gyn\u00e4kologe"}, {"key": "20_CR29", "first-page": "25", "volume": "111", "author": "L Isnardi", "year": "1896", "unstructured": "Isnardi L (1896) Die Behandlung der senilen Dysurie mit Durchschneidung und doppelseitiger Ligatur der vasa deferentia. Ther Wochenschr 111:25\u201336.", "journal-title": "Ther Wochenschr"}, {"key": "20_CR30", "doi-asserted-by": "publisher", "first-page": "662", "DOI": "10.1093/jnci/87.9.662", "volume": "87", "author": "EM John", "year": "1995", "unstructured": "John EM, Whittemore AS, Wu AH, Kolonel LN, Hislop TG, Howe GR, West DW, Hankin J, Dreon DM, Teh CZ (1995) Vasectomy and prostate cancer: results from a multiethnic case-control study. J Natl Cancer Inst 87:662\u2013669.", "journal-title": "J Natl Cancer Inst"}, {"key": "20_CR31", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1055/s-2007-1023815", "volume": "51", "author": "UA Knuth", "year": "1991", "unstructured": "Knuth UA, M\u00fchlenstedt D (1991) Kinderwunschdauer, kontrazeptives Verhalten und Rate vorausgegangener Infertilit\u00e4tsbehandlung. Geburtshilfe Frauenheilkd 51:1\u20137.", "journal-title": "Geburtshilfe Frauenheilkd"}, {"key": "20_CR32", "doi-asserted-by": "crossref", "first-page": "814", "DOI": "10.1016/S0015-0282(16)49043-6", "volume": "44", "author": "UA Knuth", "year": "1985", "unstructured": "Knuth UA, Behre HM, Beikien L, Bents H, Nieschlag E (1985) Clinical trial of 19-nortestosterone-hexyloxyphenyl-propionate (Anadur) for male fertility regulation. Fertil Steril 44:814\u2013821.", "journal-title": "Fertil Steril"}, {"key": "20_CR33", "doi-asserted-by": "crossref", "first-page": "1011", "DOI": "10.1016/S0015-0282(16)60735-5", "volume": "51", "author": "UA Knuth", "year": "1989", "unstructured": "Knuth UA, Yeung CH, Nieschlag E (1989) Combination of 19-nortestosterone-hexyloxyphenylpropionate (Anadur) and depot medroxyprogesterone acetate (Clinovir) for male contraception. Fertil Steril 51:1011\u20131018.", "journal-title": "Fertil Steril"}, {"key": "20_CR34", "doi-asserted-by": "publisher", "first-page": "169", "DOI": "10.1017/S0021932000009093", "volume": "5", "author": "KL Kohli", "year": "1973", "unstructured": "Kohli KL (1973) Motivational factors and socioeconomic characteristics of vasectomized males. J Biosoc Sci 5:169\u2013177.", "journal-title": "J Biosoc Sci"}, {"key": "20_CR35", "author": "JM Leonard", "first-page": "223", "year": "1978", "unstructured": "Leonard JM, Paulsen CA (1978) Contraceptive development studies for males: oral and parenteral steroid hormone administation. In: Pantanelli DJ (ed) Hormonal control of male fertility. Department of Health, Education and Welfare, National Institutes of Health, Bethesda, p 223.", "volume-title": "Hormonal control of male fertility"}, {"key": "20_CR36", "doi-asserted-by": "publisher", "first-page": "3018", "DOI": "10.1210/jc.81.8.3018", "volume": "81", "author": "MC Meriggiola", "year": "1996", "unstructured": "Meriggiola MC, Bremner WJ, Paulsen CA, Valdiserri A, Incorvaia L, Motta R, Pavani A, Capelli M, Flamigni C (1996) A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive: J Clin Endocrinol Metab 81:3018\u20133023.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "20_CR37", "doi-asserted-by": "publisher", "first-page": "186", "DOI": "10.1111/j.1365-2605.1994.tb01241.x", "volume": "17", "author": "R Mieusset", "year": "1994", "unstructured": "Mieusset R, Bujan L (1994) The potential of mild testicular heating as a safe, effective and reversible contraceptive method for men. Int J Androl 17:186\u2013191.", "journal-title": "Int J Androl"}, {"key": "20_CR38", "doi-asserted-by": "publisher", "first-page": "393", "DOI": "10.1016/S0010-7824(80)80017-5", "volume": "21", "author": "L Moltz", "year": "1980", "unstructured": "Moltz L, R\u00f6mmler A, Post A, Schwartz U, Hammerstein J (1980) Medium dose cyproterone acetate (CPA): effects on hormone secretion and on spermatogenesis in men. Contraception 21:393\u2013413.", "journal-title": "Contraception"}, {"key": "20_CR39", "doi-asserted-by": "publisher", "first-page": "2620", "DOI": "10.1001/jama.1993.03500200034015", "volume": "269", "author": "National Institutes of Health", "year": "1993", "unstructured": "National Institutes of Health (1993) Does vasectomy cause prostate cancer?. JAMA 269:2620.", "journal-title": "JAMA"}, {"key": "20_CR40", "author": "E Nieschlag", "first-page": "395", "year": "1986", "unstructured": "Nieschlag E (1986) Reasons for abandoning immunization against FSH as an approach to male fertility regulation. In: Zatuchni GI, Goldsmith A, Spieler JM, Sciarra JJ (eds) Male contraception: advances and future prospects. Harper and Row, Philadelphia, pp 395\u2013400.", "volume-title": "Male contraception: advances and future prospects"}, {"key": "20_CR41", "doi-asserted-by": "publisher", "first-page": "1107", "DOI": "10.1055/s-2008-1068202", "volume": "112", "author": "E Nieschlag", "year": "1987", "unstructured": "Nieschlag E (1987) Vasektomie-pro und contra. Dtsch Med Wochenschr 112:1107\u20131109.", "journal-title": "Dtsch Med Wochenschr"}, {"key": "20_CR42", "author": "E Nieschlag", "first-page": "243", "year": "1996", "unstructured": "Nieschlag E, Behre HM (1996) Hormonal male contraception: suppression of spermatogenesis with GnRH antagonists and testosterone. In: Filicori M, Flamigni GC (eds) Treatment with GnRH analogs: controversies and perspectives. Parthenon, London, pp 243\u2013248.", "volume-title": "Treatment with GnRH analogs: controversies and perspectives"}, {"key": "20_CR43", "author": "E Nieschlag", "first-page": "477", "year": "1992", "unstructured": "Nieschlag E, Behre HM, Weinbauer GF (1992) Hormonal male contraception: a real chance? In: Nieschlag E, Habenicht UF (eds) Spermatogenesis-fertilization-contraception. Molecular, cellular and endocrine events in male reproduction. Springer, Berlin Heidelberg New York, pp 477\u2013501.", "volume-title": "Spermatogenesis-fertilization-contraception. Molecular, cellular and endocrine events in male reproduction", "DOI": "10.1007/978-3-662-02815-5_20", "doi-asserted-by": "publisher"}, {"key": "20_CR44", "doi-asserted-by": "publisher", "first-page": "894", "DOI": "10.1016/0140-6736(90)90487-P", "volume": "335", "author": "A Nirapathpongporn", "year": "1990", "unstructured": "Nirapathpongporn A, Huber DH, Krieger JN (1990) No-scalpel vasectomy at the King\u2019s birthday vasectomy festival. Lancet 335:894\u2013895.", "journal-title": "Lancet"}, {"key": "20_CR45", "doi-asserted-by": "publisher", "first-page": "867", "DOI": "10.1001/jama.1899.92450430021001d", "volume": "53", "author": "AJ Ochsner", "year": "1899", "unstructured": "Ochsner AJ (1899) Surgical treatment of habitual criminals. JAMA 53:867\u2013868.", "journal-title": "JAMA"}, {"key": "20_CR46", "doi-asserted-by": "crossref", "first-page": "229", "DOI": "10.1016/S0022-5347(17)69369-8", "volume": "59", "author": "VJ O\u2019Connor", "year": "1948", "unstructured": "O\u2019Connor VJ (1948) Anastomosis of the vas deferens after purposeful division for sterility. J Urol 59:229\u2013233.", "journal-title": "J Urol"}, {"key": "20_CR47", "unstructured": "Pavlou SN, Herodotou D, Curtain M, Minaretzis D (1994) Complete suppression of spermatogenesis by coadministration of a GnRH antagonist plus a physiologic dose of testosterone. 76th Meeting Endocrine Society, Anaheim, CA, abstract 1324."}, {"key": "20_CR48", "doi-asserted-by": "publisher", "first-page": "53", "DOI": "10.1111/j.1365-2605.1982.tb00304.x", "volume": "28", "author": "MR Prasad", "year": "1982", "unstructured": "Prasad MR, Diczfalusy NE (1982) Gossypol. Int J Androl [Suppl] 28:53\u201370.", "journal-title": "Int J Androl"}, {"key": "20_CR49", "doi-asserted-by": "publisher", "first-page": "77", "DOI": "10.1093/occmed/35.3.77", "volume": "35", "author": "PE Randall", "year": "1985", "unstructured": "Randall PE, Marcuson RW (1985) Absence from work following vasectomy. J Soc Occup Med 35:77\u201378.", "journal-title": "J Soc Occup Med"}, {"key": "20_CR50", "doi-asserted-by": "crossref", "first-page": "228", "DOI": "10.1358/dof.1994.019.03.238584", "volume": "19", "author": "T Reissmann", "year": "1994", "unstructured": "Reissmann T, Engel J, Kutscher B, Bernd M, Hilgard P, Peukert M, Szelenyi I, Reichert S, Gonzales-Barcena D, Nieschlag E, Comary-Schally AM, Schally AV (1994) Cetrore-lix. Drugs Future 19:228\u2013237.", "journal-title": "Drugs Future"}, {"key": "20_CR51", "first-page": "577", "volume": "39", "author": "RD Reynolds", "year": "1994", "unstructured": "Reynolds RD (1994) Vas deferens occlusion during no-scalpel vasectomy. J Farn Pract 39:577\u2013582.", "journal-title": "J Farn Pract"}, {"key": "20_CR52", "doi-asserted-by": "publisher", "first-page": "67", "DOI": "10.2307/1966249", "volume": "14", "author": "JA Ross", "year": "1983", "unstructured": "Ross JA, Huber DH (1983) Acceptance and prevalence of vasectomy in developing countries. Stud Farn Plann 14:67\u201373.", "journal-title": "Stud Farn Plann"}, {"key": "20_CR53", "first-page": "409", "volume": "91", "author": "S Roth", "year": "1994", "unstructured": "Roth S, Hertle L (1994) Verursacht die Sterilisations-Vasektomie ein Prostatakarzinom?. Dtsch Arztebl 91:409\u2013410.", "journal-title": "Dtsch Arztebl"}, {"key": "20_CR54", "doi-asserted-by": "publisher", "first-page": "429", "DOI": "10.1016/0010-7824(92)90156-N", "volume": "45", "author": "P Russell-Brown", "year": "1992", "unstructured": "Russell-Brown P, Piedrahita C, Foldesy R, Steiner M, Townsend J (1992) Comparison of condom breakage during human use with performance in laboratory testing. Contraception 45:429\u2013437.", "journal-title": "Contraception"}, {"key": "20_CR55", "doi-asserted-by": "publisher", "first-page": "136", "DOI": "10.1111/j.1365-2605.1979.tb00047.x", "volume": "2", "author": "FA Sanchez", "year": "1979", "unstructured": "Sanchez FA, Brache V, Leon P, Faundes A (1979) Inhibition of spermatogenesis with monthly injections of medroxyprogesterone acetate and low dose testosterone enanthate. Int J Androl 2:136\u2013149.", "journal-title": "Int J Androl"}, {"key": "20_CR56", "first-page": "29", "volume": "22", "author": "C Schirren", "year": "1983", "unstructured": "Schirren C (1983) Erfahrungen mit der Vasektomie. Urologe A 22:29\u201334.", "journal-title": "Urologe A"}, {"key": "20_CR57", "doi-asserted-by": "publisher", "first-page": "19", "DOI": "10.1210/jcem-59-1-19", "volume": "59", "author": "T Sch\u00fcrmeyer", "year": "1984", "unstructured": "Sch\u00fcrmeyer T, Knuth UA, Freischem CW, Sandow J, Akhtar FB, Nieschlag E (1984) Suppression of pituitary and testicular function in normal men by constant gonadotropin-releasing hormone agonist infusion. J Clin Endocrinol 59:19\u201324.", "journal-title": "J Clin Endocrinol"}, {"key": "20_CR58", "doi-asserted-by": "publisher", "first-page": "680", "DOI": "10.1111/j.1365-2605.1978.tb00517.x", "volume": "2", "author": "SB Schearer", "year": "1978", "unstructured": "Schearer SB (1978) The use of progestins and androgens as a male contraceptive. Int J Androl [Suppl] 2:680\u2013712.", "journal-title": "Int J Androl"}, {"key": "20_CR59", "author": "SJ Segal", "year": "1985", "unstructured": "Segal SJ (1985) Gossypol: a potential contraceptive for men. Plenum, New York.", "volume-title": "Gossypol: a potential contraceptive for men"}, {"key": "20_CR60", "first-page": "411", "volume": "85", "author": "HC Sharpe", "year": "1902", "unstructured": "Sharpe HC (1902) The severing of the vasa deferentia and its relation to the neuropathic constitution. NY Med J 85:411\u2013414.", "journal-title": "NY Med J"}, {"key": "20_CR61", "doi-asserted-by": "crossref", "first-page": "72", "DOI": "10.1016/S0015-0282(16)42320-4", "volume": "28", "author": "SJ Silber", "year": "1977", "unstructured": "Silber SJ (1977) Perfect anatomical reconstruction of vas deferens with a new microscopic surgical technique. Fertil Steril 28:72\u201377.", "journal-title": "Fertil Steril"}, {"key": "20_CR62", "doi-asserted-by": "publisher", "first-page": "370", "DOI": "10.2105/AJPH.75.4.370", "volume": "75", "author": "GL Smith", "year": "1985", "unstructured": "Smith GL, Taylor GP, Smith KF (1985) Comparative risks and costs of male and female sterilization. Am J Public Health 75:370\u2013374.", "journal-title": "Am J Public Health"}, {"key": "20_CR63", "doi-asserted-by": "crossref", "first-page": "625", "DOI": "10.1530/acta.0.1020625", "volume": "102", "author": "J-C Soufi", "year": "1983", "unstructured": "Soufi J-C, Jouannet P, Marson J, Soumah A (1983) Reversible inhibition of sperm production and gonadotropin secretion in men following combined oral medroxyprogesterone acetate and percutaneous testosterone treatment. Acta Endocrinol (Kbh) 102:625\u2013632.", "journal-title": "Acta Endocrinol (Kbh)"}, {"key": "20_CR64", "doi-asserted-by": "publisher", "first-page": "279", "DOI": "10.1016/0010-7824(92)90008-H", "volume": "46", "author": "M Steiner", "year": "1992", "unstructured": "Steiner M, Foldesy R, Cole D, Carter E (1992) Study to determine the correlation between condom breakage in human use and laboratory test results. Contraception 46:279\u2013288.", "journal-title": "Contraception"}, {"key": "20_CR65", "doi-asserted-by": "publisher", "first-page": "51", "DOI": "10.2307/1966591", "volume": "21", "author": "J Trussell", "year": "1990", "unstructured": "Trussell J, Hatcher RA, Cates W, Stewart FH, Kost K (1990) Contraceptive failure in the United States: an update. Stud Farn Plann 21:51\u201354.", "journal-title": "Stud Farn Plann"}, {"key": "20_CR66", "doi-asserted-by": "publisher", "first-page": "815", "DOI": "10.1001/archpsyc.1979.01780070093011", "volume": "36", "author": "R Vaughn", "year": "1979", "unstructured": "Vaughn R (1979) Behavioral response to vasectomy. Arch Gen Psychiatry 36:815\u2013821.", "journal-title": "Arch Gen Psychiatry"}, {"key": "20_CR67", "doi-asserted-by": "crossref", "first-page": "210", "DOI": "10.1093/oxfordjournals.bmb.a072599", "volume": "49", "author": "GMH Waites", "year": "1993", "unstructured": "Waites GMH (1993) Male fertility regulation: the challenges for the year 2000. Br Med Bull 49:210\u2013221.", "journal-title": "Br Med Bull"}, {"key": "20_CR68", "doi-asserted-by": "publisher", "first-page": "245", "DOI": "10.1016/0010-7824(80)90005-0", "volume": "21", "author": "C Wang", "year": "1980", "unstructured": "Wang C, Yeung KK (1980) Use of low-dosage oral cyproterone acetate as a male contraceptive. Contraception 21:245\u2013272.", "journal-title": "Contraception"}, {"key": "20_CR69", "doi-asserted-by": "publisher", "first-page": "328", "DOI": "10.1055/s-2008-1060464", "volume": "23", "author": "W Weidner", "year": "1992", "unstructured": "Weidner W, Wei\u03b2bach L (1992) Freiwillige Vasektomie in der Familienplanung-Gedanken zur Nutzen-Risiko-Analyse. Akt Urol 23:328\u2013331.", "journal-title": "Akt Urol"}, {"key": "20_CR70", "doi-asserted-by": "publisher", "first-page": "284", "DOI": "10.1210/jcem-67-2-284", "volume": "67", "author": "GF Weinbauer", "year": "1988", "unstructured": "Weinbauer GF, G\u00f6ckeler E, Nieschlag E (1988) Testosterone prevents complete suppression of spermatogenesis in the gonadotropin-releasing hormone (GnRH) antagonist-treated non-human primate (Macaca fascicularis). J Clin Endocrinol Metab 67:284\u2013290.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "20_CR71", "doi-asserted-by": "publisher", "first-page": "303", "DOI": "10.1677/joe.0.1230303", "volume": "123", "author": "GF Weinbauer", "year": "1989", "unstructured": "Weinbauer GF, Khurshid S, Fingscheidt U, Nieschlag E (1989) Sustained inhibition of sperm production and inhibin secretion induced by a gonadotropin-releasing hormone antagonist and delayed testosterone substitution in non-human primates (Macaca fascicularis). J Endocrinol 123:303\u2013310.", "journal-title": "J Endocrinol"}, {"key": "20_CR72", "doi-asserted-by": "publisher", "first-page": "1635", "DOI": "10.1016/0277-9536(93)90352-5", "volume": "36", "author": "SC Weller", "year": "1993", "unstructured": "Weller SC (1993) A meta-analysis of condom effectiveness in reducing sexually transmitted HIV. Soc Sci Med 36:1635\u20131644.", "journal-title": "Soc Sci Med"}, {"key": "20_CR73", "unstructured": "WHO (1972\u20131995) Special programme of research, development and research training in human reproduction. Annual and Biannual Reports, WHO, Geneva."}, {"key": "20_CR74", "doi-asserted-by": "publisher", "first-page": "955", "DOI": "10.1016/0140-6736(90)92416-F", "volume": "336", "author": "WHO Task Force on Methods for the Regulation of Male Fertility", "year": "1990", "unstructured": "WHO Task Force on Methods for the Regulation of Male Fertility (1990) Contraceptive efficacy of testosterone-induced azoospermia in normal men. Lancet 336:955\u2013959.", "journal-title": "Lancet"}, {"key": "20_CR75", "doi-asserted-by": "crossref", "first-page": "1062", "DOI": "10.1016/S0015-0282(16)56411-5", "volume": "60", "author": "WHO Task Force on Methods for the Regulation of Male Fertility", "year": "1993", "unstructured": "WHO Task Force on Methods for the Regulation of Male Fertility (1993) Comparison of two androgens plus depot-medroxyprogesterone acetate for suppression to azoospermia in Indonesian men. Fertil Steril 60:1062\u20131068.", "journal-title": "Fertil Steril"}, {"key": "20_CR76", "doi-asserted-by": "publisher", "first-page": "157", "DOI": "10.1111/j.1365-2605.1995.tb00405.x", "volume": "18", "author": "WHO Task Force on Methods for the Regulation of Male Fertility", "year": "1995", "unstructured": "WHO Task Force on Methods for the Regulation of Male Fertility (1995) Rate of testosterone-induced suppression to severe oligozoospermia or azoospermia in two multinational clinical studies. Int J Androl 18:157\u2013165.", "journal-title": "Int J Androl"}, {"key": "20_CR77", "doi-asserted-by": "crossref", "first-page": "821", "DOI": "10.1016/S0015-0282(16)58221-1", "volume": "65", "author": "WHO Task Force on Methods for the Regulation of Male Fertility", "year": "1996", "unstructured": "WHO Task Force on Methods for the Regulation of Male Fertility (1996) Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men. Fertil Steril 65:821\u2013882.", "journal-title": "Fertil Steril"}, {"key": "20_CR78", "doi-asserted-by": "publisher", "first-page": "532", "DOI": "10.1016/0090-4295(79)90465-5", "volume": "13", "author": "R Wicklund", "year": "1979", "unstructured": "Wicklund R, Alexander NJ (1979) Vasovasostomy: evaluation of success. Urology 13:532\u2013534.", "journal-title": "Urology"}, {"key": "20_CR79", "author": "D Wolfers", "year": "1974", "unstructured": "Wolfers D, Wolfers H (1974) Vasectomy and vasectomania. Mayflower, London.", "volume-title": "Vasectomy and vasectomania"}, {"key": "20_CR80", "first-page": "41", "volume": "1", "author": "N Wright", "year": "1977", "unstructured": "Wright N, Johnson B, Wiggins P, Vessey M (1977) The use of sterilization as a method of birth control among participants in the Oxford Family Planning Association Contraceptive Study. Fertil Contracept 1:41\u201344.", "journal-title": "Fertil Contracept"}, {"key": "20_CR81", "doi-asserted-by": "publisher", "first-page": "257", "DOI": "10.1530/jrf.0.1030257", "volume": "103", "author": "CH Yeung", "year": "1995", "unstructured": "Yeung CH, Oberl\u00e4nder G, Cooper TG (1995) The effects of the male antifertility agent ornadizole on sperm function in vitro and in the female genital tract. J Reprod Fertil 103:257\u2013264.", "journal-title": "J Reprod Fertil"}, {"key": "20_CR82", "doi-asserted-by": "publisher", "first-page": "255", "DOI": "10.1016/0010-7824(93)90144-V", "volume": "48", "author": "L Xiaozhang", "year": "1993", "unstructured": "Xiaozhang L, Shunqiang L (1993) Vasal sterilization in China. Contraception 48:255\u2013265.", "journal-title": "Contraception"}, {"key": "20_CR83", "doi-asserted-by": "crossref", "first-page": "53", "DOI": "10.1016/S0022-5347(17)42290-7", "volume": "139", "author": "Z Xie-Yang", "year": "1988", "unstructured": "Xie-Yang Z, Yong-Zong S (1988) Vasovasostomy with use of medical needle as a support. J Urol 139:53\u201354.", "journal-title": "J Urol"}], "container-title": ["Andrology"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-662-03455-2_20", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 17]], "date-time": "2019-05-17T09:46:53Z", "timestamp": 1558086413000}, "score": 37.60511, "issued": {"date-parts": [[1997]]}, "ISBN": ["9783662034576", "9783662034552"], "references-count": 83, "URL": "http://dx.doi.org/10.1007/978-3-662-03455-2_20", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T13:37:38Z", "timestamp": 1574429858805}, "reference-count": 85, "publisher": "Elsevier BV", "issue": "5", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2010, 11, 1]], "date-time": "2010-11-01T00:00:00Z", "timestamp": 1288569600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Contraception"], "published-print": {"date-parts": [[2010, 11]]}, "DOI": "10.1016/j.contraception.2010.03.020", "type": "journal-article", "created": {"date-parts": [[2010, 5, 17]], "date-time": "2010-05-17T08:07:37Z", "timestamp": 1274083657000}, "page": "457-470", "source": "Crossref", "is-referenced-by-count": 40, "title": ["Clinical trials in male hormonal contraception"], "prefix": "10.1016", "volume": "82", "author": [{"given": "Eberhard", "family": "Nieschlag", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Contraception"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S001078241000137X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S001078241000137X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 5, 29]], "date-time": "2019-05-29T06:47:28Z", "timestamp": 1559112448000}, "score": 37.223076, "issued": {"date-parts": [[2010, 11]]}, "references-count": 85, "journal-issue": {"published-print": {"date-parts": [[2010, 11]]}, "issue": "5"}, "alternative-id": ["S001078241000137X"], "URL": "http://dx.doi.org/10.1016/j.contraception.2010.03.020", "ISSN": ["0010-7824"], "issn-type": [{"value": "0010-7824", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T07:55:02Z", "timestamp": 1575273302086}, "publisher-location": "Cham", "reference-count": 148, "publisher": "Springer International Publishing", "isbn-type": [{"value": "9783319444437", "type": "print"}, {"value": "9783319444444", "type": "electronic"}], "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2018, 1, 1]], "date-time": "2018-01-01T00:00:00Z", "timestamp": 1514764800000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "published-print": {"date-parts": [[2018]]}, "DOI": "10.1007/978-3-319-44444-4_10", "type": "book-chapter", "created": {"date-parts": [[2018, 3, 31]], "date-time": "2018-03-31T15:03:56Z", "timestamp": 1522508636000}, "page": "289-323", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Central Hypogonadism in the Male: Physiopathology, Diagnosis, and Treatment"], "prefix": "10.1007", "author": [{"given": "Julia", "family": "Rohayem", "sequence": "first", "affiliation": []}, {"given": "Eberhard", "family": "Nieschlag", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2018, 4, 1]]}, "reference": [{"key": "10_CR1", "doi-asserted-by": "crossref", "first-page": "3322", "DOI": "10.1210/jc.2015-2332", "volume": "100", "author": "A Abbara", "year": "2015", "unstructured": "Abbara A, Jayasena CN, Christopoulos G, Narayanaswamy S, Izzi-Engbeaya C, Nijher GM, Comninos AN, Peters D, Buckley A, Ratnasabapathy R, Prague JK, Salim R, Lavery SA, Bloom SR, Szigeti M, Ashby DA, Trew GH, Dhillo WS. Efficacy of kisspeptin-54 to trigger oocyte maturation in women at high risk of ovarian hyperstimulation syndrome (OHSS) during in vitro fertilization (IVF) therapy. J Clin Endocrinol Metab. 2015;100:3322\u201331.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10_CR2", "doi-asserted-by": "crossref", "first-page": "17", "DOI": "10.1016/S0303-7207(01)00619-0", "volume": "185", "author": "JC Achermann", "year": "2001", "unstructured": "Achermann JC, Meeks JJ, Jameson JL. Phenotypic spectrum of mutations in DAX-1 and SF-1. Mol Cell Endocrinol. 2001;185:17\u201325.", "journal-title": "Mol Cell Endocrinol"}, {"key": "10_CR3", "doi-asserted-by": "crossref", "first-page": "6444", "DOI": "10.4081/ni.2016.6444", "volume": "8", "author": "M Alqwaifly", "year": "2016", "unstructured": "Alqwaifly M, Bohlega S. Ataxia and hypogonadotropic hypogonadism with intrafamilial variability caused by RNF216 mutation. Neurol Int. 2016;8:6444.", "journal-title": "Neurol Int"}, {"key": "10_CR4", "doi-asserted-by": "crossref", "first-page": "379", "DOI": "10.1530/EJE-16-0912", "volume": "176", "author": "AK Bang", "year": "2017", "unstructured": "Bang AK, Nordkap L, Almstrup K, Priskorn L, Petersen JH, Rajpert-De Meyts E, Andersson AM, Juul A, J\u00f8rgensen N. Dynamic GnRH and hCG testing: establishment of new diagnostic reference levels. Eur J Endocrinol. 2017;176:379\u201391.", "journal-title": "Eur J Endocrinol"}, {"key": "10_CR5", "doi-asserted-by": "crossref", "first-page": "244", "DOI": "10.1016/S0015-0282(98)00450-6", "volume": "71", "author": "R Barrio", "year": "1999", "unstructured": "Barrio R, De Luis D, Alonso M, Lamas A, Moreno JC. Induction of puberty with human chorionic gonadotropin and follicle-stimulating hormone in adolescent males with hypogonadotropic hypogonadism. Fertil Steril. 1999;71:244\u20138.", "journal-title": "Fertil Steril"}, {"key": "10_CR6", "doi-asserted-by": "crossref", "first-page": "309", "DOI": "10.1017/CBO9781139003353.016", "volume-title": "Testosterone: action, deficiency, substitution", "author": "HM Behre", "year": "2012", "unstructured": "Behre HM, Nieschlag E. Testosterone preparations for clinical use in males. In: Nieschlag E, Behre HM, Nieschlag S, editors. Testosterone: action, deficiency, substitution. 4th ed. Cambridge: Cambridge University Press; 2012. p. 309\u201335.", "edition": "4"}, {"key": "10_CR7", "doi-asserted-by": "crossref", "first-page": "169", "DOI": "10.1007/978-3-540-78355-8_12", "volume-title": "Andrology: male reproductive health and dysfunction", "author": "HM Behre", "year": "2010", "unstructured": "Behre HM, Nieschlag E, Partsch CJ, Wieacker P, Simoni M. Diseases of the hypothalamus and the pituitary gland. In: Nieschlag E, Behre HM, editors. Andrology: male reproductive health and dysfunction. 3rd ed. Berlin: Springer; 2010. p. 169\u201392.", "edition": "3"}, {"key": "10_CR8", "doi-asserted-by": "crossref", "first-page": "629", "DOI": "10.1046/j.1365-2265.1999.00705.x", "volume": "50", "author": "HM Behre", "year": "1999", "unstructured": "Behre HM, von Eckardstein S, Kliesch S, Nieschlag E. Long-term substitution therapy of hypogonadal men with transscrotal testosterone over 7\u201310 years. Clin Endocr. 1999;50:629\u201335.", "journal-title": "Clin Endocr"}, {"key": "10_CR9", "doi-asserted-by": "crossref", "first-page": "198", "DOI": "10.3109/13685538.2012.699562", "volume": "15", "author": "HM Behre", "year": "2012", "unstructured": "Behre HM, Tammela TL, Arver S, Tolr\u00e1 JR, Bonifacio V, Lamche M, Kelly J, Hiemeyer F, European Testogel\u00ae Study Team, Giltay EJ, Gooren LJ. A randomized, double-blind, placebo-controlled trial of testosterone gel on body composition and health-related quality-of-life in men with hypogonadal to low-normal levels of serum testosterone and symptoms of androgen deficiency over 6 months with 12 months open-label follow-up. Aging Male. 2012;15:198\u2013207.", "journal-title": "Aging Male"}, {"key": "10_CR10", "doi-asserted-by": "crossref", "first-page": "101", "DOI": "10.1007/978-3-540-78355-8_6", "volume-title": "Andrology: male reproductive health and dysfunction", "author": "HM Behre", "year": "2010", "unstructured": "Behre HM, Zitzmann M. Imaging diagnosis. In: Nieschlag E, Behre HM, editors. Andrology: male reproductive health and dysfunction. 3rd ed. Berlin: Springer; 2010. p. 101\u20137.", "edition": "3"}, {"key": "10_CR11", "doi-asserted-by": "crossref", "first-page": "631", "DOI": "10.1126/science.100883", "volume": "202", "author": "PE Belchetz", "year": "1978", "unstructured": "Belchetz PE, Plant TM, Nakai Y, Keogh EJ, Knobil E. Hypophyseal responses to continuous and intermittent delivery of hypothalamic gonadotropin releasing hormone. Science. 1978;202:631\u20133.", "journal-title": "Science"}, {"key": "10_CR12", "doi-asserted-by": "crossref", "first-page": "838", "DOI": "10.1016/j.fertnstert.2014.05.044", "volume": "102", "author": "D Beneduzzi", "year": "2014", "unstructured": "Beneduzzi D, Trarbach EB, Min L, Jorge AA, Garmes HM, Renk AC, Fichna M, Fichna P, Arantes KA, Costa EM, Zhang A, Adeola O, Wen J, Carroll RS, Mendon\u00e7a BB, Kaiser UB, Latronico AC, Silveira LF. Role of gonadotropin-releasing hormone receptor mutations in patients with a wide spectrum of pubertal delay. Fertil Steril. 2014;102:838\u201346.", "journal-title": "Fertil Steril"}, {"key": "10_CR13", "doi-asserted-by": "crossref", "first-page": "2536", "DOI": "10.1210/jc.2009-2354", "volume": "6", "author": "S Bhasin", "year": "2010", "unstructured": "Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM, Task force, Endocrine Society. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;6:2536\u201359.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10_CR14", "doi-asserted-by": "crossref", "first-page": "2430", "DOI": "10.1210/jc.2010-3012", "volume": "96", "author": "S Bhasin", "year": "2011", "unstructured": "Bhasin S, Pencina M, Jasuja GK, Travison TG, Coviello A, Orwoll E, Wang PY, Nielson C, Wu F, Tajar A, Labrie F, Vesper H, Zhang A, Ulloor J, Singh R, D'Agostino R, Vasan RS. Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham heart study and applied to three geographically distinct cohorts. J Clin Endocrinol Metab. 2011;96:2430\u20139.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10_CR16", "doi-asserted-by": "crossref", "first-page": "547", "DOI": "10.1038/nrendo.2015.112", "volume": "11", "author": "U Boehm", "year": "2015", "unstructured": "Boehm U, Bouloux PM, Dattani MT, de Roux N, Dod\u00e9 C, Dunkel L, Dwyer AA, Giacobini P, Hardelin JP, Juul A, Maghnie M, Pitteloud N, Prevot V, Raivio T, Tena-Sempere M, Quinton R, Young J. Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism\u2013pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2015;11:547\u201364.", "journal-title": "Nat Rev Endocrinol"}, {"key": "10_CR17", "doi-asserted-by": "crossref", "first-page": "2742", "DOI": "10.1056/NEJMoa0900136", "volume": "360", "author": "J Bouligand", "year": "2009", "unstructured": "Bouligand J, Ghervan C, Tello JA, Brailly-Tabard S, Salenave S, Chanson P, Lomb\u00e8s M, Millar RP, Guiochon-Mantel A, Young J. Isolated familial hypogonadotropic hypogonadism and a GNRH1 mutation. N Engl J Med. 2009;360:2742\u20138.", "journal-title": "N Engl J Med"}, {"key": "10_CR18", "doi-asserted-by": "crossref", "first-page": "270", "DOI": "10.1016/S0015-0282(01)02973-9", "volume": "77", "author": "P Bouloux", "year": "2002", "unstructured": "Bouloux P, Warne DW, Loumaye E. Efficacy and safety of recombinant human follicle-stimulating hormone in men with isolated hypogonadotropic hypogonadism. Fertil Steril. 2002;77:270\u20133.", "journal-title": "Fertil Steril"}, {"key": "10_CR19", "doi-asserted-by": "crossref", "first-page": "604", "DOI": "10.1002/j.1939-4640.2003.tb02712.x", "volume": "24", "author": "PM Bouloux", "year": "2003", "unstructured": "Bouloux PM, Nieschlag E, Burger HG, Skakkebaek NE, FC W, Handelsman DJ, Baker GH, Ochsenkuehn R, Syska A, McLachlan RI, Giwercman A, Conway AJ, Turner L, van Kuijk JH, Voortman G. Induction of spermatogenesis by recombinant follicle-stimulating hormone (puregon) in hypogonadotropic azoospermic men who failed to respond to human chorionic gonadotropin alone. J Androl. 2003;24:604\u201311.", "journal-title": "J Androl"}, {"key": "10_CR20", "doi-asserted-by": "crossref", "first-page": "298", "DOI": "10.1530/eje.0.1390298", "volume": "139", "author": "D B\u00fcchter", "year": "1998", "unstructured": "B\u00fcchter D, Behre HM, Kliesch S, Nieschlag E. Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases. Eur J Endocrinol. 1998;139:298\u2013303.", "journal-title": "Eur J Endocrinol"}, {"key": "10_CR21", "doi-asserted-by": "crossref", "first-page": "980", "DOI": "10.1093/humrep/12.5.980", "volume": "12", "author": "S Burgu\u00e9s", "year": "1997", "unstructured": "Burgu\u00e9s S, Calder\u00f3n MD. Subcutaneous self-administration of highly purified follicle stimulating hormone and human chorionic gonadotrophin for the treatment of male hypogonadotrophic hypogonadism. Hum Reprod. 1997;12:980\u20136.", "journal-title": "Hum Reprod"}, {"key": "10_CR22", "doi-asserted-by": "crossref", "first-page": "1144", "DOI": "10.1210/jcem-66-6-1144", "volume": "66", "author": "AS Burris", "year": "1988", "unstructured": "Burris AS, Rodbard HW, Winters SJ, Sherins RJ. Gonadotropin therapy in men with isolated hypogonadotropic hypogonadism: the response to human chorionic gonadotropin is predicted by initial testicular size. J Endocrinol Metab. 1988;66:1144\u201351.", "journal-title": "J Endocrinol Metab"}, {"key": "10_CR23", "doi-asserted-by": "crossref", "first-page": "53", "DOI": "10.2147/AGG.S74598", "volume": "2015", "author": "MG Butler", "year": "2015", "unstructured": "Butler MG, Wang K, Marshall JD, Naggert JK, Rethmeyer JA, Gunewardena SS, Manzardo AM. Coding and noncoding expression patterns associated with rare obesity-related disorders: Prader-Willi and Alstr\u00f6m syndromes. Adv Genomics Genet. 2015;2015:53\u201375.", "journal-title": "Adv Genomics Genet"}, {"key": "10_CR24", "doi-asserted-by": "crossref", "first-page": "11703", "DOI": "10.1073/pnas.0903449106", "volume": "106", "author": "YM Chan", "year": "2009", "unstructured": "Chan YM, de Guillebon A, Lang-Muritano M, Plummer L, Cerrato F, Tsiaras S, Gaspert A, Lavoie HB, Wu CH, Crowley WF Jr, Amory JK, Pitteloud N, Seminara SB. GNRH1 mutations in patients with idiopathic hypogonadotropic hypogonadism. Proc Natl Acad Sci U S A. 2009;106:11703\u20138.", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "10_CR25", "doi-asserted-by": "crossref", "first-page": "E2762", "DOI": "10.1210/jc.2014-2233", "volume": "99", "author": "YM Chan", "year": "2014", "unstructured": "Chan YM, Lippincott MF, Butler JP, Sidhoum VF, Li CX, Plummer L, Seminara SB. Exogenous kisspeptin administration as a probe of GnRH neuronal function in patients with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2014;99:E2762\u201371.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10_CR26", "doi-asserted-by": "crossref", "first-page": "612", "DOI": "10.1210/jc.2006-1311", "volume": "92", "author": "HL Claahsen-van der Grinten", "year": "2007", "unstructured": "Claahsen-van der Grinten HL, Otten BJ, Takahashi S, Meuleman EJ, Hulsbergen-van de Kaa C, Hermus AR. Testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia: evaluation of pituitary-gonadal function before and after successful testis-sparing surgery in eight patients. J Clin Endocrinol Metab. 2007;92:612\u20135.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10_CR27", "doi-asserted-by": "crossref", "first-page": "398", "DOI": "10.1038/32911", "volume": "392", "author": "K Cl\u00e9ment", "year": "1998", "unstructured": "Cl\u00e9ment K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, Gourmelen M, Dina C, Chambaz J, Lacorte JM, Basdevant A, Bougn\u00e8res P, Lebouc Y, Froguel P, Guy-Grand B. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature. 1998;392:398\u2013401.", "journal-title": "Nature"}, {"key": "10_CR28", "doi-asserted-by": "crossref", "first-page": "5225", "DOI": "10.1210/jc.2010-1535", "volume": "95", "author": "R Coutant", "year": "2010", "unstructured": "Coutant R, Biette-Demeneix E, Bouvattier C, Bouhours-Nouet N, Gatelais F, Dufresne S, Rouleau S, Lahlou N. Baseline inhibin B and anti-Mullerian hormone measurements for diagnosis of hypogonadotropic hypogonadism (HH) in boys with delayed puberty. J Clin Endocrinol Metab. 2010;95:5225\u201332.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10_CR29", "doi-asserted-by": "crossref", "first-page": "E943", "DOI": "10.1210/jc.2012-4116", "volume": "98", "author": "FA Costa-Barbosa", "year": "2013", "unstructured": "Costa-Barbosa FA, Balasubramanian R, Keefe KW, Shaw ND, Al-Tassan N, Plummer L, Dwyer AA, Buck CL, Choi JH, Seminara SB, Quinton R, Monies D, Meyer B, Hall JE, Pitteloud N, Crowley WF Jr. Prioritizing genetic testing in patients with Kallmann syndrome using clinical phenotypes. J Clin Endocrinol Metab. 2013;98:E943\u201353.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10_CR30", "doi-asserted-by": "crossref", "first-page": "377", "DOI": "10.1054/jpai.2002.126790", "volume": "3", "author": "HW Daniell", "year": "2002", "unstructured": "Daniell HW. Hypogonadism in men consuming sustained-action oral opioids. The J Pain. 2002;3:377\u201384.", "journal-title": "The J Pain"}, {"key": "10_CR31", "doi-asserted-by": "crossref", "first-page": "216", "DOI": "10.1111/bju.13578", "volume": "119", "author": "FM Debruyne", "year": "2017", "unstructured": "Debruyne FM, Behre HM, Roehrborn CG, Maggi M, Wu FC, Schr\u00f6der FH, Jones TH, Porst H, Hackett G, Wheaton OA, Martin-Morales A, Meuleman E, Cunningham GR, Divan HA, Rosen RC, Investigators RHYME. Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the registry of hypogonadism in men. BJU Int. 2017;119:216\u201324.", "journal-title": "BJU Int"}, {"issue": "Suppl 3", "key": "10_CR32", "doi-asserted-by": "crossref", "first-page": "U89", "DOI": "10.1530/eje.0.151U089", "volume": "151", "author": "HA Delemarre-van de Waal", "year": "2004", "unstructured": "Delemarre-van de Waal HA. Application of gonadotropin releasing hormone in hypogonadotropic hypogonadism-diagnostic and therapeutic aspects. Eur J Endocrinol. 2004;151(Suppl 3):U89\u201394.", "journal-title": "Eur J Endocrinol"}, {"key": "10_CR33", "doi-asserted-by": "crossref", "first-page": "617", "DOI": "10.1530/eje.0.1470617", "volume": "147", "author": "M Depenbusch", "year": "2002", "unstructured": "Depenbusch M, von Eckardstein S, Simoni M, Nieschlag E. Maintenance of spermatogenesis in hypogonadotropic hypogonadal men with hCG alone. Eur J Endorinol. 2002;147:617\u201324.", "journal-title": "Eur J Endorinol"}, {"key": "10_CR34", "doi-asserted-by": "crossref", "first-page": "425", "DOI": "10.1093/humrep/den372", "volume": "24", "author": "W Ronde de", "year": "2009", "unstructured": "de Ronde W. Hyperandrogenism after transfer of topical testosterone gel: case report and review of published and unpublished studies. Hum Reprod. 2009;24:425\u20138.", "journal-title": "Hum Reprod"}, {"key": "10_CR35", "doi-asserted-by": "crossref", "first-page": "10972", "DOI": "10.1073/pnas.1834399100", "volume": "100", "author": "N Roux de", "year": "2003", "unstructured": "de Roux N, Genin E, Carel JC, Matsuda F, Chaussain JL, Milgrom E. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci U S A. 2003;100:10972\u20136.", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "10_CR36", "doi-asserted-by": "crossref", "first-page": "1597", "DOI": "10.1056/NEJM199711273372205", "volume": "337", "author": "N Roux de", "year": "1997", "unstructured": "de Roux N, Young J, Misrahi M, Genet R, Chanson P, Schaison G, Milgrom E. A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor. N Engl J Med. 1997;337:1597\u2013602.", "journal-title": "N Engl J Med"}, {"key": "10_CR37", "doi-asserted-by": "crossref", "first-page": "618", "DOI": "10.1007/s12020-016-1088-1", "volume": "55", "author": "SM Sousa De", "year": "2017", "unstructured": "De Sousa SM, Chapman IM, Falhammar H, Torpy DJ. Dopa-testotoxicosis: disruptive hypersexuality in hypogonadal men with prolactinomas treated with dopamine agonists. Endocrine. 2017;55:618\u201324.", "journal-title": "Endocrine"}, {"key": "10_CR38", "doi-asserted-by": "crossref", "first-page": "1186", "DOI": "10.2337/dc09-1649", "volume": "33", "author": "S Dhindsa", "year": "2010", "unstructured": "Dhindsa S, Miller MG, McWhirter CL, Mager DE, Ghanim H, Chaudhuri A, Dandona P. Testosterone concentrations in diabetic and nondiabetic obese men. Diabetes Care. 2010;33:1186\u201392.", "journal-title": "Diabetes Care"}, {"key": "10_CR39", "doi-asserted-by": "crossref", "first-page": "162", "DOI": "10.1111/j.1464-410X.2011.10837.x", "volume": "110", "author": "WW Dinsmore", "year": "2012", "unstructured": "Dinsmore WW, Wyllie MG. The long-term efficacy and safety of a testosterone mucoadhesive buccal tablet in testosterone-deficient men. Br J Urol Int. 2012;110:162\u20139.", "journal-title": "Br J Urol Int"}, {"key": "10_CR40", "doi-asserted-by": "crossref", "first-page": "463", "DOI": "10.1038/ng1122", "volume": "33", "author": "C Dod\u00e9", "year": "2003", "unstructured": "Dod\u00e9 C, Levilliers J, Dupont JM, De Paepe A, Le D\u00fb N, Soussi-Yanicostas N, Coimbra RS, Delmaghani S, Compain-Nouaille S, Baverel F, P\u00eacheux C, Le Tessier D, Cruaud C, Delpech M, Speleman F, Vermeulen S, Amalfitano A, Bachelot Y, Bouchard P, Cabrol S, Carel JC, Delemarre-van de Waal H, Goulet-Salmon B, Kottler ML, Richard O, Sanchez-Franco F, Saura R, Young J, Petit C, Hardelin JP. Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat Genet. 2003;33:463\u20135.", "journal-title": "Nat Genet"}, {"key": "10_CR41", "author": "C Dod\u00e9", "volume": "2", "year": "2006", "unstructured": "Dod\u00e9 C, Teixeira L, Levilliers J, Fouveaut C, Bouchard P, Kottler ML, Lespinasse J, Lienhardt-Roussie A, Mathieu M, Moerman A, Morgan G, Murat A, Toublanc JE, Wolczynski S, Delpech M, Petit C, Young J, Hardelin JP. Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2. PLoS Genet. 2006;2:e175.", "journal-title": "PLoS Genet", "DOI": "10.1371/journal.pgen.0020175", "doi-asserted-by": "crossref"}, {"key": "10_CR42", "unstructured": "Dohle GR, Arvers S, Bettocchi C (2012) Guidelines on male hypogonadism. European Association of Urology. www.uroweb.org."}, {"key": "10_CR43", "doi-asserted-by": "crossref", "first-page": "93", "DOI": "10.1006/neur.1995.0011", "volume": "4", "author": "RL Doty", "year": "1995", "unstructured": "Doty RL, Bromley SM, Stern MB. Olfactory testing as an aid in the diagnosis of Parkinson's disease: development of optimal discrimination criteria. Neurodegeneration. 1995;4:93\u20137.", "journal-title": "Neurodegeneration"}, {"key": "10_CR44", "doi-asserted-by": "crossref", "first-page": "229", "DOI": "10.1530/EJE-13-0894", "volume": "170", "author": "L Dunkel", "year": "2014", "unstructured": "Dunkel L, Quinton R. Transition in endocrinology: induction of puberty. Eur J Endocrinol. 2014;170:229\u201339.", "journal-title": "Eur J Endocrinol"}, {"key": "10_CR45", "doi-asserted-by": "crossref", "first-page": "R15", "DOI": "10.1530/EJE-14-0947", "volume": "173", "author": "AA Dwyer", "year": "2015", "unstructured": "Dwyer AA, Phan-Hug F, Hauschild M, Elowe-Gruau E, Pitteloud N. TRANSITION IN ENDOCRINOLOGY: Hypogonadism in adolescence. Eur J Endocrinol. 2015;173:R15\u201324.", "journal-title": "Eur J Endocrinol"}, {"key": "10_CR47", "doi-asserted-by": "crossref", "first-page": "R267", "DOI": "10.1530/EJE-15-1033", "volume": "174", "author": "AA Dwyer", "year": "2016", "unstructured": "Dwyer AA, Raivio T, Pitteloud N. MANAGEMENT OF ENDOCRINE DISEASE: Reversible hypogonadotropic hypogonadism. Eur J Endocrinol. 2016;174:R267\u201374.", "journal-title": "Eur J Endocrinol"}, {"key": "10_CR48", "doi-asserted-by": "crossref", "first-page": "892", "DOI": "10.1210/jc.2005-0902", "volume": "91", "author": "U Eiholzer", "year": "2006", "unstructured": "Eiholzer U, l'Allemand D, Rousson V, Schlumpf M, Gasser T, Girard J, Gr\u00fcters A, Simoni M. Hypothalamic and gonadal components of hypogonadism in boys with Prader-Labhart-Willi syndrome. J Clin Endocrinol Metab. 2006;91:892\u20138.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10_CR49", "doi-asserted-by": "crossref", "first-page": "256", "DOI": "10.1016/S0015-0282(98)00156-3", "volume": "70", "author": "European Metrodin HP Study Group EMHSG", "year": "1998", "unstructured": "European Metrodin HP Study Group EMHSG. Efficacy and safety of highly purified urinary follicle-stimulating hormone with human chorionic gonadotropin for treating men with isolated hypogonadotropic hypogonadism. European Metrodin HP Study Group. Fertil Steril. 1998;70:256\u201362.", "journal-title": "Fertil Steril"}, {"key": "10_CR50", "doi-asserted-by": "crossref", "first-page": "2822", "DOI": "10.1172/JCI34538", "volume": "118", "author": "J Falardeau", "year": "2008", "unstructured": "Falardeau J, Chung WC, Beenken A, Raivio T, Plummer L, Sidis Y, Jacobson-Dickman EE, Eliseenkova AV, Ma J, Dwyer A, Quinton R, Na S, Hall JE, Huot C, Alois N, Pearce SH, Cole LW, Hughes V, Mohammadi M, Tsai P, Pitteloud N. Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice. J Clin Invest. 2008;118:2822\u201331.", "journal-title": "J Clin Invest"}, {"key": "10_CR51", "first-page": "102", "volume": "73", "author": "C Fennell", "year": "2010", "unstructured": "Fennell C, Sartorius G, Ly LP, Turner L, Liu PY, Conway AJ, Handelsman DJ. Randomized cross-over clinical trial of injectable vs. implantable depot testosterone for maintenance of testosterone replacement therapy in androgen deficient men. Clin Endocrinol. 2010;73:102\u20139.", "journal-title": "Clin Endocrinol"}, {"key": "10_CR52", "doi-asserted-by": "crossref", "first-page": "651", "DOI": "10.1056/NEJM198509123131102", "volume": "313", "author": "DM Finkel", "year": "1985", "unstructured": "Finkel DM, Phillips BA, Snyder PJ. Stimulation of spermatogenesis by gonadotropins in men with hypogonadotropic hypogonadism. N Engl J Med. 1985;313:651\u20135.", "journal-title": "N Engl J Med"}, {"key": "10_CR53", "doi-asserted-by": "crossref", "first-page": "2836", "DOI": "10.1210/jc.2009-2466", "volume": "95", "author": "P Fischer-Posovszky", "year": "2010", "unstructured": "Fischer-Posovszky P, von Schnurbein J, Moepps B, Lahr G, Strauss G, Barth TF, Kassubek J, M\u00fchleder H, M\u00f6ller P, Debatin KM, Gierschik P, Wabitsch M. A new missense mutation in the leptin gene causes mild obesity and hypogonadism without affecting T cell responsiveness. J Clin Endocrinol Metab. 2010;95:2836\u201340.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10_CR54", "doi-asserted-by": "crossref", "first-page": "3888", "DOI": "10.1210/jc.2016-2118", "volume": "101", "author": "M Fleseriu", "year": "2016", "unstructured": "Fleseriu M, Hashim IA, Karavitaki N, Melmed S, Murad MH, Salvatori R, Samuels MH. Hormonal replacement in hypopituitarism in adults: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2016;101:3888\u2013921.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10_CR55", "doi-asserted-by": "crossref", "first-page": "724", "DOI": "10.1093/humrep/deq372", "volume": "26", "author": "C Frapsauce", "year": "2011", "unstructured": "Frapsauce C, Ravel C, Legendre M, Sibony M, Mandelbaum J, Donadille B, Achermann JC, Siffroi JP, Christin-Maitre S. Birth after TESE-ICSI in a man with hypogonadotropic hypogonadism and congenital adrenal hypoplasia linked to a DAX-1 (NR0B1) mutation. Hum Reprod. 2011;26:724\u20138.", "journal-title": "Hum Reprod"}, {"key": "10_CR56", "doi-asserted-by": "crossref", "first-page": "181", "DOI": "10.1007/s40271-015-0138-8", "volume": "9", "author": "HL Gelhorn", "year": "2016", "unstructured": "Gelhorn HL, Vernon MK, Stewart KD, Miller MG, Brod M, Althof SE, DeRogatis LR, Dobs A, Seftel AD, Revicki DA. Content validity of the hypogonadism impact of symptoms questionnaire (HIS-Q): a patient-reported outcome measure to evaluate symptoms of hypogonadism. Patient. 2016;9:181\u201390.", "journal-title": "Patient"}, {"key": "10_CR57", "doi-asserted-by": "crossref", "first-page": "265", "DOI": "10.1007/BF01541744", "volume": "17", "author": "L Gooren", "year": "1988", "unstructured": "Gooren L. Hypogonadotropic hypogonadal men respond less well to androgen substitution treatment than hypergonadotropic hypogonadal men. Arch Sex Behav. 1988;17:265\u201370.", "journal-title": "Arch Sex Behav"}, {"key": "10_CR58", "unstructured": "Greulich WW, Pyle SI, editors. Radiographic atlas of skeletal development of hand and wrist. 2. ed. California: Stanford University Press; 1959.", "DOI": "10.1097/00000441-195909000-00030", "doi-asserted-by": "crossref"}, {"key": "10_CR59", "doi-asserted-by": "crossref", "first-page": "81", "DOI": "10.1159/000277140", "volume": "73", "author": "RP Grinspon", "year": "2010", "unstructured": "Grinspon RP, Rey RA. Anti-mullerian hormone and sertoli cell function in paediatric male hypogonadism. Horm Res Paediatr. 2010;73:81\u201392.", "journal-title": "Horm Res Paediatr"}, {"key": "10_CR60", "doi-asserted-by": "crossref", "first-page": "1055", "DOI": "10.1172/JCI118866", "volume": "98", "author": "RL Habiby", "year": "1996", "unstructured": "Habiby RL, Boepple P, Nachtigall L, Sluss PM, Crowley WF Jr, Jameson JL. Adrenal hypoplasia congenita with hypogonadotropic hypogonadism: evidence that DAX-1 mutations lead to combined hypothalmic and pituitary defects in gonadotropin production. J Clin Invest. 1996;98:1055\u201362.", "journal-title": "J Clin Invest"}, {"key": "10_CR61", "doi-asserted-by": "crossref", "first-page": "463", "DOI": "10.1530/EJE-13-0222", "volume": "169", "author": "R Haring", "year": "2013", "unstructured": "Haring R, Baumeister SE, Nauck M, V\u00f6lzke H, Keevil BG, Brabant G, Wallaschofski H. Testosterone and cardiometabolic risk in the general population \u2013 the impact of measurement method on risk associations: a comparative study between immunoassay and mass spectrometry. Eur J Endocrinol. 2013;169:463\u201370.", "journal-title": "Eur J Endocrinol"}, {"key": "10_CR62", "doi-asserted-by": "crossref", "first-page": "3056", "DOI": "10.1210/jc.2012-1598", "volume": "97", "author": "J Harrington", "year": "2012", "unstructured": "Harrington J, Palmert MR. Clinical review: Distinguishing constitutional delay of growth and puberty from isolated hypogonadotropic hypogonadism: critical appraisal of available diagnostic tests. J Clin Endocrinol Metab. 2012;97:3056\u201367.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10_CR63", "first-page": "3027", "volume": "85", "author": "FJ Hayes", "year": "2000", "unstructured": "Hayes FJ, Seminara SB, Decruz S, Boepple PA, Crowley WF Jr. Aromatase inhibition in the human male reveals a hypothalamic site of estrogen feedback. J Clin Endocrinol Metab. 2000;85:3027\u201335.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10_CR64", "doi-asserted-by": "crossref", "first-page": "1202", "DOI": "10.1056/NEJM198205203062003", "volume": "306", "author": "DB Hier", "year": "1982", "unstructured": "Hier DB, Crowley WF Jr. Spatial ability in androgen-deficient men. N Engl J Med. 1982;306:1202\u20135.", "journal-title": "N Engl J Med"}, {"key": "10_CR65", "doi-asserted-by": "crossref", "first-page": "983", "DOI": "10.1530/EJE-11-1051", "volume": "166", "author": "IT Huhtaniemi", "year": "2012", "unstructured": "Huhtaniemi IT, Tajar A, Lee DM, O'Neill TW, Finn JD, Bartfai G, Boonen S, Casanueva FF, Giwercman A, Han TS, Kula K, Labrie F, Lean ME, Pendleton N, Punab M, Silman AJ, Vanderschueren D, Forti G, Wu FC, EMAS Group. Comparison of serum testosterone and estradiol measurements in 3174 European men using platform immunoassay and mass spectrometry; relevance for the diagnostics in aging men. Eur J Endocrinol. 2012;166:983\u201391.", "journal-title": "Eur J Endocrinol"}, {"key": "10_CR66", "doi-asserted-by": "crossref", "first-page": "237", "DOI": "10.1007/s00405-006-0173-0", "volume": "264", "author": "T Hummel", "year": "2007", "unstructured": "Hummel T, Kobal G, Gudziol H, Mackay-Sim A. Normative data for the \"Sniffin' Sticks\" including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3,000 subjects. Eur Arch Otorhinolaryngol. 2007;264:237\u201343.", "journal-title": "Eur Arch Otorhinolaryngol"}, {"key": "10_CR67", "doi-asserted-by": "crossref", "first-page": "65", "DOI": "10.1016/j.mce.2011.04.017", "volume": "346", "author": "U Jadhav", "year": "2011", "unstructured": "Jadhav U, Harris RM, Jameson JL. Hypogonadotropic hypogonadism in subjects with DAX1 mutations. Mol Cell Endocrinol. 2011;346:65\u201373.", "journal-title": "Mol Cell Endocrinol"}, {"key": "10_CR68", "doi-asserted-by": "crossref", "first-page": "1149", "DOI": "10.1002/humu.22086", "volume": "33", "author": "N Janssen", "year": "2012", "unstructured": "Janssen N, Bergman JE, Swertz MA, Tranebjaerg L, Lodahl M, Schoots J, Hofstra RM, van Ravenswaaij-Arts CM, Hoefsloot LH. Mutation update on the CHD7 gene involved in CHARGE syndrome. Hum Mutat. 2012;33:1149\u201360.", "journal-title": "Hum Mutat"}, {"key": "10_CR69", "doi-asserted-by": "crossref", "first-page": "763", "DOI": "10.1530/acta.0.0890763", "volume": "89", "author": "SG Johnsen", "year": "1978", "unstructured": "Johnsen SG. Maintenance of spermatogenesis induced by hMG treatment by means of continuous hCG treatment in hypogonadotropic men. Acta Endocrinol. 1978;89:763\u20139.", "journal-title": "Acta Endocrinol"}, {"key": "10_CR70", "doi-asserted-by": "crossref", "first-page": "167", "DOI": "10.1016/bs.pmbts.2015.10.010", "volume": "138", "author": "Z Karaca", "year": "2016", "unstructured": "Karaca Z, Tanr\u0131verdi F, \u00dcnl\u00fch\u0131zarc\u0131 K, Kelestimur F. GH and pituitary hormone alterations after traumatic brain injury. Prog Mol Biol Transl Sci. 2016;138:167\u201391.", "journal-title": "Prog Mol Biol Transl Sci"}, {"key": "10_CR71", "doi-asserted-by": "crossref", "first-page": "469", "DOI": "10.1046/j.1365-2265.1999.00827.x", "volume": "51", "author": "S Kelleher", "year": "1999", "unstructured": "Kelleher S, Turner L, Howe C, Conway AJ, Handelsman DJ. Extrusion of testosterone pellets: a randomized controlled clinical study. Clin Endocrinol. 1999;51:469\u201371.", "journal-title": "Clin Endocrinol"}, {"key": "10_CR72", "doi-asserted-by": "crossref", "first-page": "1161", "DOI": "10.1089/neu.2013.3212", "volume": "31", "author": "DF Kelly", "year": "2014", "unstructured": "Kelly DF, Chaloner C, Evans D, Mathews A, Cohan P, Wang C, Swerdloff R, Sim MS, Lee J, Wright MJ, Kernan C, Barkhoudarian G, Yuen KC, Guskiewicz K. Prevalence of pituitary hormone dysfunction, metabolic syndrome, and impaired quality of life in retired professional football players: a prospective study. J Neurotrauma. 2014;31:1161\u201371.", "journal-title": "J Neurotrauma"}, {"key": "10_CR73", "doi-asserted-by": "crossref", "first-page": "3", "DOI": "10.1111/cge.12737", "volume": "90", "author": "SA Khan", "year": "2016", "unstructured": "Khan SA, Muhammad N, Khan MA, Kamal A, Rehman ZU, Khan S. Genetics of human Bardet-Biedl syndrome, an update. Clin Genet. 2016;90:3\u201315.", "journal-title": "Clin Genet"}, {"key": "10_CR74", "doi-asserted-by": "crossref", "first-page": "1326", "DOI": "10.1016/S0015-0282(16)57619-5", "volume": "63", "author": "S Kliesch", "year": "1995", "unstructured": "Kliesch S, Behre HM, Nieschlag E. Recombinant human follicle-stimulating hormone and human chorionic gonadotropin for induction of spermatogenesis in a hypogonadotropic male. Fertil Steril. 1995;63:1326\u20138.", "journal-title": "Fertil Steril"}, {"key": "10_CR75", "doi-asserted-by": "crossref", "first-page": "317", "DOI": "10.1530/eje.1.01964", "volume": "153", "author": "B K\u00fchnert", "year": "2005", "unstructured": "K\u00fchnert B, Byrne M, Simoni M, K\u00f6pcke W, Gerss J, Lemmnitz G, Nieschlag E. Testosterone substitution with a new transdermal, hydroalcoholic gel applied to scrotal or non-scrotal skin: a multicentre trial. Eur J Endocrinol. 2005;153:317\u201326.", "journal-title": "Eur J Endocrinol"}, {"key": "10_CR77", "author": "EM Laitinen", "volume": "7", "year": "2012", "unstructured": "Laitinen EM, Tommiska J, Sane T, Vaaralahti K, Toppari J, Raivio T. Reversible congenital hypogonadotropic hypogonadism in patients with CHD7, FGFR1 or GNRHR mutations. PLoS One. 2012;7:e39450.", "journal-title": "PLoS One", "DOI": "10.1371/journal.pone.0039450", "doi-asserted-by": "crossref"}, {"key": "10_CR78", "doi-asserted-by": "crossref", "first-page": "14", "DOI": "10.1038/ng0198-14", "volume": "18", "author": "LC Layman", "year": "1998", "unstructured": "Layman LC, Cohen DP, Jin M, Xie J, Li Z, Reindollar RH, Bolbolan S, Bick DP, Sherins RR, Duck LW, Musgrove LC, Sellers JC, Neill JD. Mutations in gonadotropin-releasing hormone receptor gene cause hypogonadotropic hypogonadism. Nat Genet. 1998;18:14\u20135.", "journal-title": "Nat Genet"}, {"key": "10_CR79", "doi-asserted-by": "crossref", "first-page": "3479", "DOI": "10.1210/en.2010-0022", "volume": "151", "author": "MN Lehman", "year": "2010", "unstructured": "Lehman MN, Coolen LM, Goodman RL. Minireview: kisspeptin/neurokinin B/dynorphin (KNDy) cells of the arcuate nucleus: a central node in the control of gonadotropin-releasing hormone secretion. Endocrinology. 2010;151:3479\u201389.", "journal-title": "Endocrinology"}, {"key": "10_CR80", "doi-asserted-by": "crossref", "first-page": "4531", "DOI": "10.1073/pnas.0308767101", "volume": "101", "author": "J Licinio", "year": "2004", "unstructured": "Licinio J, Caglayan S, Ozata M, Yildiz BO, de Miranda PB, O'Kirwan F, Whitby R, Liang L, Cohen P, Bhasin S, Krauss RM, Veldhuis JD, Wagner AJ, DePaoli AM, McCann SM, Wong ML. Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. Proc Natl Acad Sci U S A. 2004;101:4531\u20136.", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "10_CR81", "doi-asserted-by": "crossref", "first-page": "1140", "DOI": "10.1210/jcem-67-6-1140", "volume": "67", "author": "L Liu", "year": "1988", "unstructured": "Liu L, Banks SM, Barnes KM, Sherins RJ. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 1988;67:1140\u20135.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10_CR83", "unstructured": "Liu PY, Gebski VJ, Turner L, Conway AJ, Wishart SM, Handelsman DJ. Predicting pregnancy and spermatogenesis by survival analysis during gonadotrophin treatment of gonadotrophin-deficient infertile men. Hum Reprod. 2002;17:625\u201333.", "DOI": "10.1093/humrep/17.3.625", "doi-asserted-by": "crossref"}, {"key": "10_CR82", "unstructured": "Liu PY, Swerdloff RS, Christenson PD, Handelsman DJ, Wang C. Hormonal Male Contraception Summit Group. Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis. Lancet. 2006;367:1412\u201320.", "DOI": "10.1016/S0140-6736(06)68614-5", "doi-asserted-by": "crossref"}, {"key": "10_CR84", "doi-asserted-by": "crossref", "first-page": "801", "DOI": "10.1210/jc.2008-1648", "volume": "94", "author": "PY Liu", "year": "2009", "unstructured": "Liu PY, Baker HW, Jayadev V, Zacharin M, Conway AJ, Handelsman DJ. Induction of spermatogenesis and fertility during gonadotropin treatment of gonadotropin-deficient infertile men: predictors of fertility outcome. J Clin Endocrinol Metab. 2009;94:801\u20138.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10_CR85", "doi-asserted-by": "crossref", "first-page": "897", "DOI": "10.1056/NEJMoa071999", "volume": "357", "author": "A Lofrano-Porto", "year": "2007", "unstructured": "Lofrano-Porto A, Barra GB, Giacomini LA, Nascimento PP, Latronico AC, Casulari LA, da Rocha Neves Fde A. Luteinizing hormone beta mutation and hypogonadism in men and women. N Engl J Med. 2007;357:897\u2013904.", "journal-title": "N Engl J Med"}, {"key": "10_CR86", "doi-asserted-by": "crossref", "first-page": "862", "DOI": "10.1093/oxfordjournals.humrep.a136051", "volume": "108", "author": "MA Mackey", "year": "1995", "unstructured": "Mackey MA, Conway AJ, Handelsman DJ. Tolerability of intramuscular injections of testosterone ester in oil vehicle. Hum Reprod. 1995;108:862\u20135.", "journal-title": "Hum Reprod"}, {"key": "10_CR87", "doi-asserted-by": "crossref", "first-page": "44", "DOI": "10.1210/jcem.87.1.8163", "volume": "87", "author": "G Mantovani", "year": "2002", "unstructured": "Mantovani G, Ozisik G, Achermann JC, Romoli R, Borretta G, Persani L, Spada A, Jameson JL, Beck-Peccoz P. Hypogonadotropic hypogonadism as a presenting feature of late-onset X-linked adrenal hypoplasia congenita. J Clin Endocrinol Metab. 2002;87:44\u20138.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10_CR88", "unstructured": "Mao JF, Liu ZX, Nie M, Wang X, HL X, Huang BK, Zheng JJ, Min L, Kaiser UB, Pulsatile WXY. Gonadotropin-releasing hormone therapy is associated with earlier spermatogenesis compared to combined gonadotropin therapy in patients with congenital hypogonadotropic hypogonadism. Asian J Androl. 2016. https://doi.org/10.4103/1008-682X.193568 .", "DOI": "10.4103/1008-682X.193568", "doi-asserted-by": "publisher"}, {"key": "10_CR89", "unstructured": "Matthews CH, Borgato S, Beck-Peccoz P, Adams M, Tone Y, Gambino G, Casagrande S, Tedeschini G, Benedetti A, Chatterjee VK. Primary amenorrhoea and infertility due to a mutation in the beta-subunit of follicle-stimulating hormone. Nat Genet. 1993;5:83\u20136.", "DOI": "10.1038/ng0993-83", "doi-asserted-by": "crossref"}, {"key": "10_CR90", "doi-asserted-by": "crossref", "first-page": "1184", "DOI": "10.1210/jcem-62-6-1184", "volume": "62", "author": "AM Matsumoto", "year": "1986", "unstructured": "Matsumoto AM, Karpas AE, Bremner WJ. Chronic human chorionic gonadotropin administration in normal men: evidence that follicle-stimulating hormone is necessary for the maintenance of quantitatively normal spermatogenesis in man. J Clin Endocrinol Metab. 1986;62:1184\u201392.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10_CR151", "unstructured": "Matsumoto AM, Snyder PJ, Bhasin S, Martin K, Weber T, Winters S, Spratt D, Brentzel J, O\u2019Dea L. Stimulation of spermatogenesis with recombinant human follicle-stimulating hormone (follitropin alfa; GONAL-f): long-term treatment in azoospermic men with hypogonadotropic hypogonadism. Fertil Steril 2009;92:979\u2013990.", "DOI": "10.1016/j.fertnstert.2008.07.1742", "doi-asserted-by": "crossref"}, {"key": "10_CR91", "doi-asserted-by": "crossref", "first-page": "477", "DOI": "10.1517/14656566.7.4.477", "volume": "7", "author": "T McNicholas", "year": "2006", "unstructured": "McNicholas T, Ong T. Review of Testim gel. Expert Opin Pharmacother. 2006;7:477\u201384.", "journal-title": "Expert Opin Pharmacother"}, {"key": "10_CR92", "first-page": "1", "volume": "24", "author": "D Nelson", "year": "2013", "unstructured": "Nelson D, Ho J, Pacaud D, Stephure D. Virilization in two pre-pubertal children exposed to topical androgen. J Pediatr Endocrinol Metab. 2013;24:1\u20135.", "journal-title": "J Pediatr Endocrinol Metab"}, {"key": "10_CR93", "doi-asserted-by": "crossref", "first-page": "182", "DOI": "10.1038/76041", "volume": "25", "author": "I Netchine", "year": "2000", "unstructured": "Netchine I, Sobrier ML, Krude H, Schnabel D, Maghnie M, Marcos E, Duriez B, Cacheux V, Moers A, Goossens M, Gruters A, Amselem S. Mutations in LHX3 result in a new syndrome revealed by combined pituitary hormone deficiency. Nat Genet. 2000;25:182\u20136.", "journal-title": "Nat Genet"}, {"key": "10_CR94", "doi-asserted-by": "crossref", "first-page": "457", "DOI": "10.1016/j.contraception.2010.03.020", "volume": "82", "author": "E Nieschlag", "year": "2010", "unstructured": "Nieschlag E. Clinical trials in male hormonal contraception. Contraception. 2010;82:457\u201370.", "journal-title": "Contraception"}, {"key": "10_CR98", "unstructured": "Nieschlag E, Nieschlag S. Testosterone deficiency: a historical perspective. Asian J Androl. 2014;16:161\u20138.", "DOI": "10.4103/1008-682X.122358", "doi-asserted-by": "crossref"}, {"key": "10_CR100", "doi-asserted-by": "crossref", "first-page": "47", "DOI": "10.1530/EJE-15-0080", "volume": "173", "author": "E Nieschlag", "year": "2015", "unstructured": "Nieschlag E, Vorona E. Medical consequences of doping with anabolic androgenic steroids: effects on reproductive functions. Eur J Endocrinol. 2015;173:47\u201358.", "journal-title": "Eur J Endocrinol"}, {"key": "10_CR95", "doi-asserted-by": "crossref", "first-page": "409", "DOI": "10.1093/humupd/dmh035", "volume": "10", "author": "E Nieschlag", "year": "2004", "unstructured": "Nieschlag E, Behre HM, Bouchard P, Corrales JJ, Jones TH, Stalla GK, Webb SM, Wu FC. Testosterone replacement therapy: current trends and future directions. Hum Reprod Update. 2004;10:409\u201319.", "journal-title": "Hum Reprod Update"}, {"key": "10_CR96", "doi-asserted-by": "crossref", "first-page": "17", "DOI": "10.1186/s12958-017-0232-y", "volume": "15", "author": "E Nieschlag", "year": "2017", "unstructured": "Nieschlag E, Bouloux P-MG, Stegmann BJ, Shankar RR, Guan Y, Tzontcheva A, McCrary Sisk C, Behre H. Efficacy and safety of the long-acting Corifollitropin Alfa in combination with hCG in adult men with hypogonadotropic hypodonadism. Reprod Endocr Biol. 2017;15:17.", "journal-title": "Reprod Endocr Biol"}, {"key": "10_CR97", "doi-asserted-by": "crossref", "first-page": "757", "DOI": "10.1046/j.1365-2265.1999.00881.x", "volume": "51", "author": "E Nieschlag", "year": "1999", "unstructured": "Nieschlag E, B\u00fcchter D, Von Eckardstein S, Abshagen K, Simoni M, Behre HM. Repeated intramuscular injections of testosterone undecanoate for substitution therapy in hypogonadal men. Clin Endocrinol. 1999a;51:757\u201363.", "journal-title": "Clin Endocrinol"}, {"key": "10_CR99", "doi-asserted-by": "crossref", "first-page": "139", "DOI": "10.1046/j.1365-2265.1999.00846.x", "volume": "51", "author": "E Nieschlag", "year": "1999", "unstructured": "Nieschlag E, Simoni M, Gromoll J, Weinbauer GF. Role of FSH in the regulation of spermatogenesis: clinical aspects. Clin Endocrinol. 1999b;51:139\u201346.", "journal-title": "Clin Endocrinol"}, {"key": "10_CR101", "year": "1992", "unstructured": "Nieschlag E, Wang C, Handelsman DJ, Swerdloff RS, Wu FCW, Einer-Jensen N, Waites GMH, editors. Guidelines for the use of androgens. Geneva: WHO Special Programme of Research/Development and Research Training in Human Reproduction; 1992.", "volume-title": "Guidelines for the use of androgens"}, {"key": "10_CR102", "doi-asserted-by": "crossref", "first-page": "1729", "DOI": "10.1056/NEJM199806113382404", "volume": "338", "author": "M Phillip", "year": "1998", "unstructured": "Phillip M, Arbelle JE, Segev Y, Parvari R. Male hypogonadism due to a mutation in the gene for the beta-subunit of follicle-stimulating hormone. N Engl J Med. 1998;338:1729\u201332.", "journal-title": "N Engl J Med"}, {"key": "10_CR103", "doi-asserted-by": "crossref", "first-page": "784", "DOI": "10.1210/jc.2007-2156", "volume": "93", "author": "N Pitteloud", "year": "2008", "unstructured": "Pitteloud N, Dwyer AA, DeCruz S, Lee H, Boepple PA, Crowley WF Jr, Hayes FJ. Inhibition of luteinizing hormone secretion by testosterone in men requires aromatization for its pituitary but not its hypothalamic effects: evidence from the tandem study of normal and gonadotropin-releasing hormone-deficient men. J Clin Endocrinol Metab. 2008;93:784\u201391.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10_CR104", "doi-asserted-by": "crossref", "first-page": "4128", "DOI": "10.1210/jc.2002-020518", "volume": "87", "author": "N Pitteloud", "year": "2002", "unstructured": "Pitteloud N, Hayes FJ, Dwyer A, Boepple PA, Lee H, Crowley WF Jr. Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2002;87:4128\u201336.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10_CR105", "doi-asserted-by": "crossref", "first-page": "457", "DOI": "10.1172/JCI29884", "volume": "117", "author": "N Pitteloud", "year": "2007", "unstructured": "Pitteloud N, Quinton R, Pearce S, Raivio T, Acierno J, Dwyer A, Plummer L, Hughes V, Seminara S, Cheng YZ, Li WP, Maccoll G, Eliseenkova AV, Olsen SK, Ibrahimi OA, Hayes FJ, Boepple P, Hall JE, Bouloux P, Mohammadi M, Crowley W. Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism. J Clin Invest. 2007;117:457\u201363.", "journal-title": "J Clin Invest"}, {"key": "10_CR106", "doi-asserted-by": "crossref", "first-page": "1424", "DOI": "10.1016/j.fertnstert.2011.09.046", "volume": "96", "author": "SD Quaynor", "year": "2011", "unstructured": "Quaynor SD, Kim HG, Cappello EM, Williams T, Chorich LP, Bick DP, Sherins RJ, Layman LC. The prevalence of digenic mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome. Fertil Steril. 2011;96:1424\u201330.", "journal-title": "Fertil Steril"}, {"key": "10_CR107", "unstructured": "Quinton R, Cheow HK, Tymms DJ, Bouloux PM, Wu FC, Jacobs HS. Kallmann\u2019s syndrome: is it always for life? Clin Endocrinol. 1999;50:481\u20135.", "DOI": "10.1046/j.1365-2265.1999.00708.x", "doi-asserted-by": "crossref"}, {"key": "10_CR108", "doi-asserted-by": "crossref", "first-page": "863", "DOI": "10.1056/NEJMoa066494", "volume": "357", "author": "T Raivio", "year": "2007", "unstructured": "Raivio T, Falardeau J, Dwyer A, Quinton R, Hayes FJ, et al. Reversal of idiopathic hypogonadotropic hypogonadism. N Engl J Med. 2007;357:863\u201373.", "journal-title": "N Engl J Med"}, {"key": "10_CR109", "doi-asserted-by": "crossref", "first-page": "851", "DOI": "10.1002/cncr.20028", "volume": "100", "author": "A Rajagopal", "year": "2004", "unstructured": "Rajagopal A, Vassilopoulou-Sellin R, Palmer JL, Kaur G, Bruera E. Symptomatic hypogonadism in male survivors of cancer with chronic exposure to opioids. Cancer. 2004;100:851\u20138.", "journal-title": "Cancer"}, {"key": "10_CR110", "doi-asserted-by": "crossref", "first-page": "513", "DOI": "10.1530/eje.1.02254", "volume": "155", "author": "V Rochira", "year": "2006", "unstructured": "Rochira V, Zirilli L, Genazzani AD, Balestrieri A, Aranda C, Fabre B, Antunez P, Diazzi C, Carani C, Maffei L. Hypothalamic-pituitary-gonadal axis in two men with aromatase deficiency: evidence that circulating estrogens are required at the hypothalamic level for the integrity of gonadotropin negative feedback. Eur J Endocrinol. 2006;155:513\u201322.", "journal-title": "Eur J Endocrinol"}, {"key": "10_CR111", "first-page": "383", "volume": "3", "author": "AD Rogol", "year": "2005", "unstructured": "Rogol AD. Pubertal androgen therapy in boys. Pediatr Endocrinol Rev. 2005;3:383\u201390.", "journal-title": "Pediatr Endocrinol Rev"}, {"key": "10_CR112", "unstructured": "Rohayem J, Hauffa BP, Zacharin M, Kliesch S, Zitzmann M. The \u201cGerman Adolescent Hypogonadotropic Hypogonadism Study Group\u201d. Testicular growth and spermatogenesis: new goals for pubertal hormone replacement in boys with hypogonadotropic hypogonadism? -a multicentre prospective study of hCG/rFSH treatment outcomes during adolescence. Clin Endocrinol (Oxford). 2017;86:75\u201387.", "DOI": "10.1111/cen.13164", "doi-asserted-by": "crossref"}, {"key": "10_CR113", "doi-asserted-by": "crossref", "first-page": "882", "DOI": "10.1111/andr.12088", "volume": "3", "author": "J Rohayem", "year": "2015", "unstructured": "Rohayem J, Nieschlag E, Kliesch S, Zitzmann M. Inhibin B, AMH, but not INSL3, IGF1 or DHEAS support differentiation between constitutional delay of growth and puberty and hypogonadotropic hypogonadism. Andrology. 2015;3:882\u20137.", "journal-title": "Andrology"}, {"key": "10_CR114", "doi-asserted-by": "crossref", "first-page": "87", "DOI": "10.1111/andr.12128", "volume": "4", "author": "J Rohayem", "year": "2016", "unstructured": "Rohayem J, Sinthofen N, Nieschlag E, Kliesch S, Zitzmann M. Causes of hypogonadotropic hypogonadism predict response to gonadotropin substitution in adults. Andrology. 2016;4:87\u201394.", "journal-title": "Andrology"}, {"key": "10_CR115", "doi-asserted-by": "crossref", "first-page": "K11", "DOI": "10.1530/EJE-13-0449", "volume": "170", "author": "J Rohayem", "year": "2014", "unstructured": "Rohayem J, T\u00fcttelmann F, Mallidis C, Nieschlag E, Kliesch S, Zitzmann M. Restoration of fertility by gonadotropin replacement in a man with hypogonadotropic azoospermia and testicular adrenal rest tumors due to untreated simple virilizing congenital adrenal hyperplasia. Eur J Endocrinol. 2014;170:K11\u20137.", "journal-title": "Eur J Endocrinol"}, {"key": "10_CR116", "doi-asserted-by": "crossref", "first-page": "755", "DOI": "10.1111/j.1365-2265.2012.04432.x", "volume": "77", "author": "G Sartorius", "year": "2012", "unstructured": "Sartorius G, Spasevska S, Idan A, Turner L, Forbes E, Zamojska A, Allan CA, Ly LP, Conway AJ, McLachlan RI, Handelsman DJ. Serum testosterone, dihydrotestosterone and estradiol concentrations in older men self-reporting very good health: the healthy man study. Clin Endocrinol. 2012;77:755\u201363.", "journal-title": "Clin Endocrinol"}, {"key": "10_CR117", "doi-asserted-by": "crossref", "first-page": "175", "DOI": "10.1093/humrep/8.suppl_2.175", "volume": "8", "author": "J Schopohl", "year": "1993", "unstructured": "Schopohl J. Pulsatile gonadotrophin releasing hormone versus gonadotrophin treatment of hypothalamic hypogonadism in males. Hum Reprod. 1993;8:175\u20139.", "journal-title": "Hum Reprod"}, {"key": "10_CR118", "doi-asserted-by": "crossref", "first-page": "1613", "DOI": "10.1210/jcem.87.4.8395", "volume": "87", "author": "IL Sedlmeyer", "year": "2002", "unstructured": "Sedlmeyer IL, Palmert MR. Delayed puberty: analysis of a large case series from an academic center. J Clin Endocrinol Metab. 2002;87:1613\u201320.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10_CR119", "doi-asserted-by": "crossref", "first-page": "1614", "DOI": "10.1056/NEJMoa035322", "volume": "349", "author": "SB Seminara", "year": "2003", "unstructured": "Seminara SB, Messager S, Chatzidaki EE, Thresher RR, Acierno JS Jr, Shagoury JK, Bo-Abbas Y, Kuohung W, Schwinof KM, Hendrick AG, Zahn D, Dixon J, Kaiser UB, Slaugenhaupt SA, Gusella JF, O'Rahilly S, Carlton MB, Crowley WF Jr, Aparicio SA, Colledge WH. The GPR54 gene as a regulator of puberty. N Engl J Med. 2003;349:1614\u201327.", "journal-title": "N Engl J Med"}, {"key": "10_CR120", "doi-asserted-by": "crossref", "first-page": "259", "DOI": "10.1111/cen.12435", "volume": "81", "author": "K Shiraishi", "year": "2014", "unstructured": "Shiraishi K, Oka S, Matsuyama H. Assessment of quality of life during gonadotrophin treatment for male hypogonadotrophic hypogonadism. Clin Endocrinol. 2014;81:259\u201365.", "journal-title": "Clin Endocrinol"}, {"key": "10_CR121", "doi-asserted-by": "crossref", "first-page": "861", "DOI": "10.1210/jc.2013-2809", "volume": "99", "author": "VF Sidhoum", "year": "2014", "unstructured": "Sidhoum VF, Chan YM, Lippincott MF, Balasubramanian R, Quinton R, Plummer L, Dwyer A, Pitteloud N, Hayes FJ, Hall JE, Martin KA, Boepple PA, Seminara SB. Reversal and relapse of hypogonadotropic hypogonadism: resilience and fragility of the reproductive neuroendocrine system. J Clin Endocrinol Metab. 2014;99:861\u201370.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10_CR122", "doi-asserted-by": "crossref", "first-page": "211", "DOI": "10.1177/1933719112461184", "volume": "20", "author": "ET Siegel", "year": "2013", "unstructured": "Siegel ET, Kim HG, Nishimoto HK, Layman LC. The molecular basis of impaired follicle-stimulating hormone action: evidence from human mutations and mouse models. Reprod Sci. 2013;20:211\u201333.", "journal-title": "Reprod Sci"}, {"key": "10_CR123", "doi-asserted-by": "crossref", "first-page": "207", "DOI": "10.1159/000442289", "volume": "85", "author": "E \u015eim\u015fek", "year": "2016", "unstructured": "\u015eim\u015fek E, Montenegro LR, Binay C, Demiral M, Ac\u0131kalin MF, Latronico AC. Clinical and hormonal features of a male adolescent with congenital isolated follicle-stimulating hormone deficiency. Horm Res Paediatr. 2016;85:207\u201312.", "journal-title": "Horm Res Paediatr"}, {"key": "10_CR124", "doi-asserted-by": "crossref", "first-page": "1029", "DOI": "10.1093/humrep/den046", "volume": "23", "author": "AA Sinisi", "year": "2008", "unstructured": "Sinisi AA, Esposito D, Maione L, Quinto MC, Visconti D, De Bellis A, Bellastella A, Conzo G, Bellastella G. Seminal anti-Mullerian hormone level is a marker of spermatogenic response during long-term gonadotropin therapy in male hypogonadotropic hypogonadism. Hum Reprod. 2008;23:1029\u201334.", "journal-title": "Hum Reprod"}, {"key": "10_CR125", "doi-asserted-by": "crossref", "first-page": "163", "DOI": "10.1016/j.yfrne.2005.10.003", "volume": "26", "author": "CL Sisk", "year": "2005", "unstructured": "Sisk CL, Zehr JL. Pubertal hormones organize the adolescent brain and behavior. Front Neuroendocrinol. 2005;26:163\u201374.", "journal-title": "Front Neuroendocrinol"}, {"key": "10_CR126", "doi-asserted-by": "crossref", "first-page": "698", "DOI": "10.4103/2230-8210.100650", "volume": "16", "author": "AT Soliman", "year": "2012", "unstructured": "Soliman AT, De Sanctis V. An approach to constitutional delay of growth and puberty. Indian J Endocrinol Metab. 2012;16:698\u2013705.", "journal-title": "Indian J Endocrinol Metab"}, {"key": "10_CR127", "doi-asserted-by": "crossref", "first-page": "283", "DOI": "10.1210/jcem-64-2-283", "volume": "64", "author": "DI Spratt", "year": "1987", "unstructured": "Spratt DI, Carr DB, Merriam GR, Scully RE, Rao PN, Crowley WF. The spectrum of abnormal patterns of gonadotropin-releasing hormone secretion in men with idiopathic hypogonadotropic hypogonadism: clinical and laboratory correlations. J Clin Endocrinol Metab. 1987;64:283\u201391.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10_CR128", "doi-asserted-by": "crossref", "first-page": "213", "DOI": "10.1038/ng0398-213", "volume": "18", "author": "A Strobel", "year": "1998", "unstructured": "Strobel A, Issad T, Camoin L, Ozata M, Strosberg AD. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet. 1998;18:213\u20135.", "journal-title": "Nat Genet"}, {"key": "10_CR129", "doi-asserted-by": "crossref", "first-page": "408", "DOI": "10.1017/CBO9781139003353.019", "volume-title": "Testosterone: action, deficiency, substitution", "author": "RS Swerdloff", "year": "2012", "unstructured": "Swerdloff RS, Wang CL. Review of guidelines on diagnosis and treatment of testosterone deficiency. In: Nieschlag E, Behre HM, Nieschlag S, editors. Testosterone: action, deficiency, substitution. 4th ed. Cambridge: Cambridge University Press; 2012. p. 408\u201320.", "edition": "4"}, {"key": "10_CR130", "doi-asserted-by": "crossref", "first-page": "3280", "DOI": "10.1210/JC.2015-1542", "volume": "100", "author": "RS Swerdloff", "year": "2015", "unstructured": "Swerdloff RS, Pak Y, Wang C, Liu PY, Bhasin S, Gill TM, Matsumoto AM, Pahor M, Surampudi P, Snyder PJ. Serum testosterone (T) level variability in T-gel-treated older hypogonadal men: treatment monitoring implications. J Clin Endocrinol Metab. 2015;100:3280\u20137.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10_CR131", "doi-asserted-by": "crossref", "first-page": "394", "DOI": "10.2169/internalmedicine.31.394", "volume": "31", "author": "T Takeda", "year": "1992", "unstructured": "Takeda T, Takasu N, Yamauchi K, Komiya I, Ohtsuka H, Nagasawa Y, Ohara N, Yamada T. Magnetic resonance imaging of the rhinencephalon in a patient with Kallmann\u2019s syndrome. Intern Med. 1992;31:394\u20136.", "journal-title": "Intern Med"}, {"key": "10_CR132", "doi-asserted-by": "crossref", "first-page": "194", "DOI": "10.1007/s00415-014-7555-9", "volume": "262", "author": "AA Tarnutzer", "year": "2015", "unstructured": "Tarnutzer AA, Gerth-Kahlert C, Timmann D, Chang DI, Harmuth F, Bauer P, Straumann D, Synofzik M. Boucher-Neuh\u00e4user syndrome: cerebellar degeneration, chorioretinal dystrophy and hypogonadotropic hypogonadism: two novel cases and a review of 40 cases from the literature. J Neurol. 2015;262:194\u2013202.", "journal-title": "J Neurol"}, {"key": "10_CR133", "doi-asserted-by": "crossref", "first-page": "171", "DOI": "10.1007/s40279-015-0411-y", "volume": "46", "author": "AS Tenforde", "year": "2016", "unstructured": "Tenforde AS, Barrack MT, Nattiv A, Fredericson M. Parallels with the female athlete triad in male athletes. Sports Med. 2016;46:171\u201382.", "journal-title": "Sports Med"}, {"key": "10_CR134", "doi-asserted-by": "crossref", "first-page": "316", "DOI": "10.1111/j.1365-2265.2012.04493.x", "volume": "78", "author": "J Tommiska", "year": "2013", "unstructured": "Tommiska J, J\u00f8rgensen N, Christiansen P, Juul A, Raivio T. A homozygous R262Q mutation in the gonadotropin-releasing hormone receptor presenting as reversal of hypogonadotropic hypogonadism and late-onset hypogonadism. Clin Endocrinol. 2013;78:316\u20137.", "journal-title": "Clin Endocrinol"}, {"key": "10_CR135", "doi-asserted-by": "crossref", "first-page": "354", "DOI": "10.1038/ng.306", "volume": "41", "author": "AK Topaloglu", "year": "2009", "unstructured": "Topaloglu AK, Reimann F, Guclu M, Yalin AS, Kotan LD, Porter KM, Serin A, Mungan NO, Cook JR, Ozbek MN, Imamoglu S, Akalin NS, Yuksel B, O'Rahilly S, Semple RK. TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for neurokinin B in the central control of reproduction. Nat Genet. 2009;41:354\u20138.", "journal-title": "Nat Genet"}, {"key": "10_CR136", "doi-asserted-by": "crossref", "first-page": "109", "DOI": "10.3389/fendo.2014.00109", "volume": "5", "author": "H Valdes-Socin", "year": "2014", "unstructured": "Valdes-Socin H, Rubio Almanza M, Tom\u00e9 Fern\u00e1ndez-Ladreda M, Debray FG, Bours V, Beckers A. Reproduction, smell, and neurodevelopmental disorders: genetic defects in different hypogonadotropic hypogonadal syndromes. Front Endocrinol (Lausanne). 2014;5:109.", "journal-title": "Front Endocrinol (Lausanne)"}, {"key": "10_CR137", "doi-asserted-by": "crossref", "first-page": "2982", "DOI": "10.1210/jcem.86.7.7685", "volume": "86", "author": "M Wabitsch", "year": "2001", "unstructured": "Wabitsch M, Ballauff A, Holl R, Blum WF, Heinze E, Remschmidt H, Hebebrand J. Serum leptin, gonadotropin, and testosterone concentrations in male patients with anorexia nervosa during weight gain. J Clin Endocrinol Metab. 2001;86:2982\u20138.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10_CR138", "first-page": "4388", "volume": "81", "author": "J Waldstreicher", "year": "1996", "unstructured": "Waldstreicher J, Seminara SB, Jameson JL, Geyer A, Nachtigall LB, Boepple PA, Holmes LB, Crowley WF Jr. The genetic and clinical heterogeneity of gonadotropin-releasing hormone deficiency in the human. J Clin Endocrinol Metab. 1996;81:4388\u201395.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10_CR139", "doi-asserted-by": "crossref", "first-page": "457", "DOI": "10.2164/jandrol.109.009597", "volume": "31", "author": "C Wang", "year": "2010", "unstructured": "Wang C, Harnett M, Dobs AS, Swerdloff RS. Pharmacokinetics and safety of long-acting testosterone undecanoate injections in hypogonadal men: an 84-week phase III clinical trial. J Androl. 2010;31:457\u201365.", "journal-title": "J Androl"}, {"key": "10_CR140", "doi-asserted-by": "crossref", "first-page": "2085", "DOI": "10.1210/jc.2003-032006", "volume": "89", "author": "C Wang", "year": "2004", "unstructured": "Wang C, Cunningham G, Dobs A, Iranmanesh A, Matsumoto AM, Snyder PJ, Weber T, Berman N, Hull L, Swerdloff RS. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab. 2004;89:2085\u201398.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10_CR141", "doi-asserted-by": "crossref", "first-page": "594", "DOI": "10.1016/j.fertnstert.2008.07.1720", "volume": "92", "author": "DW Warne", "year": "2009", "unstructured": "Warne DW, Decosterd G, Okada H, Yano Y, Koide N, Howles CM. A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin. Fertil Steril. 2009;92:594\u2013604.", "journal-title": "Fertil Steril"}, {"key": "10_CR142", "doi-asserted-by": "crossref", "first-page": "723", "DOI": "10.1210/jc.2007-1786", "volume": "93", "author": "K Wehkalampi", "year": "2008", "unstructured": "Wehkalampi K, Wid\u00e9n E, Laine T, Palotie A, Dunkel L. Patterns of inheritance of constitutional delay of growth and puberty in families of adolescent girls and boys referred to specialist pediatric care. J Clin Endocrinol Metab. 2008;93:723\u20138.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10_CR144", "author": "World Health Organization (WHO)", "year": "2010", "edition": "5", "unstructured": "World Health Organization (WHO). WHO Laboratory Manual for the Examination and Processing of Human Semen. 5th ed. Geneva: World Health Organization; 2010.", "volume-title": "WHO Laboratory Manual for the Examination and Processing of Human Semen"}, {"key": "10_CR145", "doi-asserted-by": "crossref", "first-page": "89", "DOI": "10.1016/j.jpeds.2005.08.045", "volume": "148", "author": "DA Wilson", "year": "2006", "unstructured": "Wilson DA, Hofman PL, Miles HL, Unwin KE, McGrail CE, Cutfield WS. Evaluation of the buserelin stimulation test in diagnosing gonadotropin deficiency in males with delayed puberty. J Pediatr. 2006;148:89\u201394.", "journal-title": "J Pediatr"}, {"key": "10_CR146", "doi-asserted-by": "crossref", "first-page": "147", "DOI": "10.1038/ng0298-147", "volume": "18", "author": "W Wu", "year": "1998", "unstructured": "Wu W, Cogan JD, Pfaffle RW, Dasen JS, Frisch H, O'Connell SM, Flynn SE, Brown MR, Mullis PE, Parks JS, Phillips JA 3rd, Rosenfeld MG. Mutations in PROP1 cause familial combined pituitary hormone deficiency. Nat Genet. 1998;18:147\u20139.", "journal-title": "Nat Genet"}, {"key": "10_CR147", "doi-asserted-by": "crossref", "first-page": "193", "DOI": "10.1159/000336376", "volume": "97", "author": "J Young", "year": "2013", "unstructured": "Young J, George JT, Tello JA, Francou B, Bouligand J, Guiochon-Mantel A, Brailly-Tabard S, Anderson RA, Millar RP. Kisspeptin restores pulsatile LH secretion in patients with neurokinin B signaling deficiencies: physiological, pathophysiological and therapeutic implications. Neuroendocrinology. 2013;97:193\u2013202.", "journal-title": "Neuroendocrinology"}, {"key": "10_CR148", "doi-asserted-by": "crossref", "first-page": "836", "DOI": "10.1016/j.fertnstert.2012.06.022", "volume": "98", "author": "M Zacharin", "year": "2012", "unstructured": "Zacharin M, Sabin MA, Nair VV, Dagabdhao P. Addition of recombinant follicle-stimulating hormone to human chorionic gonadotropin treatment in adolescents and young adults with hypogonadotropic hypogonadism promotes normal testicular growth and may promote early spermatogenesis. Fertil Steril. 2012;98:836\u201342.", "journal-title": "Fertil Steril"}, {"key": "10_CR152", "unstructured": "Zhu J, Choa REY, Guo MH, Plummer L, Buck C, Palmert MR, Hirschhorn JN, Seminara SB, Chan YM. A shared genetic basis for self-limited delayed puberty and idiopathic hypogonadotropic hypogonadism. The Journal of Clinical Endocrinology & Metabolism 2015;100:E646\u2013E654.", "DOI": "10.1210/jc.2015-1080", "doi-asserted-by": "crossref"}, {"key": "10_CR149", "doi-asserted-by": "crossref", "first-page": "4335", "DOI": "10.1210/jc.2006-0401", "volume": "91", "author": "M Zitzmann", "year": "2006", "unstructured": "Zitzmann M, Faber S, Nieschlag E. Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab. 2006;91:4335\u201343.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10_CR150", "doi-asserted-by": "crossref", "first-page": "3844", "DOI": "10.1210/jc.2007-0620", "volume": "92", "author": "M Zitzmann", "year": "2007", "unstructured": "Zitzmann M, Nieschlag E. Androgen receptor gene CAG repeat length and body mass index modulate the safety of long-term intramuscular testosterone undecanoate therapy in hypogonadal men. J Clin Endocrinol Metab. 2007;92:3844\u201353.", "journal-title": "J Clin Endocrinol Metab"}], "container-title": ["Endocrinology", "Hypothalamic-Pituitary Diseases"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-319-44444-4_10", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 10, 13]], "date-time": "2019-10-13T20:59:23Z", "timestamp": 1571000363000}, "score": 36.292263, "issued": {"date-parts": [[2018]]}, "ISBN": ["9783319444437", "9783319444444"], "references-count": 148, "URL": "http://dx.doi.org/10.1007/978-3-319-44444-4_10", "relation": {"cites": []}, "ISSN": ["2510-1927", "2510-1935"], "issn-type": [{"value": "2510-1927", "type": "print"}, {"value": "2510-1935", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T18:00:16Z", "timestamp": 1574272816819}, "reference-count": 2, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2007, 3, 1]], "date-time": "2007-03-01T00:00:00Z", "timestamp": 1172707200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Contraception"], "published-print": {"date-parts": [[2007, 3]]}, "DOI": "10.1016/j.contraception.2006.12.001", "type": "journal-article", "created": {"date-parts": [[2007, 2, 13]], "date-time": "2007-02-13T12:07:38Z", "timestamp": 1171368458000}, "page": "166-167", "source": "Crossref", "is-referenced-by-count": 15, "title": ["10th Summit Meeting consensus: recommendations for regulatory approval for hormonal male contraception"], "prefix": "10.1016", "volume": "75", "author": [{"given": "Eberhard", "family": "Nieschlag", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Contraception"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0010782406004549?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0010782406004549?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 1, 9]], "date-time": "2019-01-09T08:56:28Z", "timestamp": 1547024188000}, "score": 35.740574, "issued": {"date-parts": [[2007, 3]]}, "references-count": 2, "journal-issue": {"published-print": {"date-parts": [[2007, 3]]}, "issue": "3"}, "alternative-id": ["S0010782406004549"], "URL": "http://dx.doi.org/10.1016/j.contraception.2006.12.001", "ISSN": ["0010-7824"], "issn-type": [{"value": "0010-7824", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T08:58:11Z", "timestamp": 1574499491235}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2011, 4, 1]], "date-time": "2011-04-01T00:00:00Z", "timestamp": 1301616000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Best Practice & Research Clinical Endocrinology & Metabolism"], "published-print": {"date-parts": [[2011, 4]]}, "DOI": "10.1016/j.beem.2010.08.008", "type": "journal-article", "created": {"date-parts": [[2011, 3, 11]], "date-time": "2011-03-11T11:42:41Z", "timestamp": 1299843761000}, "page": "369-375", "source": "Crossref", "is-referenced-by-count": 14, "title": ["The struggle for male hormonal contraception"], "prefix": "10.1016", "volume": "25", "author": [{"given": "Eberhard", "family": "Nieschlag", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Best Practice & Research Clinical Endocrinology & Metabolism"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1521690X1000093X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1521690X1000093X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 4]], "date-time": "2018-12-04T02:26:23Z", "timestamp": 1543890383000}, "score": 35.425446, "issued": {"date-parts": [[2011, 4]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2011, 4]]}, "issue": "2"}, "alternative-id": ["S1521690X1000093X"], "URL": "http://dx.doi.org/10.1016/j.beem.2010.08.008", "ISSN": ["1521-690X"], "issn-type": [{"value": "1521-690X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T17:01:42Z", "timestamp": 1574096502964}, "reference-count": 120, "publisher": "Elsevier BV", "issue": "1-2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2000, 3, 1]], "date-time": "2000-03-01T00:00:00Z", "timestamp": 951868800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Molecular and Cellular Endocrinology"], "published-print": {"date-parts": [[2000, 3]]}, "DOI": "10.1016/s0303-7207(99)00227-0", "type": "journal-article", "created": {"date-parts": [[2002, 7, 25]], "date-time": "2002-07-25T13:54:11Z", "timestamp": 1027605251000}, "page": "73-88", "source": "Crossref", "is-referenced-by-count": 93, "title": ["Hormone substitution in male hypogonadism"], "prefix": "10.1016", "volume": "161", "author": [{"given": "M", "family": "Zitzmann", "sequence": "first", "affiliation": []}, {"given": "E", "family": "Nieschlag", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Molecular and Cellular Endocrinology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0303720799002270?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0303720799002270?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 28]], "date-time": "2019-04-28T23:27:30Z", "timestamp": 1556494050000}, "score": 35.25293, "issued": {"date-parts": [[2000, 3]]}, "references-count": 120, "journal-issue": {"published-print": {"date-parts": [[2000, 3]]}, "issue": "1-2"}, "alternative-id": ["S0303720799002270"], "URL": "http://dx.doi.org/10.1016/s0303-7207(99)00227-0", "ISSN": ["0303-7207"], "issn-type": [{"value": "0303-7207", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T20:34:36Z", "timestamp": 1574454876618}, "publisher-location": "Berlin, Heidelberg", "reference-count": 92, "publisher": "Springer Berlin Heidelberg", "isbn-type": [{"value": "9783642020612", "type": "print"}, {"value": "9783642020629", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2010]]}, "DOI": "10.1007/978-3-642-02062-9_11", "type": "book-chapter", "created": {"date-parts": [[2010, 8, 11]], "date-time": "2010-08-11T08:59:46Z", "timestamp": 1281517186000}, "page": "197-223", "source": "Crossref", "is-referenced-by-count": 8, "title": ["Male Hormonal Contraception"], "prefix": "10.1007", "author": [{"given": "E.", "family": "Nieschlag", "sequence": "first", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2010, 7, 7]]}, "reference": [{"key": "11_CR1_11", "author": "All Party Parliamentary Group on Population, Development and Reproductive Health", "year": "2007", "unstructured": "All Party Parliamentary Group on Population, Development and Reproductive Health (2007) Return of the population growth factor: its impact upon the Millennium Development Goals. House of Commons, London", "volume-title": "Return of the population growth factor: its impact upon the Millennium Development Goals"}, {"key": "11_CR2_11", "doi-asserted-by": "publisher", "first-page": "635", "DOI": "10.1016/S0010-7824(77)80002-4", "volume": "15", "author": "F Alvarez-Sanchez", "year": "1977", "unstructured": "Alvarez-Sanchez F, Faundes A, Brache V, Leon P (1977) Attainment and maintenance of azoospermia with combined monthly injections of depot medroxyprogesterone acetate and testosterone enanthate. Contraception 15:635\u2013648", "journal-title": "Contraception"}, {"key": "11_CR3_11", "first-page": "407", "volume": "20", "author": "BD Anawalt", "year": "1999", "unstructured": "Anawalt BD, Bebb RA, Bremner WJ, Matsumoto AM (1999) A lower dosage levonorgestrel and testosterone combination effectively suppresses spermatogenesis and circulating gonadotrophin levels with fewer metabolic effects than higher dosage combinations. J Androl 20:407\u2013414", "journal-title": "J Androl"}, {"key": "11_CR4_11", "doi-asserted-by": "publisher", "first-page": "707", "DOI": "10.1016/S0015-0282(00)01490-4", "volume": "74", "author": "BD Anawalt", "year": "2000", "unstructured": "Anawalt BD, Herbst KL, Matsumoto AM, Mulders TM, Coelingh-Bennink HJ, Bremner WJ (2000) Desogestrel plus testosterone effectively suppresses spermatogenesis but also causes modest weight gain and high-density lipoprotein suppression. Fertil Steril 74:707\u2013714", "journal-title": "Fertil Steril"}, {"key": "11_CR5_11", "doi-asserted-by": "publisher", "first-page": "405", "DOI": "10.2164/jandrol.04135", "volume": "26", "author": "BD Anawalt", "year": "2005", "unstructured": "Anawalt BD, Amory JK, Herbst KL, Coviello AD, Page ST, Bremner WJ, Matsumoto AM (2005) Intramuscular testosterone enanthate plus very low dosage oral levonorgestrel suppresses spermatogenesis without causing weight gain in normal young men: a randomized clinical trial. J Androl 26:405\u2013413", "journal-title": "J Androl"}, {"key": "11_CR6_11", "first-page": "3", "volume": "31", "author": "RA Anderson", "year": "1997", "unstructured": "Anderson RA, Baird DT (1997) Progress towards a male pill. IPPF Med Bull 31:3\u20134", "journal-title": "IPPF Med Bull"}, {"key": "11_CR7_11", "doi-asserted-by": "publisher", "first-page": "3640", "DOI": "10.1210/jc.87.8.3640", "volume": "87", "author": "RA Anderson", "year": "2002", "unstructured": "Anderson RA, Kinniburgh D, Baird DT (2002a) Suppression of spermatogenesis by etonogestrel implants with depot testosterone: potential for long-acting male contraception. J Clin Endocrinol Metab 87:3640\u20133649", "journal-title": "J Clin Endocrinol Metab"}, {"key": "11_CR8_11", "doi-asserted-by": "publisher", "first-page": "2869", "DOI": "10.1093/humrep/17.11.2869", "volume": "17", "author": "RA Anderson", "year": "2002", "unstructured": "Anderson RA, Van Der Spuy ZM, Dada OA, Tregoning SK, Zinn PM, AdenijiOA FTA, Smith KB, Baird DT (2002b) Investigation of hormonal male contraception in African men: suppression of spermatogenesis by oral desogestrel with depot testosterone. Hum Reprod 17:2869\u20132877", "journal-title": "Hum Reprod"}, {"key": "11_CR9_11", "first-page": "304", "volume": "88", "author": "K April", "year": "1993", "unstructured": "April K, K\u00f6ster R, Schreiner W (1993) Wie effektiv sch\u00fctzen Kondome vor einer HIV-\u00dcbertragung? Med Klin 88:304\u2013311", "journal-title": "Med Klin"}, {"key": "11_CR10_11", "doi-asserted-by": "publisher", "first-page": "121", "DOI": "10.1016/0010-7824(79)90084-2", "volume": "20", "author": "A Barfield", "year": "1979", "unstructured": "Barfield A, Melo J, Coutinho E, Alvarez-Sanchez F, Faundes A, Brache V, Leon P, Frick J, Bartsch G, Weiske WH, Brenner P, Mishell D Jr, Bernstein G, Ortiz A (1979) Pregnancies associated with sperm concentrations below 10 million/ml in clinical studies of a potential male contraceptive method, monthly depot medroxyprogesterone acetate and testosterone esters. Contraception 20:121\u2013127", "journal-title": "Contraception"}, {"key": "11_CR11_11", "doi-asserted-by": "publisher", "first-page": "6", "DOI": "10.1016/j.contraception.2005.06.070", "volume": "73", "author": "JP Barfield", "year": "2006", "unstructured": "Barfield JP, Nieschlag E, Cooper TG (2006) Fertility control in wildlife: humans as a model. Contraception 73:6\u201322", "journal-title": "Contraception"}, {"key": "11_CR12_11", "doi-asserted-by": "publisher", "first-page": "757", "DOI": "10.1210/jc.81.2.757", "volume": "81", "author": "RA Bebb", "year": "1996", "unstructured": "Bebb RA, Anawalt BD, Christensen RB, Paulsen CA, Bremner WJ, Matsumoto AM (1996) Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach. J Clin Endocrinol Metab 81:757\u2013762", "journal-title": "J Clin Endocrinol Metab"}, {"key": "11_CR13_11", "doi-asserted-by": "publisher", "first-page": "84", "DOI": "10.1210/jc.74.1.84", "volume": "74", "author": "HM Behre", "year": "1992", "unstructured": "Behre HM, Nashan D, Hubert W, Nieschlag E (1992) Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception. J Clin Endocrinol Metab 74:84\u201390", "journal-title": "J Clin Endocrinol Metab"}, {"key": "11_CR14_11", "doi-asserted-by": "publisher", "first-page": "2394", "DOI": "10.1210/jc.80.8.2394", "volume": "80", "author": "HM Behre", "year": "1995", "unstructured": "Behre HM, Baus S, Kliesch S, Keck C, Simoni M, Nieschlag E (1995) Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders. J Clin Endocrinol Metab 80:2394\u20132403", "journal-title": "J Clin Endocrinol Metab"}, {"key": "11_CR15_11", "doi-asserted-by": "publisher", "first-page": "2570", "DOI": "10.1093/humrep/16.12.2570", "volume": "16", "author": "HM Behre", "year": "2001", "unstructured": "Behre HM, Kliesch S, Lemcke B, Nieschlag E (2001) Suppression of spermatogenesis to azoospermia by combined administration of GnRH antagonist and 19-nortestosterone cannot be maintained by 19-nortestosterone alone in normal men. Hum Reprod 16:2570\u20132577", "journal-title": "Hum Reprod"}, {"key": "11_CR16_11", "doi-asserted-by": "crossref", "first-page": "405", "DOI": "10.1017/CBO9780511545221.015", "volume-title": "Testosterone: action, deficiency, substitution", "author": "HM Behre", "year": "2004", "unstructured": "Behre HM, Wang C, Handelsman DJ, Nieschlag E (2004) Pharmacology of testosterone preparations. In: Nieschlag E, Behre HM (eds) Testosterone: action, deficiency, substitution, 3rd edn. Cambridge University Press, Cambridge, pp 405\u2013444", "edition": "3"}, {"key": "11_CR18_11", "unstructured": "Birg H (2005) 100 Jahre Geburtenr\u00fcckgang. Frankfurter Allgemeine Zeitung 26.2.2005"}, {"key": "11_CR19_11", "doi-asserted-by": "publisher", "first-page": "2658", "DOI": "10.1093/humrep/deh491", "volume": "19", "author": "BM Brady", "year": "2004", "unstructured": "Brady BM, Walton M, Hollow N, Kicman AT, Baird DT, Anderson RA (2004) Depot testosterone with etonogestrel implants result in induction of azoospermia in all men for long-term contraception. Hum Reprod 19:2658\u20132667", "journal-title": "Hum Reprod"}, {"key": "11_CR20_11", "doi-asserted-by": "publisher", "first-page": "679", "DOI": "10.1016/S0010-7824(77)80005-X", "volume": "15", "author": "PF Brenner", "year": "1977", "unstructured": "Brenner PF, Mishell DR Jr, Bernstein GS, Ortiz A et al (1977) Study of medroxyprogesterone acetate and testosterone enanthate as a male contraceptive. Contraception 15:679\u2013691", "journal-title": "Contraception"}, {"key": "11_CR21_11", "doi-asserted-by": "publisher", "first-page": "1244", "DOI": "10.1210/jc.84.4.1244", "volume": "84", "author": "D B\u00fcchter", "year": "1999", "unstructured": "B\u00fcchter D, von Eckardstein S, von Eckardstein A, Kamischke A, Simoni M, Behre HM, Nieschlag E (1999) Clinical trial of transdermal testosterone and oral levonorgestrel for male contraception. J Clin Endocrinol Metab 84:1244\u20131249", "journal-title": "J Clin Endocrinol Metab"}, {"key": "11_CR22_11", "doi-asserted-by": "publisher", "first-page": "S7", "DOI": "10.1016/j.contraception.2008.04.117", "volume": "78", "author": "JE Darroch", "year": "2008", "unstructured": "Darroch JE (2008) Male fertility control \u2013 where are the men? Contraception 78:S7\u2013S17", "journal-title": "Contraception"}, {"key": "11_CR23_11", "doi-asserted-by": "crossref", "first-page": "565", "DOI": "10.1007/978-3-540-78355-8_28", "volume-title": "Andrology: male reproductive health and dysfunction", "author": "U Engelmann", "year": "2010", "unstructured": "Engelmann U, Gralla O (2010) Vasectomy and refertilisation. In: Nieschlag E, Behre HM, Nieschlag S (eds) Andrology: male reproductive health and dysfunction, 3rd edn. Springer, Heidelberg, pp 565\u2013576", "edition": "3"}, {"key": "11_CR24_11", "first-page": "98", "volume": "10", "author": "G Ersheng", "year": "1999", "unstructured": "Ersheng G, Cuihong L, Youlun G, Lamei L, Changhai H (1999) Inhibiting effects of sino-implant plus testosterone undecanoate on spermatogenesis in Chinese men. Reprod Contracept 10:98\u2013105", "journal-title": "Reprod Contracept"}, {"key": "11_CR25_11", "doi-asserted-by": "publisher", "first-page": "235", "DOI": "10.1111/j.1365-2605.1981.tb00707.x", "volume": "4", "author": "A Faundes", "year": "1981", "unstructured": "Faundes A, Brache V, Leon P, Schmidt F, Alvarez-Sanchez F (1981) Sperm suppression with monthly injections of medroxyprogesterone acetate combined with testosterone enanthate at a high dose (500 mg). Int J Androl 4:235\u2013245", "journal-title": "Int J Androl"}, {"key": "11_CR26_11", "doi-asserted-by": "crossref", "first-page": "251", "DOI": "10.1530/acta.0.0950251", "volume": "95", "author": "M Fogh", "year": "1980", "unstructured": "Fogh M, Corker CS, McLean H (1980) Clinical trial with levonorgestrel and testosterone enanthate for male fertility control. Acta Endocrinol 95:251\u2013257", "journal-title": "Acta Endocrinol"}, {"key": "11_CR27_11", "doi-asserted-by": "publisher", "first-page": "669", "DOI": "10.1016/S0010-7824(77)80004-8", "volume": "15", "author": "J Frick", "year": "1977", "unstructured": "Frick J, Bartsch G, Weiske WH (1977) The effect of monthly depot medroxyprogesterone acetate and testosterone on human spermatogenesis. II. High initial dose. Contraception 15:669\u2013677", "journal-title": "Contraception"}, {"key": "11_CR28_11", "doi-asserted-by": "publisher", "first-page": "246", "DOI": "10.1111/j.1365-2605.1982.tb00253.x", "volume": "5", "author": "J Frick", "year": "1982", "unstructured": "Frick J, Danner C, Kunit G, Joos H, Kohle R (1982) Spermatogenesis in men treated with injections of medroxyprogesterone acetate combined with testosterone enanthate. Int J Androl 5:246\u2013252", "journal-title": "Int J Androl"}, {"key": "11_CR29_11", "doi-asserted-by": "publisher", "first-page": "3562", "DOI": "10.1210/jc.87.8.3562", "volume": "87", "author": "IT Gaw Gonzalo", "year": "2002", "unstructured": "Gaw Gonzalo IT, Swerdloff RS, Nelson AL, Clevenger B, Garcia R, Berman N, Wang C (2002) Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone. J Clin Endocrinol Metab 87:3562\u20133572", "journal-title": "J Clin Endocrinol Metab"}, {"key": "11_CR30_11", "unstructured": "Grimes DA, Lopez LM, Gallo MF, Halpern V, Nanda K, Schulz KF (2007) Steroid hormones for contraception in men (review). Cochrane Database Syst Rec 004316"}, {"key": "11_CR31_11", "doi-asserted-by": "publisher", "first-page": "562", "DOI": "10.1210/jc.2002-020447", "volume": "88", "author": "Y-Q Gu", "year": "2003", "unstructured": "Gu Y-Q, Wang X-H, Xu D, Peng L, Cheng L-F, Huang M-K, Huang Z-J, Zhang G-Y (2003) A multicenter contraceptive efficacy study of injectable testosterone undecanoate in healthy Chinese men. J Clin Endocrinol Metab 88:562\u2013568", "journal-title": "J Clin Endocrinol Metab"}, {"key": "11_CR32_11", "doi-asserted-by": "publisher", "first-page": "2254", "DOI": "10.1210/jc.2003-031307", "volume": "89", "author": "YQ Gu", "year": "2004", "unstructured": "Gu YQ, Tong JS, Ma DZ, Wang XH, Yuan D, Tang WH, Bremner WJ (2004) Male hormonal contraception: effects of injections of testosterone undecanoate and depot medroxyprogesterone acetate at eight-week intervals in Chinese men. J Clin Endocrinol Metab 89:2254\u20132262", "journal-title": "J Clin Endocrinol Metab"}, {"issue": "6", "key": "11_CR33_11", "doi-asserted-by": "publisher", "first-page": "1890", "DOI": "10.1210/jc.2008-1846", "volume": "94", "author": "Y Gu", "year": "2009", "unstructured": "Gu Y, Liang X, Wu W, Liu M, Song S, Cheng L, Bo L, Xiong C, Wang X, Liu X, Peng L, Yao K (2009) Multicenter contraceptive efficacy trial of injectable testosterone undecanoate in Chinese men. J Clin Endocrinol Metab 94(6):1890\u20131892", "journal-title": "J Clin Endocrinol Metab"}, {"key": "11_CR34_11", "doi-asserted-by": "publisher", "first-page": "187", "DOI": "10.1111/j.1365-2605.1988.tb00994.x", "volume": "11", "author": "JF Guerin", "year": "1988", "unstructured": "Guerin JF, Rollet J (1988) Inhibition of spermatogenesis in men using various combinations of oral progestagens and percutaneous or oral androgens. Int J Androl 11:187\u2013199", "journal-title": "Int J Androl"}, {"key": "11_CR35_11", "doi-asserted-by": "crossref", "first-page": "720", "DOI": "10.1002/j.1939-4640.2004.tb02846.x", "volume": "25", "author": "YL Gui", "year": "2004", "unstructured": "Gui YL, He CH, Amory JK, Bremner WJ, Zheng EX, Yand J, Yand PJ, Gao ES (2004) Male hormonal contraception: suppression of spermatogenesis by injectable testosterone undecanoate alone or with levonorgestrel implants in Chinese men. J Androl 25:720\u2013727", "journal-title": "J Androl"}, {"key": "11_CR36_11", "unstructured": "Hair WM, Kitteridge K, Wu FCW (1999) A new male contraceptive pill/patch combination \u2013 oral desogestrel and transdermal testosterone: suppression of gonadotropins and spermatogenesis in men. In: The Endocrine Society\u2019s 81st Annual Meeting; 1999 June 12\u201315; San Diego, CA, USA; Poster P3\u2013374"}, {"key": "11_CR37_11", "doi-asserted-by": "publisher", "first-page": "1326", "DOI": "10.1210/jc.75.5.1326", "volume": "75", "author": "DJ Handelsman", "year": "1992", "unstructured": "Handelsman DJ, Conway AJ, Boylan LM (1992) Suppression of humanspermatogenesis by testosterone implants. J Clin Endocrinol Metab 75:1326\u20131332", "journal-title": "J Clin Endocrinol Metab"}, {"key": "11_CR38_11", "doi-asserted-by": "publisher", "first-page": "4113", "DOI": "10.1210/jc.81.11.4113", "volume": "81", "author": "DJ Handelsman", "year": "1996", "unstructured": "Handelsman DJ, Conway AJ, Howe CJ, Turner L, Mackey MA (1996) Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot. J Clin Endocrinol Metab 81:4113\u20134121", "journal-title": "J Clin Endocrinol Metab"}, {"key": "11_CR39_11", "doi-asserted-by": "crossref", "first-page": "658", "DOI": "10.3181/00379727-40-10527P", "volume": "40", "author": "M Heckel", "year": "1939", "unstructured": "Heckel M (1939) Production of oligospermia in a man by the use of testosterone propionate. Proc Soc Exp Biol Med 40:658\u2013659", "journal-title": "Proc Soc Exp Biol Med"}, {"key": "11_CR40_11", "doi-asserted-by": "publisher", "first-page": "549", "DOI": "10.1093/humrep/deh574", "volume": "20", "author": "K Heinemann", "year": "2005", "unstructured": "Heinemann K, Saad F, Wiesemes M, White S, Heinemann L (2005) Attitudes toward male fertility control: results of a multinational survey on four continents. Hum Reprod 20:549\u2013556", "journal-title": "Hum Reprod"}, {"key": "11_CR41_11", "doi-asserted-by": "publisher", "first-page": "49", "DOI": "10.1016/j.tips.2003.11.009", "volume": "25", "author": "A Kamischke", "year": "2004", "unstructured": "Kamischke A, Nieschlag E (2004) Progress towards hormonal male contraception. Trends Pharmacol Sci 25:49\u201357", "journal-title": "Trends Pharmacol Sci"}, {"key": "11_CR42_11", "doi-asserted-by": "publisher", "first-page": "43", "DOI": "10.1046/j.1365-2265.2000.01024.x", "volume": "53", "author": "A Kamischke", "year": "2000", "unstructured": "Kamischke A, Pl\u00f6ger D, Venherm S, von Eckardstein S, von Eckardstein A, Nieschlag E (2000) Intramuscular testosterone undecanoate with or without oral levonorgestrel: a randomized placebo-controlled feasibility study for male contraception. Clin Endocrinol 53:43\u201352", "journal-title": "Clin Endocrinol"}, {"key": "11_CR43_11", "doi-asserted-by": "publisher", "first-page": "303", "DOI": "10.1210/jc.86.1.303", "volume": "86", "author": "A Kamischke", "year": "2001", "unstructured": "Kamischke A, Venherm S, Pl\u00f6ger D, von Eckardstein S, Nieschlag E (2001) Intramuscular testosterone undecanoate and norethisterone enanthate in a clinical trial for male contraception. J Clin Endocrinol Metab 86:303\u2013309", "journal-title": "J Clin Endocrinol Metab"}, {"key": "11_CR44_11", "doi-asserted-by": "publisher", "first-page": "530", "DOI": "10.1210/jc.87.2.530", "volume": "87", "author": "A Kamischke", "year": "2002", "unstructured": "Kamischke A, Heuermann T, Kr\u00fcger K, von Eckardstein S, Schellschmidt I, R\u00fcbig A, Nieschlag E (2002) An effective hormonal male contraceptive using testosterone undecanoate with oral or injectable norethisterone preparations. J Clin Endocrinol Metab 87:530\u2013539", "journal-title": "J Clin Endocrinol Metab"}, {"key": "11_CR45_11", "first-page": "88", "volume": "22", "author": "D Kinniburgh", "year": "2001", "unstructured": "Kinniburgh D, Anderson RA, Baird DT (2001) Suppression of spermatogenesis with desogestrel and testosterone pellets is not enhanced by addition of finasteride. J Androl 22:88\u201395", "journal-title": "J Androl"}, {"key": "11_CR46_11", "doi-asserted-by": "publisher", "first-page": "1490", "DOI": "10.1093/humrep/17.6.1490", "volume": "17", "author": "D Kinniburgh", "year": "2002", "unstructured": "Kinniburgh D, Zhu H, Cheng L, Kicman AT, Baird DT, Anderson RA (2002) Oral desogestrel with testosterone pellets induces consistent suppression of spermatogenesis to azoospermia in both Caucasian and Chinese men. Hum Reprod 17:1490\u20131501", "journal-title": "Hum Reprod"}, {"key": "11_CR47_11", "doi-asserted-by": "crossref", "first-page": "814", "DOI": "10.1016/S0015-0282(16)49043-6", "volume": "44", "author": "UA Knuth", "year": "1985", "unstructured": "Knuth UA, Behre HM, Belkien L, Bents H, Nieschlag E (1985) Clinical trial of 19-nortestosterone-hexoxyphenylpropionate (Anadur) for male fertility regulation. Fertil Steril 44:814\u2013821", "journal-title": "Fertil Steril"}, {"key": "11_CR48_11", "doi-asserted-by": "crossref", "first-page": "1011", "DOI": "10.1016/S0015-0282(16)60735-5", "volume": "51", "author": "UA Knuth", "year": "1989", "unstructured": "Knuth UA, Yeung CH, Nieschlag E (1989) Combination of 19-nortestosterone-hexyoxyphenylpropionate (Anadur) and depot-medroxyprogesterone-acetate (Clinovir) for male contraception. Fertil Steril 51:1011\u20131018", "journal-title": "Fertil Steril"}, {"key": "11_CR49_11", "doi-asserted-by": "publisher", "first-page": "602", "DOI": "10.2164/jandrol.108.006296", "volume": "30", "author": "B Kornmann", "year": "2009", "unstructured": "Kornmann B, Nieschlag E, Zitzmann M, Gromoll J, Simoni M, von Eckardstein S (2009) Body fat content and testosterone pharmacokinetics determine gonadotropin suppression after intramuscular injections of testosterone preparations in normal men. J Androl 30:602\u2013613", "journal-title": "J Androl"}, {"key": "11_CR100_11", "doi-asserted-by": "crossref", "first-page": "1412", "DOI": "10.1016/S0140-6736(06)68614-5", "volume": "367", "author": "PY Liu", "year": "2006", "unstructured": "Liu PY, Swerdloff RS, Christenson PD, Handelsman DJ, Wang C (2006) Hormonal male contraception summit group. Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis. Lancet 367:1412\u20131420", "journal-title": "Lancet"}, {"key": "11_CR50_11", "doi-asserted-by": "publisher", "first-page": "723", "DOI": "10.1111/j.1745-7262.2008.00432.x", "volume": "10", "author": "JW Li", "year": "2008", "unstructured": "Li JW, Gu YQ (2008) Predictors for partial suppression of spermatogenesis of hormonal male contraception. Asian J Androl 10:723\u2013730", "journal-title": "Asian J Androl"}, {"key": "11_CR51_11", "doi-asserted-by": "publisher", "first-page": "1774", "DOI": "10.1210/jc.2007-2768", "volume": "93", "author": "PY Liu", "year": "2008", "unstructured": "Liu PY, Swerdloff RS, Anawalt BD, AAnderson RA, Bremner WJ, Elliesen J, Gu YQ, Kersemaekers WM, McLachlan RI, Meriggiola MC, Nieschlag E, Sitruk-Ware R, Vogelsong K, Wang XH, Wu FC, Zitzmann M, Handelsman DJ, Wang C (2008) Determinants of the rate and extent of spermatogenic suppression during hormonal male contraception: an integrated analysis. J Clin Endocrinol Metab 93:1774\u20131783", "journal-title": "J Clin Endocrinol Metab"}, {"key": "11_CR52_11", "doi-asserted-by": "publisher", "first-page": "637", "DOI": "10.1093/humrep/15.3.637", "volume": "15", "author": "CW Martin", "year": "2000", "unstructured": "Martin CW, Anderson RA, Cheng L, Ho PC, van der Spuy Z, Smith KB, Glasier AF, Everington D, Baird DT (2000) Potential impact of hormonal male contraception: cross-cultural implications for development of novel preparations. Hum Reprod 15:637\u2013645", "journal-title": "Hum Reprod"}, {"key": "11_CR101_11", "doi-asserted-by": "crossref", "first-page": "73", "DOI": "10.1016/S0010-7824(00)00139-6", "volume": "62", "author": "RI McLachlan", "year": "2000", "unstructured": "McLachlan RI, McDonald J, Rushford D, Robertson DM, Garrett C, Baker HW (2000) Efficacy and acceptability of testosterone implants, alone or in combination with a 5alpha-reductase inhibitor, for male hormonal contraception. Contraception 62:73\u201378", "journal-title": "Contraception"}, {"key": "11_CR53_11", "doi-asserted-by": "publisher", "first-page": "546", "DOI": "10.1210/jc.87.2.546", "volume": "87", "author": "RI McLachlan", "year": "2002", "unstructured": "McLachlan RI, O\u2019Donnell L, Stanton PG, Balourdos G, Frydenberg M, DeKretser DM, Robertson DM (2002) Effects of testosterone plus medroxyprogesterone acetate on semen quality, reproductive hormones and germ cell populations in normal young men. J Clin Endocrinol Metab 87:546\u2013556", "journal-title": "J Clin Endocrinol Metab"}, {"key": "11_CR54_11", "doi-asserted-by": "publisher", "first-page": "627", "DOI": "10.1016/S0010-7824(77)80001-2", "volume": "15", "author": "JF Melo", "year": "1977", "unstructured": "Melo JF, Coutinho EM (1977) Inhibition of spermatogenesis in men with monthly injections of medroxyprogesterone acetate and testosterone enanthate. Contraception 15:627\u2013634", "journal-title": "Contraception"}, {"key": "11_CR55_11", "doi-asserted-by": "publisher", "first-page": "3018", "DOI": "10.1210/jc.81.8.3018", "volume": "81", "author": "MC Meriggiola", "year": "1996", "unstructured": "Meriggiola MC, Bremner WJ, Paulsen CA, Valdiserri A, Incorvala L, Motta R, Pavani A, Capelli M, Flamigni C (1996) A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive. J Clin Endocrinol Metab 81:3018\u20133023", "journal-title": "J Clin Endocrinol Metab"}, {"key": "11_CR56_11", "doi-asserted-by": "publisher", "first-page": "844", "DOI": "10.1016/S0015-0282(97)00363-4", "volume": "68", "author": "MC Meriggiola", "year": "1997", "unstructured": "Meriggiola MC, Bremner WJ, Costantino A, Pavani A, Capelli M, Flamigni C (1997) An oral regimen of cyproterone acetate and testosterone undecanoate for spermatogenic suppression in men. Fertil Steril 68:844\u2013850", "journal-title": "Fertil Steril"}, {"key": "11_CR57_11", "doi-asserted-by": "publisher", "first-page": "1225", "DOI": "10.1093/humrep/13.5.1225", "volume": "13", "author": "MC Meriggiola", "year": "1998", "unstructured": "Meriggiola MC, Bremner WJ, Costantino A, Di Cintio G, Flamigni C (1998) Low dose of cyproterone acetate and testosterone enanthate for contraception in men. Hum Reprod 13:1225\u20131229", "journal-title": "Hum Reprod"}, {"key": "11_CR58_11", "first-page": "684", "volume": "23", "author": "MC Meriggiola", "year": "2002", "unstructured": "Meriggiola MC, Costantino A, Bremner WJ, Morselli-Labate AM (2002) Higher testosterone dose impairs sperm suppression induced by a combined androgen-progestin regimen. J Androl 23:684\u2013690", "journal-title": "J Androl"}, {"key": "11_CR59_11", "doi-asserted-by": "publisher", "first-page": "5818", "DOI": "10.1210/jc.2003-030574", "volume": "88", "author": "MC Meriggiola", "year": "2003", "unstructured": "Meriggiola MC, Costantino A, Cerpolini S, Bremner WJ, Huebler D, Morselli-Labate AM, Kirsch B, Bertaccini A, Pelusi C, Pelusi G (2003) Testosterone undecanoate maintains spermatogenic suppression induced by cyproterone acetate plus testosterone undecanoate in normal men. J Clin Endocrinol Metab 88:5818\u20135826", "journal-title": "J Clin Endocrinol Metab"}, {"key": "11_CR60_11", "doi-asserted-by": "publisher", "first-page": "2005", "DOI": "10.1210/jc.2004-1852", "volume": "90", "author": "MC Meriggiola", "year": "2005", "unstructured": "Meriggiola MC, Costantino SF, D\u2019Emidio L, Morselli Labate AM, Bertaccini A, Bremner WJ, Rudolph I, Ernst M, Kirsch B, Martorana G, Pelusi G (2005) Norethisterone enanthate plus testosterone undecanoate for male contraception: effects of various injection intervals on spermatogenesis, reproductive hormones, testis, and prostate. J Clin Endocrinol Metab 90:2005\u20132014", "journal-title": "J Clin Endocrinol Metab"}, {"key": "11_CR61_11", "doi-asserted-by": "publisher", "first-page": "2033", "DOI": "10.1093/humrep/del094", "volume": "21", "author": "MC Meriggiola", "year": "2006", "unstructured": "Meriggiola MC, Cerpolini S, Bremner WJ, Mbizvo MT, Vogelsong KM, Martorana G, Pelosi G (2006) Acceptability of an injectable male contraceptive regimen of norethisterone enanthate and testosterone undecanoate for men. Hum Reprod 21:2033\u20132040", "journal-title": "Hum Reprod"}, {"key": "11_CR62_11", "doi-asserted-by": "publisher", "first-page": "2572", "DOI": "10.1210/jc.2008-0265", "volume": "93", "author": "E Mommers", "year": "2008", "unstructured": "Mommers E, Kersemaeker WM, Elliesen J, Kepers M, Apter D, Behre HM, Beynon J, Bouloux PM, Costantino A, Gerbershagen HP, Gronlund L, Heger-Mahn D, Huhtaniemi I, Koldewihn EL, Lange C, Lindenberg S, Meriggiola MC, Meuleman E, Mulder PFA, Nieschlag E, Perheentupa A, Solomon A, V\u00e4is\u00e4l\u00e4 L, FC W, Zitzmann M (2008) Male hormonal contraception: a double-blind, placebo-controlled study. J Clin Endocrinol Metab 93:2572\u20132580", "journal-title": "J Clin Endocrinol Metab"}, {"key": "11_CR63_11", "doi-asserted-by": "publisher", "first-page": "275", "DOI": "10.1111/j.1365-2265.2006.02618.x", "volume": "65", "author": "E Nieschlag", "year": "2006", "unstructured": "Nieschlag E (2006) Testosterone treatment comes of age: new options for hypogonadal men. Clin Endocrinol 65:275\u2013281", "journal-title": "Clin Endocrinol"}, {"key": "11_CR64_11", "doi-asserted-by": "publisher", "first-page": "1890", "DOI": "10.1210/jc.2009-0704", "volume": "94", "author": "E Nieschlag", "year": "2009", "unstructured": "Nieschlag E (2009) Male hormonal contraception: love\u2019s labour\u2019s lost? J Clin Endocrinol Metab 94:1890\u20131892", "journal-title": "J Clin Endocrinol Metab"}, {"key": "11_CR65_11", "doi-asserted-by": "publisher", "first-page": "166", "DOI": "10.1016/j.contraception.2006.12.001", "volume": "75", "author": "E Nieschlag", "year": "2007", "unstructured": "Nieschlag E, 10th Summit Meeting Group (2007) 10th Summit Meeting on consensus: recommendations for regulatory approval for hormonal male contraception. October 22\u201323, 2006. Contraception 75:166\u2013167", "journal-title": "Contraception"}, {"key": "11_CR66_11", "doi-asserted-by": "crossref", "first-page": "577", "DOI": "10.1007/978-3-540-78355-8_29", "volume-title": "Andrology: male reproductive health and dysfunction", "author": "E Nieschlag", "year": "2010", "unstructured": "Nieschlag E, Behre HM (2010) Approaches to hormonal male contraception. In: Nieschlag E, Behre HM, Nieschlag S (eds) Andrology: male reproductive health and dysfunction, 3rd edn. Springer, Heidelberg, pp 577\u2013587", "edition": "3"}, {"key": "11_CR67_11", "doi-asserted-by": "publisher", "first-page": "607", "DOI": "10.1016/0010-7824(78)90045-8", "volume": "18", "author": "E Nieschlag", "year": "1978", "unstructured": "Nieschlag E, Hoogen H, B\u00f6lk M, Schuster H, Wickings EJ (1978) Clinical trial with testosterone undecanoate for male fertility control. Contraception 18:607\u2013614", "journal-title": "Contraception"}, {"key": "11_CR68_11", "doi-asserted-by": "crossref", "first-page": "685", "DOI": "10.1017/CBO9780511545221.024", "volume-title": "Testosterone: action, deficiency, substitution", "author": "E Nieschlag", "year": "2004", "unstructured": "Nieschlag E, Kamischke A, Behre HM (2004) Hormonal male contraception: the essential role of testosterone. In: Nieschlag E, Behre HM (eds) Testosterone: action, deficiency, substitution, 3rd edn. Cambridge University Press, Cambridge, pp 685\u2013714", "edition": "3"}, {"key": "11_CR69_11", "author": "E Nieschlag", "year": "2009", "edition": "3", "unstructured": "Nieschlag E, Behre HM, Wieacker P, Meschede D, Kamischke A, Kliesch S (2009) Disorders at the testicular level (chap. 13). In: Nieschlag E, Behre HM, Nieschlag S (eds) Andrology: male reproductive health and dysfunction, 3rd edn. Springer, Heidelberg", "volume-title": "Andrology: male reproductive health and dysfunction", "DOI": "10.1007/978-3-540-92963-5", "doi-asserted-by": "crossref"}, {"key": "11_CR70_11", "doi-asserted-by": "publisher", "first-page": "4374", "DOI": "10.1210/jc.2006-1411", "volume": "91", "author": "ST Page", "year": "2006", "unstructured": "Page ST, Amory JK, Anawalt BD, Irwig MS, Brockenbrough AT, Matsumoto AM, Bremner WJ (2006) Testosterone gel combined with depomedroxyprogesterone acetate is an effective male hormonal contraceptive regimen and is not enhanced by the addition of a GnRH antagonist. J Clin Endocrinol Metab 91:4374\u20134380", "journal-title": "J Clin Endocrinol Metab"}, {"key": "11_CR71_11", "doi-asserted-by": "publisher", "first-page": "465", "DOI": "10.1210/er.2007-0041", "volume": "29", "author": "ST Page", "year": "2008", "unstructured": "Page ST, Amory JK, Bremner WJ (2008) Advances in male contraception. Endocr Rev 29:465\u2013493", "journal-title": "Endocr Rev"}, {"key": "11_CR72_11", "doi-asserted-by": "publisher", "first-page": "248", "DOI": "10.1111/j.1365-2605.1991.tb01089.x", "volume": "14", "author": "W Pangkahila", "year": "1991", "unstructured": "Pangkahila W (1991) Reversible azoospermia induced by an androgen-progestin combination regimen in Indonesian men. Int J Androl 14:248\u2013256", "journal-title": "Int J Androl"}, {"key": "11_CR73_11", "doi-asserted-by": "publisher", "first-page": "369", "DOI": "10.1046/j.1365-2605.2001.00319.x", "volume": "24", "author": "P P\u00f6ll\u00e4nen", "year": "2001", "unstructured": "P\u00f6ll\u00e4nen P, Nikkanen V, Huhtaniemi I (2001) Combination of subcutaneous levonorgestrel implants and transdermal dihydrotestosterone gel for male hormonal contraception. Int J Androl 24:369\u2013380", "journal-title": "Int J Androl"}, {"key": "11_CR74_11", "doi-asserted-by": "publisher", "first-page": "853", "DOI": "10.2164/jandrol.106.000281", "volume": "27", "author": "A Qoubaitary", "year": "2006", "unstructured": "Qoubaitary A, Meriggiola C, Ng CM, Lumbreras L, Cerpolini S, Pelusi G, Christensen PD, Hull L, Swerdloff RS, Wang C (2006) Pharmacokinetics of testosterone undecanoate injected alone or in combination with norethisterone enanthate in healthy men. J Androl 27:853\u2013867", "journal-title": "J Androl"}, {"key": "11_CR75_11", "doi-asserted-by": "publisher", "first-page": "717", "DOI": "10.1016/j.fertnstert.2006.11.003", "volume": "87", "author": "JF Strauss", "year": "2007", "unstructured": "Strauss JF, Chaudhuri G (2007) The accelerated pace of pharma abandonment of research and development in family planning and fertility: will reproductive health technology be frozen in time? Fertil Steril 87:717\u2013718", "journal-title": "Fertil Steril"}, {"key": "11_CR76_11", "doi-asserted-by": "publisher", "first-page": "3527", "DOI": "10.1210/jc.83.10.3527", "volume": "83", "author": "RS Swerdloff", "year": "1998", "unstructured": "Swerdloff RS, Bagatell CJ, Wang C, Anawalt BD, Berman N, Steiner B, Bremner WJ (1998) Suppression of spermatogenesis in man induced by Nal-Glu gonadotropin releasing hormone antagonist and testosterone enanthate (TE) is maintained by TE alone. J Clin Endocrinol Metab 83:3527\u20133533", "journal-title": "J Clin Endocrinol Metab"}, {"key": "11_CR77_11", "doi-asserted-by": "publisher", "first-page": "4659", "DOI": "10.1210/jc.2003-030107", "volume": "88", "author": "L Turner", "year": "2003", "unstructured": "Turner L, Conway AJ, Jimenez M, Liu PY, Forbes E, McLachlan RI, Handelsman DJ (2003) Contraceptive efficacy of a depot progestin and androgen combination in men. J Clin Endocrinol Metab 88:4659\u20134667", "journal-title": "J Clin Endocrinol Metab"}, {"key": "11_CR78_11", "doi-asserted-by": "publisher", "first-page": "647", "DOI": "10.1046/j.1365-2265.2002.01652.x", "volume": "57", "author": "S Eckardstein von", "year": "2002", "unstructured": "von Eckardstein S, Schmidt A, Kamischke A, Simoni M, Gromoll J, Nieschlag E (2002) CAG repeat length in the androgen receptor gene and gonadotrophin suppression influence the effectiveness of hormonal male contraception. Clin Endocrinol 57:647\u2013655", "journal-title": "Clin Endocrinol"}, {"key": "11_CR79_11", "doi-asserted-by": "publisher", "first-page": "5232", "DOI": "10.1210/jc.2002-022043", "volume": "88", "author": "S Eckardstein von", "year": "2003", "unstructured": "von Eckardstein S, Noe G, Brache V, Nieschlag E, Croxatto H, Alvarez F, Moo-Young A, Sivin I, Kumar N, Small M, Sundaram K, International Committee for Contraception Research, The Population Council (2003) A clinical trial of 7 alpha-methyl-19-nortestosterone implants for possible use as a long-acting contraceptive formen. J Clin Endocrinol Metab 88:5232\u20135239", "journal-title": "J Clin Endocrinol Metab"}, {"key": "11_CR80_11", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1016/S0015-0282(03)00577-6", "volume": "80", "author": "GMH Waites", "year": "2003", "unstructured": "Waites GMH (2003) Development of methods of male contraception: impact of the World Health Organization task force. Fertil Steril 80:1\u201315", "journal-title": "Fertil Steril"}, {"key": "11_CR81_11", "doi-asserted-by": "publisher", "first-page": "679", "DOI": "10.2164/jandrol.107.002683", "volume": "28", "author": "MJ Walton", "year": "2007", "unstructured": "Walton MJ, Kumar N, Baird DT, Ludlow H, Anderson RA (2007) 7\u03b1-methyl-19-nortestosterone (MENT) vs testosterone in combination with etonogestrel implants for spermatogenic suppression in healthy men. J Androl 28:679\u2013688", "journal-title": "J Androl"}, {"key": "11_CR82_11", "doi-asserted-by": "publisher", "first-page": "460", "DOI": "10.1210/jc.2005-1743", "volume": "91", "author": "C Wang", "year": "2006", "unstructured": "Wang C, Wang XH, Nelson AL (2006) Levonorgestrel implants enhanced the suppression of spermatogenesis by testosterone implants: comparison between Chinese and non-Chinese men. J Clin Endocrinol Metab 91:460\u2013470", "journal-title": "J Clin Endocrinol Metab"}, {"key": "11_CR83_11", "doi-asserted-by": "publisher", "first-page": "3292", "DOI": "10.1210/jc.2007-0367", "volume": "92", "author": "C Wang", "year": "2007", "unstructured": "Wang C, Cui YG, Wang XH, Jia Y, Hikim AS, Lue YH, Tong JS, Qian LX, Sha JH, Zhou ZM, Hull L, Leung A, Swerdloff RS (2007) Transient scrotal hyperthermia and levonorgestrel enhance testosterone-induced spermatogenesis suppression in men through increased germ cell apoptosis. J Clin Endocrinol Metab 92:3292\u20133304", "journal-title": "J Clin Endocrinol Metab"}, {"key": "11_CR84_11", "unstructured": "WHO (2005) Controlled trials register NET-EN plus TU as a male contraceptive (WHO-HRP ID A25165). \n                    http://www.who.int/reproductive-health/rhl/a25165.html\n                    \n                  . Accessed 29 Nov 2005"}, {"key": "11_CR85_11", "doi-asserted-by": "publisher", "first-page": "955", "DOI": "10.1016/0140-6736(90)92416-F", "volume": "336", "author": "World Health Organization Task Force on Methods for the Regulation of Male Fertility", "year": "1990", "unstructured": "World Health Organization Task Force on Methods for the Regulation of Male Fertility (1990) Contraceptive efficacy of testosterone-induced azoospermia in normal men. Lancet 336:955\u2013959", "journal-title": "Lancet"}, {"key": "11_CR86_11", "doi-asserted-by": "crossref", "first-page": "1062", "DOI": "10.1016/S0015-0282(16)56411-5", "volume": "60", "author": "World Health Organization Task Force on Methods for the Regulation of Male Fertility", "year": "1993", "unstructured": "World Health Organization Task Force on Methods for the Regulation of Male Fertility (1993) Comparison of two androgens plus depot-medroxyprogesterone acetate for suppression to azoospermia in Indonesian men. Fertil Steril 60:1062\u20131068", "journal-title": "Fertil Steril"}, {"key": "11_CR87_11", "doi-asserted-by": "crossref", "first-page": "821", "DOI": "10.1016/S0015-0282(16)58221-1", "volume": "65", "author": "World Health Organization Task Force on Methods for the Regulation of Male Fertility", "year": "1996", "unstructured": "World Health Organization Task Force on Methods for the Regulation of Male Fertility (1996) Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men. Fertil Steril 65:821\u2013829", "journal-title": "Fertil Steril"}, {"key": "11_CR88_11", "doi-asserted-by": "crossref", "first-page": "691", "DOI": "10.1016/S0015-0282(16)60623-4", "volume": "51", "author": "FC Wu", "year": "1989", "unstructured": "Wu FC, Aitken RJ (1989) Suppression of sperm function by depot medroxyprogesterone acetate and testosterone enanthate in steroid male contraception. Fertil Steril 51:691\u2013698", "journal-title": "Fertil Steril"}, {"key": "11_CR89_11", "doi-asserted-by": "publisher", "first-page": "112", "DOI": "10.1210/jc.84.1.112", "volume": "84", "author": "FCW Wu", "year": "1999", "unstructured": "Wu FCW, Balasubramanian R, Mulders TMT, Coelingh-Bennink HJT (1999) Oral progestogen combined with testosterone as a potential male contraceptive: additive effects between desogestrel and testosterone enanthate in suppression of spermatogenesis, pituitary-testicular axis, and lipid metabolism. J Clin Endocrinol Metab 84:112\u2013122", "journal-title": "J Clin Endocrinol Metab"}, {"key": "11_CR90_11", "doi-asserted-by": "publisher", "first-page": "3642", "DOI": "10.1210/jc.84.10.3642", "volume": "84", "author": "GY Zhang", "year": "1999", "unstructured": "Zhang GY, Gu YQ, Wang XH, Cui YG, Bremner WJ (1999) A clinical trial of injectable testosterone undecanoate as a potential male contraceptive in normal Chinese men. J Clin Endocrinol Metab 84:3642\u20133647", "journal-title": "J Clin Endocrinol Metab"}, {"key": "11_CR91_11", "doi-asserted-by": "publisher", "first-page": "548", "DOI": "10.1016/j.contraception.2005.10.012", "volume": "73", "author": "L Zhang", "year": "2006", "unstructured": "Zhang L, Shal IH, Liu Y, Vogelsong KM, Zhang L (2006) The acceptability of an injectable, once-a-month male contraceptive in China. Contraception 73:548\u2013553", "journal-title": "Contraception"}], "container-title": ["Handbook of Experimental Pharmacology", "Fertility Control"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-642-02062-9_11", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 20]], "date-time": "2019-03-20T10:45:45Z", "timestamp": 1553078745000}, "score": 34.985497, "issued": {"date-parts": [[2010]]}, "ISBN": ["9783642020612", "9783642020629"], "references-count": 92, "URL": "http://dx.doi.org/10.1007/978-3-642-02062-9_11", "relation": {"cites": []}, "ISSN": ["0171-2004", "1865-0325"], "issn-type": [{"value": "0171-2004", "type": "print"}, {"value": "1865-0325", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T19:09:43Z", "timestamp": 1575140983045}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "9459", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2005, 2, 18]], "date-time": "2005-02-18T00:00:00Z", "timestamp": 1108684800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["The Lancet"], "published-print": {"date-parts": [[2005, 2, 18]]}, "DOI": "10.1016/s0140-6736(05)70774-1", "type": "journal-article", "created": {"date-parts": [[2005, 4, 4]], "date-time": "2005-04-04T13:29:06Z", "timestamp": 1112621346000}, "page": "554-556", "source": "Crossref", "is-referenced-by-count": 15, "title": ["Hopes for male contraception"], "prefix": "10.1016", "volume": "365", "author": [{"given": "E", "family": "NIESCHLAG", "sequence": "first", "affiliation": []}, {"given": "A", "family": "HENKE", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["The Lancet"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0140673605707741?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0140673605707741?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 1, 27]], "date-time": "2019-01-27T20:30:20Z", "timestamp": 1548621020000}, "score": 34.879448, "issued": {"date-parts": [[2005, 2, 18]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2005, 2, 18]]}, "issue": "9459"}, "alternative-id": ["S0140673605707741"], "URL": "http://dx.doi.org/10.1016/s0140-6736(05)70774-1", "ISSN": ["0140-6736"], "issn-type": [{"value": "0140-6736", "type": "print"}], "subject": ["General Medicine"]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T15:04:31Z", "timestamp": 1575212671478}, "publisher-location": "Cham", "reference-count": 148, "publisher": "Springer International Publishing", "isbn-type": [{"value": "9783319291956", "type": "print"}, {"value": "9783319291956", "type": "electronic"}], "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2017, 11, 3]], "date-time": "2017-11-03T00:00:00Z", "timestamp": 1509667200000}, "delay-in-days": 0, "content-version": "unspecified"}, {"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2017, 11, 3]], "date-time": "2017-11-03T00:00:00Z", "timestamp": 1509667200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "published-print": {"date-parts": [[2018]]}, "DOI": "10.1007/978-3-319-38681-2_10-1", "type": "book-chapter", "created": {"date-parts": [[2017, 12, 21]], "date-time": "2017-12-21T22:49:34Z", "timestamp": 1513896574000}, "page": "1-35", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Central Hypogonadism in the Male: Physiopathology, Diagnosis and Treatment"], "prefix": "10.1007", "author": [{"given": "Julia", "family": "Rohayem", "sequence": "first", "affiliation": []}, {"given": "Eberhard", "family": "Nieschlag", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2017, 11, 3]]}, "reference": [{"key": "10-1_CR1", "doi-asserted-by": "publisher", "first-page": "3322", "DOI": "10.1210/jc.2015-2332", "volume": "100", "author": "A Abbara", "year": "2015", "unstructured": "Abbara A, Jayasena CN, Christopoulos G, Narayanaswamy S, Izzi-Engbeaya C, Nijher GM, Comninos AN, Peters D, Buckley A, Ratnasabapathy R, Prague JK, Salim R, Lavery SA, Bloom SR, Szigeti M, Ashby DA, Trew GH, Dhillo WS. Efficacy of kisspeptin-54 to trigger oocyte maturation in women at high risk of ovarian hyperstimulation syndrome (OHSS) during in vitro fertilization (IVF) therapy. J Clin Endocrinol Metab. 2015;100:3322\u201331.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10-1_CR2", "doi-asserted-by": "publisher", "first-page": "17", "DOI": "10.1016/S0303-7207(01)00619-0", "volume": "185", "author": "JC Achermann", "year": "2001", "unstructured": "Achermann JC, Meeks JJ, Jameson JL. Phenotypic spectrum of mutations in DAX-1 and SF-1. Mol Cell Endocrinol. 2001;185:17\u201325.", "journal-title": "Mol Cell Endocrinol"}, {"key": "10-1_CR3", "doi-asserted-by": "publisher", "first-page": "6444", "DOI": "10.4081/ni.2016.6444", "volume": "8", "author": "M Alqwaifly", "year": "2016", "unstructured": "Alqwaifly M, Bohlega S. Ataxia and hypogonadotropic hypogonadism with intrafamilial variability caused by RNF216 mutation. Neurol Int. 2016;8:6444.", "journal-title": "Neurol Int"}, {"key": "10-1_CR4", "doi-asserted-by": "publisher", "first-page": "379", "DOI": "10.1530/EJE-16-0912", "volume": "176", "author": "AK Bang", "year": "2017", "unstructured": "Bang AK, Nordkap L, Almstrup K, Priskorn L, Petersen JH, Rajpert-De Meyts E, Andersson AM, Juul A, J\u00f8rgensen N. Dynamic GnRH and hCG testing: establishment of new diagnostic reference levels. Eur J Endocrinol. 2017;176:379\u201391.", "journal-title": "Eur J Endocrinol"}, {"key": "10-1_CR5", "doi-asserted-by": "publisher", "first-page": "244", "DOI": "10.1016/S0015-0282(98)00450-6", "volume": "71", "author": "R Barrio", "year": "1999", "unstructured": "Barrio R, De Luis D, Alonso M, Lamas A, Moreno JC. Induction of puberty with human chorionic gonadotropin and follicle-stimulating hormone in adolescent males with hypogonadotropic hypogonadism. Fertil Steril. 1999;71:244\u20138.", "journal-title": "Fertil Steril"}, {"key": "10-1_CR6", "doi-asserted-by": "publisher", "first-page": "309", "DOI": "10.1017/CBO9781139003353.016", "volume-title": "Testosterone: action, deficiency, substitution", "author": "HM Behre", "year": "2012", "unstructured": "Behre HM, Nieschlag E. Testosterone preparations for clinical use in males. In: Nieschlag E, Behre HM, Nieschlag S, editors. Testosterone: action, deficiency, substitution. 4th ed. Cambridge: Cambridge University Press; 2012. p. 309\u201335.", "edition": "4"}, {"key": "10-1_CR7", "doi-asserted-by": "publisher", "first-page": "169", "DOI": "10.1007/978-3-540-78355-8_12", "volume-title": "Andrology: male reproductive health and dysfunction", "author": "HM Behre", "year": "2010", "unstructured": "Behre HM, Nieschlag E, Partsch CJ, Wieacker P, Simoni M. Diseases of the hypothalamus and the pituitary gland. In: Nieschlag E, Behre HM, editors. Andrology: male reproductive health and dysfunction. 3rd ed. Berlin: Springer; 2010. p. 169\u201392.", "edition": "3"}, {"key": "10-1_CR8", "doi-asserted-by": "publisher", "first-page": "629", "DOI": "10.1046/j.1365-2265.1999.00705.x", "volume": "50", "author": "HM Behre", "year": "1999", "unstructured": "Behre HM, von Eckardstein S, Kliesch S, Nieschlag E. Long-term substitution therapy of hypogonadal men with transscrotal testosterone over 7\u201310 years. Clin Endocr. 1999;50:629\u201335.", "journal-title": "Clin Endocr"}, {"key": "10-1_CR9", "doi-asserted-by": "publisher", "first-page": "198", "DOI": "10.3109/13685538.2012.699562", "volume": "15", "author": "HM Behre", "year": "2012", "unstructured": "Behre HM, Tammela TL, Arver S, Tolr\u00e1 JR, Bonifacio V, Lamche M, Kelly J, Hiemeyer F, European Testogel\u00ae Study Team, Giltay EJ, Gooren LJ. A randomized, double-blind, placebo-controlled trial of testosterone gel on body composition and health-related quality-of-life in men with hypogonadal to low-normal levels of serum testosterone and symptoms of androgen deficiency over 6 months with 12 months open-label follow-up. Aging Male. 2012;15:198\u2013207.", "journal-title": "Aging Male"}, {"key": "10-1_CR10", "doi-asserted-by": "publisher", "first-page": "101", "DOI": "10.1007/978-3-540-78355-8_6", "volume-title": "Andrology: male reproductive health and dysfunction", "author": "HM Behre", "year": "2010", "unstructured": "Behre HM, Zitzmann M. Imaging diagnosis. In: Nieschlag E, Behre HM, editors. Andrology: male reproductive health and dysfunction. 3rd ed. Berlin: Springer; 2010. p. 101\u20137.", "edition": "3"}, {"key": "10-1_CR11", "doi-asserted-by": "publisher", "first-page": "631", "DOI": "10.1126/science.100883", "volume": "202", "author": "PE Belchetz", "year": "1978", "unstructured": "Belchetz PE, Plant TM, Nakai Y, Keogh EJ, Knobil E. Hypophyseal responses to continuous and intermittent delivery of hypothalamic gonadotropin releasing hormone. Science. 1978;202:631\u20133.", "journal-title": "Science"}, {"key": "10-1_CR12", "doi-asserted-by": "publisher", "first-page": "838", "DOI": "10.1016/j.fertnstert.2014.05.044", "volume": "102", "author": "D Beneduzzi", "year": "2014", "unstructured": "Beneduzzi D, Trarbach EB, Min L, Jorge AA, Garmes HM, Renk AC, Fichna M, Fichna P, Arantes KA, Costa EM, Zhang A, Adeola O, Wen J, Carroll RS, Mendon\u00e7a BB, Kaiser UB, Latronico AC, Silveira LF. Role of gonadotropin-releasing hormone receptor mutations in patients with a wide spectrum of pubertal delay. Fertil Steril. 2014;102:838\u201346.", "journal-title": "Fertil Steril"}, {"key": "10-1_CR13", "doi-asserted-by": "publisher", "first-page": "2536", "DOI": "10.1210/jc.2009-2354", "volume": "6", "author": "S Bhasin", "year": "2010", "unstructured": "Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM, Task force, Endocrine Society. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;6:2536\u201359.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10-1_CR14", "doi-asserted-by": "publisher", "first-page": "2430", "DOI": "10.1210/jc.2010-3012", "volume": "96", "author": "S Bhasin", "year": "2011", "unstructured": "Bhasin S, Pencina M, Jasuja GK, Travison TG, Coviello A, Orwoll E, Wang PY, Nielson C, Wu F, Tajar A, Labrie F, Vesper H, Zhang A, Ulloor J, Singh R, D'Agostino R, Vasan RS. Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham heart study and applied to three geographically distinct cohorts. J Clin Endocrinol Metab. 2011;96:2430\u20139.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10-1_CR16", "doi-asserted-by": "crossref", "first-page": "547", "DOI": "10.1038/nrendo.2015.112", "volume": "11", "author": "U Boehm", "year": "2015", "unstructured": "Boehm U, Bouloux PM, Dattani MT, de Roux N, Dod\u00e9 C, Dunkel L, Dwyer AA, Giacobini P, Hardelin JP, Juul A, Maghnie M, Pitteloud N, Prevot V, Raivio T, Tena-Sempere M, Quinton R, Young J. Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism\u2013pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2015;11:547\u201364.", "journal-title": "Nat Rev Endocrinol"}, {"key": "10-1_CR17", "doi-asserted-by": "publisher", "first-page": "2742", "DOI": "10.1056/NEJMoa0900136", "volume": "360", "author": "J Bouligand", "year": "2009", "unstructured": "Bouligand J, Ghervan C, Tello JA, Brailly-Tabard S, Salenave S, Chanson P, Lomb\u00e8s M, Millar RP, Guiochon-Mantel A, Young J. Isolated familial hypogonadotropic hypogonadism and a GNRH1 mutation. N Engl J Med. 2009;360:2742\u20138.", "journal-title": "N Engl J Med"}, {"key": "10-1_CR18", "doi-asserted-by": "publisher", "first-page": "270", "DOI": "10.1016/S0015-0282(01)02973-9", "volume": "77", "author": "P Bouloux", "year": "2002", "unstructured": "Bouloux P, Warne DW, Loumaye E. Efficacy and safety of recombinant human follicle-stimulating hormone in men with isolated hypogonadotropic hypogonadism. Fertil Steril. 2002;77:270\u20133.", "journal-title": "Fertil Steril"}, {"key": "10-1_CR19", "doi-asserted-by": "publisher", "first-page": "604", "DOI": "10.1002/j.1939-4640.2003.tb02712.x", "volume": "24", "author": "PM Bouloux", "year": "2003", "unstructured": "Bouloux PM, Nieschlag E, Burger HG, Skakkebaek NE, FC W, Handelsman DJ, Baker GH, Ochsenkuehn R, Syska A, McLachlan RI, Giwercman A, Conway AJ, Turner L, van Kuijk JH, Voortman G. Induction of spermatogenesis by recombinant follicle-stimulating hormone (puregon) in hypogonadotropic azoospermic men who failed to respond to human chorionic gonadotropin alone. J Androl. 2003;24:604\u201311.", "journal-title": "J Androl"}, {"key": "10-1_CR20", "doi-asserted-by": "publisher", "first-page": "298", "DOI": "10.1530/eje.0.1390298", "volume": "139", "author": "D B\u00fcchter", "year": "1998", "unstructured": "B\u00fcchter D, Behre HM, Kliesch S, Nieschlag E. Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases. Eur J Endocrinol. 1998;139:298\u2013303.", "journal-title": "Eur J Endocrinol"}, {"key": "10-1_CR21", "doi-asserted-by": "publisher", "first-page": "980", "DOI": "10.1093/humrep/12.5.980", "volume": "12", "author": "S Burgu\u00e9s", "year": "1997", "unstructured": "Burgu\u00e9s S, Calder\u00f3n MD. Subcutaneous self-administration of highly purified follicle stimulating hormone and human chorionic gonadotrophin for the treatment of male hypogonadotrophic hypogonadism. Hum Reprod. 1997;12:980\u20136.", "journal-title": "Hum Reprod"}, {"key": "10-1_CR22", "doi-asserted-by": "publisher", "first-page": "1144", "DOI": "10.1210/jcem-66-6-1144", "volume": "66", "author": "AS Burris", "year": "1988", "unstructured": "Burris AS, Rodbard HW, Winters SJ, Sherins RJ. Gonadotropin therapy in men with isolated hypogonadotropic hypogonadism: the response to human chorionic gonadotropin is predicted by initial testicular size. J Endocrinol Metab. 1988;66:1144\u201351.", "journal-title": "J Endocrinol Metab"}, {"key": "10-1_CR23", "doi-asserted-by": "publisher", "first-page": "53", "DOI": "10.2147/AGG.S74598", "volume": "2015", "author": "MG Butler", "year": "2015", "unstructured": "Butler MG, Wang K, Marshall JD, Naggert JK, Rethmeyer JA, Gunewardena SS, Manzardo AM. Coding and noncoding expression patterns associated with rare obesity-related disorders: Prader-Willi and Alstr\u00f6m syndromes. Adv Genomics Genet. 2015;2015:53\u201375.", "journal-title": "Adv Genomics Genet"}, {"key": "10-1_CR24", "doi-asserted-by": "publisher", "first-page": "11703", "DOI": "10.1073/pnas.0903449106", "volume": "106", "author": "YM Chan", "year": "2009", "unstructured": "Chan YM, de Guillebon A, Lang-Muritano M, Plummer L, Cerrato F, Tsiaras S, Gaspert A, Lavoie HB, Wu CH, Crowley WF Jr, Amory JK, Pitteloud N, Seminara SB. GNRH1 mutations in patients with idiopathic hypogonadotropic hypogonadism. Proc Natl Acad Sci U S A. 2009;106:11703\u20138.", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "10-1_CR25", "doi-asserted-by": "publisher", "first-page": "E2762", "DOI": "10.1210/jc.2014-2233", "volume": "99", "author": "YM Chan", "year": "2014", "unstructured": "Chan YM, Lippincott MF, Butler JP, Sidhoum VF, Li CX, Plummer L, Seminara SB. Exogenous kisspeptin administration as a probe of GnRH neuronal function in patients with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2014;99:E2762\u201371.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10-1_CR26", "doi-asserted-by": "publisher", "first-page": "612", "DOI": "10.1210/jc.2006-1311", "volume": "92", "author": "HL Claahsen-van der Grinten", "year": "2007", "unstructured": "Claahsen-van der Grinten HL, Otten BJ, Takahashi S, Meuleman EJ, Hulsbergen-van de Kaa C, Hermus AR. Testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia: evaluation of pituitary-gonadal function before and after successful testis-sparing surgery in eight patients. J Clin Endocrinol Metab. 2007;92:612\u20135.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10-1_CR27", "doi-asserted-by": "publisher", "first-page": "398", "DOI": "10.1038/32911", "volume": "392", "author": "K Cl\u00e9ment", "year": "1998", "unstructured": "Cl\u00e9ment K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, Gourmelen M, Dina C, Chambaz J, Lacorte JM, Basdevant A, Bougn\u00e8res P, Lebouc Y, Froguel P, Guy-Grand B. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature. 1998;392:398\u2013401.", "journal-title": "Nature"}, {"key": "10-1_CR28", "doi-asserted-by": "publisher", "first-page": "5225", "DOI": "10.1210/jc.2010-1535", "volume": "95", "author": "R Coutant", "year": "2010", "unstructured": "Coutant R, Biette-Demeneix E, Bouvattier C, Bouhours-Nouet N, Gatelais F, Dufresne S, Rouleau S, Lahlou N. Baseline inhibin B and anti-Mullerian hormone measurements for diagnosis of hypogonadotropic hypogonadism (HH) in boys with delayed puberty. J Clin Endocrinol Metab. 2010;95:5225\u201332.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10-1_CR29", "doi-asserted-by": "publisher", "first-page": "E943", "DOI": "10.1210/jc.2012-4116", "volume": "98", "author": "FA Costa-Barbosa", "year": "2013", "unstructured": "Costa-Barbosa FA, Balasubramanian R, Keefe KW, Shaw ND, Al-Tassan N, Plummer L, Dwyer AA, Buck CL, Choi JH, Seminara SB, Quinton R, Monies D, Meyer B, Hall JE, Pitteloud N, Crowley WF Jr. Prioritizing genetic testing in patients with Kallmann syndrome using clinical phenotypes. J Clin Endocrinol Metab. 2013;98:E943\u201353.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10-1_CR30", "doi-asserted-by": "publisher", "first-page": "377", "DOI": "10.1054/jpai.2002.126790", "volume": "3", "author": "HW Daniell", "year": "2002", "unstructured": "Daniell HW. Hypogonadism in men consuming sustained-action oral opioids. The J Pain. 2002;3:377\u201384.", "journal-title": "The J Pain"}, {"key": "10-1_CR31", "doi-asserted-by": "publisher", "first-page": "216", "DOI": "10.1111/bju.13578", "volume": "119", "author": "FM Debruyne", "year": "2017", "unstructured": "Debruyne FM, Behre HM, Roehrborn CG, Maggi M, Wu FC, Schr\u00f6der FH, Jones TH, Porst H, Hackett G, Wheaton OA, Martin-Morales A, Meuleman E, Cunningham GR, Divan HA, Rosen RC, Investigators RHYME. Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the registry of hypogonadism in men. BJU Int. 2017;119:216\u201324.", "journal-title": "BJU Int"}, {"issue": "Suppl 3", "key": "10-1_CR32", "doi-asserted-by": "publisher", "first-page": "U89", "DOI": "10.1530/eje.0.151U089", "volume": "151", "author": "HA Delemarre-van de Waal", "year": "2004", "unstructured": "Delemarre-van de Waal HA. Application of gonadotropin releasing hormone in hypogonadotropic hypogonadism-diagnostic and therapeutic aspects. Eur J Endocrinol. 2004;151(Suppl 3):U89\u201394.", "journal-title": "Eur J Endocrinol"}, {"key": "10-1_CR33", "doi-asserted-by": "publisher", "first-page": "617", "DOI": "10.1530/eje.0.1470617", "volume": "147", "author": "M Depenbusch", "year": "2002", "unstructured": "Depenbusch M, von Eckardstein S, Simoni M, Nieschlag E. Maintenance of spermatogenesis in hypogonadotropic hypogonadal men with hCG alone. Eur J Endorinol. 2002;147:617\u201324.", "journal-title": "Eur J Endorinol"}, {"key": "10-1_CR34", "doi-asserted-by": "publisher", "first-page": "425", "DOI": "10.1093/humrep/den372", "volume": "24", "author": "W Ronde de", "year": "2009", "unstructured": "de Ronde W. Hyperandrogenism after transfer of topical testosterone gel: case report and review of published and unpublished studies. Hum Reprod. 2009;24:425\u20138.", "journal-title": "Hum Reprod"}, {"key": "10-1_CR35", "doi-asserted-by": "publisher", "first-page": "10972", "DOI": "10.1073/pnas.1834399100", "volume": "100", "author": "N Roux de", "year": "2003", "unstructured": "de Roux N, Genin E, Carel JC, Matsuda F, Chaussain JL, Milgrom E. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci U S A. 2003;100:10972\u20136.", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "10-1_CR36", "doi-asserted-by": "publisher", "first-page": "1597", "DOI": "10.1056/NEJM199711273372205", "volume": "337", "author": "N Roux de", "year": "1997", "unstructured": "de Roux N, Young J, Misrahi M, Genet R, Chanson P, Schaison G, Milgrom E. A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor. N Engl J Med. 1997;337:1597\u2013602.", "journal-title": "N Engl J Med"}, {"key": "10-1_CR37", "doi-asserted-by": "publisher", "first-page": "618", "DOI": "10.1007/s12020-016-1088-1", "volume": "55", "author": "SM Sousa De", "year": "2017", "unstructured": "De Sousa SM, Chapman IM, Falhammar H, Torpy DJ. Dopa-testotoxicosis: disruptive hypersexuality in hypogonadal men with prolactinomas treated with dopamine agonists. Endocrine. 2017;55:618\u201324.", "journal-title": "Endocrine"}, {"key": "10-1_CR38", "doi-asserted-by": "publisher", "first-page": "1186", "DOI": "10.2337/dc09-1649", "volume": "33", "author": "S Dhindsa", "year": "2010", "unstructured": "Dhindsa S, Miller MG, McWhirter CL, Mager DE, Ghanim H, Chaudhuri A, Dandona P. Testosterone concentrations in diabetic and nondiabetic obese men. Diabetes Care. 2010;33:1186\u201392.", "journal-title": "Diabetes Care"}, {"key": "10-1_CR39", "doi-asserted-by": "publisher", "first-page": "162", "DOI": "10.1111/j.1464-410X.2011.10837.x", "volume": "110", "author": "WW Dinsmore", "year": "2012", "unstructured": "Dinsmore WW, Wyllie MG. The long-term efficacy and safety of a testosterone mucoadhesive buccal tablet in testosterone-deficient men. Br J Urol Int. 2012;110:162\u20139.", "journal-title": "Br J Urol Int"}, {"key": "10-1_CR40", "doi-asserted-by": "publisher", "first-page": "463", "DOI": "10.1038/ng1122", "volume": "33", "author": "C Dod\u00e9", "year": "2003", "unstructured": "Dod\u00e9 C, Levilliers J, Dupont JM, De Paepe A, Le D\u00fb N, Soussi-Yanicostas N, Coimbra RS, Delmaghani S, Compain-Nouaille S, Baverel F, P\u00eacheux C, Le Tessier D, Cruaud C, Delpech M, Speleman F, Vermeulen S, Amalfitano A, Bachelot Y, Bouchard P, Cabrol S, Carel JC, Delemarre-van de Waal H, Goulet-Salmon B, Kottler ML, Richard O, Sanchez-Franco F, Saura R, Young J, Petit C, Hardelin JP. Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat Genet. 2003;33:463\u20135.", "journal-title": "Nat Genet"}, {"key": "10-1_CR41", "author": "C Dod\u00e9", "volume": "2", "year": "2006", "unstructured": "Dod\u00e9 C, Teixeira L, Levilliers J, Fouveaut C, Bouchard P, Kottler ML, Lespinasse J, Lienhardt-Roussie A, Mathieu M, Moerman A, Morgan G, Murat A, Toublanc JE, Wolczynski S, Delpech M, Petit C, Young J, Hardelin JP. Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2. PLoS Genet. 2006;2:e175.", "journal-title": "PLoS Genet", "DOI": "10.1371/journal.pgen.0020175", "doi-asserted-by": "publisher"}, {"key": "10-1_CR42", "unstructured": "Dohle GR, Arvers S, Bettocchi C (2012) Guidelines on male hypogonadism. European Association of Urology. www.uroweb.org."}, {"key": "10-1_CR43", "doi-asserted-by": "publisher", "first-page": "93", "DOI": "10.1006/neur.1995.0011", "volume": "4", "author": "RL Doty", "year": "1995", "unstructured": "Doty RL, Bromley SM, Stern MB. Olfactory testing as an aid in the diagnosis of Parkinson's disease: development of optimal discrimination criteria. Neurodegeneration. 1995;4:93\u20137.", "journal-title": "Neurodegeneration"}, {"key": "10-1_CR44", "doi-asserted-by": "publisher", "first-page": "229", "DOI": "10.1530/EJE-13-0894", "volume": "170", "author": "L Dunkel", "year": "2014", "unstructured": "Dunkel L, Quinton R. Transition in endocrinology: induction of puberty. Eur J Endocrinol. 2014;170:229\u201339.", "journal-title": "Eur J Endocrinol"}, {"key": "10-1_CR45", "doi-asserted-by": "publisher", "first-page": "R15", "DOI": "10.1530/EJE-14-0947", "volume": "173", "author": "AA Dwyer", "year": "2015", "unstructured": "Dwyer AA, Phan-Hug F, Hauschild M, Elowe-Gruau E, Pitteloud N. TRANSITION IN ENDOCRINOLOGY: Hypogonadism in adolescence. Eur J Endocrinol. 2015;173:R15\u201324.", "journal-title": "Eur J Endocrinol"}, {"key": "10-1_CR47", "doi-asserted-by": "publisher", "first-page": "R267", "DOI": "10.1530/EJE-15-1033", "volume": "174", "author": "AA Dwyer", "year": "2016", "unstructured": "Dwyer AA, Raivio T, Pitteloud N. MANAGEMENT OF ENDOCRINE DISEASE: Reversible hypogonadotropic hypogonadism. Eur J Endocrinol. 2016;174:R267\u201374.", "journal-title": "Eur J Endocrinol"}, {"key": "10-1_CR48", "doi-asserted-by": "publisher", "first-page": "892", "DOI": "10.1210/jc.2005-0902", "volume": "91", "author": "U Eiholzer", "year": "2006", "unstructured": "Eiholzer U, l'Allemand D, Rousson V, Schlumpf M, Gasser T, Girard J, Gr\u00fcters A, Simoni M. Hypothalamic and gonadal components of hypogonadism in boys with Prader-Labhart-Willi syndrome. J Clin Endocrinol Metab. 2006;91:892\u20138.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10-1_CR49", "doi-asserted-by": "publisher", "first-page": "256", "DOI": "10.1016/S0015-0282(98)00156-3", "volume": "70", "author": "European Metrodin HP Study Group EMHSG", "year": "1998", "unstructured": "European Metrodin HP Study Group EMHSG. Efficacy and safety of highly purified urinary follicle-stimulating hormone with human chorionic gonadotropin for treating men with isolated hypogonadotropic hypogonadism. European Metrodin HP Study Group. Fertil Steril. 1998;70:256\u201362.", "journal-title": "Fertil Steril"}, {"key": "10-1_CR50", "doi-asserted-by": "publisher", "first-page": "2822", "DOI": "10.1172/JCI34538", "volume": "118", "author": "J Falardeau", "year": "2008", "unstructured": "Falardeau J, Chung WC, Beenken A, Raivio T, Plummer L, Sidis Y, Jacobson-Dickman EE, Eliseenkova AV, Ma J, Dwyer A, Quinton R, Na S, Hall JE, Huot C, Alois N, Pearce SH, Cole LW, Hughes V, Mohammadi M, Tsai P, Pitteloud N. Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice. J Clin Invest. 2008;118:2822\u201331.", "journal-title": "J Clin Invest"}, {"key": "10-1_CR51", "first-page": "102", "volume": "73", "author": "C Fennell", "year": "2010", "unstructured": "Fennell C, Sartorius G, Ly LP, Turner L, Liu PY, Conway AJ, Handelsman DJ. Randomized cross-over clinical trial of injectable vs. implantable depot testosterone for maintenance of testosterone replacement therapy in androgen deficient men. Clin Endocrinol. 2010;73:102\u20139.", "journal-title": "Clin Endocrinol"}, {"key": "10-1_CR52", "doi-asserted-by": "publisher", "first-page": "651", "DOI": "10.1056/NEJM198509123131102", "volume": "313", "author": "DM Finkel", "year": "1985", "unstructured": "Finkel DM, Phillips BA, Snyder PJ. Stimulation of spermatogenesis by gonadotropins in men with hypogonadotropic hypogonadism. N Engl J Med. 1985;313:651\u20135.", "journal-title": "N Engl J Med"}, {"key": "10-1_CR53", "doi-asserted-by": "publisher", "first-page": "2836", "DOI": "10.1210/jc.2009-2466", "volume": "95", "author": "P Fischer-Posovszky", "year": "2010", "unstructured": "Fischer-Posovszky P, von Schnurbein J, Moepps B, Lahr G, Strauss G, Barth TF, Kassubek J, M\u00fchleder H, M\u00f6ller P, Debatin KM, Gierschik P, Wabitsch M. A new missense mutation in the leptin gene causes mild obesity and hypogonadism without affecting T cell responsiveness. J Clin Endocrinol Metab. 2010;95:2836\u201340.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10-1_CR54", "doi-asserted-by": "publisher", "first-page": "3888", "DOI": "10.1210/jc.2016-2118", "volume": "101", "author": "M Fleseriu", "year": "2016", "unstructured": "Fleseriu M, Hashim IA, Karavitaki N, Melmed S, Murad MH, Salvatori R, Samuels MH. Hormonal replacement in hypopituitarism in adults: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2016;101:3888\u2013921.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10-1_CR55", "doi-asserted-by": "publisher", "first-page": "724", "DOI": "10.1093/humrep/deq372", "volume": "26", "author": "C Frapsauce", "year": "2011", "unstructured": "Frapsauce C, Ravel C, Legendre M, Sibony M, Mandelbaum J, Donadille B, Achermann JC, Siffroi JP, Christin-Maitre S. Birth after TESE-ICSI in a man with hypogonadotropic hypogonadism and congenital adrenal hypoplasia linked to a DAX-1 (NR0B1) mutation. Hum Reprod. 2011;26:724\u20138.", "journal-title": "Hum Reprod"}, {"key": "10-1_CR56", "doi-asserted-by": "publisher", "first-page": "181", "DOI": "10.1007/s40271-015-0138-8", "volume": "9", "author": "HL Gelhorn", "year": "2016", "unstructured": "Gelhorn HL, Vernon MK, Stewart KD, Miller MG, Brod M, Althof SE, DeRogatis LR, Dobs A, Seftel AD, Revicki DA. Content validity of the hypogonadism impact of symptoms questionnaire (HIS-Q): a patient-reported outcome measure to evaluate symptoms of hypogonadism. Patient. 2016;9:181\u201390.", "journal-title": "Patient"}, {"key": "10-1_CR57", "doi-asserted-by": "publisher", "first-page": "265", "DOI": "10.1007/BF01541744", "volume": "17", "author": "L Gooren", "year": "1988", "unstructured": "Gooren L. Hypogonadotropic hypogonadal men respond less well to androgen substitution treatment than hypergonadotropic hypogonadal men. Arch Sex Behav. 1988;17:265\u201370.", "journal-title": "Arch Sex Behav"}, {"key": "10-1_CR58", "unstructured": "Greulich WW, Pyle SI, editors. Radiographic atlas of skeletal development of hand and wrist. 2. ed. California: Stanford University Press; 1959.", "DOI": "10.1097/00000441-195909000-00030", "doi-asserted-by": "crossref"}, {"key": "10-1_CR59", "doi-asserted-by": "publisher", "first-page": "81", "DOI": "10.1159/000277140", "volume": "73", "author": "RP Grinspon", "year": "2010", "unstructured": "Grinspon RP, Rey RA. Anti-mullerian hormone and sertoli cell function in paediatric male hypogonadism. Horm Res Paediatr. 2010;73:81\u201392.", "journal-title": "Horm Res Paediatr"}, {"key": "10-1_CR60", "doi-asserted-by": "publisher", "first-page": "1055", "DOI": "10.1172/JCI118866", "volume": "98", "author": "RL Habiby", "year": "1996", "unstructured": "Habiby RL, Boepple P, Nachtigall L, Sluss PM, Crowley WF Jr, Jameson JL. Adrenal hypoplasia congenita with hypogonadotropic hypogonadism: evidence that DAX-1 mutations lead to combined hypothalmic and pituitary defects in gonadotropin production. J Clin Invest. 1996;98:1055\u201362.", "journal-title": "J Clin Invest"}, {"key": "10-1_CR61", "doi-asserted-by": "publisher", "first-page": "463", "DOI": "10.1530/EJE-13-0222", "volume": "169", "author": "R Haring", "year": "2013", "unstructured": "Haring R, Baumeister SE, Nauck M, V\u00f6lzke H, Keevil BG, Brabant G, Wallaschofski H. Testosterone and cardiometabolic risk in the general population \u2013 the impact of measurement method on risk associations: a comparative study between immunoassay and mass spectrometry. Eur J Endocrinol. 2013;169:463\u201370.", "journal-title": "Eur J Endocrinol"}, {"key": "10-1_CR62", "doi-asserted-by": "publisher", "first-page": "3056", "DOI": "10.1210/jc.2012-1598", "volume": "97", "author": "J Harrington", "year": "2012", "unstructured": "Harrington J, Palmert MR. Clinical review: Distinguishing constitutional delay of growth and puberty from isolated hypogonadotropic hypogonadism: critical appraisal of available diagnostic tests. J Clin Endocrinol Metab. 2012;97:3056\u201367.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10-1_CR63", "first-page": "3027", "volume": "85", "author": "FJ Hayes", "year": "2000", "unstructured": "Hayes FJ, Seminara SB, Decruz S, Boepple PA, Crowley WF Jr. Aromatase inhibition in the human male reveals a hypothalamic site of estrogen feedback. J Clin Endocrinol Metab. 2000;85:3027\u201335.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10-1_CR64", "doi-asserted-by": "publisher", "first-page": "1202", "DOI": "10.1056/NEJM198205203062003", "volume": "306", "author": "DB Hier", "year": "1982", "unstructured": "Hier DB, Crowley WF Jr. Spatial ability in androgen-deficient men. N Engl J Med. 1982;306:1202\u20135.", "journal-title": "N Engl J Med"}, {"key": "10-1_CR65", "doi-asserted-by": "publisher", "first-page": "983", "DOI": "10.1530/EJE-11-1051", "volume": "166", "author": "IT Huhtaniemi", "year": "2012", "unstructured": "Huhtaniemi IT, Tajar A, Lee DM, O'Neill TW, Finn JD, Bartfai G, Boonen S, Casanueva FF, Giwercman A, Han TS, Kula K, Labrie F, Lean ME, Pendleton N, Punab M, Silman AJ, Vanderschueren D, Forti G, Wu FC, EMAS Group. Comparison of serum testosterone and estradiol measurements in 3174 European men using platform immunoassay and mass spectrometry; relevance for the diagnostics in aging men. Eur J Endocrinol. 2012;166:983\u201391.", "journal-title": "Eur J Endocrinol"}, {"key": "10-1_CR66", "doi-asserted-by": "publisher", "first-page": "237", "DOI": "10.1007/s00405-006-0173-0", "volume": "264", "author": "T Hummel", "year": "2007", "unstructured": "Hummel T, Kobal G, Gudziol H, Mackay-Sim A. Normative data for the \"Sniffin' Sticks\" including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3,000 subjects. Eur Arch Otorhinolaryngol. 2007;264:237\u201343.", "journal-title": "Eur Arch Otorhinolaryngol"}, {"key": "10-1_CR67", "doi-asserted-by": "publisher", "first-page": "65", "DOI": "10.1016/j.mce.2011.04.017", "volume": "346", "author": "U Jadhav", "year": "2011", "unstructured": "Jadhav U, Harris RM, Jameson JL. Hypogonadotropic hypogonadism in subjects with DAX1 mutations. Mol Cell Endocrinol. 2011;346:65\u201373.", "journal-title": "Mol Cell Endocrinol"}, {"key": "10-1_CR68", "doi-asserted-by": "publisher", "first-page": "1149", "DOI": "10.1002/humu.22086", "volume": "33", "author": "N Janssen", "year": "2012", "unstructured": "Janssen N, Bergman JE, Swertz MA, Tranebjaerg L, Lodahl M, Schoots J, Hofstra RM, van Ravenswaaij-Arts CM, Hoefsloot LH. Mutation update on the CHD7 gene involved in CHARGE syndrome. Hum Mutat. 2012;33:1149\u201360.", "journal-title": "Hum Mutat"}, {"key": "10-1_CR69", "doi-asserted-by": "crossref", "first-page": "763", "DOI": "10.1530/acta.0.0890763", "volume": "89", "author": "SG Johnsen", "year": "1978", "unstructured": "Johnsen SG. Maintenance of spermatogenesis induced by hMG treatment by means of continuous hCG treatment in hypogonadotropic men. Acta Endocrinol. 1978;89:763\u20139.", "journal-title": "Acta Endocrinol"}, {"key": "10-1_CR70", "doi-asserted-by": "publisher", "first-page": "167", "DOI": "10.1016/bs.pmbts.2015.10.010", "volume": "138", "author": "Z Karaca", "year": "2016", "unstructured": "Karaca Z, Tanr\u0131verdi F, \u00dcnl\u00fch\u0131zarc\u0131 K, Kelestimur F. GH and pituitary hormone alterations after traumatic brain injury. Prog Mol Biol Transl Sci. 2016;138:167\u201391.", "journal-title": "Prog Mol Biol Transl Sci"}, {"key": "10-1_CR71", "doi-asserted-by": "publisher", "first-page": "469", "DOI": "10.1046/j.1365-2265.1999.00827.x", "volume": "51", "author": "S Kelleher", "year": "1999", "unstructured": "Kelleher S, Turner L, Howe C, Conway AJ, Handelsman DJ. Extrusion of testosterone pellets: a randomized controlled clinical study. Clin Endocrinol. 1999;51:469\u201371.", "journal-title": "Clin Endocrinol"}, {"key": "10-1_CR72", "doi-asserted-by": "publisher", "first-page": "1161", "DOI": "10.1089/neu.2013.3212", "volume": "31", "author": "DF Kelly", "year": "2014", "unstructured": "Kelly DF, Chaloner C, Evans D, Mathews A, Cohan P, Wang C, Swerdloff R, Sim MS, Lee J, Wright MJ, Kernan C, Barkhoudarian G, Yuen KC, Guskiewicz K. Prevalence of pituitary hormone dysfunction, metabolic syndrome, and impaired quality of life in retired professional football players: a prospective study. J Neurotrauma. 2014;31:1161\u201371.", "journal-title": "J Neurotrauma"}, {"key": "10-1_CR73", "doi-asserted-by": "publisher", "first-page": "3", "DOI": "10.1111/cge.12737", "volume": "90", "author": "SA Khan", "year": "2016", "unstructured": "Khan SA, Muhammad N, Khan MA, Kamal A, Rehman ZU, Khan S. Genetics of human Bardet-Biedl syndrome, an update. Clin Genet. 2016;90:3\u201315.", "journal-title": "Clin Genet"}, {"key": "10-1_CR74", "doi-asserted-by": "publisher", "first-page": "1326", "DOI": "10.1016/S0015-0282(16)57619-5", "volume": "63", "author": "S Kliesch", "year": "1995", "unstructured": "Kliesch S, Behre HM, Nieschlag E. Recombinant human follicle-stimulating hormone and human chorionic gonadotropin for induction of spermatogenesis in a hypogonadotropic male. Fertil Steril. 1995;63:1326\u20138.", "journal-title": "Fertil Steril"}, {"key": "10-1_CR75", "doi-asserted-by": "publisher", "first-page": "317", "DOI": "10.1530/eje.1.01964", "volume": "153", "author": "B K\u00fchnert", "year": "2005", "unstructured": "K\u00fchnert B, Byrne M, Simoni M, K\u00f6pcke W, Gerss J, Lemmnitz G, Nieschlag E. Testosterone substitution with a new transdermal, hydroalcoholic gel applied to scrotal or non-scrotal skin: a multicentre trial. Eur J Endocrinol. 2005;153:317\u201326.", "journal-title": "Eur J Endocrinol"}, {"key": "10-1_CR77", "author": "EM Laitinen", "volume": "7", "year": "2012", "unstructured": "Laitinen EM, Tommiska J, Sane T, Vaaralahti K, Toppari J, Raivio T. Reversible congenital hypogonadotropic hypogonadism in patients with CHD7, FGFR1 or GNRHR mutations. PLoS One. 2012;7:e39450.", "journal-title": "PLoS One", "DOI": "10.1371/journal.pone.0039450", "doi-asserted-by": "publisher"}, {"key": "10-1_CR78", "doi-asserted-by": "publisher", "first-page": "14", "DOI": "10.1038/ng0198-14", "volume": "18", "author": "LC Layman", "year": "1998", "unstructured": "Layman LC, Cohen DP, Jin M, Xie J, Li Z, Reindollar RH, Bolbolan S, Bick DP, Sherins RR, Duck LW, Musgrove LC, Sellers JC, Neill JD. Mutations in gonadotropin-releasing hormone receptor gene cause hypogonadotropic hypogonadism. Nat Genet. 1998;18:14\u20135.", "journal-title": "Nat Genet"}, {"key": "10-1_CR79", "doi-asserted-by": "publisher", "first-page": "3479", "DOI": "10.1210/en.2010-0022", "volume": "151", "author": "MN Lehman", "year": "2010", "unstructured": "Lehman MN, Coolen LM, Goodman RL. Minireview: kisspeptin/neurokinin B/dynorphin (KNDy) cells of the arcuate nucleus: a central node in the control of gonadotropin-releasing hormone secretion. Endocrinology. 2010;151:3479\u201389.", "journal-title": "Endocrinology"}, {"key": "10-1_CR80", "doi-asserted-by": "publisher", "first-page": "4531", "DOI": "10.1073/pnas.0308767101", "volume": "101", "author": "J Licinio", "year": "2004", "unstructured": "Licinio J, Caglayan S, Ozata M, Yildiz BO, de Miranda PB, O'Kirwan F, Whitby R, Liang L, Cohen P, Bhasin S, Krauss RM, Veldhuis JD, Wagner AJ, DePaoli AM, McCann SM, Wong ML. Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. Proc Natl Acad Sci U S A. 2004;101:4531\u20136.", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "10-1_CR81", "doi-asserted-by": "publisher", "first-page": "1140", "DOI": "10.1210/jcem-67-6-1140", "volume": "67", "author": "L Liu", "year": "1988", "unstructured": "Liu L, Banks SM, Barnes KM, Sherins RJ. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 1988;67:1140\u20135.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10-1_CR83", "unstructured": "Liu PY, Gebski VJ, Turner L, Conway AJ, Wishart SM, Handelsman DJ. Predicting pregnancy and spermatogenesis by survival analysis during gonadotrophin treatment of gonadotrophin-deficient infertile men. Hum Reprod. 2002;17:625\u201333.", "DOI": "10.1093/humrep/17.3.625", "doi-asserted-by": "crossref"}, {"key": "10-1_CR82", "unstructured": "Liu PY, Swerdloff RS, Christenson PD, Handelsman DJ, Wang C. Hormonal Male Contraception Summit Group. Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis. Lancet. 2006;367:1412\u201320.", "DOI": "10.1016/S0140-6736(06)68614-5", "doi-asserted-by": "crossref"}, {"key": "10-1_CR84", "doi-asserted-by": "publisher", "first-page": "801", "DOI": "10.1210/jc.2008-1648", "volume": "94", "author": "PY Liu", "year": "2009", "unstructured": "Liu PY, Baker HW, Jayadev V, Zacharin M, Conway AJ, Handelsman DJ. Induction of spermatogenesis and fertility during gonadotropin treatment of gonadotropin-deficient infertile men: predictors of fertility outcome. J Clin Endocrinol Metab. 2009;94:801\u20138.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10-1_CR85", "doi-asserted-by": "publisher", "first-page": "897", "DOI": "10.1056/NEJMoa071999", "volume": "357", "author": "A Lofrano-Porto", "year": "2007", "unstructured": "Lofrano-Porto A, Barra GB, Giacomini LA, Nascimento PP, Latronico AC, Casulari LA, da Rocha Neves Fde A. Luteinizing hormone beta mutation and hypogonadism in men and women. N Engl J Med. 2007;357:897\u2013904.", "journal-title": "N Engl J Med"}, {"key": "10-1_CR86", "doi-asserted-by": "publisher", "first-page": "862", "DOI": "10.1093/oxfordjournals.humrep.a136051", "volume": "108", "author": "MA Mackey", "year": "1995", "unstructured": "Mackey MA, Conway AJ, Handelsman DJ. Tolerability of intramuscular injections of testosterone ester in oil vehicle. Hum Reprod. 1995;108:862\u20135.", "journal-title": "Hum Reprod"}, {"key": "10-1_CR87", "doi-asserted-by": "publisher", "first-page": "44", "DOI": "10.1210/jcem.87.1.8163", "volume": "87", "author": "G Mantovani", "year": "2002", "unstructured": "Mantovani G, Ozisik G, Achermann JC, Romoli R, Borretta G, Persani L, Spada A, Jameson JL, Beck-Peccoz P. Hypogonadotropic hypogonadism as a presenting feature of late-onset X-linked adrenal hypoplasia congenita. J Clin Endocrinol Metab. 2002;87:44\u20138.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10-1_CR88", "unstructured": "Mao JF, Liu ZX, Nie M, Wang X, HL X, Huang BK, Zheng JJ, Min L, Kaiser UB, Pulsatile WXY. Gonadotropin-releasing hormone therapy is associated with earlier spermatogenesis compared to combined gonadotropin therapy in patients with congenital hypogonadotropic hypogonadism. Asian J Androl. 2016. \n                  https://doi.org/10.4103/1008-682X.193568\n                  \n                .", "DOI": "10.4103/1008-682X.193568", "doi-asserted-by": "publisher"}, {"key": "10-1_CR89", "unstructured": "Matthews CH, Borgato S, Beck-Peccoz P, Adams M, Tone Y, Gambino G, Casagrande S, Tedeschini G, Benedetti A, Chatterjee VK. Primary amenorrhoea and infertility due to a mutation in the beta-subunit of follicle-stimulating hormone. Nat Genet. 1993;5:83\u20136.", "DOI": "10.1038/ng0993-83", "doi-asserted-by": "crossref"}, {"key": "10-1_CR90", "doi-asserted-by": "publisher", "first-page": "1184", "DOI": "10.1210/jcem-62-6-1184", "volume": "62", "author": "AM Matsumoto", "year": "1986", "unstructured": "Matsumoto AM, Karpas AE, Bremner WJ. Chronic human chorionic gonadotropin administration in normal men: evidence that follicle-stimulating hormone is necessary for the maintenance of quantitatively normal spermatogenesis in man. J Clin Endocrinol Metab. 1986;62:1184\u201392.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10-1_CR151", "unstructured": "Matsumoto AM, Snyder PJ, Bhasin S, Martin K, Weber T, Winters S, Spratt D, Brentzel J, O\u2019Dea L. Stimulation of spermatogenesis with recombinant human follicle-stimulating hormone (follitropin alfa; GONAL-f): long-term treatment in azoospermic men with hypogonadotropic hypogonadism. Fertil Steril 2009;92:979\u2013990.", "DOI": "10.1016/j.fertnstert.2008.07.1742", "doi-asserted-by": "crossref"}, {"key": "10-1_CR91", "doi-asserted-by": "publisher", "first-page": "477", "DOI": "10.1517/14656566.7.4.477", "volume": "7", "author": "T McNicholas", "year": "2006", "unstructured": "McNicholas T, Ong T. Review of Testim gel. Expert Opin Pharmacother. 2006;7:477\u201384.", "journal-title": "Expert Opin Pharmacother"}, {"key": "10-1_CR92", "first-page": "1", "volume": "24", "author": "D Nelson", "year": "2013", "unstructured": "Nelson D, Ho J, Pacaud D, Stephure D. Virilization in two pre-pubertal children exposed to topical androgen. J Pediatr Endocrinol Metab. 2013;24:1\u20135.", "journal-title": "J Pediatr Endocrinol Metab"}, {"key": "10-1_CR93", "doi-asserted-by": "publisher", "first-page": "182", "DOI": "10.1038/76041", "volume": "25", "author": "I Netchine", "year": "2000", "unstructured": "Netchine I, Sobrier ML, Krude H, Schnabel D, Maghnie M, Marcos E, Duriez B, Cacheux V, Moers A, Goossens M, Gruters A, Amselem S. Mutations in LHX3 result in a new syndrome revealed by combined pituitary hormone deficiency. Nat Genet. 2000;25:182\u20136.", "journal-title": "Nat Genet"}, {"key": "10-1_CR94", "doi-asserted-by": "publisher", "first-page": "457", "DOI": "10.1016/j.contraception.2010.03.020", "volume": "82", "author": "E Nieschlag", "year": "2010", "unstructured": "Nieschlag E. Clinical trials in male hormonal contraception. Contraception. 2010;82:457\u201370.", "journal-title": "Contraception"}, {"key": "10-1_CR98", "unstructured": "Nieschlag E, Nieschlag S. Testosterone deficiency: a historical perspective. Asian J Androl. 2014;16:161\u20138.", "DOI": "10.4103/1008-682X.122358", "doi-asserted-by": "crossref"}, {"key": "10-1_CR100", "doi-asserted-by": "publisher", "first-page": "47", "DOI": "10.1530/EJE-15-0080", "volume": "173", "author": "E Nieschlag", "year": "2015", "unstructured": "Nieschlag E, Vorona E. Medical consequences of doping with anabolic androgenic steroids: effects on reproductive functions. Eur J Endocrinol. 2015;173:47\u201358.", "journal-title": "Eur J Endocrinol"}, {"key": "10-1_CR95", "doi-asserted-by": "publisher", "first-page": "409", "DOI": "10.1093/humupd/dmh035", "volume": "10", "author": "E Nieschlag", "year": "2004", "unstructured": "Nieschlag E, Behre HM, Bouchard P, Corrales JJ, Jones TH, Stalla GK, Webb SM, Wu FC. Testosterone replacement therapy: current trends and future directions. Hum Reprod Update. 2004;10:409\u201319.", "journal-title": "Hum Reprod Update"}, {"key": "10-1_CR96", "doi-asserted-by": "publisher", "first-page": "17", "DOI": "10.1186/s12958-017-0232-y", "volume": "15", "author": "E Nieschlag", "year": "2017", "unstructured": "Nieschlag E, Bouloux P-MG, Stegmann BJ, Shankar RR, Guan Y, Tzontcheva A, McCrary Sisk C, Behre H. Efficacy and safety of the long-acting Corifollitropin Alfa in combination with hCG in adult men with hypogonadotropic hypodonadism. Reprod Endocr Biol. 2017;15:17.", "journal-title": "Reprod Endocr Biol"}, {"key": "10-1_CR97", "doi-asserted-by": "publisher", "first-page": "757", "DOI": "10.1046/j.1365-2265.1999.00881.x", "volume": "51", "author": "E Nieschlag", "year": "1999", "unstructured": "Nieschlag E, B\u00fcchter D, Von Eckardstein S, Abshagen K, Simoni M, Behre HM. Repeated intramuscular injections of testosterone undecanoate for substitution therapy in hypogonadal men. Clin Endocrinol. 1999a;51:757\u201363.", "journal-title": "Clin Endocrinol"}, {"key": "10-1_CR99", "doi-asserted-by": "publisher", "first-page": "139", "DOI": "10.1046/j.1365-2265.1999.00846.x", "volume": "51", "author": "E Nieschlag", "year": "1999", "unstructured": "Nieschlag E, Simoni M, Gromoll J, Weinbauer GF. Role of FSH in the regulation of spermatogenesis: clinical aspects. Clin Endocrinol. 1999b;51:139\u201346.", "journal-title": "Clin Endocrinol"}, {"key": "10-1_CR101", "year": "1992", "unstructured": "Nieschlag E, Wang C, Handelsman DJ, Swerdloff RS, Wu FCW, Einer-Jensen N, Waites GMH, editors. Guidelines for the use of androgens. Geneva: WHO Special Programme of Research/Development and Research Training in Human Reproduction; 1992.", "volume-title": "Guidelines for the use of androgens"}, {"key": "10-1_CR102", "doi-asserted-by": "publisher", "first-page": "1729", "DOI": "10.1056/NEJM199806113382404", "volume": "338", "author": "M Phillip", "year": "1998", "unstructured": "Phillip M, Arbelle JE, Segev Y, Parvari R. Male hypogonadism due to a mutation in the gene for the beta-subunit of follicle-stimulating hormone. N Engl J Med. 1998;338:1729\u201332.", "journal-title": "N Engl J Med"}, {"key": "10-1_CR103", "doi-asserted-by": "publisher", "first-page": "784", "DOI": "10.1210/jc.2007-2156", "volume": "93", "author": "N Pitteloud", "year": "2008", "unstructured": "Pitteloud N, Dwyer AA, DeCruz S, Lee H, Boepple PA, Crowley WF Jr, Hayes FJ. Inhibition of luteinizing hormone secretion by testosterone in men requires aromatization for its pituitary but not its hypothalamic effects: evidence from the tandem study of normal and gonadotropin-releasing hormone-deficient men. J Clin Endocrinol Metab. 2008;93:784\u201391.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10-1_CR104", "doi-asserted-by": "publisher", "first-page": "4128", "DOI": "10.1210/jc.2002-020518", "volume": "87", "author": "N Pitteloud", "year": "2002", "unstructured": "Pitteloud N, Hayes FJ, Dwyer A, Boepple PA, Lee H, Crowley WF Jr. Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2002;87:4128\u201336.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10-1_CR105", "doi-asserted-by": "publisher", "first-page": "457", "DOI": "10.1172/JCI29884", "volume": "117", "author": "N Pitteloud", "year": "2007", "unstructured": "Pitteloud N, Quinton R, Pearce S, Raivio T, Acierno J, Dwyer A, Plummer L, Hughes V, Seminara S, Cheng YZ, Li WP, Maccoll G, Eliseenkova AV, Olsen SK, Ibrahimi OA, Hayes FJ, Boepple P, Hall JE, Bouloux P, Mohammadi M, Crowley W. Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism. J Clin Invest. 2007;117:457\u201363.", "journal-title": "J Clin Invest"}, {"key": "10-1_CR106", "doi-asserted-by": "publisher", "first-page": "1424", "DOI": "10.1016/j.fertnstert.2011.09.046", "volume": "96", "author": "SD Quaynor", "year": "2011", "unstructured": "Quaynor SD, Kim HG, Cappello EM, Williams T, Chorich LP, Bick DP, Sherins RJ, Layman LC. The prevalence of digenic mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome. Fertil Steril. 2011;96:1424\u201330.", "journal-title": "Fertil Steril"}, {"key": "10-1_CR107", "unstructured": "Quinton R, Cheow HK, Tymms DJ, Bouloux PM, Wu FC, Jacobs HS. Kallmann\u2019s syndrome: is it always for life? Clin Endocrinol. 1999;50:481\u20135.", "DOI": "10.1046/j.1365-2265.1999.00708.x", "doi-asserted-by": "crossref"}, {"key": "10-1_CR108", "doi-asserted-by": "publisher", "first-page": "863", "DOI": "10.1056/NEJMoa066494", "volume": "357", "author": "T Raivio", "year": "2007", "unstructured": "Raivio T, Falardeau J, Dwyer A, Quinton R, Hayes FJ, et al. Reversal of idiopathic hypogonadotropic hypogonadism. N Engl J Med. 2007;357:863\u201373.", "journal-title": "N Engl J Med"}, {"key": "10-1_CR109", "doi-asserted-by": "publisher", "first-page": "851", "DOI": "10.1002/cncr.20028", "volume": "100", "author": "A Rajagopal", "year": "2004", "unstructured": "Rajagopal A, Vassilopoulou-Sellin R, Palmer JL, Kaur G, Bruera E. Symptomatic hypogonadism in male survivors of cancer with chronic exposure to opioids. Cancer. 2004;100:851\u20138.", "journal-title": "Cancer"}, {"key": "10-1_CR110", "doi-asserted-by": "publisher", "first-page": "513", "DOI": "10.1530/eje.1.02254", "volume": "155", "author": "V Rochira", "year": "2006", "unstructured": "Rochira V, Zirilli L, Genazzani AD, Balestrieri A, Aranda C, Fabre B, Antunez P, Diazzi C, Carani C, Maffei L. Hypothalamic-pituitary-gonadal axis in two men with aromatase deficiency: evidence that circulating estrogens are required at the hypothalamic level for the integrity of gonadotropin negative feedback. Eur J Endocrinol. 2006;155:513\u201322.", "journal-title": "Eur J Endocrinol"}, {"key": "10-1_CR111", "first-page": "383", "volume": "3", "author": "AD Rogol", "year": "2005", "unstructured": "Rogol AD. Pubertal androgen therapy in boys. Pediatr Endocrinol Rev. 2005;3:383\u201390.", "journal-title": "Pediatr Endocrinol Rev"}, {"key": "10-1_CR112", "unstructured": "Rohayem J, Hauffa BP, Zacharin M, Kliesch S, Zitzmann M. The \u201cGerman Adolescent Hypogonadotropic Hypogonadism Study Group\u201d. Testicular growth and spermatogenesis: new goals for pubertal hormone replacement in boys with hypogonadotropic hypogonadism? -a multicentre prospective study of hCG/rFSH treatment outcomes during adolescence. Clin Endocrinol (Oxford). 2017;86:75\u201387.", "DOI": "10.1111/cen.13164", "doi-asserted-by": "crossref"}, {"key": "10-1_CR113", "doi-asserted-by": "publisher", "first-page": "882", "DOI": "10.1111/andr.12088", "volume": "3", "author": "J Rohayem", "year": "2015", "unstructured": "Rohayem J, Nieschlag E, Kliesch S, Zitzmann M. Inhibin B, AMH, but not INSL3, IGF1 or DHEAS support differentiation between constitutional delay of growth and puberty and hypogonadotropic hypogonadism. Andrology. 2015;3:882\u20137.", "journal-title": "Andrology"}, {"key": "10-1_CR114", "doi-asserted-by": "publisher", "first-page": "87", "DOI": "10.1111/andr.12128", "volume": "4", "author": "J Rohayem", "year": "2016", "unstructured": "Rohayem J, Sinthofen N, Nieschlag E, Kliesch S, Zitzmann M. Causes of hypogonadotropic hypogonadism predict response to gonadotropin substitution in adults. Andrology. 2016;4:87\u201394.", "journal-title": "Andrology"}, {"key": "10-1_CR115", "doi-asserted-by": "publisher", "first-page": "K11", "DOI": "10.1530/EJE-13-0449", "volume": "170", "author": "J Rohayem", "year": "2014", "unstructured": "Rohayem J, T\u00fcttelmann F, Mallidis C, Nieschlag E, Kliesch S, Zitzmann M. Restoration of fertility by gonadotropin replacement in a man with hypogonadotropic azoospermia and testicular adrenal rest tumors due to untreated simple virilizing congenital adrenal hyperplasia. Eur J Endocrinol. 2014;170:K11\u20137.", "journal-title": "Eur J Endocrinol"}, {"key": "10-1_CR116", "doi-asserted-by": "publisher", "first-page": "755", "DOI": "10.1111/j.1365-2265.2012.04432.x", "volume": "77", "author": "G Sartorius", "year": "2012", "unstructured": "Sartorius G, Spasevska S, Idan A, Turner L, Forbes E, Zamojska A, Allan CA, Ly LP, Conway AJ, McLachlan RI, Handelsman DJ. Serum testosterone, dihydrotestosterone and estradiol concentrations in older men self-reporting very good health: the healthy man study. Clin Endocrinol. 2012;77:755\u201363.", "journal-title": "Clin Endocrinol"}, {"key": "10-1_CR117", "doi-asserted-by": "publisher", "first-page": "175", "DOI": "10.1093/humrep/8.suppl_2.175", "volume": "8", "author": "J Schopohl", "year": "1993", "unstructured": "Schopohl J. Pulsatile gonadotrophin releasing hormone versus gonadotrophin treatment of hypothalamic hypogonadism in males. Hum Reprod. 1993;8:175\u20139.", "journal-title": "Hum Reprod"}, {"key": "10-1_CR118", "doi-asserted-by": "publisher", "first-page": "1613", "DOI": "10.1210/jcem.87.4.8395", "volume": "87", "author": "IL Sedlmeyer", "year": "2002", "unstructured": "Sedlmeyer IL, Palmert MR. Delayed puberty: analysis of a large case series from an academic center. J Clin Endocrinol Metab. 2002;87:1613\u201320.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10-1_CR119", "doi-asserted-by": "publisher", "first-page": "1614", "DOI": "10.1056/NEJMoa035322", "volume": "349", "author": "SB Seminara", "year": "2003", "unstructured": "Seminara SB, Messager S, Chatzidaki EE, Thresher RR, Acierno JS Jr, Shagoury JK, Bo-Abbas Y, Kuohung W, Schwinof KM, Hendrick AG, Zahn D, Dixon J, Kaiser UB, Slaugenhaupt SA, Gusella JF, O'Rahilly S, Carlton MB, Crowley WF Jr, Aparicio SA, Colledge WH. The GPR54 gene as a regulator of puberty. N Engl J Med. 2003;349:1614\u201327.", "journal-title": "N Engl J Med"}, {"key": "10-1_CR120", "doi-asserted-by": "publisher", "first-page": "259", "DOI": "10.1111/cen.12435", "volume": "81", "author": "K Shiraishi", "year": "2014", "unstructured": "Shiraishi K, Oka S, Matsuyama H. Assessment of quality of life during gonadotrophin treatment for male hypogonadotrophic hypogonadism. Clin Endocrinol. 2014;81:259\u201365.", "journal-title": "Clin Endocrinol"}, {"key": "10-1_CR121", "doi-asserted-by": "publisher", "first-page": "861", "DOI": "10.1210/jc.2013-2809", "volume": "99", "author": "VF Sidhoum", "year": "2014", "unstructured": "Sidhoum VF, Chan YM, Lippincott MF, Balasubramanian R, Quinton R, Plummer L, Dwyer A, Pitteloud N, Hayes FJ, Hall JE, Martin KA, Boepple PA, Seminara SB. Reversal and relapse of hypogonadotropic hypogonadism: resilience and fragility of the reproductive neuroendocrine system. J Clin Endocrinol Metab. 2014;99:861\u201370.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10-1_CR122", "doi-asserted-by": "publisher", "first-page": "211", "DOI": "10.1177/1933719112461184", "volume": "20", "author": "ET Siegel", "year": "2013", "unstructured": "Siegel ET, Kim HG, Nishimoto HK, Layman LC. The molecular basis of impaired follicle-stimulating hormone action: evidence from human mutations and mouse models. Reprod Sci. 2013;20:211\u201333.", "journal-title": "Reprod Sci"}, {"key": "10-1_CR123", "doi-asserted-by": "publisher", "first-page": "207", "DOI": "10.1159/000442289", "volume": "85", "author": "E \u015eim\u015fek", "year": "2016", "unstructured": "\u015eim\u015fek E, Montenegro LR, Binay C, Demiral M, Ac\u0131kalin MF, Latronico AC. Clinical and hormonal features of a male adolescent with congenital isolated follicle-stimulating hormone deficiency. Horm Res Paediatr. 2016;85:207\u201312.", "journal-title": "Horm Res Paediatr"}, {"key": "10-1_CR124", "doi-asserted-by": "publisher", "first-page": "1029", "DOI": "10.1093/humrep/den046", "volume": "23", "author": "AA Sinisi", "year": "2008", "unstructured": "Sinisi AA, Esposito D, Maione L, Quinto MC, Visconti D, De Bellis A, Bellastella A, Conzo G, Bellastella G. Seminal anti-Mullerian hormone level is a marker of spermatogenic response during long-term gonadotropin therapy in male hypogonadotropic hypogonadism. Hum Reprod. 2008;23:1029\u201334.", "journal-title": "Hum Reprod"}, {"key": "10-1_CR125", "doi-asserted-by": "publisher", "first-page": "163", "DOI": "10.1016/j.yfrne.2005.10.003", "volume": "26", "author": "CL Sisk", "year": "2005", "unstructured": "Sisk CL, Zehr JL. Pubertal hormones organize the adolescent brain and behavior. Front Neuroendocrinol. 2005;26:163\u201374.", "journal-title": "Front Neuroendocrinol"}, {"key": "10-1_CR126", "doi-asserted-by": "publisher", "first-page": "698", "DOI": "10.4103/2230-8210.100650", "volume": "16", "author": "AT Soliman", "year": "2012", "unstructured": "Soliman AT, De Sanctis V. An approach to constitutional delay of growth and puberty. Indian J Endocrinol Metab. 2012;16:698\u2013705.", "journal-title": "Indian J Endocrinol Metab"}, {"key": "10-1_CR127", "doi-asserted-by": "publisher", "first-page": "283", "DOI": "10.1210/jcem-64-2-283", "volume": "64", "author": "DI Spratt", "year": "1987", "unstructured": "Spratt DI, Carr DB, Merriam GR, Scully RE, Rao PN, Crowley WF. The spectrum of abnormal patterns of gonadotropin-releasing hormone secretion in men with idiopathic hypogonadotropic hypogonadism: clinical and laboratory correlations. J Clin Endocrinol Metab. 1987;64:283\u201391.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10-1_CR128", "doi-asserted-by": "publisher", "first-page": "213", "DOI": "10.1038/ng0398-213", "volume": "18", "author": "A Strobel", "year": "1998", "unstructured": "Strobel A, Issad T, Camoin L, Ozata M, Strosberg AD. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet. 1998;18:213\u20135.", "journal-title": "Nat Genet"}, {"key": "10-1_CR129", "doi-asserted-by": "publisher", "first-page": "408", "DOI": "10.1017/CBO9781139003353.019", "volume-title": "Testosterone: action, deficiency, substitution", "author": "RS Swerdloff", "year": "2012", "unstructured": "Swerdloff RS, Wang CL. Review of guidelines on diagnosis and treatment of testosterone deficiency. In: Nieschlag E, Behre HM, Nieschlag S, editors. Testosterone: action, deficiency, substitution. 4th ed. Cambridge: Cambridge University Press; 2012. p. 408\u201320.", "edition": "4"}, {"key": "10-1_CR130", "doi-asserted-by": "publisher", "first-page": "3280", "DOI": "10.1210/JC.2015-1542", "volume": "100", "author": "RS Swerdloff", "year": "2015", "unstructured": "Swerdloff RS, Pak Y, Wang C, Liu PY, Bhasin S, Gill TM, Matsumoto AM, Pahor M, Surampudi P, Snyder PJ. Serum testosterone (T) level variability in T-gel-treated older hypogonadal men: treatment monitoring implications. J Clin Endocrinol Metab. 2015;100:3280\u20137.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10-1_CR131", "doi-asserted-by": "publisher", "first-page": "394", "DOI": "10.2169/internalmedicine.31.394", "volume": "31", "author": "T Takeda", "year": "1992", "unstructured": "Takeda T, Takasu N, Yamauchi K, Komiya I, Ohtsuka H, Nagasawa Y, Ohara N, Yamada T. Magnetic resonance imaging of the rhinencephalon in a patient with Kallmann\u2019s syndrome. Intern Med. 1992;31:394\u20136.", "journal-title": "Intern Med"}, {"key": "10-1_CR132", "doi-asserted-by": "publisher", "first-page": "194", "DOI": "10.1007/s00415-014-7555-9", "volume": "262", "author": "AA Tarnutzer", "year": "2015", "unstructured": "Tarnutzer AA, Gerth-Kahlert C, Timmann D, Chang DI, Harmuth F, Bauer P, Straumann D, Synofzik M. Boucher-Neuh\u00e4user syndrome: cerebellar degeneration, chorioretinal dystrophy and hypogonadotropic hypogonadism: two novel cases and a review of 40 cases from the literature. J Neurol. 2015;262:194\u2013202.", "journal-title": "J Neurol"}, {"key": "10-1_CR133", "doi-asserted-by": "publisher", "first-page": "171", "DOI": "10.1007/s40279-015-0411-y", "volume": "46", "author": "AS Tenforde", "year": "2016", "unstructured": "Tenforde AS, Barrack MT, Nattiv A, Fredericson M. Parallels with the female athlete triad in male athletes. Sports Med. 2016;46:171\u201382.", "journal-title": "Sports Med"}, {"key": "10-1_CR134", "doi-asserted-by": "publisher", "first-page": "316", "DOI": "10.1111/j.1365-2265.2012.04493.x", "volume": "78", "author": "J Tommiska", "year": "2013", "unstructured": "Tommiska J, J\u00f8rgensen N, Christiansen P, Juul A, Raivio T. A homozygous R262Q mutation in the gonadotropin-releasing hormone receptor presenting as reversal of hypogonadotropic hypogonadism and late-onset hypogonadism. Clin Endocrinol. 2013;78:316\u20137.", "journal-title": "Clin Endocrinol"}, {"key": "10-1_CR135", "doi-asserted-by": "publisher", "first-page": "354", "DOI": "10.1038/ng.306", "volume": "41", "author": "AK Topaloglu", "year": "2009", "unstructured": "Topaloglu AK, Reimann F, Guclu M, Yalin AS, Kotan LD, Porter KM, Serin A, Mungan NO, Cook JR, Ozbek MN, Imamoglu S, Akalin NS, Yuksel B, O'Rahilly S, Semple RK. TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for neurokinin B in the central control of reproduction. Nat Genet. 2009;41:354\u20138.", "journal-title": "Nat Genet"}, {"key": "10-1_CR136", "doi-asserted-by": "crossref", "first-page": "109", "DOI": "10.3389/fendo.2014.00109", "volume": "5", "author": "H Valdes-Socin", "year": "2014", "unstructured": "Valdes-Socin H, Rubio Almanza M, Tom\u00e9 Fern\u00e1ndez-Ladreda M, Debray FG, Bours V, Beckers A. Reproduction, smell, and neurodevelopmental disorders: genetic defects in different hypogonadotropic hypogonadal syndromes. Front Endocrinol (Lausanne). 2014;5:109.", "journal-title": "Front Endocrinol (Lausanne)"}, {"key": "10-1_CR137", "doi-asserted-by": "publisher", "first-page": "2982", "DOI": "10.1210/jcem.86.7.7685", "volume": "86", "author": "M Wabitsch", "year": "2001", "unstructured": "Wabitsch M, Ballauff A, Holl R, Blum WF, Heinze E, Remschmidt H, Hebebrand J. Serum leptin, gonadotropin, and testosterone concentrations in male patients with anorexia nervosa during weight gain. J Clin Endocrinol Metab. 2001;86:2982\u20138.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10-1_CR138", "first-page": "4388", "volume": "81", "author": "J Waldstreicher", "year": "1996", "unstructured": "Waldstreicher J, Seminara SB, Jameson JL, Geyer A, Nachtigall LB, Boepple PA, Holmes LB, Crowley WF Jr. The genetic and clinical heterogeneity of gonadotropin-releasing hormone deficiency in the human. J Clin Endocrinol Metab. 1996;81:4388\u201395.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10-1_CR139", "doi-asserted-by": "publisher", "first-page": "457", "DOI": "10.2164/jandrol.109.009597", "volume": "31", "author": "C Wang", "year": "2010", "unstructured": "Wang C, Harnett M, Dobs AS, Swerdloff RS. Pharmacokinetics and safety of long-acting testosterone undecanoate injections in hypogonadal men: an 84-week phase III clinical trial. J Androl. 2010;31:457\u201365.", "journal-title": "J Androl"}, {"key": "10-1_CR140", "doi-asserted-by": "publisher", "first-page": "2085", "DOI": "10.1210/jc.2003-032006", "volume": "89", "author": "C Wang", "year": "2004", "unstructured": "Wang C, Cunningham G, Dobs A, Iranmanesh A, Matsumoto AM, Snyder PJ, Weber T, Berman N, Hull L, Swerdloff RS. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab. 2004;89:2085\u201398.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10-1_CR141", "doi-asserted-by": "publisher", "first-page": "594", "DOI": "10.1016/j.fertnstert.2008.07.1720", "volume": "92", "author": "DW Warne", "year": "2009", "unstructured": "Warne DW, Decosterd G, Okada H, Yano Y, Koide N, Howles CM. A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin. Fertil Steril. 2009;92:594\u2013604.", "journal-title": "Fertil Steril"}, {"key": "10-1_CR142", "doi-asserted-by": "publisher", "first-page": "723", "DOI": "10.1210/jc.2007-1786", "volume": "93", "author": "K Wehkalampi", "year": "2008", "unstructured": "Wehkalampi K, Wid\u00e9n E, Laine T, Palotie A, Dunkel L. Patterns of inheritance of constitutional delay of growth and puberty in families of adolescent girls and boys referred to specialist pediatric care. J Clin Endocrinol Metab. 2008;93:723\u20138.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10-1_CR144", "author": "World Health Organization (WHO)", "year": "2010", "edition": "5", "unstructured": "World Health Organization (WHO). WHO Laboratory Manual for the Examination and Processing of Human Semen. 5th ed. Geneva: World Health Organization; 2010.", "volume-title": "WHO Laboratory Manual for the Examination and Processing of Human Semen"}, {"key": "10-1_CR145", "doi-asserted-by": "publisher", "first-page": "89", "DOI": "10.1016/j.jpeds.2005.08.045", "volume": "148", "author": "DA Wilson", "year": "2006", "unstructured": "Wilson DA, Hofman PL, Miles HL, Unwin KE, McGrail CE, Cutfield WS. Evaluation of the buserelin stimulation test in diagnosing gonadotropin deficiency in males with delayed puberty. J Pediatr. 2006;148:89\u201394.", "journal-title": "J Pediatr"}, {"key": "10-1_CR146", "doi-asserted-by": "publisher", "first-page": "147", "DOI": "10.1038/ng0298-147", "volume": "18", "author": "W Wu", "year": "1998", "unstructured": "Wu W, Cogan JD, Pfaffle RW, Dasen JS, Frisch H, O'Connell SM, Flynn SE, Brown MR, Mullis PE, Parks JS, Phillips JA 3rd, Rosenfeld MG. Mutations in PROP1 cause familial combined pituitary hormone deficiency. Nat Genet. 1998;18:147\u20139.", "journal-title": "Nat Genet"}, {"key": "10-1_CR147", "doi-asserted-by": "publisher", "first-page": "193", "DOI": "10.1159/000336376", "volume": "97", "author": "J Young", "year": "2013", "unstructured": "Young J, George JT, Tello JA, Francou B, Bouligand J, Guiochon-Mantel A, Brailly-Tabard S, Anderson RA, Millar RP. Kisspeptin restores pulsatile LH secretion in patients with neurokinin B signaling deficiencies: physiological, pathophysiological and therapeutic implications. Neuroendocrinology. 2013;97:193\u2013202.", "journal-title": "Neuroendocrinology"}, {"key": "10-1_CR148", "doi-asserted-by": "publisher", "first-page": "836", "DOI": "10.1016/j.fertnstert.2012.06.022", "volume": "98", "author": "M Zacharin", "year": "2012", "unstructured": "Zacharin M, Sabin MA, Nair VV, Dagabdhao P. Addition of recombinant follicle-stimulating hormone to human chorionic gonadotropin treatment in adolescents and young adults with hypogonadotropic hypogonadism promotes normal testicular growth and may promote early spermatogenesis. Fertil Steril. 2012;98:836\u201342.", "journal-title": "Fertil Steril"}, {"key": "10-1_CR152", "unstructured": "Zhu J, Choa REY, Guo MH, Plummer L, Buck C, Palmert MR, Hirschhorn JN, Seminara SB, Chan YM. A shared genetic basis for self-limited delayed puberty and idiopathic hypogonadotropic hypogonadism. The Journal of Clinical Endocrinology & Metabolism 2015;100:E646\u2013E654.", "DOI": "10.1210/jc.2015-1080", "doi-asserted-by": "crossref"}, {"key": "10-1_CR149", "doi-asserted-by": "publisher", "first-page": "4335", "DOI": "10.1210/jc.2006-0401", "volume": "91", "author": "M Zitzmann", "year": "2006", "unstructured": "Zitzmann M, Faber S, Nieschlag E. Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab. 2006;91:4335\u201343.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10-1_CR150", "doi-asserted-by": "publisher", "first-page": "3844", "DOI": "10.1210/jc.2007-0620", "volume": "92", "author": "M Zitzmann", "year": "2007", "unstructured": "Zitzmann M, Nieschlag E. Androgen receptor gene CAG repeat length and body mass index modulate the safety of long-term intramuscular testosterone undecanoate therapy in hypogonadal men. J Clin Endocrinol Metab. 2007;92:3844\u201353.", "journal-title": "J Clin Endocrinol Metab"}], "container-title": ["Endocrinology", "Thyroid Diseases"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-319-38681-2_10-1", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 8]], "date-time": "2019-05-08T15:27:41Z", "timestamp": 1557329261000}, "score": 34.7674, "issued": {"date-parts": [[2017, 11, 3]]}, "ISBN": ["9783319291956", "9783319291956"], "references-count": 148, "URL": "http://dx.doi.org/10.1007/978-3-319-38681-2_10-1", "relation": {"cites": []}, "ISSN": ["2510-1927", "2510-1935"], "issn-type": [{"value": "2510-1927", "type": "print"}, {"value": "2510-1935", "type": "electronic"}], "assertion": [{"value": "14 March 2017, 00:00:00", "order": 1, "name": "received", "label": "Received", "group": {"name": "ChapterHistory", "label": "Chapter History"}}, {"value": "21 March 2017, 00:00:00", "order": 2, "name": "accepted", "label": "Accepted", "group": {"name": "ChapterHistory", "label": "Chapter History"}}, {"value": "3 November 2017", "order": 3, "name": "first_online", "label": "First Online", "group": {"name": "ChapterHistory", "label": "Chapter History"}}]}, {"indexed": {"date-parts": [[2019, 12, 16]], "date-time": "2019-12-16T22:19:11Z", "timestamp": 1576534751968}, "reference-count": 0, "publisher": "Oxford University Press", "isbn-type": [{"value": "9780199235292", "type": "print"}, {"value": "9780199608232", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2011, 7]]}, "abstract": "<p>Special therapeutic modalities for individual disorders, where these are available, have been mentioned in the preceding chapters. However, the therapeutic principles of hormone substitution described below apply to a number of disorders. Areas of conventional treatment of male infertility that were not described in previous chapters will also be covered here.</p>\n               <p>When dealing with infertility in men, it is also important to consider the woman. Thorough diagnosis and treatment of conditions affecting female reproductive functions are mandatory, since their optimization constitutes a substantial part of the treatment of male infertility.</p>", "DOI": "10.1093/med/9780199235292.003.9104", "type": "book-chapter", "created": {"date-parts": [[2011, 7, 15]], "date-time": "2011-07-15T03:30:21Z", "timestamp": 1310700621000}, "page": "1432-1440", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Treatment of hypogonadism and infertility"], "prefix": "10.1093", "author": [{"given": "Eberhard", "family": "Nieschlag", "sequence": "first", "affiliation": []}], "member": "286", "published-online": {"date-parts": [[2011, 7]]}, "container-title": ["Oxford Textbook of Endocrinology and Diabetes"], "original-title": ["Treatment of hypogonadism and infertility"], "deposited": {"date-parts": [[2019, 12, 16]], "date-time": "2019-12-16T13:33:42Z", "timestamp": 1576503222000}, "score": 34.297478, "issued": {"date-parts": [[2011, 7]]}, "ISBN": ["9780199235292", "9780199608232"], "references-count": 0, "URL": "http://dx.doi.org/10.1093/med/9780199235292.003.9104"}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T11:32:42Z", "timestamp": 1575459162583}, "reference-count": 58, "publisher": "Springer Science and Business Media LLC", "issue": "5", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2003, 5, 1]], "date-time": "2003-05-01T00:00:00Z", "timestamp": 1051747200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J Endocrinol Invest"], "published-print": {"date-parts": [[2003, 5]]}, "DOI": "10.1007/bf03345206", "type": "journal-article", "created": {"date-parts": [[2014, 3, 31]], "date-time": "2014-03-31T12:32:33Z", "timestamp": 1396269153000}, "page": "481-489", "source": "Crossref", "is-referenced-by-count": 13, "title": ["Testosterone replacement therapy in male hypogonadism"], "prefix": "10.1007", "volume": "26", "author": [{"given": "M. M.", "family": "Byrne", "sequence": "first", "affiliation": []}, {"given": "E.", "family": "Nieschlag", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2014, 3, 18]]}, "reference": [{"key": "BF03345206_CR1", "doi-asserted-by": "crossref", "first-page": "929", "DOI": "10.1210/jcem-65-5-929", "volume": "65", "author": "JD Veldhuis", "year": "1987", "unstructured": "Veldhuis J.D., King J.C, Urban R.J., et al. Operating characteristics of the male hypothalamopituitary-gonadal axis: Pulsatile release of testosterone and follicle-stimulating hormone and their temporal coupling with luteinizing hormone. J. Clin. Endocrinol. Metab. 1987, 65: 929\u2013941.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "BF03345206_CR2", "doi-asserted-by": "crossref", "first-page": "1102", "DOI": "10.1016/0888-7543(91)90038-G", "volume": "11", "author": "EP Jenkins", "year": "1991", "unstructured": "Jenkins E.P., Hsieh C.L., Milatovich A., et al. Characterization and chromosomal mapping of a human steroid 5\u03b1-reductase gene and pseudogene and mapping of the mouse homologue. Genomics 1991, 11: 1102\u20131112.", "journal-title": "Genomics"}, {"key": "BF03345206_CR3", "doi-asserted-by": "crossref", "first-page": "903", "DOI": "10.1172/JCI116665", "volume": "92", "author": "AE Thigpen", "year": "1993", "unstructured": "Thigpen A.E., Silver R.I., Guileyardo J.M., Casey M.L., McConnell J.D., Russell D.W. Tissue distribution and ontogeny of steroid 5\u03b1-reductase isoenzyme expression. J. Clin. Invest. 1993, 92: 903\u2013910.", "journal-title": "J. Clin. Invest."}, {"key": "BF03345206_CR4", "doi-asserted-by": "crossref", "first-page": "20229", "DOI": "10.1074/jbc.274.29.20229", "volume": "29", "author": "PW Hsiao", "year": "1999", "unstructured": "Hsiao P.W., Lin D.L., Nakao R., Chang C. The linkage of Kennedy\u2019s neuron disease to ARA 24, the first identified androgen receptor polyglutamine region-associated coactivator. J. Biol. Chem. 1999, 29: 20229\u201320234.", "journal-title": "J. Biol. Chem."}, {"key": "BF03345206_CR5", "first-page": "3893", "volume": "87", "author": "S Dejager", "year": "2002", "unstructured": "Dejager S., Bry-Gauillard H., Bruckert E., et al. A comprehensive endocrine description of Kennedy\u2019s disease revealing androgen insensitivity linked to CAG repeat length. J. Clin. Endocrinol. Metab. 2002, 87: 3893\u20133901.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "BF03345206_CR6", "first-page": "2585", "volume": "86", "author": "S Eckardstein von", "year": "2001", "unstructured": "von Eckardstein S., Syska A., Gromoll J., Kamischke A., Simoni M., Nieschlag E. Inverse correlation between sperm concentration and number of androgen receptor CAG repeats in normal men. J. Clin. Endocrinol. Metab. 2001, 86: 2585\u20132590.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "BF03345206_CR7", "doi-asserted-by": "crossref", "first-page": "44", "DOI": "10.1016/S0140-6736(02)07280-X", "volume": "359", "author": "E Rajpert-De Meyts", "year": "2002", "unstructured": "Rajpert-De Meyts E., Leffers H., Petersen J.H., et al. CAG repeat length in androgen-receptor gene and reproductive variables in fertile and infertile men. Lancet 2002, 359: 44\u201346.", "journal-title": "Lancet"}, {"key": "BF03345206_CR8", "doi-asserted-by": "crossref", "first-page": "4867", "DOI": "10.1210/jcem.86.10.7889", "volume": "86", "author": "M Zitzmann", "year": "2001", "unstructured": "Zitzmann M., Brune M., Kornmann B., et al. The CAG repeat polymorphism in the AR gene affects high density ipoprotein cholesterol and arterial vasoreactivity. J. Clin. Endocrinol. Metab. 2001, 86: 4867\u201373.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "BF03345206_CR9", "doi-asserted-by": "crossref", "first-page": "649", "DOI": "10.1046/j.1365-2265.2001.01391.x", "volume": "55", "author": "M Zitzmann", "year": "2001", "unstructured": "Zitzmann M., Brune M., Kornmann B., Gromoll J., Junker R., Nieschlag E. The CAG repeat polymorphism in the androgen receptor gene affects bone density and bone metabolism in healthy males. Clin. Endocrinol. (Oxf.) 2001, 55: 649\u201357.", "journal-title": "Clin. Endocrinol. (Oxf.)"}, {"key": "BF03345206_CR10", "doi-asserted-by": "crossref", "first-page": "137", "DOI": "10.1677/joe.0.1620137", "volume": "162", "author": "K Krithivas", "year": "1999", "unstructured": "Krithivas K., Yurgalevitch S.M., Mohr B.A., et al. Evidence that the CAG repeat in the androgen receptor gene is associated with the age-related decline in serum androgen evels in men. J. Endocrinol. 1999, 162: 137\u2013142.", "journal-title": "J. Endocrinol."}, {"key": "BF03345206_CR11", "first-page": "4400", "volume": "81", "author": "DO Hardy", "year": "1996", "unstructured": "Hardy D.O., Scher H.I., Bogenreider T., et al. Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onset. J. Clin. Endocrinol. Metab. 1996, 81: 4400\u20134405.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "BF03345206_CR12", "doi-asserted-by": "crossref", "first-page": "724", "DOI": "10.1210/jcem.86.2.7219", "volume": "88", "author": "SM Harman", "year": "2001", "unstructured": "Harman S.M., Metler E.J., Tobin J.D., Pearson J., Blackman M.R. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J. Clin. Endocrinol. Metab. 2001, 88: 724\u2013731.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "BF03345206_CR13", "doi-asserted-by": "crossref", "first-page": "589", "DOI": "10.1210/jcem.87.2.8201", "volume": "87", "author": "HA Feldman", "year": "2002", "unstructured": "Feldman H.A., Longcope C., Derby C.A., et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J. Clin. Endocrinol. Metab. 2002, 87: 589\u201398.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "BF03345206_CR14", "doi-asserted-by": "crossref", "first-page": "676", "DOI": "10.1210/jcem-55-4-676", "volume": "55", "author": "E Nieschlag", "year": "1982", "unstructured": "Nieschlag E., Lammers U., Freischem C.W., Langer K., Wickings E.J. Reproductive functions in young fathers and grandfathers. J. Clin. Endocrinol. Metab. 1982, 55: 676\u2013681.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "BF03345206_CR15", "doi-asserted-by": "crossref", "first-page": "5547", "DOI": "10.1210/jcem.86.11.8004", "volume": "86", "author": "T Mulligan", "year": "2001", "unstructured": "Mulligan T., Iranmanesh A., Veldhuis J.D. Pulsatile iv infusion of recombinant human LH in leuprolide-suppressed men unmasks impoverished Leydig-cell secretory responsiveness to midphysiological LH drive in the aging male. J. Clin. Endocrinol. Metab. 2001, 86: 5547\u2013553.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "BF03345206_CR16", "doi-asserted-by": "crossref", "first-page": "1016", "DOI": "10.1210/jcem-73-5-1016", "volume": "73", "author": "A Gray", "year": "1991", "unstructured": "Gray A., Feldman H.A., McKinlay J.B., Longcope C. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts male aging study. J. Clin. Endocrinol. Metab. 1991, 73: 1016\u20131025.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "BF03345206_CR17", "doi-asserted-by": "crossref", "first-page": "278", "DOI": "10.1210/jcem-56-6-1278", "volume": "56", "author": "WJ Bremner", "year": "1983", "unstructured": "Bremner W.J., Prinz P.N. A loss of circadian rhythmicity in blood testosterone levels with aging in normal men. J. Clin. Endocrinol. Metab. 1983, 56: 278\u20131281.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "BF03345206_CR18", "first-page": "2647", "volume": "84", "author": "PJ Snyder", "year": "1999", "unstructured": "Snyder P.J., Peachey H., Hannoush P., et al. Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J. Clin. Endocrinol. Metab. 1999, 84: 2647\u20132653.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "BF03345206_CR19", "first-page": "1966", "volume": "84", "author": "PJ Snyder", "year": "1999", "unstructured": "Snyder P.J., Peachey H., Hannoush P., et al. Effect of testosterone treatment on bone mineral density in men over 65 years of age. J. Clin. Endocrinol. Metab. 1999, 84: 1966\u20131972.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "BF03345206_CR20", "doi-asserted-by": "crossref", "first-page": "74", "DOI": "10.1080/713604676", "volume": "5", "author": "A Morales", "year": "2002", "unstructured": "Morales A., Lunenfeld B. Investigation, treatment and monitoring of late-onset hypogonadism in males. Official recommendations of ISSAM. Aging Male 2002, 5: 74\u201386.", "journal-title": "Aging Male"}, {"key": "BF03345206_CR21", "doi-asserted-by": "crossref", "first-page": "955", "DOI": "10.1210/jcem-48-6-955", "volume": "48", "author": "JM Davidson", "year": "1979", "unstructured": "Davidson J.M., Camargo C.A., Smith E.R. Effects of androgen on sexual behaviour in hypogonadal men. J. Clin. Endocrinol. Metab. 1979, 48: 955\u2013958.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "BF03345206_CR22", "doi-asserted-by": "crossref", "first-page": "187", "DOI": "10.1007/978-3-642-72185-4_6", "volume-title": "Testosterone: Action, Deficiency, Substitution", "author": "JS Finkelstein", "year": "1998", "unstructured": "Finkelstein J.S. Androgens and bone metabolism. In: Nieschlag E., Behre H.M. (Eds.), Testosterone: Action, Deficiency, Substitution, 2nd ed. Springer-Verlag, Berlin, Heidelberg, 1998, p.187.", "edition": "2nd ed."}, {"key": "BF03345206_CR23", "doi-asserted-by": "crossref", "first-page": "2386", "DOI": "10.1210/jcem.82.8.4163", "volume": "82", "author": "HM Behre", "year": "1997", "unstructured": "Behre H.M., Kliesch S., Leifke E., Link T.M., Nieschlag E. Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. J. Clin. Endocrinol. Metab. 1997, 82: 2386\u20132390.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "BF03345206_CR24", "doi-asserted-by": "crossref", "first-page": "209", "DOI": "10.1007/978-3-642-72185-4_7", "volume-title": "Testosterone: Action, Deficiency, Substitution", "author": "S Bhasin", "year": "1998", "unstructured": "Bhasin S., Bross R., Storer T.W., Casaburi R. Androgens and muscles. In: Nieschlag E. and Behre H.M. (Eds.), Testosterone: Action, Deficiency, Substitution, 2nd ed. Springer-Verlag, Berlin, Heidelberg, 1998, p. 209.", "edition": "2nd ed."}, {"key": "BF03345206_CR25", "doi-asserted-by": "crossref", "first-page": "505", "DOI": "10.1530/eje.0.1460505", "volume": "146", "author": "C Rolf", "year": "2002", "unstructured": "Rolf C., von Eckardstein S., Koken U., Nieschlag E. Testosterone substitution of hypogonadal men prevents the age-dependent increases in body mass index, body fat and eptin seen in healthy ageing men: results of a cross-sectional study. Eur. J. Endocrinol. 2002, 146: 505\u201311.", "journal-title": "Eur. J. Endocrinol."}, {"key": "BF03345206_CR26", "doi-asserted-by": "crossref", "first-page": "329", "DOI": "10.1007/978-3-642-72185-4_11", "volume-title": "Testosterone: Action, Deficiency, Substitution", "author": "HM Behre", "year": "1998", "unstructured": "Behre H.M., Nieschlag E. Comparative pharmacokinetics of testosterone esters. In: Nieschlag E. and Behre H.M. (Eds.), Testosterone: Action, Deficiency, Substitution, 2nd ed. Springer-Verlag, Berlin, Heidelberg, 1998, p. 329.", "edition": "2nd ed."}, {"key": "BF03345206_CR27", "doi-asserted-by": "crossref", "first-page": "943", "DOI": "10.1016/S0140-6736(86)90600-8", "volume": "2", "author": "M Bals-Pratsch", "year": "1986", "unstructured": "Bals-Pratsch M., Knuth U.A., Yoon Y.D., Nieschlag E. Transdermal testosterone substitution therapy for male hypogonadism. Lancet 1986, 2: 943\u2013946.", "journal-title": "Lancet"}, {"key": "BF03345206_CR28", "doi-asserted-by": "crossref", "first-page": "2525", "DOI": "10.1001/jama.1989.03420170069032", "volume": "261", "author": "GR Cunningham", "year": "1989", "unstructured": "Cunningham G.R., Cordero E., Thornby J.I. Testosterone replacement with transdermal therapeutic systems. J.A.M.A. 1989, 261: 2525\u20132530.", "journal-title": "J.A.M.A."}, {"key": "BF03345206_CR29", "doi-asserted-by": "crossref", "first-page": "629", "DOI": "10.1046/j.1365-2265.1999.00705.x", "volume": "50", "author": "HM Behre", "year": "1999", "unstructured": "Behre H.M., von Eckardstein S., Kliesch S., Nieschlag E. Long-term substitution therapy of hypogonadal men with transscrotal testosterone over 7\u201310 years. Clin. Endocrinol. (Oxf.) 1999, 50: 629\u2013635.", "journal-title": "Clin. Endocrinol. (Oxf.)"}, {"key": "BF03345206_CR30", "first-page": "1832", "volume": "81", "author": "WA Meikle", "year": "1996", "unstructured": "Meikle W.A., Arver S., Dobs A.S., Sanders S.W., Rajaram L., Mazer N.A. Pharmacokinetics and metabolism of a permeation enhanced testosterone transdermal system in hypogonadal men: influence of application site \u2014 a clinical research study. J. Clin. Endocrinol. Metab. 1996, 81: 1832\u20131840.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "BF03345206_CR31", "doi-asserted-by": "crossref", "first-page": "727", "DOI": "10.1046/j.1365-2265.1997.3071113.x", "volume": "47", "author": "S Arver", "year": "1997", "unstructured": "Arver S., Dobs A.S., Meikle A.W., et al. Long-term efficacy and safety of a permeation-enhanced testosterone transdermal system in hypogonadal men. Clin. Endocrinol. (Oxf.) 1997, 47: 727\u2013737.", "journal-title": "Clin. Endocrinol. (Oxf.)"}, {"key": "BF03345206_CR32", "doi-asserted-by": "crossref", "first-page": "1604", "DOI": "10.1016/S0022-5347(01)66141-X", "volume": "155", "author": "SA Arver", "year": "1996", "unstructured": "Arver S.A., Dobs A.S., Meikle A.W., Allen R.P., Sanders S.W., Mazer N.A. Improvement of sexual function in testosterone deficient men treated for 1 year with a permeation enhanced testosterone transdermal system. J. Urol. 1996, 155: 1604\u20131608.", "journal-title": "J. Urol."}, {"key": "BF03345206_CR33", "doi-asserted-by": "crossref", "first-page": "191", "DOI": "10.1016/S0090-4295(96)00445-1", "volume": "49", "author": "AW Meikle", "year": "1997", "unstructured": "Meikle A.W., Arver S., Dobs A.S., et al. Prostate size in hypogonadal men treated with a nonscrotal permeation-enhanced testosterone transdermal system. Urology 1997, 49: 191\u2013196.", "journal-title": "Urology"}, {"key": "BF03345206_CR34", "first-page": "4500", "volume": "85", "author": "RS Swerdloff", "year": "2000", "unstructured": "Swerdloff R.S., Wang C., Cunningham G., et al. Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men. J. Clin. Endocrinol. Metab. 2000, 85: 4500\u20134515.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "BF03345206_CR35", "first-page": "2839", "volume": "85", "author": "C Wang", "year": "2000", "unstructured": "Wang C., Swerdloff R.S., Iranmanesh A., et al. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J. Clin. Endocrinol. Metab. 2000, 85: 2839\u20132853.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "BF03345206_CR36", "doi-asserted-by": "crossref", "first-page": "739", "DOI": "10.1046/j.1365-2265.2001.01271.x", "volume": "54", "author": "C Wang", "year": "2001", "unstructured": "Wang C., Swerdloff R.S., Iranmanesh A., et al. Effects of transdermal testosterone gel on bone turnover markers and bone mineral density in hypogonadal men. Clin. Endocrinol. (Oxf.) 2001, 54: 739\u2013750.", "journal-title": "Clin. Endocrinol. (Oxf.)"}, {"key": "BF03345206_CR37", "doi-asserted-by": "crossref", "first-page": "637", "DOI": "10.1046/j.1365-2265.2002.01529.x", "volume": "56", "author": "C Rolf", "year": "2002", "unstructured": "Rolf C., Knie U., Lemmnitz G., Nieschlag E. Interpersona testosterone transfer after topical application of a newly developed testosterone gel preparation. Clin. Endocrinol. (Oxf.) 2002, 56: 637\u2013641.", "journal-title": "Clin. Endocrinol. (Oxf.)"}, {"key": "BF03345206_CR38", "doi-asserted-by": "crossref", "first-page": "673", "DOI": "10.1530/eje.0.1460673", "volume": "146", "author": "C Rolf", "year": "2002", "unstructured": "Rolf C., Kemper S., Lemmnitz G., Eickenberg U., Nieschlag E. Pharmacokinetics of a new transdermal testosterone gel in gonadotrophin-suppressed normal men. Eur. J. Endocrinol. 2002, 146: 673\u2013679.", "journal-title": "Eur. J. Endocrinol."}, {"key": "BF03345206_CR39", "doi-asserted-by": "crossref", "first-page": "423", "DOI": "10.1007/978-3-642-72185-4_15", "volume-title": "Testosterone: Action, Deficiency, Substitution", "author": "G Schaison", "year": "1998", "unstructured": "Schaison G., Couzinet B. Percutaneous dihydrotestosterone treatment. In: Nieschlag E. and Behre H.M. (Eds.), Testosterone: Action, Deficiency, Substitution, 2nd ed. Springer-Verlag, Berlin, Heidelberg, 1998, p. 423.", "edition": "2nd ed."}, {"key": "BF03345206_CR40", "doi-asserted-by": "crossref", "first-page": "1462", "DOI": "10.1210/jcem.87.4.8488", "volume": "87", "author": "C Wang", "year": "2002", "unstructured": "Wang C., Swerdloff R.S. Should the nonaromatizable androgen dihydrotestosterone be considered as an alternative to testosterone in the treatment of the andropause? J. Clin. Endocrinol. Metab. 2002, 87: 1462\u20131466.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "BF03345206_CR41", "doi-asserted-by": "crossref", "first-page": "276", "DOI": "10.1016/S0140-6736(84)90144-2", "volume": "1", "author": "D Delanoe", "year": "1984", "unstructured": "Delanoe D., Fougeyrollas B., Meyer L., Thonneau P. Androgenisation of female partners of men on medroxyprogesterone acetate/percutaneous testosterone contraception. Lancet 1984, 1: 276.", "journal-title": "Lancet"}, {"key": "BF03345206_CR42", "doi-asserted-by": "crossref", "first-page": "4078", "DOI": "10.1210/jcem.86.9.7821", "volume": "86", "author": "LP Ly", "year": "2001", "unstructured": "Ly LP., Jimenez M., Zhuang T.N., Celermajer D.S., Conway A.J., Handelsman D.J. A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency. J. Clin. Endocrinol. Metab. 2001, 86: 4078\u20134088.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "BF03345206_CR43", "doi-asserted-by": "crossref", "first-page": "349", "DOI": "10.1007/978-3-642-72185-4_12", "volume-title": "Testosterone: Action, Deficiency, Substitution", "author": "DJ Handelsman", "year": "1998", "unstructured": "Handelsman D.J. Clinical pharmacology of testosterone pellet implants. In: Nieschlag E. and Behre H.M. (Eds.), Testosterone: Action, Deficiency, Substitution, ed. 2. Springer-Verlag, Berlin, Heidelberg, 1998, p. 349.", "edition": "ed. 2"}, {"key": "BF03345206_CR44", "first-page": "1204", "volume": "75", "author": "HM Behre", "year": "1992", "unstructured": "Behre H.M., Nieschlag E. Testosterone buciclate (20 Aet-1) in hypogonadal men: pharmacokinetics and pharmacodynamics of the new long-acting androgen ester. J. Clin. Endocrinol. Metab. 1992, 75: 1204\u20131210.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "BF03345206_CR45", "first-page": "419", "volume": "23", "author": "S Eckardstein von", "year": "2002", "unstructured": "von Eckardstein S., Nieschlag E. Treatment of male hypogonadism with testosterone undecanoate injected at extended intervals of 12 weeks: a phase II study. J. Androl. 2002, 23: 419\u2013425.", "journal-title": "J. Androl."}, {"key": "BF03345206_CR46", "doi-asserted-by": "crossref", "first-page": "530", "DOI": "10.1210/jcem.87.2.8218", "volume": "87", "author": "A Kamischke", "year": "2002", "unstructured": "Kamischke A., Heuermann T., Kr\u00fcger K., et al. An effective hormonal male contraceptive using testosterone undecanoate with oral or injectable norethisterone preparations. J. Clin. Endocrinol. Metab. 2002, 87: 530\u2013539.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "BF03345206_CR47", "first-page": "4212", "volume": "83", "author": "DE Cummings", "year": "1998", "unstructured": "Cummings D.E., Kumar N., Bardin D.W., Sundaram K., Bremmner W.J. Prostate-sparing effects in primates of the potent androgen 7\u03b1-methyl-19-nortestosterone: a potential alternative to testosterone for androgen replacement and male contraception. J. Clin. Endocrinol. Metab. 1998, 83: 4212\u20134219.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "BF03345206_CR48", "first-page": "3556", "volume": "84", "author": "RA Anderson", "year": "1999", "unstructured": "Anderson R.A., Martin C.W., Kung A.W., et al. 7\u03b1-methyl-19-nortestosterone maintains sexual behavior and mood in hypogonadal men. J. Clin. Endocrinol. Metab. 1999, 84: 3556\u20133562.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "BF03345206_CR49", "first-page": "3567", "volume": "80", "author": "B Salehian", "year": "1995", "unstructured": "Salehian B., Wang C., Alexander G., et al. Pharmacokinetics, bioefficacy, and safety of sublingual testosterone cyclodextrin in hypogonadal men: comparison to testosterone enanthate \u2014 a clinical research center study. J. Clin. Endocrinol. Metab. 1995, 80: 3567\u20133575.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "BF03345206_CR50", "first-page": "3654", "volume": "81", "author": "C Wang", "year": "1996", "unstructured": "Wang C., Eyre D.R., Clark R., et al. Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men \u2014 a clinical research center study. J. Clin. Endocrinol. Metab. 1996, 81: 3654\u20133662.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "BF03345206_CR51", "first-page": "33", "volume": "83", "author": "AS Dobs", "year": "1998", "unstructured": "Dobs A.S., Hoover D.R., Chen M.C., Allen R. Pharmacokinetic characteristics, efficacy, and safety of buccal testosterone in hypogonadal males: a pilot study. J. Clin. Endocrinol. Metab. 1998, 83: 33\u201339.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "BF03345206_CR52", "doi-asserted-by": "crossref", "first-page": "849", "DOI": "10.1016/S0022-5347(01)65062-6", "volume": "157", "author": "A Morales", "year": "1997", "unstructured": "Morales A., Johnston B., Heaton J.P., Lundie M. Testosterone supplementation for hypogonadal impotence assessment of biochemical measures and therapeutic outcomes. J. Urol. 1997, 157: 849\u2013854.", "journal-title": "J. Urol."}, {"key": "BF03345206_CR53", "doi-asserted-by": "crossref", "first-page": "3793", "DOI": "10.1210/jcem.82.11.4387", "volume": "82", "author": "RR Hajjar", "year": "1997", "unstructured": "Hajjar R.R., Kaiser F.E., Morley J.E. Outcomes of long-term testosterone replacement in older hypogonadal males: a retrospective analysis. J. Clin. Endocrinol. Metab. 1997, 82: 3793\u20133796.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "BF03345206_CR54", "doi-asserted-by": "crossref", "first-page": "508", "DOI": "10.1056/NEJM198303033080908", "volume": "308", "author": "RE Sandblom", "year": "1983", "unstructured": "Sandblom R.E., Matsumoto A.M., Schoene R.B., Lee K.A., Giblin E.C., Bremner W.J., Pierson D.J. Obstructive sleep apnea induced by testosterone administration. N. Engl. J. Med. 1983, 308: 508\u2013510.", "journal-title": "N. Engl. J. Med."}, {"key": "BF03345206_CR55", "doi-asserted-by": "crossref", "first-page": "3394", "DOI": "10.1210/jcem.87.7.8663", "volume": "87", "author": "R Luboshitzky", "year": "2002", "unstructured": "Luboshitzky R., Aviv A., Hefetz A., et al. Decreased pituitary-gonadal secretion in men with obstructive sleep apnea. J. Clin. Endocrinol. Metab. 2002, 87: 3394\u20133398.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "BF03345206_CR56", "doi-asserted-by": "crossref", "first-page": "341", "DOI": "10.1111/j.1365-2265.1994.tb03929.x", "volume": "40", "author": "HM Behre", "year": "1994", "unstructured": "Behre H.M., Bohmeyer J., Nieschlag E. Prostate volume in testosterone-treated and untreated hypogonadal men in comparison to age-matched normal controls. Clin. Endocrinol. (Oxf.) 1994, 40: 341\u2013349.", "journal-title": "Clin. Endocrinol. (Oxf.)"}, {"key": "BF03345206_CR57", "doi-asserted-by": "crossref", "first-page": "3459", "DOI": "10.1210/jcem.84.10.6122", "volume": "84", "author": "A Negro-Vilar", "year": "1999", "unstructured": "Negro-Vilar A. Selective androgen receptor modulators (SARMs): A novel approach to androgen therapy for the new millennium. J. Clin. Endocrinol. Metab. 1999, 84: 3459\u20133462.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "BF03345206_CR58", "doi-asserted-by": "crossref", "first-page": "81", "DOI": "10.1007/978-3-662-03455-2", "volume-title": "Andrology: Male reproductive health and dysfunction", "author": "E Nieschlag", "year": "1997", "unstructured": "Nieschlag E., Behre H.M. (Eds.), Andrology: Male reproductive health and dysfunction, 1st ed. Springer-Verlag, Heidelberg, New York, 1997, p. 81.", "edition": "1st ed."}], "container-title": ["Journal of Endocrinological Investigation"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/BF03345206.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/BF03345206/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/BF03345206", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 22]], "date-time": "2019-05-22T10:25:29Z", "timestamp": 1558520729000}, "score": 33.94329, "issued": {"date-parts": [[2003, 5]]}, "references-count": 58, "journal-issue": {"published-print": {"date-parts": [[2003, 5]]}, "issue": "5"}, "alternative-id": ["BF03345206"], "URL": "http://dx.doi.org/10.1007/bf03345206", "relation": {"cites": []}, "ISSN": ["0391-4097", "1720-8386"], "issn-type": [{"value": "0391-4097", "type": "print"}, {"value": "1720-8386", "type": "electronic"}], "subject": ["Endocrinology, Diabetes and Metabolism", "Endocrinology"]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T13:43:27Z", "timestamp": 1574775807757}, "publisher-location": "Cham", "reference-count": 71, "publisher": "Springer International Publishing", "isbn-type": [{"value": "9783319532967", "type": "print"}, {"value": "9783319532981", "type": "electronic"}], "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2017, 1, 1]], "date-time": "2017-01-01T00:00:00Z", "timestamp": 1483228800000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2017]]}, "DOI": "10.1007/978-3-319-53298-1_20", "type": "book-chapter", "created": {"date-parts": [[2017, 4, 25]], "date-time": "2017-04-25T11:44:32Z", "timestamp": 1493120672000}, "page": "423-436", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Stimulation of Spermatogenesis in Hypogonadotropic Men"], "prefix": "10.1007", "author": [{"given": "Julia", "family": "Rohayem", "sequence": "first", "affiliation": []}, {"given": "Eberhard", "family": "Nieschlag", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2017, 4, 26]]}, "reference": [{"key": "20_CR1", "unstructured": "Weinbauer GF, Luetjens CM, Simoni M, Nieschlag E. Physiology of testicular function. In: Nieschlag E, Behre HM, Nieschlag S, editors. Andrology: male reproductive health and dysfunction. 3rd ed. Berlin: Springer; 2010. p. 11\u201359.", "DOI": "10.1007/978-3-540-78355-8_2", "doi-asserted-by": "publisher"}, {"key": "20_CR2", "doi-asserted-by": "publisher", "first-page": "139", "DOI": "10.1046/j.1365-2265.1999.00846.x", "volume": "51", "author": "E Nieschlag", "year": "1999", "unstructured": "Nieschlag E, Simoni M, Gromoll J, Weinbauer GF. Role of FSH in the regulation of spermatogenesis: clinical aspects. Clin Endocrinol. 1999;51:139\u201346.", "journal-title": "Clin Endocrinol"}, {"key": "20_CR3", "unstructured": "Behre HM. Zitzmann M Imaging diagnosis. In: Nieschlag E, Behre HM, Nieschlag S, editors. Andrology: male reproductive health and dysfunction. 3rd ed. Berlin: Springer; 2010. p. 101\u20137.", "DOI": "10.1007/978-3-540-78355-8_6", "doi-asserted-by": "publisher"}, {"key": "20_CR4", "unstructured": "Greulich WW, Pyle SI (Hrsg). Radiographic atlas of skeletal development of hand and wrist. 2nd ed. California: Stanford University Press; 1959.", "DOI": "10.1097/00000441-195909000-00030", "doi-asserted-by": "crossref"}, {"key": "20_CR5", "doi-asserted-by": "publisher", "first-page": "298", "DOI": "10.1530/eje.0.1390298", "volume": "139", "author": "D B\u00fcchter", "year": "1998", "unstructured": "B\u00fcchter D, Behre HM, Kliesch S, Nieschlag E. Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases. Eur J Endocrinol. 1998;139:298\u2013303.", "journal-title": "Eur J Endocrinol"}, {"key": "20_CR6", "doi-asserted-by": "publisher", "first-page": "189", "DOI": "10.1111/j.1365-2265.1984.tb03459.x", "volume": "21", "author": "DV Morris", "year": "1984", "unstructured": "Morris DV, Adeniyi-Jones R, Wheeler M, Sonksen P, Jacobs HS. The treatment of hypogonadotropic hypogonadism in men by the pulsatile infusion of luteinising hormone-releasing hormone. Clin Endocrinol. 1984;21:189\u2013200.", "journal-title": "Clin Endocrinol"}, {"key": "20_CR7", "doi-asserted-by": "publisher", "first-page": "1140", "DOI": "10.1210/jcem-67-6-1140", "volume": "67", "author": "L Liu", "year": "1988", "unstructured": "Liu L, Banks SM, Barnes KM, Sherins RJ. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 1988;67:1140\u20135.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "20_CR8", "doi-asserted-by": "publisher", "first-page": "175", "DOI": "10.1093/humrep/8.suppl_2.175", "volume": "8", "author": "J Schopohl", "year": "1993", "unstructured": "Schopohl J. Pulsatile gonadotrophin releasing hormone versus gonadotrophin treatment of hypothalamic hypogonadism in males. Hum Reprod. 1993;8:175\u20139.", "journal-title": "Hum Reprod"}, {"key": "20_CR9", "doi-asserted-by": "publisher", "first-page": "93", "DOI": "10.1056/NEJM199101103240205", "volume": "324", "author": "PM Conn", "year": "1991", "unstructured": "Conn PM, Crowley JR. Gonadotropin-releasing hormone and its analogues. N Engl J Med. 1991;324:93\u2013103.", "journal-title": "N Engl J Med"}, {"issue": "Suppl 3", "key": "20_CR10", "doi-asserted-by": "publisher", "first-page": "U89", "DOI": "10.1530/eje.0.151U089", "volume": "151", "author": "HA Delemarre-van de Waal", "year": "2004", "unstructured": "Delemarre-van de Waal HA. Application of gonadotropin releasing hormone in hypogonadotropic hypogonadism-diagnostic and therapeutic aspects. Eur J Endocrinol. 2004;151(Suppl 3):U89\u201394.", "journal-title": "Eur J Endocrinol"}, {"key": "20_CR11", "doi-asserted-by": "publisher", "first-page": "3", "DOI": "10.1210/jcem-70-1-3", "volume": "70", "author": "RW Whitcomb", "year": "1990", "unstructured": "Whitcomb RW, Crowley WF. Clinical review 4: diagnosis and treatment of isolated gonadotropin-releasing hormone deficiency in men. J Clin Endocrinol Metab. 1990;70:3\u20137.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "20_CR12", "doi-asserted-by": "publisher", "first-page": "985", "DOI": "10.1210/jcem-12-8-985", "volume": "12", "author": "WO Maddock", "year": "1952", "unstructured": "Maddock WO, Nelson WO. The effects of chorionic gonadotropin in adult men: increased estrogen and 17-ketosteroid excretion, gynecomastia, Leydig cell stimulation and seminiferous tubule damage. J Clin Endocrinol Metab. 1952;12:985\u20131014.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "20_CR13", "doi-asserted-by": "publisher", "first-page": "1356", "DOI": "10.1210/endo-102-5-1356", "volume": "102", "author": "ES Siris", "year": "1978", "unstructured": "Siris ES, Nisula BC, Catt KJ, Horner K, Birken S, Canfield RE, Ross GT. New evidence for intrinsic follicle-stimulating hormone-like activity in human chorionic gonadotropin and luteinizing hormone. Endocrinology. 1978;102:1356\u201361.", "journal-title": "Endocrinology"}, {"key": "20_CR14", "doi-asserted-by": "publisher", "first-page": "1184", "DOI": "10.1210/jcem-62-6-1184", "volume": "62", "author": "AM Matsumoto", "year": "1986", "unstructured": "Matsumoto AM, Karpas AE, Bremner WJ. Chronic human chorionic gonadotropin administration in normal men: Evidence that follicle-stimulating hormone is necessary for the maintenance of quantitatively normal spermatogenesis in man. J Clin Endocrinol Metab. 1986;62:1184\u201392.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "20_CR15", "doi-asserted-by": "publisher", "first-page": "205", "DOI": "10.1038/ng0297-205", "volume": "15", "author": "JS Tapanainen", "year": "1997", "unstructured": "Tapanainen JS, Aittomaki K, Min J, Vaskivuo T, Huhtaniemi IT. Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility. Nat Genet. 1997;15:205\u20136.", "journal-title": "Nat Genet"}, {"key": "20_CR16", "doi-asserted-by": "publisher", "first-page": "1061", "DOI": "10.1056/NEJM196605122741905", "volume": "274", "author": "B Lytton", "year": "1966", "unstructured": "Lytton B, Kase N. Effects of human menopausal gonadotrophin on a eunuchoidal male. N Engl J Med. 1966;274:1061\u20134.", "journal-title": "N Engl J Med"}, {"key": "20_CR17", "doi-asserted-by": "publisher", "first-page": "980", "DOI": "10.1093/humrep/12.5.980", "volume": "12", "author": "S Burgu\u00e9s", "year": "1997", "unstructured": "Burgu\u00e9s S, Calder\u00f3n MD. Subcutaneous self-administration of highly purified follicle stimulating hormone and human chorionic gonadotrophin for the treatment of male hypogonadotropic hypogonadism. Hum Reprod. 1997;12:980\u20136.", "journal-title": "Hum Reprod"}, {"key": "20_CR18", "doi-asserted-by": "publisher", "first-page": "256", "DOI": "10.1016/S0015-0282(98)00156-3", "volume": "70", "author": "European Metrodin HP Study Group EMHSG", "year": "1998", "unstructured": "European Metrodin HP Study Group EMHSG. Efficacy and safety of highly purified urinary follicle-stimulating hormone with human chorionic gonadotropin for treating men with isolated hypogonadotropic hypogonadism. European Metrodin HP Study Group. Fertil Steril. 1998;70:256\u201362.", "journal-title": "Fertil Steril"}, {"key": "20_CR19", "doi-asserted-by": "publisher", "first-page": "1326", "DOI": "10.1016/S0015-0282(16)57619-5", "volume": "63", "author": "S Kliesch", "year": "1995", "unstructured": "Kliesch S, Behre HM, Nieschlag E. Recombinant human follicle-stimulating hormone and human chorionic gonadotropin for induction of spermatogenesis in a hypogonadotropic male. Fertil Steril. 1995;63:1326\u20138.", "journal-title": "Fertil Steril"}, {"key": "20_CR20", "doi-asserted-by": "publisher", "first-page": "604", "DOI": "10.1002/j.1939-4640.2003.tb02712.x", "volume": "24", "author": "PM Bouloux", "year": "2003", "unstructured": "Bouloux PM, Nieschlag E, Burger HG, Skakkebaek NE, Wu FC, Handelsman DJ, Baker GH, Ochsenkuehn R, Syska A, McLachlan RI, Giwercman A, Conway AJ, Turner L, van Kuijk JH, Voortman G. Induction of spermatogenesis by recombinant follicle-stimulating hormone (puregon) in hypogonadotropic azoospermic men who failed to respond to human chorionic gonadotropin alone. J Androl. 2003;24:604\u201311.", "journal-title": "J Androl"}, {"key": "20_CR21", "doi-asserted-by": "publisher", "first-page": "594", "DOI": "10.1016/j.fertnstert.2008.07.1720", "volume": "92", "author": "DW Warne", "year": "2009", "unstructured": "Warne DW, Decosterd G, Okada H, Yano Y, Koide N, Howles CM. A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin. Fertil Steril. 2009;92:594\u2013604.", "journal-title": "Fertil Steril"}, {"key": "20_CR22", "doi-asserted-by": "publisher", "first-page": "979", "DOI": "10.1016/j.fertnstert.2008.07.1742", "volume": "92", "author": "AM Matsumoto", "year": "2009", "unstructured": "Matsumoto AM, Snyder PJ, Bhasin S, Martin K, Weber T, Winters S, Spratt D, Brentzel J, O\u2019Dea L. Stimulation of spermatogenesis with recombinant human follicle-stimulating hormone (follitropin alfa; GONAL-f\u00ae): long-term treatment in azoospermic men with hypogonadotropic hypogonadism. Fertil Steril. 2009;92:979\u201390.", "journal-title": "Fertil Steril"}, {"key": "20_CR23", "doi-asserted-by": "publisher", "first-page": "2607", "DOI": "10.1210/jc.86.6.2607", "volume": "86", "author": "The European Recombinant LH Study Group", "year": "2001", "unstructured": "The European Recombinant LH Study Group. Human recombinant luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures: results of a multicenter double-blind study. J Clin Endocrinol Metab. 2001;86:2607\u201318.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "20_CR24", "unstructured": "Debate group: \u201cBye-bye urinary gonadotropins?\u201d Matorra R, Rodriguez-Escudero F. \u201cThe use of urinary gonadotropins should be discouraged\u201d. Crosignani PG. \u201cRisk of infection is not the main problem\u201d. Balen A. \u201cIs there a risk of prion disease after the administration of urinary-derived gonadotropins?\u201d. Dyer J. \u201cThe conflict between effective and affordable health care\u2014a perspective from the developing world\u201d. Hum Reprod 2002;17:1675\u201383.", "DOI": "10.1093/humrep/17.7.1675", "doi-asserted-by": "crossref"}, {"key": "20_CR25", "unstructured": "Pouwer AW, Farquhar C, Kremer JA. Long-acting FSH versus daily FSH for women undergoing assisted reproduction. Cochrane Database Syst Rev. 2015;7:CD009577.", "DOI": "10.1002/14651858.CD009577.pub3", "doi-asserted-by": "publisher"}, {"key": "20_CR26", "unstructured": "Bouloux PM, Handelsman DJ, Jockenh\u00f6vel F, Nieschlag E, Rabinovici J, Frasa WL, de Bie JJ, Voortman G, Itskovitz-Eldor J. FSH-CTP study group. First human exposure to FSH-CTP in hypogonadotropic hypogonadal males. Hum Reprod. 2001;16:1592\u201397.", "DOI": "10.1093/humrep/16.8.1592", "doi-asserted-by": "publisher"}, {"key": "20_CR27", "doi-asserted-by": "publisher", "first-page": "651", "DOI": "10.1056/NEJM198509123131102", "volume": "313", "author": "DM Finkel", "year": "1985", "unstructured": "Finkel DM, Phillips BA, Snyder PJ. Stimulation of spermatogenesis by gonadotropins in men with hypogonadotropic hypogonadism. N Engl J Med. 1985;313:651\u20135.", "journal-title": "N Engl J Med"}, {"key": "20_CR28", "doi-asserted-by": "publisher", "first-page": "320", "DOI": "10.1111/j.1365-2605.1992.tb01131.x", "volume": "15", "author": "E Vicari", "year": "1992", "unstructured": "Vicari E, Mongioi A, Calogero AE, Moncada ML, Sidoti G, Polosa P, D\u2019Agata R. Therapy with human chorionic gonadotropin alone induces spermatogenesis in men with isolated hypogonadotropic hypogonadism\u2014long-term follow-up. Int J Androl. 1992;15:320\u20139.", "journal-title": "Int J Androl"}, {"key": "20_CR29", "doi-asserted-by": "publisher", "first-page": "406", "DOI": "10.1016/S0015-0282(16)58108-4", "volume": "65", "author": "B Mannaerts", "year": "1996", "unstructured": "Mannaerts B, Fauser B, Lahlou N, Harlin J, Shoham Z, Bennink HC, Bouchard P. Serum hormone concentrations during treatment with multiple rising doses of recombinant follicle stimulating hormone (Puregon) in men with hypogonadotropic hypogonadism. Fertil Steril. 1996;65:406\u201310.", "journal-title": "Fertil Steril"}, {"key": "20_CR30", "doi-asserted-by": "publisher", "first-page": "105", "DOI": "10.1530/eje.1.02315", "volume": "156", "author": "T Raivio", "year": "2007", "unstructured": "Raivio T, Wikstr\u00f6m AM, Dunkel L. Treatment of gonadotropin-deficient boys with recombinant human FSH: long-term observation and outcome. Eur J Endocrinol. 2007;156:105\u201311.", "journal-title": "Eur J Endocrinol"}, {"key": "20_CR31", "doi-asserted-by": "publisher", "first-page": "787", "DOI": "10.1002/jemt.20754", "volume": "72", "author": "RA Rey", "year": "2009", "unstructured": "Rey RA, Musse M, Venara M, Chemes HE. Ontogeny of the androgen receptor expression in the fetal and postnatal testis: its relevance on Sertoli cell maturation and the onset of adult spermatogenesis. Microsc Res Tech. 2009;72:787\u201395.", "journal-title": "Microsc Res Tech"}, {"key": "20_CR32", "doi-asserted-by": "publisher", "first-page": "E1790", "DOI": "10.1210/jc.2013-2518", "volume": "98", "author": "AA Dwyer", "year": "2013", "unstructured": "Dwyer AA, Sykiotis GP, Hayes FJ, Boepple PA, Lee H, Loughlin KR, Dym M, Sluss PM, Crowley WF Jr, Pitteloud N. Trial of recombinant follicle-stimulating hormone pretreatment for GnRH-induced fertility in patients with congenital hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2013;98:E1790\u20135.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "20_CR33", "doi-asserted-by": "publisher", "first-page": "244", "DOI": "10.1016/S0015-0282(98)00450-6", "volume": "71", "author": "R Barrio", "year": "1999", "unstructured": "Barrio R, De Luis D, Alonso M, Lamas A, Moreno JC. Induction of puberty with human chorionic gonadotropin and follicle-stimulating hormone in adolescent males with hypogonadotropic hypogonadism. Fertil Steril. 1999;71:244\u20138.", "journal-title": "Fertil Steril"}, {"key": "20_CR34", "doi-asserted-by": "publisher", "first-page": "1029", "DOI": "10.1093/humrep/den046", "volume": "23", "author": "AA Sinisi", "year": "2008", "unstructured": "Sinisi AA, Esposito D, Maione L, Quinto MC, Visconti D, De Bellis A, Bellastella A, Conzo G, Bellastella G. Seminal anti-Mullerian hormone level is a marker of spermatogenic response during long-term gonadotropin therapy in male hypogonadotropic hypogonadism. Hum Reprod. 2008;23:1029\u201334.", "journal-title": "Hum Reprod"}, {"key": "20_CR35", "doi-asserted-by": "publisher", "first-page": "836", "DOI": "10.1016/j.fertnstert.2012.06.022", "volume": "98", "author": "M Zacharin", "year": "2012", "unstructured": "Zacharin M, Sabin MA, Nair VV, Dagabdhao P. Addition of recombinant follicle-stimulating hormone to human chorionic gonadotropin treatment in adolescents and young adults with hypogonadotropic hypogonadism promotes normal testicular growth and may promote early spermatogenesis. Fertil Steril. 2012;98:836\u201342.", "journal-title": "Fertil Steril"}, {"key": "20_CR36", "unstructured": "Rohayem J, Hauffa BP, Zacharin M, Kliesch S, Zitzmann M, and the \u201cGerman Adolescent Hypogonadotropic Hypogonadism Study Group\u201d. Testicular growth and spermatogenesis: new goals for pubertal hormone replacement in boys with hypogonadotropic hypogonadism? A multicentre prospective study of hCG/rFSH treatment outcomes during adolescence. Clin Endocrinol (Oxf). 2017;86:75\u201387.", "DOI": "10.1111/cen.13164", "doi-asserted-by": "publisher"}, {"key": "20_CR37", "doi-asserted-by": "publisher", "first-page": "259", "DOI": "10.1111/cen.12435", "volume": "81", "author": "K Shiraishi", "year": "2014", "unstructured": "Shiraishi K, Oka S, Matsuyama H. Assessment of quality of life during gonadotrophin treatment for male hypogonadotropic hypogonadism. Clin Endocrinol (Oxf). 2014;81:259\u201365.", "journal-title": "Clin Endocrinol (Oxf)"}, {"key": "20_CR38", "doi-asserted-by": "publisher", "first-page": "801", "DOI": "10.1210/jc.2008-1648", "volume": "94", "author": "PY Liu", "year": "2009", "unstructured": "Liu PY, Baker HWG, Jayadev V, Zacharin M, Conway AJ, Handelsman DJ. Induction of spermatogenesis and fertility during gonadotropin treatment of gonadotropin-deficient infertile men: predictors of fertility outcome. J Clin Endocrinol Metab. 2009;94:801\u20138.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "20_CR39", "first-page": "383", "volume": "3", "author": "AD Rogol", "year": "2005", "unstructured": "Rogol AD. Pubertal androgen therapy in boys. Pediatr Endocrinol Rev. 2005;3:383\u201390.", "journal-title": "Pediatr Endocrinol Rev"}, {"key": "20_CR40", "doi-asserted-by": "publisher", "first-page": "270", "DOI": "10.1016/S0015-0282(01)02973-9", "volume": "77", "author": "P Bouloux", "year": "2002", "unstructured": "Bouloux P, Warne DW, Loumaye E. Efficacy and safety of recombinant human follicle-stimulating hormone in men with isolated hypogonadotropic hypogonadism. Fertil Steril. 2002;77:270\u20133.", "journal-title": "Fertil Steril"}, {"key": "20_CR41", "doi-asserted-by": "crossref", "first-page": "763", "DOI": "10.1530/acta.0.0890763", "volume": "89", "author": "SG Johnsen", "year": "1978", "unstructured": "Johnsen SG. Maintenance of spermatogenesis induced by hMG treatment by means of continuous hCG treatment in hypogonadotropic men. Acta Endocrinol. 1978;89:763\u20139.", "journal-title": "Acta Endocrinol"}, {"key": "20_CR42", "doi-asserted-by": "publisher", "first-page": "617", "DOI": "10.1530/eje.0.1470617", "volume": "147", "author": "M Depenbusch", "year": "2002", "unstructured": "Depenbusch M, von Eckardstein S, Simoni M, Nieschlag E. Maintenance of spermatogenesis in hypogonadotropic hypogonadal men with hCG alone. Eur J Endorinol. 2002;147:617\u201324.", "journal-title": "Eur J Endorinol"}, {"key": "20_CR43", "doi-asserted-by": "publisher", "first-page": "929", "DOI": "10.1210/jcem-52-5-929", "volume": "52", "author": "RZ Sokol", "year": "1981", "unstructured": "Sokol RZ, McClure RD, Peterson M, Swerdloff RS. Gonadotropin therapy failure secondary to human chorionic gonadotropin-induced antibodies. J Clin Endocrinol Metab. 1981;52:929\u201333.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "20_CR44", "doi-asserted-by": "publisher", "first-page": "1041", "DOI": "10.1210/jcem-57-5-1041", "volume": "57", "author": "B Claustrat", "year": "1983", "unstructured": "Claustrat B, David L, Faure A, Francois R. Development of anti-human chorionic gonadotropin antibodies in patients with hypogonadotropic hypogonadism. A study of four patients. J Clin Endocrinol Metab. 1983;57:1041\u20137.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "20_CR45", "doi-asserted-by": "publisher", "first-page": "862", "DOI": "10.1210/jcem-66-4-862", "volume": "66", "author": "RB Thau", "year": "1988", "unstructured": "Thau RB, Goldstein M, Yamamoto Y, Burrow GN, Phillips D, Bardin CW. Failure of gonadotropin therapy secondary to chorionic gonadotropin-induced antibodies. J Clin Endocrinol Metab. 1988;66:862\u20137.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "20_CR46", "doi-asserted-by": "publisher", "first-page": "1128", "DOI": "10.1007/BF03345263", "volume": "26", "author": "T Ogura", "year": "2003", "unstructured": "Ogura T, Mimura Y, Otsuka F, Kishida M, Yokota K, Suzuki J, Nagai A, Hirakawa S, Makino H, Tobe K. Hypothyroidism associated with anti-human chorionic gonadotropin antibodies secondarily produced by gonadotropin therapy in a case of idiopathic hypothalamic hypogonadism. J Endocrinol Invest. 2003;26:1128\u201335.", "journal-title": "J Endocrinol Invest"}, {"key": "20_CR47", "author": "World Health Organisation", "year": "2010", "edition": "5", "unstructured": "World Health Organisation. (WHO) Laboratory Manual for the Examination and Processing of Human Semen. 5th ed. Geneva, Switzerland: World Health Organization; 2010.", "volume-title": "(WHO) Laboratory Manual for the Examination and Processing of Human Semen"}, {"key": "20_CR48", "doi-asserted-by": "publisher", "first-page": "481", "DOI": "10.1046/j.1365-2265.1999.00708.x", "volume": "50", "author": "R Quinton", "year": "1999", "unstructured": "Quinton R, Cheow HK, Tymms DJ, Bouloux PM, Wu FC, et al. Kallmann\u2019s syndrome: is it always for life? Clin Endocrinol (Oxf). 1999;50:481\u20135.", "journal-title": "Clin Endocrinol (Oxf)"}, {"key": "20_CR49", "doi-asserted-by": "publisher", "first-page": "863", "DOI": "10.1056/NEJMoa066494", "volume": "357", "author": "T Raivio", "year": "2007", "unstructured": "Raivio T, Falardeau J, Dwyer A, Quinton R, Hayes FJ, et al. Reversal of idiopathic hypogonadotropic hypogonadism. N Engl J Med. 2007;357:863\u201373.", "journal-title": "N Engl J Med"}, {"key": "20_CR50", "unstructured": "Laitinen EM, Tommiska J, Sane T, Vaaralahti K, Toppari J, Raivio T. Reversible congenital hypogonadotropic hypogonadism in patients with CHD7, FGFR1 or GNRHR mutations. PLoS One. 2012;7:e39450.", "DOI": "10.1371/journal.pone.0039450", "doi-asserted-by": "publisher"}, {"key": "20_CR51", "doi-asserted-by": "publisher", "first-page": "316", "DOI": "10.1111/j.1365-2265.2012.04493.x", "volume": "78", "author": "J Tommiska", "year": "2013", "unstructured": "Tommiska J, J\u00f8rgensen N, Christiansen P, Juul A, Raivio T. A homozygous R262Q mutation in the gonadotropin-releasing hormone receptor presenting as reversal of hypogonadotropic hypogonadism and late-onset hypogonadism. Clin Endocrinol (Oxf). 2013;78:316\u20137.", "journal-title": "Clin Endocrinol (Oxf)"}, {"key": "20_CR52", "doi-asserted-by": "publisher", "first-page": "861", "DOI": "10.1210/jc.2013-2809", "volume": "99", "author": "VF Sidhoum", "year": "2014", "unstructured": "Sidhoum VF, Chan YM, Lippincott MF, Balasubramanian R, Quinton R, et al. Reversal and relapse of hypogonadotropic hypogonadism: resilience and fragility of the reproductive neuroendocrine system. J Clin Endocrinol Metab. 2014;99:861\u201370.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "20_CR53", "doi-asserted-by": "publisher", "first-page": "47", "DOI": "10.1530/EJE-15-0080", "volume": "173", "author": "E Nieschlag", "year": "2015", "unstructured": "Nieschlag E, Vorona E. Medical consequences of doping with anabolic androgenic steroids: effects on reproductive functions. Eur J Endocrinol. 2015;173:47\u201358.", "journal-title": "Eur J Endocrinol"}, {"key": "20_CR54", "unstructured": "Tenforde AS, Barrack MT, Nattiv A, Fredericson M. Parallels with the female athlete triad in male athletes. Sports Med. 2015. (Epub ahead of print).", "DOI": "10.1007/s40279-015-0411-y", "doi-asserted-by": "crossref"}, {"key": "20_CR55", "doi-asserted-by": "publisher", "first-page": "457", "DOI": "10.1016/j.contraception.2010.03.020", "volume": "82", "author": "E Nieschlag", "year": "2010", "unstructured": "Nieschlag E. Clinical trials in male hormonal contraception. Contraception. 2010;82:457\u201370.", "journal-title": "Contraception"}, {"key": "20_CR56", "doi-asserted-by": "publisher", "first-page": "1412", "DOI": "10.1016/S0140-6736(06)68614-5", "volume": "367", "author": "PY Liu", "year": "2006", "unstructured": "Liu PY, Swerdloff RS, Christenson PD, Handelsman DJ, Wang C. Hormonal Male Contraception Summit Group. Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis. Lancet. 2006;367:1412\u201320.", "journal-title": "Lancet"}, {"key": "20_CR57", "first-page": "17", "volume": "7", "author": "TJ Cicero", "year": "1974", "unstructured": "Cicero TJ, Meyer ER, Bell RD, Wiest WG. Effects of morphine on the secondary sex organs and plasma testosterone levels of rats. Res Commun Chem Pathol Pharmacol. 1974;7:17\u201324.", "journal-title": "Res Commun Chem Pathol Pharmacol"}, {"key": "20_CR58", "doi-asserted-by": "publisher", "first-page": "377", "DOI": "10.1054/jpai.2002.126790", "volume": "3", "author": "HW Daniell", "year": "2002", "unstructured": "Daniell HW. Hypogonadism in men consuming sustained-action oral opioids. J Pain. 2002;3:377\u201384.", "journal-title": "J Pain"}, {"key": "20_CR59", "doi-asserted-by": "publisher", "first-page": "851", "DOI": "10.1002/cncr.20028", "volume": "100", "author": "A Rajagopal", "year": "2004", "unstructured": "Rajagopal A, Vassilopoulou-Sellin R, Palmer JL, Kaur G, Bruera E. Symptomatic hypogonadism in male survivors of cancer with chronic exposure to opioids. Cancer. 2004;100:851\u20138.", "journal-title": "Cancer"}, {"key": "20_CR60", "first-page": "87", "volume": "4", "author": "J Rohayem", "year": "2016", "unstructured": "Rohayem J, Sinthofen N, Nieschlag E, Kliesch S, Zitzmann M. Causes of hypogonadotropic hypogonadism predict response to gonadotropin substitution in adults Andrology. 2016;4:87\u201394.", "journal-title": "Causes of hypogonadotropic hypogonadism predict response to gonadotropin substitution in adults Andrology"}, {"key": "20_CR61", "doi-asserted-by": "publisher", "first-page": "152", "DOI": "10.1210/jcem.87.1.8131", "volume": "87", "author": "N Pitteloud", "year": "2002", "unstructured": "Pitteloud N, Hayes FJ, Boepple PA, DeCruz S, Seminara SB, MacLaughlin DT, Crowley WF Jr. The role of prior pubertal development, biochemical markers of testicular maturation, and genetics in elucidating the phenotypic heterogeneity of idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2002;87:152\u201360.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "20_CR62", "doi-asserted-by": "publisher", "first-page": "1144", "DOI": "10.1210/jcem-66-6-1144", "volume": "66", "author": "AS Burris", "year": "1988", "unstructured": "Burris AS, Rodbard HW, Winters SJ, Sherins RJ. Gonadotropin therapy in men with isolated hypogonadotropic hypogonadism: the response to human chorionic gonadotropin is predicted by initial testicular size. J Endocrinol Metab. 1988;66:1144\u201351.", "journal-title": "J Endocrinol Metab"}, {"key": "20_CR63", "doi-asserted-by": "publisher", "first-page": "445", "DOI": "10.1016/S0022-3468(74)80003-5", "volume": "9", "author": "W Mengel", "year": "1974", "unstructured": "Mengel W, Hienz HA, Sippe WG, Hecker WC. Studies on cryptorchidism: a comparison of histological findings in the germinative epithelium before and after the second year of life. J Pediatr Surg. 1974;9:445\u201350.", "journal-title": "J Pediatr Surg"}, {"key": "20_CR64", "doi-asserted-by": "publisher", "first-page": "4128", "DOI": "10.1210/jc.2002-020518", "volume": "87", "author": "N Pitteloud", "year": "2002", "unstructured": "Pitteloud N, Hayes FJ, Dwyer A, Boepple PA, Lee H, Crowley WF Jr. Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2002;87:4128\u201336.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "20_CR65", "doi-asserted-by": "publisher", "first-page": "2072", "DOI": "10.1097/01.ju.0000158133.09197.f4", "volume": "173", "author": "Y Miyagawa", "year": "2005", "unstructured": "Miyagawa Y, Tsujimura A, Matsumiya K, Takao T, Tohda A, Koga M, Takeyama M, Fujioka H, Takada S, Koide T, Okuyama A. Outcome of gonadotropin therapy for male hypogonadotropic hypogonadism at university affiliated male infertility centers: a 30-year retrospective study. J Urol. 2005;173:2072\u20135.", "journal-title": "J Urol"}, {"key": "20_CR66", "unstructured": "Jones TH, Darne JF. Self-administered subcutaneous human menopausal gonadotrophin for the stimulation of testicular growth and the initiation of spermatogenesis in hypogonadotropic hypogonadism. Clin Endocrinol (Oxf).1993;38:203\u20138.", "DOI": "10.1111/j.1365-2265.1993.tb00994.x", "doi-asserted-by": "publisher"}, {"key": "20_CR67", "doi-asserted-by": "publisher", "first-page": "746", "DOI": "10.1210/jcem-61-4-746", "volume": "61", "author": "SB Ley", "year": "1985", "unstructured": "Ley SB, Leonard JM. Male hypogonadotropic hypogonadism: factors influencing response to human chorionic gonadotropin and human menopausal gonadotropin, including prior exogenous androgens. J Clin Endocrinol Metab. 1985;61:746\u201352.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "20_CR68", "doi-asserted-by": "publisher", "first-page": "625", "DOI": "10.1093/humrep/17.3.625", "volume": "17", "author": "PY Liu", "year": "2002", "unstructured": "Liu PY, Gebski VJ, Turner L, Conway AJ, Wishart SM, Handelsman DJ. Predicting pregnancy and spermatogenesis by survival analysis during gonadotrophin treatment of gonadotrophin-deficient infertile men. Hum Reprod. 2002;17:625\u201333.", "journal-title": "Hum Reprod"}, {"key": "20_CR69", "doi-asserted-by": "publisher", "first-page": "156", "DOI": "10.1016/S1472-6483(10)60703-1", "volume": "15", "author": "ME Bakircioglu", "year": "2007", "unstructured": "Bakircioglu ME, Erden HF, Ciray HN, Bayazit N, Bah\u00e7eci M. Gonadotrophin therapy in combination with ICSI in men with hypogonadotropic hypogonadism. Reprod Biomed Online. 2007;15:156\u201360.", "journal-title": "Reprod Biomed Online."}, {"key": "20_CR70", "doi-asserted-by": "publisher", "first-page": "724", "DOI": "10.1093/humrep/deq372", "volume": "26", "author": "C Frapsauce", "year": "2011", "unstructured": "Frapsauce C, Ravel C, Legendre M, Sibony M, Mandelbaum J, Donadille B, Achermann JC, Siffroi JP, Christin-Maitre S. Birth after TESE-ICSI in a man with hypogonadotropic hypogonadism and congenital adrenal hypoplasia linked to a DAX-1(NR0B1) mutation. Hum Reprod. 2011;26:724\u20138.", "journal-title": "Hum Reprod"}, {"key": "20_CR71", "doi-asserted-by": "publisher", "first-page": "71", "DOI": "10.1186/s13023-015-0287-9", "volume": "10", "author": "J Sarfati", "year": "2015", "unstructured": "Sarfati J, Bouvattier C, Bry-Gauillard H, Cartes A, Bouligand J, Young J. Kallmann syndrome with FGFR1 and KAL1 mutations detected during fetal life. Orphanet J Rare Dis. 2015;10:71.", "journal-title": "Orphanet J Rare Dis"}], "container-title": ["Male Hypogonadism"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-319-53298-1_20", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 21]], "date-time": "2019-09-21T21:31:50Z", "timestamp": 1569101510000}, "score": 33.717854, "issued": {"date-parts": [[2017]]}, "ISBN": ["9783319532967", "9783319532981"], "references-count": 71, "URL": "http://dx.doi.org/10.1007/978-3-319-53298-1_20", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T21:38:07Z", "timestamp": 1575236287289}, "publisher-location": "Totowa, NJ", "reference-count": 78, "publisher": "Humana Press", "isbn-type": [{"value": "9781607617396", "type": "print"}, {"value": "9781592597277", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2004]]}, "DOI": "10.1007/978-1-59259-727-7_19", "type": "book-chapter", "created": {"date-parts": [[2013, 6, 15]], "date-time": "2013-06-15T04:42:23Z", "timestamp": 1371271343000}, "page": "371-386", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Stimulation of Spermatogenesis in Hypogonadotropic Men"], "prefix": "10.1007", "author": [{"given": "Marion", "family": "Depenbusch", "sequence": "first", "affiliation": []}, {"given": "Eberhard", "family": "Nieschlag", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "19_CR1", "first-page": "23", "volume-title": "Andrology: Male Reproductive Health and Dysfunction", "author": "GF Weinbauer", "year": "2000", "unstructured": "Weinbauer GF, Gromoll J, Simoni M, Nieschlag E. Physiology of testicular function. In: Nieschlag E, Behre HM, eds. Andrology: Male Reproductive Health and Dysfunction, 2nd ed. Springer, Berlin, 2000, pp. 23\u201361.", "edition": "2"}, {"key": "19_CR2", "doi-asserted-by": "publisher", "first-page": "139", "DOI": "10.1046/j.1365-2265.1999.00846.x", "volume": "51", "author": "E Nieschlag", "year": "1999", "unstructured": "Nieschlag E, Simoni M, Gromoll J, Weinbauer GF. Role of FSH in the regulation of spermatogenesis: clinical aspects. Clin Endocrinol 1999; 51: 139\u2013146.", "journal-title": "Clin Endocrinol"}, {"key": "19_CR3", "first-page": "89", "volume-title": "Andrology: Male Reproductive Health and Dysfunction", "author": "HM Behre", "year": "2000", "unstructured": "Behre HM, Yeung CH, Holstein AF, Weinbauer GF, Gassner P, Nieschlag E. Diagnosis of male infertility and hypogonadism. In: Nieschlag E, Behre HM, eds. Andrology: Male Reproductive Health and Dysfunction, 2nd ed. Springer, Berlin, 2000, pp. 89\u2013124.", "edition": "2"}, {"key": "19_CR4", "first-page": "125", "volume-title": "Andrology: Male Reproductive Health and Dysfunction", "author": "HM Behre", "year": "2000", "unstructured": "Behre HM, Nieschlag E, Meschede D, Partsch CJ. Diseases of the hypothalamus and the pituitary gland. In: Nieschlag E, Behre HM, eds. Andrology: Male Reproductive Health and Dysfunction, 2nd ed. Springer, Berlin, 2000, pp. 125\u2013143.", "edition": "2"}, {"key": "19_CR5", "doi-asserted-by": "publisher", "first-page": "746", "DOI": "10.1210/jcem-61-4-746", "volume": "61", "author": "SB Ley", "year": "1985", "unstructured": "Ley SB, Leonard JM. Male hypogonadotropic hypogonadism: factors influencing response to human chorionic gonadotropin and human menopausal gonadotropin, including prior exogenous androgens. J Clin Endocrinol Metab 1985; 61: 746\u2013752.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "19_CR6", "doi-asserted-by": "publisher", "first-page": "1545", "DOI": "10.1210/jc.77.6.1545", "volume": "77", "author": "G Schaison", "year": "1993", "unstructured": "Schaison G, Young J, Pholsena M, Nahoul K, Couzinet B. Failure of combined follicle-stimulating hormone-testosterone administration to initiate and/or maintain spermatogenesis in men with hypogonadotropic hypogonadism. J Clin Endocrinol Metab 1993; 77: 1545\u20131549.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "19_CR7", "doi-asserted-by": "publisher", "first-page": "298", "DOI": "10.1530/eje.0.1390298", "volume": "139", "author": "D Buechter", "year": "1998", "unstructured": "Buechter D, Behre HM, Kliesch S, Nieschlag E. Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases. Eur J Endocrinol 1998; 139: 298\u2013303.", "journal-title": "Eur J Endocrinol"}, {"key": "19_CR8", "doi-asserted-by": "crossref", "first-page": "763", "DOI": "10.1530/acta.0.0890763", "volume": "89", "author": "SG Johnsen", "year": "1978", "unstructured": "Johnsen SG. Maintenance of spermatogenesis induced by hMG treatment by means of continuous hCG treatment in hypogonadotropic men. Acta Endocrinol 1978; 89: 763\u2013769.", "journal-title": "Acta Endocrinol"}, {"key": "19_CR9", "doi-asserted-by": "publisher", "first-page": "617", "DOI": "10.1530/eje.0.1470617", "volume": "147", "author": "M Depenbusch", "year": "2002", "unstructured": "Depenbusch M, von Eckardstein S, Simoni M, Nieschlag E. Maintenance of spermatogenesis in hypogonadotropic hypogonadal men with hCG alone. Eur J Endocrinol 2002; 147: 617\u2013624.", "journal-title": "Eur J Endocrinol"}, {"key": "19_CR10", "doi-asserted-by": "crossref", "first-page": "1143", "DOI": "10.1016/S0015-0282(16)54730-X", "volume": "56", "author": "J Schopohl", "year": "1991", "unstructured": "Schopohl J, Mehltretter G, von Zumbusch R, Eversmann T, von Werder K. Comparison of gonadotropin-releasing hormone and gonadotropin therapy in male patients with idiopathic hypothalamic hypogonadism. Fertil Steril 1991; 56: 1143\u20131150.", "journal-title": "Fertil Steril"}, {"key": "19_CR11", "doi-asserted-by": "publisher", "first-page": "93", "DOI": "10.1056/NEJM199101103240205", "volume": "324", "author": "PM Conn", "year": "1991", "unstructured": "Conn PM, Crowley JR. Gonadotropin-releasing hormone and its analogs. N Engl J Med 1991; 324: 93\u2013103.", "journal-title": "N Engl J Med"}, {"key": "19_CR12", "doi-asserted-by": "publisher", "first-page": "3", "DOI": "10.1210/jcem-70-1-3", "volume": "70", "author": "RW Whitcomb", "year": "1990", "unstructured": "Whitcomb RW, Crowley WF. Clinical review 4: diagnosis and treatment of isolated gonadotropinreleasing hormone deficiency in men. J Clin Endocrinol Metab 1990; 70: 3\u20137.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "19_CR13", "doi-asserted-by": "publisher", "first-page": "990", "DOI": "10.1210/jc.84.3.990", "volume": "84", "author": "P Caron", "year": "1999", "unstructured": "Caron P, Chauvin S, Christin-Maitre S, et al. Resistance of hypogonadic patients with mutated GnRH receptor genes to pulsatile GnRH administration. J Clin Endocrinol Metab 1999; 84: 990\u2013996.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "19_CR14", "doi-asserted-by": "publisher", "first-page": "1597", "DOI": "10.1056/NEJM199711273372205", "volume": "337", "author": "N Roux", "year": "1997", "unstructured": "De Roux N, Young J, Misrahi M, et al. A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor. N Engl J Med 1997; 337: 1597\u20131602.", "journal-title": "N Engl J Med"}, {"key": "19_CR15", "doi-asserted-by": "publisher", "first-page": "14", "DOI": "10.1038/ng0198-14", "volume": "18", "author": "LC Layman", "year": "1998", "unstructured": "Layman LC, Cohen DP, Jin M, et al. Mutations in the gonadotropin-releasing hormone receptor gene cause hypogonadotropic hypogonadism. Nat Genet 1998; 18: 14\u201315.", "journal-title": "Nat Genet"}, {"key": "19_CR16", "doi-asserted-by": "publisher", "first-page": "525", "DOI": "10.1046/j.1365-2265.1999.00859.x", "volume": "51", "author": "R Quinton", "year": "1999", "unstructured": "Quinton R, Barnett P, Coskeran P, Bouloux PM. Gordon Holmes spinocerebellar ataxia: a gonadotropin deficiency syndrome resistant to treatment with pulsatile gonadotropin-releasing hormone. Clin Endocrinol 1999; 51: 525\u2013529.", "journal-title": "Clin Endocrinol"}, {"key": "19_CR17", "doi-asserted-by": "publisher", "first-page": "189", "DOI": "10.1111/j.1365-2265.1984.tb03459.x", "volume": "21", "author": "DV Morris", "year": "1984", "unstructured": "Morris DV, Adeniyi-Jones R, Wheeler M, Sonksen P, Jacobs HS. The treatment of hypogonadotropic hypogonadism in men by the pulsatile infusion of luteinizing hormone-releasing hormone. Clin Endocrinol 1984; 21: 189\u2013200.", "journal-title": "Clin Endocrinol"}, {"key": "19_CR18", "doi-asserted-by": "crossref", "first-page": "622", "DOI": "10.1016/S0015-0282(16)60195-4", "volume": "50", "author": "Z Blumenfeld", "year": "1988", "unstructured": "Blumenfeld Z, Frisch L, Conn PM. Gonadotropin-releasing hormone (GnRH) antibodies formation in hypogonadotropic azoospermic men treated with pulsatile GnRH-diagnosis and possible alternative treatment. Fertil Steril 1988; 50: 622\u2013629.", "journal-title": "Fertil Steril"}, {"key": "19_CR19", "doi-asserted-by": "publisher", "first-page": "651", "DOI": "10.1056/NEJM198509123131102", "volume": "313", "author": "DM Finkel", "year": "1985", "unstructured": "Finkel DM, Phillips BA, Snyder PJ. Stimulation of spermatogenesis by gonadotropins in men with hypogonadotropic hypogonadism. N Engl J Med 1985; 313: 651\u2013655.", "journal-title": "N Engl J Med"}, {"key": "19_CR20", "doi-asserted-by": "publisher", "first-page": "1144", "DOI": "10.1210/jcem-66-6-1144", "volume": "66", "author": "AS Burris", "year": "1988", "unstructured": "Burris AS, Rodbard HW, Winters SJ, Sherins RJ. Gonadotropin therapy in men with isolated hypogonadotropic hypogonadism: the response to human chorionic gonadotropin is predicted by initial testicular size. J Clin Endocrinol Metab 1988; 66: 1144\u20131151.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "19_CR21", "doi-asserted-by": "publisher", "first-page": "57", "DOI": "10.1111/j.1365-2265.1994.tb03785.x", "volume": "41", "author": "JW Kirk", "year": "1994", "unstructured": "Kirk JMW, Savage MO, Grant DB, Bouloux P-MG, Besser GM. Gonadal function and response to human chorionic and menopausal gonadotropin therapy in male patients with idiopathic hypogonadotropic hypogonadism. Clin Endocrinol 1994; 41: 57\u201363.", "journal-title": "Clin Endocrinol"}, {"key": "19_CR22", "doi-asserted-by": "publisher", "first-page": "163", "DOI": "10.1017/S0962279900001150", "volume": "4", "author": "M Simoni", "year": "1995", "unstructured": "Simoni M, Nieschlag E. FSH in therapy: physiological basis, new preparations and clinical use. Reprod Med Rev 1995; 4: 163\u2013177.", "journal-title": "Reprod Med Rev"}, {"key": "19_CR23", "doi-asserted-by": "publisher", "first-page": "929", "DOI": "10.1210/jcem-52-5-929", "volume": "52", "author": "RZ Sokol", "year": "1981", "unstructured": "Sokol RZ, McClure RD, Peterson M, Swerdloff RS. Gonadotropin therapy failure secondary to human chorionic gonadotropin-induced antibodies. J Clin Endocrinol Metab 1981; 52: 929\u2013933.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "19_CR24", "doi-asserted-by": "publisher", "first-page": "320", "DOI": "10.1111/j.1365-2605.1992.tb01131.x", "volume": "15", "author": "E Vicari", "year": "1992", "unstructured": "Vicari E, Mongioi A, Calogero AE, et al. Therapy with human chorionic gonadotropin alone induces spermatogenesis in men with isolated hypogonadotropic hypogonadism\u2014long-term follow-up. Int J Androl 1992; 15: 320\u2013329.", "journal-title": "Int J Androl"}, {"key": "19_CR25", "doi-asserted-by": "publisher", "first-page": "3125", "DOI": "10.1210/jc.87.7.3125", "volume": "87", "author": "PY Liu", "year": "2002", "unstructured": "Liu PY, Wishart SM, Handelsman DJ. A double-blind placebo-controlled, randomized clinical trial of recombinant human chorionic gonadotropin on muscle strength and physical function and activity in older men with partial age-related androgen deficiency. J Clin Endocrinol Metab 2002; 87: 3125\u20133135.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "19_CR26", "first-page": "2607", "volume": "86", "author": "The European Recombinant LH Study Group", "year": "2001", "unstructured": "The European Recombinant LH Study Group. Human recombinant luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures: results of a multicenter double-blind study. J Clin Endocrinol Metab 2001; 86: 2607\u20132618.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "19_CR27", "doi-asserted-by": "publisher", "first-page": "67", "DOI": "10.1016/S0015-0282(01)01851-9", "volume": "76", "author": "P Choung", "year": "2001", "unstructured": "Choung P, Kenley S, Burns T, et al. Recombinant human chorionic gonadotropin (rhCG) in assisted reproductive technology: results of a clinical trial comparing two doses of rhCG (Ovidrel) to urinary hCG (Profasi) for induction of final follicular maturation in in vitro fertilization-embryo transfer. Fertil Steril 2001; 76: 67\u201374.", "journal-title": "Fertil Steril"}, {"key": "19_CR28", "doi-asserted-by": "crossref", "first-page": "343", "DOI": "10.1016/S0015-0282(16)60084-5", "volume": "50", "author": "AS Burris", "year": "1988", "unstructured": "Burris AS, Clark RV, Vantman DJ, Sherins RJ. A low sperm concentration does not preclude fertility in men with isolated hypogonadotropic hypogonadism after gonadotropin therapy. Fertil Steril 1988; 50: 343\u2013347.", "journal-title": "Fertil Steril"}, {"key": "19_CR29", "doi-asserted-by": "publisher", "first-page": "244", "DOI": "10.1016/S0015-0282(98)00450-6", "volume": "71", "author": "R Barrio", "year": "1999", "unstructured": "Barrio R, de Luis D, Alonso M, Lamas A, Moreno JC. Induction of puberty with human chorionic gonadotropin and follicle-stimulating hormone in adolescent males with hypogonadotropic hypogonadism. Fertil Steril 1999; 71: 244\u2013248.", "journal-title": "Fertil Steril"}, {"key": "19_CR30", "doi-asserted-by": "crossref", "first-page": "256", "DOI": "10.1016/S0015-0282(98)00156-3", "volume": "70", "author": "European Metrodin HP Study Group", "year": "1998", "unstructured": "European Metrodin HP Study Group. Efficacy and safety of highly purified urinary follicle-stimulating hormone with human chorionic gonadotropin for treating men with isolated hypogonadotropic hypogonadism. Fertil Steril 1998; 70: 256\u2013262.", "journal-title": "Fertil Steril"}, {"key": "19_CR31", "doi-asserted-by": "publisher", "first-page": "285", "DOI": "10.1111/j.1439-0272.1991.tb02561.x", "volume": "23", "author": "I Mastrogiacomo", "year": "1991", "unstructured": "Mastrogiacomo I, Motta RG, Botteon S, Bonanni G, Schiesaro M. Achievement of spermatogenesis and genital tract maturation in hypogonadotropic subjects during long-term treatment with gonadotropins or LHRH. Andrologia 1991; 23: 285\u2013289.", "journal-title": "Andrologia"}, {"key": "19_CR32", "doi-asserted-by": "publisher", "first-page": "980", "DOI": "10.1093/humrep/12.5.980", "volume": "12", "author": "S Burgu\u00e9s", "year": "1997", "unstructured": "Burgu\u00e9s S, Calder\u00f3n MD, the Spanish Collaborative Group on Male Hypogonadotropic Hypogonadism. Subcutaneous self-administration of highly purified follicle-stimulating hormone and human chorionic gonadotropin for the treatment of male hypogonadotropic hypogonadism. Hum Reprod 1997; 12: 980\u2013986.", "journal-title": "Hum Reprod"}, {"key": "19_CR33", "doi-asserted-by": "publisher", "first-page": "239", "DOI": "10.1093/humrep/15.2.239", "volume": "15", "author": "J Harlin", "year": "2000", "unstructured": "Harlin J, Csemiczky G, Wramsby H, Fried G. Recombinant follicle-stimulating hormone in in-vitro fertilization treatment\u2014clinical experience with follitropin alpha and follitropin beta. Hum Reprod 2000; 15: 239\u2013244.", "journal-title": "Hum Reprod"}, {"key": "19_CR34", "doi-asserted-by": "crossref", "first-page": "604", "DOI": "10.1002/j.1939-4640.2003.tb02712.x", "volume": "24", "author": "P Bouloux", "year": "2003", "unstructured": "Bouloux P, Nieschlag E, Burger HG, et al. Induction of spermatogenesis by recombinant follicle-stimulating hormone (Puregon) in hypogonadotropic azoospermic men who failed to respond to human chorionic gonadotropin alone. J Androl 2003; 24: 604\u2013611.", "journal-title": "J Androl"}, {"key": "19_CR35", "doi-asserted-by": "publisher", "first-page": "1540", "DOI": "10.1093/humrep/14.6.1540", "volume": "14", "author": "PY Liu", "year": "1999", "unstructured": "Liu PY, Turner L, Rushford D, et al. Efficacy and safety of recombinant human follicle-stimulating hormone (Gonal-F) with urinary human chorionic gonadotropin for induction of spermatogenesis and fertility in gonadotropin-deficient men. Hum Reprod 1999; 14: 1540\u20131545.", "journal-title": "Hum Reprod"}, {"key": "19_CR36", "doi-asserted-by": "publisher", "first-page": "270", "DOI": "10.1016/S0015-0282(01)02973-9", "volume": "77", "author": "PG Bouloux", "year": "2002", "unstructured": "Bouloux PMG, Warne DW, Loumaye E. Efficacy and safety of recombinant human follicle-stimulating hormone in men with isolated hypogonadotropic hypogonadism. Fertil Steril 2002; 77: 270\u2013273.", "journal-title": "Fertil Steril"}, {"key": "19_CR37", "unstructured": "O\u2019Dea L, Hemsey G, Brentzel J, Bock D, Matsumoto AM. Long-term treatment with follitropin Alfa (Gonal-F\u00ae) in male hypogonadotropic hypogonadism (HH). Endocrine Society, San Francisco, 2002, (Abstract) pp. 2\u2013661."}, {"key": "19_CR38", "doi-asserted-by": "publisher", "first-page": "1592", "DOI": "10.1093/humrep/16.8.1592", "volume": "16", "author": "P Bouloux", "year": "2001", "unstructured": "Bouloux P, Handelsman DJ, Jockenh\u00f6vel F, et al. FSH-CTP study group. First human exposure to FSH-CTP in hypogonadotropic hypogonadal males. Hum Reprod 2001; 16: 1592\u20131597.", "journal-title": "Hum Reprod"}, {"key": "19_CR39", "doi-asserted-by": "publisher", "first-page": "73", "DOI": "10.1016/S0303-7207(99)00227-0", "volume": "161", "author": "M Zitzmann", "year": "2000", "unstructured": "Zitzmann M, Nieschlag E. Hormone substitution in male hypogonadism. Mol Cell Endocrinol 2000; 161: 73\u201388.", "journal-title": "Mol Cell Endocrinol"}, {"key": "19_CR40", "doi-asserted-by": "publisher", "first-page": "283", "DOI": "10.1210/jcem-64-2-283", "volume": "64", "author": "DI Spratt", "year": "1987", "unstructured": "Spratt DI, Carr DB, Merriam GR, Scully RE, Rao PN, Crowley WF. The spectrum of abnormal patterns of gonadotropin-releasing hormone secretion in men with idiopathic hypogonadotropic hypogonadism: clinical and laboratory correlations. J Clin Endocrinol Metab 1987; 64: 283\u2013291.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "19_CR41", "doi-asserted-by": "publisher", "first-page": "445", "DOI": "10.1016/S0022-3468(74)80003-5", "volume": "9", "author": "W Mengel", "year": "1974", "unstructured": "Mengel W, Hienz HA, Sippe WG, Hecker WC. Studies on cryptorchidism: a comparison of histological findings in the germinative epithelium before and after the second year of life. J Pediatr Surg 1974; 9: 445\u2013450.", "journal-title": "J Pediatr Surg"}, {"key": "19_CR42", "doi-asserted-by": "publisher", "first-page": "152", "DOI": "10.1210/jc.87.1.152", "volume": "87", "author": "N Pitteloud", "year": "2002", "unstructured": "Pitteloud N, Hayes FJ, Boepple PA, et al. The role of prior pubertal development, biochemical markers of testicular maturation, and genetics in elucidating the phenotypic heterogeneity of idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 2002; 87: 152\u2013160.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "19_CR43", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1007/978-3-662-05739-1", "volume-title": "Andrology: Male Reproductive Health and Dysfunction", "author": "E Nieschlag", "year": "2000", "unstructured": "Nieschlag E. Scope and goals of andrology. In: Nieschlag E, Behre HM, eds. Andrology: Male Reproductive Health and Dysfunction, 2nd ed. Springer, Berlin, 2000, pp. 1\u20138.", "edition": "2"}, {"key": "19_CR44", "first-page": "271", "volume-title": "Andrology: Male Reproductive Health and Dysfunction", "author": "UA Knuth", "year": "2000", "unstructured": "Knuth UA, Schneider HPG, Behre HM. Gynecology relevant to andrology. In: Nieschlag E, Behre HM, eds. Andrology: Male Reproductive Health and Dysfunction, 2nd ed. Springer, Berlin, 2000, pp. 271\u2013309.", "edition": "2"}, {"key": "19_CR45", "doi-asserted-by": "crossref", "first-page": "302", "DOI": "10.1016/S0015-0282(16)59720-9", "volume": "49", "author": "L Liu", "year": "1988", "unstructured": "Liu L, Chaudhari N, Corle D, Sherins RJ. Comparison of pulsatile subcutaneous gonadotropin-releasing hormone and exogenous gonadotropins in the treatment of men with isolated hypogonadotropic hypogonadism. Fertil Steril 1988; 49: 302\u2013308.", "journal-title": "Fertil Steril"}, {"key": "19_CR46", "doi-asserted-by": "publisher", "first-page": "857", "DOI": "10.1093/humrep/17.4.857", "volume": "17", "author": "JF Zwartvan Rijkom", "year": "2002", "unstructured": "Zwart-van Rijkom JEF, Broekmans FJ, Leufkens HGM. From hMG through purified urinary FSH preparations to recombinant FSH: a substitution study. Hum Reprod 2002; 17: 857\u2013865.", "journal-title": "Hum Reprod"}, {"key": "19_CR47", "doi-asserted-by": "crossref", "first-page": "1675", "DOI": "10.1093/humrep/17.7.1675", "volume": "17", "author": "Debate group", "year": "2002", "unstructured": "Debate group: \u201cBye-bye urinary gonadotropins?\u201d Matorra R, Rodriguez-Escudero F. \u201cThe use of urinary gonadotropins should be discouraged.\u201d Crosignani PG. \u201cRisk of infection is not the main problem.\u201d Balen A. \u201cIs there a risk of prion disease after the administration of urinary-derived gonadotropins?\u201d Dyer J. \u201cThe conflict between effective and affordable health care\u2014a perspective from the developing world.\u201d Hum Reprod 2002; 17: 1675\u20131683.", "journal-title": "Hum Reprod"}, {"key": "19_CR48", "doi-asserted-by": "crossref", "first-page": "406", "DOI": "10.1016/S0015-0282(16)58108-4", "volume": "65", "author": "B Mannaerts", "year": "1996", "unstructured": "Mannaerts B, Fauser B, Lahlou N, et al. Serum hormone concentrations during treatment with multiple rising doses of recombinant follicle stimulating hormone (Puregon) in men with hypogonadotropic hypogonadism. Fertil Steril 1996; 65: 406\u2013410.", "journal-title": "Fertil Steril"}, {"key": "19_CR49", "doi-asserted-by": "crossref", "first-page": "669", "DOI": "10.1016/S0015-0282(16)56644-8", "volume": "61", "author": "JY Cotonnec", "year": "1994", "unstructured": "Le Cotonnec JY, Porchet HC, Beltrami V, Khan A, toon S, Rowland M. Clinical pharmacology of recombinant human follicle-stimulating hormone (FSH). I. comparative pharmacokinetics with urinary human FSH. Fertil Steril 1994; 61: 669\u2013678.", "journal-title": "Fertil Steril"}, {"key": "19_CR50", "doi-asserted-by": "publisher", "first-page": "138", "DOI": "10.1016/S0015-0282(97)81490-2", "volume": "68", "author": "HJ Out", "year": "1997", "unstructured": "Out HJ, Driessen SGAJ, Mannaerts BMJL, Coelingh Bennink HJT. Recombinant follicle-stimulating hormone (follitropin beta, Puregon) yields higher pregnancy rates in in vitro fertilization than urinary gonadotropins. Fertil Steril 1997; 68: 138\u2013142.", "journal-title": "Fertil Steril"}, {"key": "19_CR51", "doi-asserted-by": "publisher", "first-page": "2207", "DOI": "10.1093/humrep/14.9.2207", "volume": "14", "author": "S Daya", "year": "1999", "unstructured": "Daya S, Gunby J. Recombinant versus urinary follicle-stimulating hormone for ovarian stimulation in assisted reproduction. Hum Reprod 1999; 14: 2207\u20132215.", "journal-title": "Hum Reprod"}, {"key": "19_CR52", "doi-asserted-by": "publisher", "first-page": "338", "DOI": "10.1016/S0015-0282(99)00519-1", "volume": "73", "author": "R Agrawal", "year": "2000", "unstructured": "Agrawal R, Holmes J, Howard SJ. Follicle-stimulating hormone or human menopausal gonadotropin for ovarian stimulation in in vitro fertilization cycles: a meta-analysis. Fertil Steril 2000; 73: 338\u2013343.", "journal-title": "Fertil Steril"}, {"key": "19_CR53", "doi-asserted-by": "publisher", "first-page": "3050", "DOI": "10.1210/endo-124-6-3050", "volume": "124", "author": "Y Arsenijevic", "year": "1989", "unstructured": "Arsenijevic Y, Wehrenberg WB, Conz A, Eshkol A, Sizonenko PC, Aubert NL. Growth hormone (GH) deprivation induced by passive immunization against rat GH-releasing factor delays sexual maturation in the male rat. Endocrinology 1989; 124: 3050\u20133059.", "journal-title": "Endocrinology"}, {"key": "19_CR54", "doi-asserted-by": "publisher", "first-page": "1857", "DOI": "10.1210/endo-128-4-1857", "volume": "128", "author": "PG Chatelain", "year": "1991", "unstructured": "Chatelain PG, Sanchez P, Saez JM. Growth hormone and insulin-like growth factor I treatment increases testicular luteinizing hormone receptor and steroidogenic responsiveness of growth hormone deficient dwarf mice. Endocrinology 1991; 128: 1857\u20131862.", "journal-title": "Endocrinology"}, {"key": "19_CR55", "unstructured": "Syed V, Khan SA, Nieschlag E. Epidermal growth factor stimulates testosterone production on human Leydig cells in vitro. J Endocrinol Invest 199 1; 14: 93\u201397.", "DOI": "10.1007/BF03350275", "doi-asserted-by": "crossref"}, {"key": "19_CR56", "doi-asserted-by": "publisher", "first-page": "266", "DOI": "10.1016/0039-128X(90)90043-B", "volume": "55", "author": "M Bebaker", "year": "1990", "unstructured": "Bebaker M, Honour JW, Foster D, Liu YL, Jacobes HS. Regulation of testicular function by insulin and transforming growth factor-P. Steroids 1990; 55: 266\u2013270.", "journal-title": "Steroids"}, {"key": "19_CR57", "doi-asserted-by": "publisher", "first-page": "463", "DOI": "10.1111/j.1365-2265.1981.tb00689.x", "volume": "15", "author": "HE Kulin", "year": "1981", "unstructured": "Kulin HE, Samojlik E, Santen R, Santner S. The effect of growth hormone on the Leydig cell response to chorionic gonadotropin in boys with hypopituitarism. Clin Endocrinol 1981; 15: 463\u2013472.", "journal-title": "Clin Endocrinol"}, {"key": "19_CR58", "doi-asserted-by": "crossref", "first-page": "1044", "DOI": "10.1016/S0015-0282(16)55023-7", "volume": "57", "author": "Z Shoham", "year": "1992", "unstructured": "Shoham Z, Conway GS, Ostergaard H, Lahlou N, Bouchard P, Jacobs HS. Cotreatment with growth hormone for induction of spermatogenesis in patients with hypogonadotropic hypogonadism. Fertil Steril 1992; 57: 1044\u20131051.", "journal-title": "Fertil Steril"}, {"key": "19_CR59", "doi-asserted-by": "publisher", "first-page": "47", "DOI": "10.1080/014850199262724", "volume": "43", "author": "VA Giagulli", "year": "1999", "unstructured": "Giagulli VA. Absence of effect of recombinant growth hormone to classic gonadotropin treatment on spermatogenesis of patients with severe hypogonadotropic hypogonadism. Arch Androl 1999; 43: 47\u201353.", "journal-title": "Arch Androl"}, {"key": "19_CR60", "doi-asserted-by": "publisher", "first-page": "224", "DOI": "10.1530/eje.0.1400224", "volume": "140", "author": "C Carani", "year": "1999", "unstructured": "Carani C, Granata AR, De Rosa M, et al. The effect of chronic treatment with GH on gonadal function in men with isolated GH deficiency. Eur J Endocrinol 1999; 140: 224\u2013230.", "journal-title": "Eur J Endocrinol"}, {"key": "19_CR61", "doi-asserted-by": "publisher", "first-page": "417", "DOI": "10.1002/ajmg.1320150307", "volume": "15", "author": "BJ White", "year": "1983", "unstructured": "White BJ, Rogol AD, Brown KS, Lieblich JM, Rosen SW. The syndrome of anosmia with hypogonadotropic hypogonadism: a genetic study of 18 new families and a review. Am J Med Genet 1983; 15: 417\u2013435.", "journal-title": "Am J Med Genet"}, {"key": "19_CR62", "doi-asserted-by": "publisher", "first-page": "341", "DOI": "10.1111/j.1365-2265.1990.tb00875.x", "volume": "32", "author": "JS Dean", "year": "1990", "unstructured": "Dean JCS, Johnston AW, Klopper AI. Isolated hypogonadotropic hypogonadism: a family with autosomal dominant inheritance. Clin Endocrinol 1990; 32: 341\u2013347.", "journal-title": "Clin Endocrinol"}, {"key": "19_CR63", "doi-asserted-by": "publisher", "first-page": "202", "DOI": "10.1159/000181003", "volume": "29", "author": "JL Chaussian", "year": "1988", "unstructured": "Chaussian JL, Toublanc JE, Feingold J, Naud C, Vassal J, Job JC. Mode of inheritance in familial cases of primary gonadotropic deficiency. Horm Res 1988; 29: 202\u2013206.", "journal-title": "Horm Res"}, {"key": "19_CR64", "doi-asserted-by": "publisher", "first-page": "529", "DOI": "10.1038/353529a0", "volume": "353", "author": "B Franco", "year": "1991", "unstructured": "Franco B, Guioli S, Pragliola A, et al. A gene deleted in Kallmann\u2019s syndrome shares homology with neural cell adhesion and axonal path-finding molecules. Nature 1991; 353: 529\u2013536.", "journal-title": "Nature"}, {"key": "19_CR65", "doi-asserted-by": "publisher", "first-page": "3811", "DOI": "10.1210/jc.84.10.3811", "volume": "84", "author": "FP Pralong", "year": "1999", "unstructured": "Pralong FP, Gomez F, Castillo E, et al. Complete hypogonadotropic hypogonadism associated with a novel inactivating mutation of the gonadotropin-releasing hormone receptor. J Clin Endocrinol Metab 1999; 84: 3811\u20133816.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "19_CR66", "doi-asserted-by": "publisher", "first-page": "567", "DOI": "10.1210/jc.84.2.567", "volume": "84", "author": "N Roux", "year": "1999", "unstructured": "De Roux N, Young J, Brailly-Tabard S, Misrahi M, Milgrom E, Schaison G. The same molecular defects of the gonadotropin-releasing hormone receptor determine a variable degree of hypogonadism in affected kindred. J Clin Endocrionl Metab 1999; 84: 567\u2013572.", "journal-title": "J Clin Endocrionl Metab"}, {"key": "19_CR67", "doi-asserted-by": "publisher", "first-page": "635", "DOI": "10.1038/372635a0", "volume": "372", "author": "E Zanaria", "year": "1994", "unstructured": "Zanaria E, Muscatelli F, Bardoni B, et al. An unusual member of the nuclear hormone receptor super-family responsible for X-linked adrenal hypoplasia congenita. Nature 1994; 372: 635\u2013641.", "journal-title": "Nature"}, {"key": "19_CR68", "doi-asserted-by": "publisher", "first-page": "1055", "DOI": "10.1172/JCI118866", "volume": "98", "author": "RL Habiby", "year": "1996", "unstructured": "Habiby RL, Boepple P, Nachtigall L, Sluss PM, Crowley WF, Jameson JL. Adrenal hypoplasia congenita with hypogonadotropic hypogonadism: evidence that the DAX-1 mutations lead to combined hypothalamic and pituitary defects in gonadotropin production. J Clin Invest 1996; 98: 1055\u20131062.", "journal-title": "J Clin Invest"}, {"key": "19_CR69", "doi-asserted-by": "publisher", "first-page": "147", "DOI": "10.1038/ng0298-147", "volume": "18", "author": "W Wu", "year": "1998", "unstructured": "Wu W, Cogan JD, Pfaeffle RW, et al. Mutations in PROP 1 cause familial combined pituitary hormone deficiency. Nat Genet 1998; 18: 147\u2013149.", "journal-title": "Nat Genet"}, {"key": "19_CR70", "doi-asserted-by": "publisher", "first-page": "315", "DOI": "10.1002/ajmg.10295", "volume": "108", "author": "S Vermeulen", "year": "2002", "unstructured": "Vermeulen S, Messiaen L, Scheir P, De Bie S, Speleman F, De Paepe A. Kallmann syndrome in a patient with congenital spherocytosis and an interstitial 8p11.2 deletion. Am J Med Genet 2002; 108: 315\u2013318.", "journal-title": "Am J Med Genet"}, {"key": "19_CR71", "doi-asserted-by": "publisher", "first-page": "182", "DOI": "10.1038/76041", "volume": "25", "author": "I Netchine", "year": "2000", "unstructured": "Netchine I, Sobrier ML, Krude H, et al. Mutations in LHX 3 result in a new syndrome revealed by combined pituitary hormone deficiency. Nat Genet 2000; 25: 182\u2013186.", "journal-title": "Nat Genet"}, {"key": "19_CR72", "doi-asserted-by": "publisher", "first-page": "125", "DOI": "10.1038/477", "volume": "19", "author": "MT Dattani", "year": "1998", "unstructured": "Dattani MT, Martinez-Barbera JP, Thomas PQ, et al. Mutations in the homebox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nat Genet 1998; 19: 125\u2013133.", "journal-title": "Nat Genet"}, {"key": "19_CR73", "doi-asserted-by": "publisher", "first-page": "213", "DOI": "10.1038/ng0398-213", "volume": "18", "author": "A Strobel", "year": "1998", "unstructured": "Strobel A, Issad T, Camoin L, Ozata M, Strosberg AD. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet 1998; 18: 213\u2013215.", "journal-title": "Nat Genet"}, {"key": "19_CR74", "doi-asserted-by": "publisher", "first-page": "398", "DOI": "10.1038/32911", "volume": "392", "author": "K Cl\u00e9ment", "year": "1998", "unstructured": "Cl\u00e9ment K, Vaisse C, Lahlou N, et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998; 392: 398\u2013401.", "journal-title": "Nature"}, {"key": "19_CR75", "doi-asserted-by": "publisher", "first-page": "303", "DOI": "10.1038/ng0797-303", "volume": "16", "author": "RS Jackson", "year": "1997", "unstructured": "Jackson RS, Creemers JW, Ohagi S, et al. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat Genet 1997; 16: 303\u2013306.", "journal-title": "Nat Genet"}, {"key": "19_CR76", "doi-asserted-by": "publisher", "first-page": "163", "DOI": "10.1046/j.1365-2265.2001.01277.x", "volume": "55", "author": "R Quinton", "year": "2001", "unstructured": "Quinton R, Duke VM, Robertson A, et al. Idiopathic gonadotropin deficiency: genetic questions addressed through phenotypic characterization. Clin Endocrinol 2001; 55: 163\u2013174.", "journal-title": "Clin Endocrinol"}, {"key": "19_CR77", "doi-asserted-by": "publisher", "first-page": "213", "DOI": "10.1210/jc.82.1.213", "volume": "82", "author": "NA Georgopoulos", "year": "1997", "unstructured": "Georgopoulos NA, Pralong FP, Seidman CE, Seidman JG, Crowley WF, Vallejo M. Genetic heterogeneity evidenced by low incidence of KAL-1 gene mutations in sporadic cases of gonadotropinreleasing hormone deficiency. J Clin Endocrinol Metab 1997; 82: 213\u2013217.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "19_CR78", "doi-asserted-by": "crossref", "first-page": "1216", "DOI": "10.1001/archpedi.1977.02120240034007", "volume": "131", "author": "GR Merriam", "year": "1977", "unstructured": "Merriam GR, Beitins IZ, Bode HH. Father-to-son transmission of hypogonadism with anosmia: Kallmann\u2019s syndrome. Am J Dis Child 1977; 131: 1216\u20131219.", "journal-title": "Am J Dis Child"}], "container-title": ["Male Hypogonadism"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-1-59259-727-7_19", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 14]], "date-time": "2019-05-14T04:58:50Z", "timestamp": 1557809930000}, "score": 33.717854, "issued": {"date-parts": [[2004]]}, "ISBN": ["9781607617396", "9781592597277"], "references-count": 78, "URL": "http://dx.doi.org/10.1007/978-1-59259-727-7_19", "relation": {"cites": []}}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}